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Abstract  
Clostridium difficile is the most common bacterial cause of infectious diarrhoea in 
healthcare environments and in 2014 was responsible for 13,785 infections in the UK. 
C. difficile infection (CDI) is spread via the faecal-oral route and by contact with 
contaminated surfaces. However, despite the healthcare concerns no tests are 
available to validate if sufficient cleaning has been conducted. In addition, Polymerase 
Chain Reaction (PCR) and Enzyme Immunoassays (EIAs)-based tests used to diagnose 
CDI lack sensitivity and specificity and hence false negative results are commonly 
obtained. To overcome these concerns the aim of the PhD research has been to 
develop the first diagnostic test that exploits the specific interactions of C. difficile 
bacteriophages (phages), viruses that specifically infect and kill C. difficile. In order to 
develop a C. difficile phage-based test, first suitable phages that can be used for the 
test were identified and this was conducted by screening 35 different C. difficile 
phages against 160 clinically relevant C. difficile isolates. Five phages were found to 
infect the most number of isolates and were investigated further to identify whether a 
phage-based diagnostic could be developed based on phages binding (adsorption) to 
different C. difficile subgroups. However, for all five phages, adsorption rates were not 
consistently high for C. difficile subgroups in comparison to other common bacteria 
found in similar locations to C. difficile. Therefore, to increase specificity of the phage-
based diagnostic test a new approach was taken by tagging two phages with 
luminescence luxAB genes (reporter phages), which would be expressed once 
C. difficile cells were infected with the phages. To design the C. difficile reporter 
phages, non-essential phage genes were replaced with the luxAB genes, but this study 
revealed mutagenesis of C. difficile was troublesome and extensive optimisation was 
required. In addition, once the reporter phages had successfully been constructed the 
luxAB genes were unstable within the phage genome and were lost during phage 
replication. Despite extensive optimisation and due to time constrains the luxAB genes 
were not stabilised within the phages but future work will focus on stabilising the 
genes. 
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1.1 Background 
Clostridium difficile is a major health concern for the NHS and 13,785 patients in 2014 
were infected with the bacterium (Public Health England, 2014). Although, overall the 
number of recorded C. difficile infections (CDI) has reduced over the past ten years, it 
still represents a significant financial burden. This is because a single CDI case costs the 
NHS £7,000 (Public Health England 2012) and annual costs in Europe are over 
€3,000 million (Bouza 2012). The significant high costs are due to antibiotic 
treatments, extended bed stay, as relapse is common with previously infected 
patients, and for the maintenance of hygienic environments within wards by 
decontamination procedures. The latter is vital as C. difficile is a spore-forming 
organism and the spores are hardy, thick-walled resting cells produced by the 
bacterium to protect against unfavourable conditions. C. difficile spores are able to 
survive on surfaces, such as bed rails, hospital equipment, and on floors for over six 
months (Biswas et al. 2015; Cheng et al. 2015). Unfortunately, spores are resistant to 
alcohol hand rubs commonly used in hospitals and some disinfectants. Therefore, CDI 
is spread in the form of spores from patient-to-patient within healthcare 
environments via the faecal-oral route and by contact with contaminated hands of 
patients and healthcare workers (Ananthakrishnan 2011). 
Consequently, it is of vital importance to maintain clean hospital environments to 
prevent spread of C. difficile, which also helps to limit patients relapsing and from the 
occurrence of new infections. Although, current chlorine-based disinfectants and 
highly concentrated vaporised hydrogen peroxide have shown some success, other 
disinfectants such as ammonium-based preparations are not so effective (Speight et 
al. 2011; Vohra and Poxton 2011). Despite the concerns of C. difficile being spread in 
the environment, there are currently no tests available to validate if C. difficile has 
been eliminated from healthcare environments. Culture-based methods can 
potentially be used but the method is slow and would take up to five days (Schmelcher 
and Loessner 2014). Instead, the development of a test where results can be obtained 
within the same working day would be ideal. In addition, using Polymerase Chain 
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Reaction (PCR) based tests would be difficult as it would be hard to extract DNA from 
spores, the number of C. difficile would be low and may not be detected via PCR.  
Aside from the maintenance of hygienic hospital environments, another significant 
issue is diagnosis of C. difficile itself from patients. Current patient diagnostic tests lack 
specificity and sensitivity; which has led to missed diagnosis and false positives. This is 
the main reason why the Department of Health issued an official two-step algorithm, 
i.e. two different diagnostic tests used in combination to confirm CDI (Department of 
Health 2012). Although, even with multiple tests missed diagnosis remains a problem 
and reagents used for the tests are expensive (Barbut et al. 2014). New diagnostic 
tests are urgently required for this purpose, which are both highly sensitive and 
specific.  
Therefore, both a specific test to validate sufficient cleaning and to diagnose CDI 
from patients is needed. The development of a bacteriophage (phage)-based 
diagnostic test could provide a solution to both. Phages are viruses that are able to 
infect and kill only bacteria, they are specific to bacterial species and often can only 
infect sub-groups within species (Nobrega et al. 2015). In addition, phages infect 
bacteria in a very specific manner by first attachment of phages to bacterial cells, 
injection of phage DNA within cells, replication and then release of new phages, after 
which the replication cycle is repeated (Hyman and Abedon 2009). Any stage of the 
infection cycle can be used as a marker for bacterial identification. For example, by 
detection of the step where phages adsorb to bacterial cells or by the addition of a tag 
within the phage genome (referred to as reporter phages) to identify when phage DNA 
has been injected within target bacterial cells. For both examples, a measureable 
signal is produced and if the target bacterium is present the signal is significantly 
amplified (Schofield et al. 2015).  
Phage-based diagnostic tests have been developed to detect pathogens such as 
Yersinia pestis, Escherichia coli, Salmonella and Bacillus anthracis (Kim et al. 2014; 
Schofield et al. 2009; Schofield and Westwater 2009). The assays are very sensitive and 
are able to detect as few as ten bacterial cells within 24 hours from blood, food and 
sputum samples. Furthermore, the tests allow detection of the target bacterium 
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despite an abundance of bacterial diversity within the samples (Schmelcher and 
Loessner 2014; Schofield et al. 2012; Smartt and Ripp 2011). The numerous benefits 
highlight how the development of a phage-based diagnostic test would be 
advantageous to prevent spread of CDI within healthcare environments and to limit 
missed diagnosis. 
1.2   Research aims  
The overall aim of the PhD research was to develop a phage-based diagnostic test for 
detection of C. difficile. The test can be used to diagnose CDI from patients as current 
tests lack specificity and sensitivity. In addition, the phage-based test can be used to 
validate if sufficient cleaning has been conducted in healthcare environments to 
remove C. difficile from the environment. This would help to minimise the spread and 
occurrence of new CDIs. 
For the development of the C. difficile phage-based diagnostic test the specific 
research aims were: 
i. Isolation of new C. difficile phages from the environment followed by 
characterisation to identify their structure, genome sizes and their infection 
cycles. 
ii. Identification of which C. difficile subgroups the new phages, and those present 
in a catalogue of previously isolated phages in Professor Martha Clokie’s 
laboratory (University of Leicester, UK) are able to infect. Those that are able to 
infect numerous ribotypes can be used for the development of the phage-
based diagnostic test.   
iii. Establishment of a method based on chromatography to rapidly purify 
C. difficile phages, as purified phage will be required for the phage-based 
detection assay. 
iv. Investigation of the adsorption efficiencies of C. difficile phages that are able to 
infect multiple common ribotypes found within the UK. This is to identify 
whether phage adsorption can be used as a marker for bacterial detection.  
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v. The development of a phage-based diagnostic test by designing reporter 
phages using broad host range C. difficile phages as templates. Construction of 
the reporter phages will be carried out with the use of molecular methods and 
clonal reporter phage stock will be produced, which can then be used for 
detection of C. difficile.  
1.3   Structure of thesis  
Below is a brief summary of each chapter: 
Chapter 1: Introduction  
• The subject of the thesis is introduced. 
• The key aims of the PhD research are outlined. 
Chapter 2: Literature review 
• The chapter reviews published literature to provide a detailed background in 
context to the research conducted. 
• The topics covered are: 
o General knowledge on C. difficile: CDI infection, prevalence, 
epidemiology, cost of infection, antibiotic treatment, how CDI can be 
spread by patient-to-patient, hospital decontamination procedures, 
common techniques used to subgroup C. difficile and diagnosis 
methods.  
o Genetics tools that are widely used to genetically manipulate 
Clostridium species.  
o General contextualisation of phages with regards to their infection 
cycles and classification. 
o C. difficile phage biology. 
o The approaches used to develop phage-based diagnostic tests. 
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Chapter 3: Isolation and characterisation of C. difficile phages for the development of 
a phage-based diagnostic test 
• The aim of this chapter is to identify suitable phages, which can be used for the 
development of a phage-based diagnostic test and to investigate if 
chromatography can be used to purify phages. 
• Suitable phages were identified by: 
o Isolation of new phages by screening water samples from the River 
Tame, Birmingham, UK. 
o Structure, genome size and burst sizes were investigated for the new 
phages.  
o New phages and previously isolated phages were screened against 29 
different C. difficile sub-groups to identify which they were able to 
infect. 
Chapter 4: Investigation of adsorption rates of five broad host range C. difficile 
phages to determine if a phage adsorption-based detection test could be developed 
• The aim of this chapter is to explore whether phage adsorption can be used as 
marker for C. difficile detection for the development of the diagnostic test. 
• This was conducted by: 
o Examination of phage adsorption efficiencies of five broad-host range 
phages identified in Chapter 3 to clinically relevant ribotypes.  
o Factors that can potentially influence phage adsorption were tested and 
discussed. 
Chapter 5: Construction of reporter phages for identification of C. difficile  
• An alternative method was devised to develop the phage-based diagnostic test 
and the aim of this chapter is to begin construction of reporter phages. 
• Reporter constructs with the luxAB reporter genes were designed to replace 
predicted ‘unessential’ genes from two broad host range C. difficile phages. 
o The constructs were developed in a general cloning plasmid and in 
Clostridium-E. coli shuttle plasmids by the use of molecular techniques. 
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Chapter 6: Transfer of reporter constructs from E. coli to C. difficile phages for the 
development of the reporter phage diagnostic test 
• The aim of this chapter is to transfer the reporter constructs developed in 
Chapter 5 to their target C. difficile phage via the method conjugation. 
• To achieve this, the conjugation process was optimised and a number of 
parameters were investigated.   
• An effective protocol for conjugation was established, and phages with the 
reporter genes were purified to establish a clonal reporter phage stock. 
Chapter 7: Conclusions and future work 
• The chapter discusses the main conclusions that rose from the research within 
this thesis. 
• Brief outlines are included of proposals for future work.  
Chapter 8: Appendix  
• List of media, buffers and PCR primers used in this study. 
• Host ranges of C. difficile phages. 
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2.1   Clostridium difficile and C. difficile infection 
The obligate anaerobic, Gram-positive, spore-forming bacillus, Clostridium difficile was 
first identified in neonates as a constituent of normal intestinal flora in 1935 by Hall 
and O’Toole (Ananthakrishnan 2011). However, in 1978 C. difficile was first recognised 
as a cause of pseudomembranous colitis (Bartlett et al. 1978). Since then the entero-
pathogen has become one of the leading causes of infectious diarrhoea, accountable 
for 15 to 25% of all cases and is also referred to in the literature as C. difficile-
Associated Diarrhoea (CDAD) and toxin-mediated diarrhoea. Other clinical features of 
this infection seen after 24 to 72 hours include fever, abdominal pain and leukocytosis 
(Ramesh et al. 1999).  
CDI can be spread from person-to-person by the faecal-oral route. In addition, CDI 
can also be acquired from spores produced by the bacterium. These spores are present 
in the environment and can remain viable on inanimate surfaces for up to five months 
(Ananthakrishnan 2011). The C. difficile spores are difficult to remove from healthcare 
environments and in addition, alcohol hand rubs commonly used in hospitals are 
unsuccessful at killing spores. Therefore CDI can develop in patients after 
hospitalisation as once C. difficile spores are ingested they are able to germinate into 
vegetative cells, thus cause infection (Meader et al. 2010). 
In particular, patients at high risk of CDI are hospitalised patients above 65 years of 
age who have been recently exposed to antibiotic treatments. This is because CDI is 
universally recognised as being associated with antibiotics, as over-exposure to broad-
spectrum antibiotics depletes the protective gut flora and diminishes the expected 
immune response to CDI (Burke and Lamont 2014). This allows colonisation of the 
opportunist C. difficile within the gastrointestinal tract leading to CDI and CDAD. 
Consequently, C. difficile is responsible for 30% of antibiotic-associated diarrhoea cases 
but under normal healthy conditions, the guts natural microbiota acts as a barrier 
against colonisation of C. difficile (Lyerly et al. 1988). However the epidemiology of CDI 
is changing and populations previously not considered to be at risk have become 
infected with CDI. This includes individuals with no recent healthcare contact, patients 
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with inflammatory bowel disease, children and pregnant women (Ananthakrishnan 
2011).  
2.1.2   Pathogenesis   
C. difficile is able to colonise the large intestine of humans as well as domestic and wild 
animals. Colonisation occurs by both toxigenic and non-toxigenic strains of C. difficile 
but only toxigenic, pathogenic strains can cause disease in humans (Burke and Lamont 
2014). The pathogenic strains secrete two toxins: toxin A (TcdA) and toxin B (TcdB), 
which are encoded within a 19.6 kilo-base (kb) pathogenicity locus. The toxins are large 
proteins that consist of four domains. Three domains: the binding, translocation, and 
cysteine protease domains act together to deliver the fourth domain, the 
glucosyltransferase domain, directly into the cytosol of intestinal epithelium cells. This 
leads to disruption of the actin cytoskeleton that causes cell death, triggers the 
inflammatory cascade exacerbating tissue damage, pseudomembranous colitis and 
diarrhoea (Ivarsson et al. 2014; Ananthakrishnan 2011). However, expression of the 
toxin genes is controlled: TcdR is the positive regulator and TcdC is the negative 
regulator. Deletion in the tcdC gene commonly occurs in nucleotide 117 and causes 
truncation of TcdC. This may cause higher production of toxins, increased disease 
severity and isolates which have these deletions are referred to as ‘hypervirulent’ 
strains (Sirard et al. 2011).  
A third toxin, the binary toxin, was identified in 1987 and is produced by some but 
not all C. difficile isolates and was previously infrequently found as a cause of CDI. 
However, prevalence of isolates with the binary toxin has increased over the last ten 
years and has prompted research into characterisation of the toxin. Studies have 
shown the binary toxin consists of two proteins: CdtA and CdtB that are coded on the 
transferase locus, distinctly different from the pathogenicity locus of toxin A and 
toxin B (Gerding et al. 2014). It is thought the presence of the binary toxin leads to 
C. difficile strains that may produce a significantly greater amount of both toxin A and 
toxin B that causes severe disease (Mcellistrem et al. 2005; Mcdonald et al. 2005). 
Although, the exact association of binary toxin and disease severity in unknown 
(Ananthakrishnan 2011). 
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2.1.3   C. difficile biogeography  
C. difficile is widely distributed in healthcare environments but is also abundant in the 
general environment and consequently the population at large is generally exposed to 
the bacterium. This was evident in the large study conducted by Saif and Brazier (1996) 
in South Wales. They found the organism to be highly prevalent in open freshwaters, 
which includes lakes, rivers, seas, drainage channels, swimming pools and main taps. 
However, this study pre-dates molecular characterisation and the strains of C. difficile 
present in the environment were not identified or sub-grouped. The study also found 
C. difficile to be present in soils, raw vegetables and in faeces of farmyard animals. In 
addition to C. difficile being present in the environment, it also exists as an enteric 
pathogen in numerous animal species: horses, pigs, hare, cats, dogs, poultry and swine 
(Dubberke et al. 2011).  
2.1.4   Prevalence of CDI 
C. difficile has emerged as a troublesome pathogen over the last few decades in 
healthcare settings globally, especially across Europe, Australia, Canada and the USA 
(Kuijper et al. 2008; Wiegand et al. 2012). Annually in the USA 250,000 cases of CDI are 
reported with 14,000 associated deaths (Centres for Disease Control and Prevention 
2013; Lessa et al. 2015). From the total number of CDI cases approximately 11 to 28% 
are community associated, which has also been observed in most countries, including 
the UK (Ananthakrishnan 2011; Bauer et al. 2011).  
Since April 2007, all acute National Health Service (NHS) trusts in England and 
Wales have been legally made to report all incidences of CDI in patients aged two 
years and over. Every three months this data is collected by Public Health England 
(PHE), which enables surveillance of the infection and allows epidemiology to be 
studied. Monthly, quarterly and annual reports on incidences of CDI are published by 
PHE and can be accessed by the general public (https://www.gov.uk/government-
/collections/clostridiumdifficile-guidance-data-and-analysis#epidemiology) (Dubberke 
et al. 2015). The number of CDI cases reported by the NHS trusts between 2004 and 
2014 is shown in Figure 2.1. Between the years the highest number of CDI incidences 
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was observed in 2006 at 55,635. However, overall there has been a steady decline in 
the number of reported CDI cases in the UK from 44,563 in 2004 to 13,785 in 2014 
(NHS 2014; Department of Health 2014). 
The reduction in CDI cases is likely due to improvements in infection control 
protocols and increased awareness of CDI in healthcare environments (Health 
Protection Agency 2010). An enormous effort has been placed on CDI management 
strategies, which includes: antibiotic stewardship, mandatory reporting as discussed in 
this section and financial penalties of C. difficile outbreaks within hospitals (Hargreaves 
and Clokie 2014; Wilcox 2011). Also, variations in laboratory C. difficile diagnosis 
methods could have contributed to the observed decline (discussed in Section 2.2) 
(Goldenberg and French 2011; Wilcox and Smyth 1998).  
Another reason to explain the reduction of CDI incidences could be due to under-
reporting of C. difficile-associated deaths and infections. This was evident in a large-
scale study conducted by Davies et al. (2014) across 428 hospitals in 20 different 
European countries, including the UK. In the study, stool samples were collected from 
hospitals over four months between 2012 and 2013. Standardising laboratory tests 
were performed to screen for CDI (Section 2.4) and overall the study revealed 23% of 
cases were un-diagnosed and missed, which is likely due to inadequate laboratory 
diagnosis within hospitals (Figure 2.2). A similar under-diagnosis rate was found by 
Alcalá et al. (2012) across 122 Spanish microbiology laboratories. 
2.1.5   Financial costs of CDI 
The financial healthcare costs associated with treatment and management of 
C. difficile are vast, such that costs linked with hospitalised CDI patients are 33 to 54% 
greater in comparison to an un-infected patients (Noren 2010). In the UK, treatment of 
a single CDI case costs approximately £7,000 (Public Health England 2012) and the 
annual cost in Europe is €3000 million. In the USA the cost per infected patient is 
$12,825 and annually costs $800 million (Bouza 2012; Ananthakrishnan 2011). The high 
costs are due to CDI patients spending on average an extra one to three weeks in 
hospital in comparison to non-infected CDI patients. Other major contributors include: 
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constant maintenance of high levels of hygiene for patient care, daily environmental 
decontamination to prevent spread of CDI across the hospital and ward closures. 
Additionally, recurrent CDI infections are common and total costs linked to treatment 
are approximately three-fold higher in comparison to the primary episode of CDI 
(Bouza 2012). 
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Figure 2.1 Annual C. difficile cases in patients aged two years and over in England and 
Wales NHS trusts from 2004 to 2014. 
Data was obtained from Public Health England (https://www.gov.uk/government-
/collections/clostridium-difficile-guidance-data-and-analysis).  
 
 
Figure 2.2 Percentage of undiagnosed CDI cases from faecal samples submitted at 
participating hospitals across Europe. 
Data was obtained from Davies et al. (2014). 
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2.1.6   Antibiotic treatment of C. difficile  
Historically, antibiotic-associated pseudomembranous colitis CDI has been linked with 
the antibiotic clindamycin and more recently with fluoroquinolones: moxifloxacin and 
gatifloxacin. Often termination of the antimicrobial resulting in CDI leads to the 
resolution of the infection (Burnham and Carroll 2013). Though, if this is not successful, 
standard antibiotic treatment for over 30 years has consisted of either administration 
of vancomycin or oral metronidazole (Noren 2010). However, a recent systematic 
review by Vardakas et al. (2012) found that treatment failure with metronidazole was 
22.4% and with vancomycin 14.2%. Due to the high rates of treatment failure CDI can 
remerge and 27.1% reoccurrence of CDI was found with metronidazole and lower 
levels at 24% was observed for vancomycin.  
However, the new antibiotic Fidaxomicin (Optimer Pharmaceuticals, USA), 
approved in 2011 by the US Food and Administration (FDA) for treatment of CDI has 
significantly lowed levels of reoccurrence at 13.3% observed during clinical trials. 
Despite the clinically proven advantages of fidaxomicin, its use has been limited due to 
increased costs in comparison to metronidazole and vancomycin. It has been estimated 
a typical 10-day regime of metronidazole, vancomycin and fidaxomicin costs (in US 
dollars) approximately $22, $680 and $2800, respectively. Vancomycin is 
approximately thirty times as costly as metronidazole, therefore, metronidazole is the 
recommended antibiotic for mild infections and only if unsuccessful vancomycin is 
administered (Ivarsson et al. 2014). This is because it is of great concern the emergence 
of vancomycin-resistant C. difficile and vancomycin-resistant enterococci due to the 
antibiotic being able to kill most intestinal microflora. This would allow a population of 
established vancomycin-resistant enterococci to emerge (Ananthakrishnan 2011) and 
justifies why vancomycin is only administered to severe patients (Ramesh et al. 1999).   
2.2   Genetic tools developed for C. difficile 
Previously, understanding and exploiting C. difficile genomes has been hindered by the 
lack of mutagenesis tools available. However, Professor Minton’s research group 
(Clostridia Research Group, University of Nottingham, UK) successfully tackled this 
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issue in 2007 by the development of the ClosTron system (Heap et al. 2010; Heap et al. 
2007) and in 2009 they constructed a range of modular shuttle plasmids for 
Clostridium, which were used in the present study (Heap et al. 2009). Plasmids are 
small circular DNA molecule, which can replicate independently and they allow stable 
mutants to be produced, which has aided in revolutionised genomic studies within 
Clostridia species.  
Bacterial mutants, i.e. gene knock out, addition of genes or disruption of resident 
genes within the genome are produced with the procedure called cloning. Cloning is 
defined as a DNA sequence, for example a known gene, being transferred from one 
organism to another with plasmids via genetic engineering techniques. The four key 
cloning steps are (Sambrook and MacCallum 2000): 
1. PCR amplification of the DNA sequence that will be cloned. 
2. Ligation, which is the transfer of DNA sequence being cloned to a plasmid. 
3. Transformation that is the process of inserting the plasmid and newly cloned 
gene to E. coli cells.  
4. Screen and selection of cells that have been successfully transfected with the 
plasmid and the cloned gene. 
2.2.1   The ClosTron system  
The ClosTron system allows for directed mutagenesis within Clostridia by utilisation of 
bacterial broad host range elements group II introns. They are widespread among 
prokaryotic genomes and located within protein encoding and RNA genes. Group II 
introns are catalytic RNAs that are able to excise themselves from RNA transcripts and 
then can insert themselves to a new target site. The group II introns carry an Open 
Reading Frame (ORF) with a multifunctional Intron Encoded Protein (IEP) and by the 
action of IEP the introns can self-catalytically splice out the targeted RNA sequence of 
the host gene. The IEP then synthesises the corresponding complementary DNA strand 
via activity of reverse transcriptase. The group II introns can propagate within their 
directed target site through a mechanism called RNA-mediated ‘retrohoming’, which 
allows the targeted site of recognition which is attained by base-pairing between the 
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intron RNA and the targeted DNA site. Therefore, the target specificity of the intron 
can be re-programmed by the change of the DNA sequence that encodes the suitable 
section of the intron (Heap et al. 2010).  
The frequencies of intron integration vary greatly among target DNA sites, which 
make the screening of mutants laborious. The addition of a phenotypic screen, for 
example an antibiotic gene can make screening more efficient. Consequently, the 
ClosTron system has incorporated the ermB gene that encodes for the erythromycin 
resistance antibiotic gene within the coding region of the group II intron element: 
Ll.LtrB intron. This intron is derived from Lactococcus lactis and has been placed on the 
plasmid annotated as pMTL007 (Kuehne and Minton 2012).  
The pMTL007 ClosTron system has been successfully used to mutate numerous 
genes of C. difficile. For example, two C. difficile genes were mutated: pyrF causing 
uracil auxotrophy and spoOA to disrupt spore formation. High levels of frequency 
integration was noted for C. difficile and mutants were produced within ten days 
(Heap et al. 2007). The system is helping to provide fundamental information on the 
roles of virulence factors, such as flagella, toxins and adhesins to help overcome the 
problem of CDI (Kuehne and Minton 2012). 
2.2.2   Clostridium-E. coli shuttle plasmids  
In addition to the Clostron system, Heap et al. (2009) constructed nine recombinant 
and replicative modular Clostridium-E. coli shuttle plasmids called the pMTL80000 
range. The plasmids can replicate in both Gram-positive and Gram-negative bacteria. 
The main advantage of these plasmids is that they can be initially manipulated in 
E. coli, i.e. genes of interests are cloned in the fast growing and easy to handle E. coli 
cells before being transferred to Clostridium, which is slower growing, anaerobic and 
harder to manipulate. The transfer from E. coli to C. difficile occurs via the process 
conjugation (Purdy et al. 2002), which is the transfer of genetic material by direct cell-
to-cell contact between bacterial cells (Sambrook and MacCallum 2000).  
Each Clostridium-E. coli shuttle plasmid consists of four modules:  
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1. A Gram-negative replicon that allows for replication in E. coli.  
2. An antibiotic marker to screen for mutants.  
3. A Gram-positive replicon that allows for replication in Clostridium.  
4. A Multiple Cloning Site (MCS), which enables cloning of the gene of interest 
with/or a conjugal transfer function.  
There are variations in all modules (Table 2.1 and Table 2.2) but each module is 
flanked by identical restriction sites (four to eight base DNA sequences that are 
recognised and cleaved by restriction endonucleases). The addition of restriction sites 
further allows the user to build their own plasmid with the specific modules they 
require.  
The modular plasmids have been successfully used to identify virulence factors of 
C. difficile. For example Martin et al. (2013) investigated the role of the transcriptional 
regulator agrA gene by point mutation of the gene with the plasmid pMTL84151. They 
found mutants poorly flagellated and there were reduced levels of colonisation hence 
the gene plays a role in C. difficile virulence. Similarly, Aubry et al. (2012) used plasmid 
pMTL84151 to investigate whether toxin production is changed in C. difficile cells, 
which are unable to form flagella filaments. By using the plasmid they inactivated six 
flagellar genes and the study found toxin production was altered in cells that could not 
form flagellar filaments.    
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Table 2.1 The four modules of the pMTL80000-series plasmids (Heap et al. 2009).  
Module  Module between 
restriction sites  
Variety within 
the module  
Comments  
Gram positive 
replicon 
AscI and FseI pBP1 Derived from C. botulinum NCTC 2916. 
pCB102 Derived from C. butyricum. 
pCD6 Derived from C. difficile. 
pIM13 Derived from Bacillus subtilis. 
Antibiotic 
marker 
FseI and PmeI catP Chloramphenicol resistance gene. 
ermB Erythromycin resistance gene. 
aad9 Spectinomycin adenytransferase gene. 
tetA Tetracycline resistance gene. 
Gram 
negative 
replicon 
PmeI and SbfI P15a Low copy number replicon that allows 
cloning of expression constructs that 
would be toxic or could place a 
metabolic burden on cells if a high 
copy number plasmid was used. 
P15a + tra Low copy number replicon plus 
transfer gene. 
ColE1 High-copy number replicon that would 
suit the cloning of most genes.  
ColE1 + tra High-copy number replicon plus 
transfer gene. 
Application 
specific 
SbfI and AscI MCS MCS from plasmid pMTL120 
(Chambers et al. 1988). 
Pf dx + MCS MCS with the promoter ferredoxin 
(f dx) gene, for gene expression. 
Pthl + MCS MCS with the promoter thiolase gene 
(thl), for gene expression. 
catP reporter catP the chloramphenicol gene plus 
promoter and terminator sequences. 
 
 
Table 2.2 Summary of all pMTL80000-series plasmids available (adapted from (Heap et 
al. 2009)). 
Plasmid  Gram positive 
replicon 
Antibiotic marker Gram negative 
replicon 
Application-
specific 
pMTL80110 Spacer Chloramphenicol  P15a Spacer  
pMTL82254 pBP1 Erythromycin  ColE1 + tra catP reporter  
pMTL83353 pCB102 Spectinomycin  ColE1 + tra Pf dx + MCS 
pMTL84422 pCD6 Tetracycline  P15a + tra Pthl + MCS 
pMTL85141 pIM13 Chloramphenicol ColE1 MCS 
pMTL82151 pBP1 Chloramphenicol ColE1 + tra MCS 
pMTL83151 pCB102 Chloramphenicol ColE1 + tra MCS 
pMTL84151 pCD6 Chloramphenicol ColE1 + tra MCS 
pMTL85151 pIM13 Chloramphenicol ColE1 + tra MCS 
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2.3   Differentiation between C. difficile strains  
In order to diagnose C. difficile you need to know you can diagnose all its related 
subgroups. Consequently there has been renewed interest into its molecular 
epidemiology and genetic content (Roberts and Mullany 2010). Various genotyping 
molecular methods have been used to discriminate between subgroups of C. difficile as 
it is important to distinguish which groups are the most prominent. The methods used 
are: Polymerase Chain Reaction (PCR) Ribotyping, Pulse-Field Gel Electrophoresis 
(PFGE), Restriction Endonuclease Analysis (REA), and Multi-Locus Variable-Number 
Tandem-Repeat Analysis (MLVA). The latter method is highly discriminative with the 
potential to provide insights into relationships between CDI cases and method of 
C. difficile transmission (Burns et al. 2010). However, the technique most commonly 
used in Europe is PCR ribotyping (Goldenberg and French 2011). 
2.3.1   PCR Ribotyping  
PCR ribotyping is characterised by the amplification of 16S to 23S intergenic spacer 
regions within the rRNA operon. The operon contains multiple copies of the region 
within the C. difficile genome with variations in genomic sizes. One primer set is used 
for PCR, which results in a pattern of bands between 238 to 566 bp and can be 
visualised on an agarose gel (Sadeghifard et al. 2006). PCR ribotyping can successfully 
discriminate between subgroups and those with similar banding patterns are classed as 
the same ribotype. However, it is difficult to compare results between laboratories 
without using analysis software’s and consequently, the PCR ribotyping method was 
updated by Indra et al. (2008) to high-resolution capillary-based gel electrophoresis.  
The improved technique involved the incorporation of a fluorescent primer during 
the PCR amplification process, followed by the addition of a standard marker to allow 
analysis of the fragments on a DNA sequencing machine. The results are numerous 
peaks that correspond to certain fragment sizes and ribotypes are assigned accordingly 
to these fragment sizes. Not only has high-resolution capillary-based gel 
electrophoresis helped to improve inter-laboratory sharing of data, the method is 
more discriminatory than the classic agarose gel, accurate, allows for easier 
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differentiation between ribotypes and characterisation from the fragment profiles 
produced (Indra et al. 2008). With the method, to date over 350 ribotypes have been 
identified but the number continues to grow (Fawley et al. 2008; Health Protection 
Agency 2011; Public Health England 2014). 
2.3.1.1    Prevalent C. difficile PCR ribotypes  
Since 2004 there has been a marked increase in the number of CDI cases and the PCR 
ribotype responsible for most cases of mortality and mobility was identified as 
Ribotype 027 (R027), also referred to as North American Pulsed-Field Type 1 or group 
BI. Healthcare associated outbreaks of R027 have been found across the world: North 
America, Canada and mainland Europe and the UK (Smits 2013; Rupnik et al. 2009; 
Fawley et al. 2008). The emergence of R027 is thought to be due to the excessive 
administration of fluoroquinolones and has become a clinical problem. This may also 
be due to a number of virulence factors associated with the ribotype. For example, 
increased sporulation of R027 could be a contributing factor for increased 
dissemination and persistence noted in healthcare environments (Noren 2010; Smits 
2013). Ribotype R027 can also produce the binary toxin that is thought to lead to the 
hyper production of toxins A and B (Ananthakrishnan 2011). In addition, strains of R027 
carry deletions in tcdC genes important for repression of the toxin genes (Section 
2.1.2), which again may cause over production of C. difficile toxins (Sirard et al. 2011).  
Due to the high global prevalence of R027, Fawley et al. (2008) sub-grouped R027 
further to study its epidemiology. The research group examined 91 isolates of 
C. difficile in Leeds, UK using two molecular techniques: MLVA and PFGE. PFGE typing 
characterised five pulsovars of R027 at a threshold of over 98% similarity and MLVA 
identified 23 subtypes of R027 with a threshold of over 71% similarity. These enhanced 
fingerprinting techniques helped to distinguish between discrete C. difficile ribotypes 
and has aided to identify specific R027 subgroups responsible for CDI outbreaks. For 
example, a study conducted for over 20 months found two clusters of distinct MVLA 
types of R027 were responsible for CDI outbreaks across nine wards from two hospitals 
in the same institute. If ribotyping alone was used the clusters would have been missed 
(Fawley and Wilcox 2011). 
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R078 has also been reported to be another hypervirulent ribotype responsible for 
CDI cases worldwide, which is also likely due to the excessive production of toxin A and 
toxin B. However, in comparison to R027, R078 infects patients at a younger age of 64 
years vs. 73 years for R027 and more community acquired CDI cases are associated 
with R078 (Cartman et al. 2010). R078 has been classified as the second most prevalent 
ribotype in the Netherlands. This was shown by a two and half year study where the 
occurrence of R078 increased from 3% in 2005 to 13% in 2008 (Goorhuis et al. 2008). In 
Ireland, R078 is also the second most frequent ribotype and has been linked to 
numerous outbreaks of CDI (Burns et al. 2010).  
The theory that all strains from hypervirulent ribotypes R027 and R078 establish 
severe CDI has been disputed. Reports have suggested knowledge of the infecting 
ribotype alone is not sufficient to predict disease outcome (Boone et al. 2014). Walk et 
al. (2012) tested the concept by analysis of 34 severe CDI cases and found the link 
between R027 and R078 and severity was not significant. Instead investigation of 
patients albumin level and blood white cell count were improved predictors of severe 
CDI. Similarly, Sirard et al. (2011) found no association of increased clinical outcome or 
severity for the fourteen strains of R027 investigated, even though all isolates also had 
deletions in tcdC genes and hence increased levels of toxins were produced.  
2.3.1.2   Change in epidemiology of prevalent C. difficile ribotypes  
Over the past seven years ribotype C. difficile epidemiology has changed and there has 
been a steady decline in the prevalence of R027, which could be due to improved 
control measures and increased understanding of R027 (Public Health England 2014). 
Also, there may be a possibility that whilst R027 was being controlled it led to an 
increase in the prevalence of other ribotypes (Tschudin-Sutter et al. 2012). Examples 
include, ribotypes 001 in China and Korea, 002 in Japan and Hong Kong, 014/020 in 
European counties and the US, 017 in Northern Europe and especially 078 all over 
Europe (Goudarzi et al. 2014; Burke and Lamont 2014).  
The occurrence of prevalent ribotypes was investigated further in a major study 
conducted by Bauer et al. (2011) who explored the prevalent ribotypes across 34 
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European countries in 106 laboratories in November 2008. From the study they 
identified 65 different ribotypes but R014/020 was the most common followed by 
R001 and R078. One observation from the study was CDIs caused by R018 and R056 
were associated with severe disease and complicated outcomes but the reasons why 
were unknown. This again supports the theory that other ribotypes have outcompeted 
R027. 
2.3.1.3   Prevalent C. difficile ribotypes in the UK 
Since 2007 capillary-based gel electrophoresis is being used by PHE to identify national 
trends of the most prevalent C. difficile ribotypes in England and Northern Ireland. It 
allows detailed analysis of ribotype clusters and identification of closely related strains. 
This is because the PHE ribotypes samples if there is increased frequency, severity, 
complications, mortality and recurrence of CDI cases within healthcare environments. 
The service is referred to as the Clostridium difficile Ribotyping Network (CDRN) and 
consists of nine participating Public Health NHS laboratories (italicised are the regions 
represented) (Public Health England 2014): 
1. Belfast (Royal Victoria Hospital) in Northern Ireland: Northern Ireland region. 
2. Birmingham (Heartlands Hospital): West and East Midland regions. 
3. Bristol (Bristol Royal Infirmary): South West region. 
4. Cambridge (Addenbrooke’s Hospital): East of England region. 
5. Leeds (CDRN Reference Laboratory, Leeds General Infirmary): Yorkshire and 
Humber. 
6. London (Barts Health): London region. 
7. Manchester (Manchester Royal Infirmary): North West region. 
8. Newcastle (Royal Victoria Infirmary): North East region. 
9. Southampton (Southampton General Hospital): South East region. 
The most recent report published in 2014 by PHE on behalf of CDRN discusses 
statistics as percentages (raw data and numbers were not included) of the prevalence 
of C. difficile ribotypes between 2007 and 2013. There has been a significant decrease 
in R027 from 65% in 2007 to 5% in 2013 across all regions. Smaller reductions were 
noted for R001 from 10% in 2007 to 5% in 2013 and for R106 from 8% in 2007 to 2% in 
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2013. These changes correlate with reductions in CDI and motility in England and 
Northern Ireland (Wilcox et al. 2012). Although, the decline of some ribotypes has led 
to ‘compensatory’ rises in other ribotypes especially R002, R005, R014/020, R015, 
R023 and R078 (Public Health England 2014). The CDRN hopes that by identification of 
those ribotypes that cause infections, new control measures can be placed to limit 
their spread within healthcare environments (Wilcox et al. 2012).  
2.4   Diagnosis of CDI  
The initial diagnosis of CDI is dependent on the presence of ‘typical’ symptoms, which 
are: fever, loose diarrhoea, leucocytosis and abdominal pain. Secondly, through the 
use of laboratory diagnostic tests (Goudarzi et al. 2014) and an ideal diagnostic test 
would be quick, accurate, sensitive and specific to C. difficile. Rapid diagnosis of CDI is a 
critical step in successful management of the disease within healthcare environments 
(Barbut et al. 2014; Wren et al. 2009).  
Diagnosis of CDI from patient stool samples is conducted in laboratories via the 
detection of C. difficile toxins and a wide range of assays have been developed 
(Table 2.3). C. difficile diagnostic tests include (Goldenberg et al. 2011; Chand et al. 
2011):  
1. C. difficile culture.  
2. C. difficile toxigenic culture.  
3. Enzyme Immunoassays (EIAs) for identification of toxins A and B.  
4. EIAs for detection of Glutamate Dehydrogenase (GDH), which is a cell surface 
enzyme present in both toxigenic and non-toxigenic strains. 
5. PCR-based Nucleic Acid Amplification Test (NAAT) for identification of toxins A 
and B genes.  
The sensitivity of the diagnostic assays differs with EIA being the least sensitive at 
38%. No individual test is 100% selective for CDI and false positives are obtained 
regularly, which adds to the financial burden of the infection (Walker et al. 2012). Also, 
diagnostic tests with suboptimal sensitivity will lead to missed diagnosis, which could in 
turn increase the rates of CDI within healthcare environments (Wilcox 2011). This is the 
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reason why diagnostic tests are used in combination to deliver the most accurate 
results and why the Department of Health developed an official algorithm for 
C. difficile diagnosis in March 2012 (Figure 2.3) (Department of Health 2012). The 
updated algorithm has helped in the reporting and recording of CDI cases as all 
healthcare environments follow the same procedure (Barbut et al. 2014). Therefore, it 
has enabled accurate comparisons between institutes and if patients are GDH EIA and 
toxin EIA positive then PHE are informed, who then include the information in their CDI 
quarterly reports (Planche et al. 2013).  
Since the introduction of the algorithm there has been an improvement in patient 
care in comparison to stand-alone tests. This is because results are obtained within a 
working day, the combinations of tests are sensitive and correct treatment can be 
given sooner to patients, although, overall the NAAT diagnostic test is expensive and 
has consequently added to the financial burden of the infection (Barbut et al. 2014). 
Efforts need to be placed in the development of accurate, sensitive, cheaper and 
quicker methods for diagnoses of CDI from patients (Wilcox 2011). Phage-based 
diagnostic tests fulfil these criteria, as not only are they specific and highly sensitive, 
they are also relatively inexpensive (discussed in section 2.8). 
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Table 2.3 C. difficile diagnostic tests commonly used to diagnose CDI from patient stool samples. 
Diagnostic test Sensitivitya Specificitya Commentsa  
C. difficile culture  Low  Moderate  • Unable to distinguish between non-toxigenic and toxigenic isolates.  
• Time to result can take up to 72 hours therefore not ideal in a clinical 
setting. 
• High cost and resource intensive.  
Toxigenic culture  High  High  • Highly sensitive.   
• Reference method.  
• Limited diagnostic use.  
Cell culture neutralisation assay  High  High • Sensitive and specific.  
• Labour intensive.  
EIAs for identification of C. difficile 
toxins A and B 
63 – 90% 65 – 100% • Specific and rapid for identification of toxigenic strains. 
• Detects both toxins A and B. 
• Cost effective.  
• Low sensitivity and high rates of false positive results.  
EIAs for identification of GDH 70 – 90% 65 – 90% • High sensitivity.  
• Unable to distinguish between non-toxigenic and toxigenic isolates.  
• Toxigenic strains are identified by a second test of toxin EIA. 
PCR NAAT for detection of genes 
involved in the regulation of 
C. difficile toxins A and B 
0 – 85% 60 – 96% • Rapid turnaround time.   
• High sensitivity and specificity.  
• High rates of false positive results. 
• Test is only useful for patients with acute diarrhoea.  
• Expensive.  
a References (Ananthakrishnan 2011; Burke and Lamont 2014; Surawicz et al. 2013; Goudarzi et al. 2014). 
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Figure 2.3 The official algorithm outlined by the Department of Health for the 
diagnosis of C. difficile from patient stool samples in the UK (Department of Health 
2012). 
 
1. Glutamate Dehydrogenase (GDH) 
                Enzyme Immunoassays (EIA) 
GDH Negative  
No C. difficile 
infection  
GDH Positive   
C. difficile infection   
 
2. Toxin EIA   
Toxin EIA Negative 
Potential C. difficile 
excretor    
Toxin EIA Positive 
C. difficile infection   
3. OPTIONAL – Toxin gene PCR 
(Nucleic Amplification Test 
(NAAT)   
NAAT Negative 
No C. difficile infection 
or carriage    
NAAT Positive 
C. difficile carriage 
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2.5   Control and prevention of CDI within healthcare environments  
Contamination of environmental surfaces with C. difficile in healthcare settings has 
been well documented as the organism produces resilient spores, which are highly 
resistant to disinfectants and can survive in the environment for months. This is unlike 
vegetative C. difficile cells, which are rapidly killed when exposed to oxygen and room 
air (Ananthakrishnan 2011). The spores are spread either through faecal shedding or 
by contact with contaminated hands of patients and healthcare workers. Overall, the 
reported rates of C. difficile contamination are high and approximately 60% of 
healthcare environments are contaminated with the bacterium, which includes 
hospital wards and patient equipment (Landelle et al. 2014).  
A recent study by Biswas et al. (2015) also suggested antibiotic treatment may be 
linked to the level of environmental contamination. 36.8% of patients who were 
treated with fidaxomicin contaminated surfaces whereas higher rates were found for 
patients treated with metronidazole and/or vancomycin at 57.8%. Rates are also 
higher in rooms and wards of symptomatic carriers of C. difficile than of those who are 
asymptomatic carriers. Surprisingly, C. difficile spores have also been isolated from 
rooms of patients who tested negative for CDI. This could be due to insufficient 
cleaning that allowed persistent spores from a previously infected patients to linger 
and/or as a result of aerial dissemination of C. difficile spores during toilet flushing and 
bed changes (Barbut 2015). 
High touch surfaces and patient care equipment are especially highly contaminated 
with spores, such as: door handles, bed railings, light switches, toilet seats, sinks, 
telephones, call buttons, ultrasounds machines, thermometers and blood pressure 
cuffs. A recent study by Cheng et al. (2015) found bedside rails had the highest mean 
touch frequency at 13.6 per hour by healthcare workers and visitors. Therefore, the 
surfaces may provide a reservoir for spores to disseminate and ultimately inadequate 
cleaning of patient wards and rooms leads to spread of spores in environment. This 
could potentially establish infection in new patients (Badger et al. 2012). 
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Application of appropriate environmental decontaminants will reduce the 
transmission of CDI and typically phenolic acid derivatives and ammonium compounds 
are used but neither are sporicidal and they encourage sporulation of C. difficile. 
Instead, the Centre for Disease Control (CDC) and numerous studies (Speight et al. 
2011; Vohra and Poxton 2011; Dawson et al. 2011) recommend using highly 
concentrated vaporised hydrogen peroxide and chlorine-based disinfectants, which 
are able to kill C. difficile spores. Fawley et al. (2007) concluded chlorine-based 
detergents were able to eliminate spores of both epidemic and non-epidemic strains 
and did not promote further sporulation. These disinfectants should be used for daily 
routine cleaning of infected areas and isolation rooms after the transfer or discharge 
of infected patients (Macleod-Glover and Sadowski 2010).  However, even though 
measures are taken to eliminate C. difficile, residual spores are often observed 
following disinfection. Studies have shown less than 50% of surfaces in-patient rooms 
are adequately cleaned. This could be due to insufficient allocated time for cleaning 
staff to disinfect rooms before the next patient arrives or variances in disinfection 
procedures between staff (Barbut 2015).    
Controlling the spread of C. difficile has proved to be a challenge and increased 
collaborations between healthcare personnel’s and providers will help to promote a 
safe patient environment (Badger et al. 2012). Currently, there is no environmental 
test available for the detection of C. difficile to confirm whether sufficient cleaning has 
been carried out. Often culture based methods are used but it can take up to 72 hours 
to obtain results (Malik et al. 2013). A rapid and specific method needs to be 
developed, where results are obtained in the same working day in order to control the 
spread of CDI within healthcare environments. A phage-based test would be able to 
provide this and furthermore would allow specific detection of C. difficile (Section 2.8).  
 
 
Chapter 2 
 
 
30 
2.6   Bacteriophages  
Phages are bacteria-specific viruses that can kill and replicate within bacteria. Phages 
are naturally found in nature, commonly where their infecting bacteria are present, 
such as in sewage sites, faecal samples, farms and soil. Consequently, phages are the 
most abundant life form on Earth and it has been estimated 1032 phages exist (Singh et 
al. 2013). To date only a small fraction of phages have been studied but it has been 
predicted for every bacteria has at least one infecting phages. However, what has 
been learnt from the sequencing of both bacterial and phage genomes is that phages 
can not only kill bacteria but can also influence bacterial virulence and play a role in 
the evolution of the bacteria (Loc-Carrillo and Abedon 2011).  
Phages were discovered independently in the 20th century by Frederick Twort in 
1915 and Félix D’Hérelle in 1917 and the study of them has since underpinned the 
basis of bacterial genetics and molecular biology (Nobrega et al. 2015). Research into 
using phages therapeutically followed and began to be developed in 1919 (Alisky et al. 
1998). Phage therapy research and development has continued in Eastern Europe, in 
particular at the Eliava Institute of Bacteriophage, Microbiology and Virology, Georgia 
since 1923 (Merril et al. 2003). 
2.6.1   Phage infection cycle  
Phages can undergo two distinct types of life cycles: lytic and lysogenic (Figure 2.4). 
Lytic phages are able to attach to their host and inject their phage nucleic acid, which 
leads to disruption of bacterial metabolism. It also causes the switch of bacterial 
protein machinery to allow assembly of new phage progeny but production of new 
phages utilises all resources of the bacterial cell. Consequently, cells become weak and 
the bacterial cell wall is disrupted, which causes cells to burst. Host bacterial cells are 
lysed and new phage progeny are released (Campbell 2003). Cell lysis is mediated by 
two phage proteins: the holin protein that produces pores within the cytoplasmic 
membrane and the endolysin protein, which is responsible for the production of 
hydrolytic enzymes to cleave the bacterial cell wall (Schmelcher and Loessner 2014).   
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Similar to lytic phages, lysogenic phages also referred to as temperate phages attach 
and inject their DNA into their bacterial host. Then lysogenic phages can either initiate 
cell lysis, exist as plasmids within the bacterial cell or integrate into the genome of 
their host to become prophages. The incorporated prophage DNA is replicated 
alongside the bacterial genome and the next generation of bacterial cells inherit phage 
DNA (Sulakvelidze et al. 2001; Merril et al. 2003). The prophage can remain quiescent 
for an unspecified amount of time. Though, under certain conditions dependent on 
bacterial state or through addition of antibiotics, excision of the prophage can be 
stimulated. Consequently, it is then possible for prophages to follow the lytic cycle 
instead of the lysogenic cycle (Nale et al. 2012). 
The integration of phage DNA within bacterial cells is mediated via the integrase 
gene present in the phage genome and identified through phage sequencing. The 
integrase gene is responsible for site-specific integration events and is therefore 
present in lysogenic phages but absent in lytic phages (Fogg et al. 2014). Through the 
use of molecular methods the integrase gene can be either mutated or knocked out to 
prevent the integration of phage DNA within the host genome (Goh et al. 2007). 
Consequently, the mutated phage could then be considered to be used 
therapeutically, as currently only lytic phages are being used in phage therapy 
(Nobrega et al. 2015).  
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Figure 2.4 A summary diagram of the key steps involved in the phage infection cycle. Phages can either follow the lytic cycle, which leads to 
lysis of the bacterial cell or the lysogenic cycle where phage DNA is incorporated within the bacterial genome. 
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2.6.2   Structure and classification of phages  
The typical structure of phages as visualised through Transmission Electron 
Microscopy (TEM) is an icosahedral head called the capsid, which protects the phage 
genome (Figure 2.5). The phage genome can either be RNA or DNA but 90% of phage 
genomes contain double stranded DNA (dsDNA). The remaining 10% of phages contain 
dsRNA, single stranded RNA (ssRNA) or ssDNA within their genomes. Ackermann 
(2009) used the phage nucleic acid properties and morphology to establish a universal 
phage classification system (Ackermann 2009; Monk et al. 2010). 
Ackermann (2009) noted that the most common morphology of phages at 96% 
were the dsDNA tailed phages classified in the order Caudavirales. The group can be 
further divided into three phylogenetically related families: Siphoviridae with long 
non-contractile tails that consist of 61% of tailed phages, Myoviridae with long 
contractile tails at 25% and Podoviridae with short non-contractile tails at 14% (Figure 
2.5). The families differ in tail length, overall phage size from 24 to 400 nm and 
genome length from 18 to 400 kb.  
However, the overall structures of phages within the order Caudavirales are very 
similar (Figure 2.5d), such that the phage capsid is attached to the tail through a 
connector that serves as an adaptor. The connector also plays several vital roles during 
the phage infection cycle, such as packaging dsDNA into the capsid and participating in 
the release of phage DNA to the host bacterium after transmission of a signal from the 
phage tail. The tail itself acts as a pipeline for phage DNA to be delivered to the host 
cell. At the ends of tails there are tail fibres and a needle or tip, which binds specifically 
to its bacterial receptor. This attachment causes the release of the phage genome via 
the opening of the connector and then phage replication occurs (Ackermann 2009). 
Succeeding phage amplification, lysis of the host bacterial cells occurs to release the 
new phage progeny (Schmelcher and Loessner 2014).   
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Figure 2.5 Images represent the overall structure of phages. 
 
TEM images of viruses from the order Caudovirales, which is further divided into three families: a: Myoviridae, b: Siphoviridae and 
c: Podoviridae. For the images the black bar represents 50 nm (images were adapted from (Krupovic et al. 2011)). d: a schematic 
representation of common phage features shared between all three families from the order Caudovirales (image adapted from (Nobrega et al. 
2015)). 
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2.7   C. difficile phages  
Research into C. difficile phages actively killing the bacterium is limited in comparison 
to other pathogenic bacteria such as MRSA. This could be due to difficulties in the 
isolation and propagation of C. difficile phages. Also CDI has not been reported as a 
problematic in the countries where studies into the application of phages continued 
following the discovery of antibiotics (Hargreaves and Clokie 2014).  
Early research investigated C. difficile phages for typing purposes to provide 
information on epidemiology and transmission of C. difficile (Sell et al. 1983). 
However, phage typing was unsuccessful and is no longer in practise. This was due to 
the narrow host ranges of phages, for example only one isolate from a possible ten of 
the same ribotype being identified. Instead molecular typing techniques are used, such 
as PCR ribotyping (Dei 1989). After which researchers focused on isolation of lytic 
C. difficile phages to be used therapeutically but to date only lysogenic phages from 
the order Caudavirales have been isolated, although, these phages have been shown 
to infect some C. difficile strains lytically (Goh et al. 2005; Fortier and Moineau 2007; 
Sekulovic et al. 2014).  
2.8   Phage-based diagnostic tests 
Traditional culture-dependent diagnostics are the benchmark of most pathogen 
detection schemes for identification of problematic bacteria present in food, 
healthcare settings, in clinical and environmental samples. The fundamental 
microbiology method is most sensitive with the added benefit of production of 
bacterial colonies, which can then be subjected to further tests and used for tracking 
which sub-groups of bacteria cause outbreaks or infections. However, culture based 
methods are labour intensive, slow and can take between 48 to 72 hours to produce 
results (Smartt and Ripp 2011).  
There is significant demand to detect bacteria in minutes or hours instead of days 
and culture-independent bacterial diagnostics have therefore been developed. Those 
with the broadest application are PCR-based methods that are able to detect the 
target bacterial DNA, ELISA tests that uses targeted specific antibodies to identify the 
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bacteria of interest and mass spectrometry to detect bacterial DNA and proteins. 
Although these methods are quicker there are many drawbacks, such as: some 
methods initially require lengthy pre-enrichment steps, reagents are expensive and 
unstable, expensive machinery is required and often it is difficult to handle and 
interpret final results. In addition, PCR can only detect the presence of DNA rather 
than distinguishing between living and dead cells. This is a major problem especially 
for clinical diagnostic tests as it would not be able to identify active bacterial infections 
and subsequently a secondary test would need to be conducted to make the 
differentiation. Likewise, detection of environmental bacterial contamination would 
also be compromised and PCR would not be able to determine whether 
decontamination procedures have been successful (Schmelcher and Loessner 2014). 
Alternatively, the specific interactions of phages with their bacterial hosts can be 
harnessed to develop highly sensitive and rapid bacterial diagnostic tests. There are 
many advantages of using phages over current diagnostic methods, such as they are 
easy to use, not labour intensive and phages are inexpensive to produce. Most 
importantly phages are able to distinguish between viable and nonviable bacterial 
cells, as phages can only infect living bacterial cells unlike current PCR diagnostic 
methods. Also phages are robust, such that they retain infectivity between pH 3 to 
pH 10 and can withstand small alterations in temperature. Due to these properties 
phages are able to detect bacterial cells in culture, water, food, and environmental 
and clinical matrices. Furthermore, phage based diagnostics are used in vitro where 
conditions can be manipulated and controlled to favour bacterial and phage growth. 
However, despite the numerous advantages of developing phage-based diagnostic 
tests very few have made the transition from a research laboratory to a widely 
available commercial clinical diagnostic test (Monk et al. 2010; Merwe et al. 2014).  
Phage-based diagnostic tests have been constructed by using any of the key phage 
infection steps: adsorption, phage propagation, cell lysis and release of phage progeny 
(Figure 2.4) as a marker for bacterial detection. They are listed in Table 2.4 and 
although all methods have proven applicable to many bacterial pathogens they each 
have their own advantages and disadvantages (Smartt and Ripp 2011). Although 
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different strategies have been employed to develop phage-based diagnostic tests, to 
date no such tests have been developed to detect C. difficile. This is likely due to the 
difficulty in the isolation of specific C. difficile phages but in Professor Martha Clokie’s 
laboratory we have devised robust protocols for the isolation of C. difficile phages and 
have successful isolated a wide selection of phages. This has made it possible for the 
development of a phage-based diagnostic test in this study. 
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Table 2.4 Summary table of different methods used to develop phage-based diagnostic tests (adapted from (Smartt and Ripp 2011; 
Schmelcher and Loessner 2014). 
Detection method  Definition   Example(s) of application Comments   
Labelled phage  
(utilises the phage 
adsorption step of 
the infection cycle) 
Recognises the initial binding 
of phage to its bacterial host 
by labelling phage DNA. 
Willford et al. (2011) labelled STEC 
phages with horse radish peroxidase 
and the assay was able to detect 
STEC within 20 minutes.  
• The method used to label phage is simple.  
• Different wavelength fluorescent dyes are widely 
available that allows identification of numerous 
bacteria. 
• Phages can bind to non-target hosts, which can then 
lead to false negative results. 
Phage amplification 
assay (utilises the 
assembly of new 
phages step during 
the infection cycle) 
Tests the presence of bacteria 
by infecting with phages 
specific for the target 
bacterium. Then a virucide is 
added to remove any free 
phages and so only infected 
cells are plated and counted. 
Botsaris et al. (2013) used the phage 
amplification assay coupled with PCR 
to detect Mycobacteriumavium 
paratuberculosis in milk samples. In 
comparison to culture-based 
techniques, this method was highly 
sensitive. 
• Non-engineered phages are used in this method. 
• Only living bacterial cells are detected. 
• Addition of virucide is required and if ineffective can 
lead to false-positive results. 
Reporter phages 
(utilises the phage 
DNA injection step 
of the infection 
cycle) 
Constructed by inserting 
fluorescent gene(s) to the 
phage genome, which then 
during infection are 
transferred to the bacterial 
host and produces a 
quantifiable signal. This signal 
is dependent on cell viability. 
Reporter phages constructed for 
numerous pathogens, such as E. coli 
0157:H7, Salmonella enterica, 
L. monocytogenes, Yersinia pestis, 
E. coli and B. anthracis (discussed in 
Section 2.8.1). The USA based 
company Sample 6 has made 
significant progress in bringing 
reporter phages to the market. 
• Fast, sensitive and the increased specificity reduces the 
time for bacterial sample preparation and purification. 
• Able to differentiate between living and dead cells. 
• Phage needs to be sequenced and the method requires 
genetic engineering that can be time-consuming and 
labour intensive. 
• Legal issues may be faced due to development of 
recombinant phages.  
Phage typing 
(utilises the bacterial 
cell lysis step of the 
infection cycle) 
Broad host range phages are 
used to identify bacterial 
pathogens. 
Widely available for all National 
Institute of Allergy and Infectious 
Disease category pathogens, such as: 
Bacillus anthracis, Staphylococcus, 
and Salmonella. 
• Utilises non-engineered, naturally occurring phages. 
• Highly specific and no complex machinery are required. 
• Slow, laborious and bacterial host strains need to be 
culturable.  
• Requires a large collection of phages. 
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Table 2.4 continued.  
Detection method  Definition   Example(s) of application Comments   
Phage-induced 
bacterial host lysis 
(utilises the bacterial 
cell lysis step of the 
infection cycle) 
When phages lyse target 
bacterial cells new phage 
progeny are released but 
there is also a release of 
intracellular components, such 
as Adenosine Triphosphate 
(ATP) and Adenylate Kinase 
(AK). They can be quantified 
and used as markers for 
measurement of phage lysis. 
Wu et al. (2001) measured the level 
of AK following phage lysis against 
E. coli and Salmonella cells. 
Detection limits under optimal 
conditions for both bacteria were 
less than 103 CFU/ml within two 
hours. 
• Non-engineered phages are used in this method. 
• Cost-effective and easy to use assay. 
• Requires lytically infecting phages.  
• False-positive results may be produced if non-phage 
related lysis of bacterial cells occurs.  
Conductance 
measurements  
(utilises the bacterial 
cell lysis step of the 
infection cycle) 
The growth of bacteria leads 
to changes in conductivity 
within the growth media and 
further changes in 
conductivity are observed 
after addition of phages and 
lysis of cells. Therefore this 
method can be used to detect 
target bacterial cells. 
Chang et al. (2002) showed 
conductance could be used to detect 
E. coli 0157:H7 by monitoring the 
change in conductance after 
addition of specific phage. The 
method was highly specific and 
99.4% of non-target bacteria 
produced negative results. 
• The assay was primarily used in 1990’s and early 
2000’s. 
• Non-engineered phages are used in this method. 
• Cost-effective and easy to use assay. 
• Lacks sensitivity.  
• Sample or culture medium can interfere with 
measurements.  
Cell wall binding 
proteins (utilises the 
bacterial cell lysis 
step of the infection 
cycle) 
Cell Wall Binding Domains 
(CBDs) of phage endolysins are 
involved in cleaving bacterial 
cell walls and CBDs can be 
used to detect target bacterial 
cells.  
Kretzer et al. (2007) developed CBDs 
immobilised on paramagnetic beads 
for two different Listeria phages. The 
CBD magnetic beads had high-
affinity for target cells from food 
samples with 90% recovery after 40 
minutes. 
• Fast, sensitive and CBDs have high specificity for target 
bacterial cells. 
• Binding spectra of CBDs are broad in comparison to 
whole phages. 
• Directed at Gram-positive bacteria as the cell wall is not 
protected by an outer membrane. 
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2.8.1   Phage infection based diagnostic test: reporter phages 
The result of a successful phage infection is the transfer of the phage genome to the 
bacterial host cell. One method of exploitation of this crucial step of the phage 
infection cycle, can be through the insertion of a user-defined gene(s) within the 
phage genome via molecular cloning methods. Then following phage infection the 
gene(s) are transcribed, translated and expressed and a new set of genetic instructions 
are dictated to the host cell. Such genes are referred to as reporter genes (Table 2.5) 
and phages with these genes are called reporter phages. The most extensively utilised 
reporter genes are from the firefly Photinus pyralis luciferase gene and from Vibrio 
harveyi and Vibrio fischeri the luxCDABE operon. The reporter genes produce 
quantifiable reporter protein products during expression in bacterial cells. The 
products are easy-to-measure and produced are fluorescence, bioluminescence or 
colorimetric signals (Smartt and Ripp 2011; Merwe et al. 2014).  
Among all the reporter genes available, luciferase reporter genes have been 
utilised and cloned in phages the most for bacterial detection. They have many 
advantages, such as they produce a highly sensitive bioluminescent signal, have a high 
signal-to-noise ratio and detection limits as low as 10 CFU/ml have been noted 
(Schmelcher and Loessner 2014). Also, reporter phages require metabolically active 
cells as they use the transcriptional and translational machinery of the host to produce 
the bioluminescence signal. Therefore, a signal is only produced for living cells and 
only these cells are detected (Brigati et al. 2007).     
The luminescent equation that occurs within the bacterial cells after expression of 
the luciferase reporter gene is shown below:  
                                            
FMNH2 + RCH0 + 02                                        FMN + H20 + RC00H + Light (490 nm) 
 
Luminescence light emission involves the conversion of the long chain aliphatic 
aldehyde (RCH0) to carboxylic acid (RC00H) and requires the reducing agent flavin 
mononucleotide (FMNH2) and oxygen (02). The aldehyde substrate is produced by 
three genes luxC, luxD and luxE when the whole luxCDABE operon is used. When the 
Luciferase 
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luxAB reporter genes are used then an aldehyde substrate, typically n-decanal is added 
exogenously to allow light emission to occur. Luminesce signal is then detected by the 
use of luminometers or sensitive cameras (Goodridge and Griffiths 2002). 
The first luciferase reporter phage was developed by Ulitzer and Kuhn (1987) for 
detection of E. coli cells. The E. coli reporter phage was constructed by insertion of the 
whole luxCDABE operon from Vibrio fischeri and as little as 10 E. coli cells in milk were 
detected (Van der Merwe et al. 2014). Since then a multitude of reporter phages have 
been developed against Salmonella, Listeria, E. coli 0157:H7, Mycobacterium 
tuberculosis and Staphylococcus aureus. The assay has also been able to detect 
bacteria in food, such as in spinach, milk, ground beef and soft cheese (Magliulo et al. 
2007). 
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Table 2.5 Common reporter genes used to develop phage-based bacterial diagnostic 
tests. 
Reporter gene  Comments   
luxCDABE • Luciferase genes typically obtained from the bacteria Vibrio fischeri 
and Vibrio harveyi.  
• High sensitivity but weak luminescence signal. 
• Substrate addition not required. 
• Whole operon is approximately 7 kb therefore there are packaging 
constraints within the phage genome (Kim et al, 2014).  
luxAB • Luciferase genes typically obtained from the bacteria Vibrio fischeri 
and Vibrio harveyi.  
• High sensitivity but temporary luminescence signal. 
• Substrate addition is required.  
• luxAB genes are over 2 kb so limited packaging constraints within 
the phage genome (Schofield et al, 2009). 
luxI • luxI is involved in quorum sensing and generates the autoinducer 
acylated homoserine lactone that stimulates transcription of 
luxCDABE genes. 
• High sensitivity.  
• Substrate addition is not required but a bioreporter strain with the 
luxCDABE is needed. 
• Frequently observe false negative results (Schmelcher and Loessner 
2004).  
luc • A bioluminescent protein from firefly Photinus pyralis. 
• High sensitivity.  
• Substrate addition is required but substrate is expensive.  
• Luminescence signal is short lived (Smartt and Ripp 2011).  
inaW • The inaW gene encodes for ice nucleation. 
• Highest sensitivity in comparison to other reporter genes. 
• Fluorescent dye needs to be added to produce signal. 
• Specialised equipment is not needed (Goodridge and Griffiths, 
2002).  
lacZ • The lacZ gene encodes the β-galactosidase enzyme.  
• Substrate addition is required. 
• Specialised equipment is not needed. 
• High background (Schmelcher and Loessner 2004).  
gfp • From the jellyfish Aequorea victoria. 
• Very stable and produces a long-lasting luminescence signal that 
escalates over time.  
• Expensive equipment is required, such as a fluorescence 
microscope (Smartt and Ripp 2011).  
celB • From the Pyrococcus furiosus species of Archaea. 
• Thermostable and produces a long-lasting luminescence signal that 
escalates over time. 
• Substrate addition is required (Hagens et al, 2011). 
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3.1   Introduction 
The first C. difficile phage was isolated in 1983, for bacterial typing purposes (Sell et al. 
1983) and since then over 50 phages have been described in the literature. The degree 
of characterisation of C. difficile phages differs between studies but most include 
information on: phage morphology, infection cycle, the phages host range, whole 
genome sequencing and comparative genomics. The latter is only possible after 
purification and isolation of C. difficile phage DNA. This has provided insightful 
information on the relationship of phage with C. difficile and has allowed this specific 
interaction to be exploited for phage therapy (Hargreaves and Clokie 2014).  
The C. difficile and phage interaction can also be harnessed for the development of 
phage-based diagnostic tests for detection of C. difficile, although to date none have 
been developed. However, learning from previous phage-based tests that have been 
developed against bacterial species, they have used phages with broad host ranges. 
These are phages that can infect a wide array of subgroups of the bacterium and have 
hence helped to maximise the sensitivity of the phage-based detection assay. 
Consequently, Chapter 3 has focused on the isolation, characterisation and 
purification of such broad host range C. difficile phages that could be used for the 
development of the phage-based diagnostic test.   
3.1.1   C. difficile phage isolation  
Three different methods have been used to isolate C. difficile phages: 
1. Induction of resident prophages. 
2. Direct screen of soil, sediment and river samples. 
3. Prior enrichment of soil, sediment and river samples with nutrient rich media. 
From the three, the most common method used is the induction of resident 
prophages from C. difficile strains with antibiotics mitomycin C and norfloxacin. This is 
because detailed analysis of sequenced C. difficile strains has detected the presence of 
at least one resident prophage in most genomes (Fortier and Moineau 2007; Sekulovic 
et al. 2014). Furthermore 90% of clinically relevant ribotypes carry one or more 
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prophages within their genomes (Shan et al. 2012). It is unclear how the carriage of 
prophages benefits the hosts. However, based on knowledge of better-characterised 
prophages of other bacterial species, and the information from C. difficile phage 
genomes, the prophages may contribute to the pathogenicity of the bacterial host. 
This could be through the regulation of bacterial toxins or by the prevention of 
infection from other phages (Goh et al. 2005; Govind et al. 2006). 
Aside from induction of prophages, the other isolation method is the direct screen 
or enrichment of samples from sites where the bacterium itself is habitant, such as 
from farm animals and their faeces. This is because C. difficile is both a pathogen and 
commensal in domestic and food animals (Gould and Limbago 2010). Therefore farm 
animals could be a natural reservoir for C. difficile and potentially be a source for its 
phages too (Goorhuis et al. 2008; Burns et al. 2010). A recent study showed the 
successful isolation of C. difficile and its associated phages from horses, calves, pigs 
and dog faeces. From those faecal samples C. difficile ribotypes 002, 014/020, 027, 050 
and 078 and nine phages were isolated (Sekulovic et al. 2014a). 
In addition to association of C. difficile with animals, the bacterium has also been 
isolated from other natural environments, such as estuaries, rivers and soil samples 
(Saif and Brazier 1996; Zidaric et al. 2010). Strains isolated from these sites may also 
be a good source for phage isolation via induction of prophages, and Hargreaves et al. 
(2013a) tested this concept. They were able to isolate 22 C. difficile strains from 
estuarine samples and prophages were found in 75% of these strain.  
3.1.2   Isolation of temperate C. difficile phages  
Regardless of the isolation method, to date only putative temperate phages have been 
identified. However, studies have shown that these phages can infect C. difficile 
lytically (Goh et al. 2005; Sekulovic et al. 2014a). The phages have been designated as 
temperate on the basis of genome sequence analysis, which has shown the presence 
of the integrase gene. Consequently, the phages have the potential to integrate within 
the bacterial chromosome (Hargreaves and Clokie 2014). Moreover, there is also a 
possibility that temperate phages could play a part in the transduction of antibiotic 
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resistance genes and a recent study found this to be a possibility with C. difficile 
phages. Goh et al. (2013) experimentally showed phage C2 was able to transduce the 
erythromycin resistance gene to one out of four tested recipient C. difficile strains at a 
frequency of 10-6 per phage particle. Although the transfer frequency was low, other 
C. difficile phages may also be capable of transduction. 
3.1.3   Host range of C. difficile phages  
After successful isolation of phages, host range analysis is conducted to determine 
which subgroups or ribotypes of C. difficile the phages are able to infect. An ideal 
phage to be used in the development of phage-based diagnostic test is one that can 
infect multiple clinically relevant ribotypes. Therefore, a large set of phages need to be 
screened against isolates from different ribotypes, but to date most studies of phage 
host range analysis have been conducted on a small scale. The highest number of 
phages screened in any published study is nine against 47 isolates from 22 different 
C. difficile ribotypes (Fortier and Moineau 2007; Sekulovic et al. 2014a). The ribotypes 
included the prevalent UK ribotypes 002, 005, 014/020, 015, and 078 (England 2014; 
Burke and Lamont 2014). 
3.1.4   Phage purification methods and sequencing  
In order to understand C. difficile phage infectivity and to identify which genes are 
involved with infection, detailed characterisation of phages is needed via whole 
genome sequencing. This information will also be required for any approach taken for 
the development of the phage-based diagnostic test. For example to develop reporter 
phages, a luminescence tag needs to be inserted within the phage genome. Typically a 
predicted ‘non-essential’ gene is replaced with the luminescence gene within the 
phage genome and therefore the phage needs to be fully sequenced and annotated 
(Schmelcher and Loessner 2014).   
For whole phage genome sequencing it is mandatory for phage stocks to be free 
from bacterial derived contaminants, such as debris, membranes, proteins, ribosomes 
and nucleic acids. However, the purification method used needs to retain a high level 
of phage infectivity. The standard method used for purification initially requires the 
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concentration of phage particles with polyethylene glycol that aids phage 
precipitation. This is then followed by purification with Caesium Chloride (CsCl2) that 
involves the use of CsCl2 solutions of different densities and ultracentrifugation. After 
the ultracentrifugation step a distinct, often blue coloured phage band is observed, 
collected and often a minimum volume of 300 µl of phage is recovered (Boulanger 
2009; Pickard 2009).  
Although, CsCl2 is the standard method for phage purification and has some merit 
as it provides high quality DNA, the final yield of phage is very low. In addition, the 
method can take two to three days to complete and is not easily scalable. Phages can 
also be damaged by the centrifugal forces and when phages interact with CsCl2 it can 
lead to lose of phage infectivity (Adriaenssens et al. 2012). Furthermore, the CsCl2 
purification is not applicable for all phages and has been reported in the literature to 
be especially troublesome for C. difficile phages (Hargreaves and Clokie 2014). Due to 
these reasons, substitute phage purification methods are required. 
Anion-exchange chromatography could provide an alternative method for phage 
purification (Adriaenssens et al. 2012). Convective Interactive Medias (CIMs) monolith 
columns developed by BIA Separations (Slovenia) are now commercially available with 
two types of anion-exchange matrices: weak anion-exchange Diethyl Amine (DEAE) 
and strong anion-exchange Quaternary Amine (QA). Both matrices can be applied for 
phage purification and have been used for successful purification of Staphylococcus 
phage VDX-10 (Kramberger et al. 2010) and Escherichia coli phage T4 (Smrekar et al. 
2008). With both examples anion-exchange chromatography could simultaneously 
produce high phage yields of 7 x 1013 PFU/ml at scalable quantities from millilitres to 
litres (Adriaenssens et al. 2012). Given the advantages, this method could be applied 
to the phages used for development of the C. difficile diagnostic tests.  
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3.2   Aim of this study 
The aim of Chapter 3 was to identify potentially exploitable phages for the 
development of the phage-based diagnostic test. Ideal phages that will be used for the 
test are those that have broad host ranges. To isolate broad host range phages, 13 
water and soil samples from the River Tame (Birmingham, UK) were collected, 
enriched and screened for phages. Seven new C. difficile phages were isolated and 
they were characterised to determine their morphology by TEM, their genome size by 
Pulsed-Field Gel Electrophoresis (PFGE) and their burst sizes were calculated from one-
step growth curve experiments.  
After which host range analysis was conducted for the seven new phages and 25 
C. difficile phages previously isolated in Professor Martha Clokie’s laboratory 
(University of Leicester, UK) against 115 clinically relevant and 45 environmental 
isolates of C. difficile. These isolates consisted of 29 different ribotypes. After 
characterisation of phages a new rapid method with anion-exchange chromatography 
was designed for rapid purification and phage DNA isolation.  
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3.3   Methods 
3.3.1   General culture methods for C. difficile  
C. difficile was streaked on 7% horse blood agar plates (Chapter 9, Table 9.1) and  
henceforth will be referred to as blood plates with a sterile 5 μl loop (Microspec, UK). 
Blood plates were incubated for 48 hours at 37°C inside an anaerobic chamber (Don 
Whitley Scientific Ltd, UK). C. difficile colonies were examined under long wave 
UltraViolet (UV) light at 365 nm and colonies with a distinct green or yellow glow were 
characterised further. Other indicators for C. difficile were a distinct odour of horse 
manure and colony morphology. 
From blood plates, a single colony of C. difficile was transferred into a bijou vial 
(Sterlin, UK), which contained 7 ml pre-reduced Fastidious Anaerobic broth (FA broth) 
(Chapter 9, Table 9.1). The FA media had been pre-reduced by overnight incubation in 
the anaerobic chamber. The FA cultures were incubated overnight at 37˚C inside the 
anaerobic chamber and turbidity of the culture was used as an indicator for liquid 
growth.  
Cryogenic stocks of cultures were prepared by centrifugation of an overnight FA 
C. difficile culture at 13,000 x g (Beckmen Coulter, UK) for 5 minutes at room 
temperature. The supernatant was decanted and the pellet was re-suspended with 
200 μl of glycerol taken from cryopreservation vials with a Pasteur pipette (Fisher 
Scientific, UK). The solution was transferred back to the vial and stored at -80˚C. All 
C. difficile isolates were maintained as cryopreservation stocks at -80˚C. 
3.3.2   C. difficile strains 
Environmental strains of C. difficile were isolated and characterised by Dr Katherine 
Hargreaves (University of Leicester, UK) between the years 2008 and 2010 from horse 
manure, soil and sediment samples from Hampshire along the Southern Coast of 
England (Hargreaves et al. 2013b). Environmental strains S1 (R010) and S7 (R031) were 
isolated from Slovenian river samples and were kindly donated by Professor Maja 
Rupnik (University of Maribor, Slovenia).  
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Clinical C. difficile strains were isolated and ribotyped by Dr Krusha Patel 
(Loughborough University, UK) who processed faecal samples positive for C. difficile 
toxin A/B detected by PCR. The faecal samples were collected from Glenfield General 
Hospital, Leicester Royal Infirmary, Leicester General Hospital, general practitioner 
surgeries and healthcare centres within the University Hospitals of Leicester, UK NHS 
Trust between years 2008 and 2010. PCR ribotying was carried out in collaboration 
with Professor Mark Wilcox and Dr Warren Fawley (University of Leeds, UK). 
3.3.3   Isolation of new C. difficile strains  
New strains of C. difficile were isolated from water and soil samples collected from 
River Tame. 2 ml of sample was mixed with 12 ml supplemented FA broth (Chapter 9, 
Table 9.1) and incubated anaerobically for 10 days. Cultures were centrifuged at 
5,000 x g for 10 minutes; supernatant collected (used for the isolation of new 
C. difficile phages) and the pellet was re-suspended in an equal volume of Industrial 
Methylated Spirit (IMS). This sample was incubated for 30 minutes, streaked on 
Cefoxitin Cycloserine Egg-Yolk (CCEY) plates (Chapter 9, Table 9.1) and incubated for 
48 hours inside the anaerobic chamber. If colonies were visible, they were sub-
cultured three times on blood agar plates and colony morphology was checked under 
UV light (Hargreaves et al. 2013; al Saif and Brazier 1996).  
3.3.3.1   C. difficile DNA extraction for polymerase chain reaction 
After bacterial colonies were re-streaked DNA was extracted. A loopful of bacteria was 
added to 5% Chelex-100 (BioRad, UK), mixed thoroughly, heated at 100°C for 
15 minutes and cooled for 5 minutes at room temperature. Samples were centrifuged 
at 21,000 x g for 5 minutes, supernatant recovered, stored at -20°C and the isolated 
DNA was used for PCR. 
3.3.3.2   Polymerase chain reaction 
A PCR was ran with primers: FCD16s and RCD16s (Chapter 9, Table 9.5) designed by 
Rinttila et al. (2004) that targets the small subunit rRNA of C. difficile. In a total volume 
of 25 µl the following regents were added (all reagents purchased from Bioline, UK): 
Chapter 3 
51 
 
1 µM of each primer FCD16s and RCD16s, 0.25 mM dNTPs, 3 mM MgCl2, 0.5 U of 
BioTaq polymerase and 50 ng of template DNA (extracted as described in Section 
3.3.3.1). The PCR program was: initial denaturation at 95°C for 5 minutes followed by 
30 cycles of denaturation at 95°C for 30 seconds, annealing step at 50°C for 30 seconds 
and extension at 72°C for 45 seconds, final extension at 72°C for 5 minutes and PCR 
reactions were stored at 4°C. PCR reactions were run on a 1% agarose gel (Bioline, UK) 
at 100 V for 60 minutes and if C. difficile was present a band at approximately 
200 base pairs (bp) was observed. 
A PCR was ran with universal 16S primers: 8F and 1391R (Chapter 9, Table 9.5) 
(Turner et al. 1999). These primers specifically anneal to conserved regions of the 16S 
rRNA bacterial gene to amplify a DNA fragment that allows species identification after 
culture. In a total volume of 50 µl the following regents were added (all reagents 
purchased from Bioline, UK): 0.5 µM of each primer 8F and 1391R, 0.25 mM dNTPs, 
3 mM MgCl2, 0.5 U of BioTaq polymerase and 50 ng of template DNA (extracted as 
described in Section 3.3.3.1). The PCR cycle was: initial denaturation at 95°C for 
5 minutes followed by 30 cycles of denaturation at 95°C for 30 seconds, annealing step 
at 55°C for 1 minute, extension at 72°C for 1 minute, final extension at 72°C for 
10 minutes and the PCR reactions were stored at 4°C. PCR products were run on a 
1% agarose gel and if a band was visible at approximately 1200 bp, then the PCR 
products were purified with the PCR Isolate II: PCR and Gel extraction kit (Bioline, UK) 
as per the manufactures instructions. The purified PCR products were then sent for 
sequencing to GATC (UK) and sequenced data was received within three days. 
3.3.4   C. difficile phages  
C. difficile phages (25) were previously isolated by Dr Katherine Hargreaves, Holly 
Colvin and Krystin Norman (University of Leicester, UK) from sediment samples 
collected from Hampshire along the Southern Coast of England (Table 3.1). The phages 
were propagated (Section 3.3.6) on C. difficile strains 10 (R010), S7, T6 (R076), ATJ 
(R014/020), AIU (R027) and S1. These strains were selected as high titre phage stocks 
could be produced consistently.  
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3.3.4.1   Phage nomenclature 
Phages were named in accordance to the strain they are propagated on and were 
assigned a number or letter. For example phage ‘T6ɸ12’, where T6 is the propagation 
host, the symbol ɸ represents the symbol for phage and 12 is the assigned code. 
3.3.5   Isolation of new C. difficile phages 
The same protocol as described in Section 3.3.3 was used. The supernatant of the 
centrifuged 10-day culture was spot tested on different environmental and clinical 
C. difficile isolates. If a clear zone of lysis or plaques were observed, individual plaques 
were picked with a 5 µl loops and placed in 500 µl of Brain Heart Infusion (BHI) broth 
(Chapter 9, Table 9.1). The individual plaque was propagated on the same host via 
plaque assays (Section 3.3.6.2) and further plaques were picked. The procedure was 
repeated three times to establish a clonal phage stock.    
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Table 3.1 List of C. difficile phages and their propagation hosts. 
a Phages were isolated by Dr Katherine Hargreaves, Holly Colvin and Krystin Norman. 
b Phages were isolated by Anisha Thanki (Loughborough University, UK and University 
of Leicester, UK) in this study. 
 
 
 
C. difficile phage Phage classification Propagation host  Propagation host: 
Clinical or 
Environmental 
S1ɸ5dBHa Myoviridae S1 Environmental  
S1ɸ5ba Myoviridae S1 Environmental 
S1ɸ10Ha Myoviridae S1 Environmental 
S1ɸ10aHa Myoviridae S1 Environmental 
S1ɸ10bHa Myoviridae S1 Environmental 
S1ɸS11a Myoviridae S1 Environmental 
S1ɸ16a Myoviridae S1 Environmental 
S1ɸ17.1Ha Myoviridae S1 Environmental 
S1ɸS8a Myoviridae S1 Environmental 
S7ɸ1ca Myoviridae S7 Environmental 
S7ɸ5dBHa Myoviridae S7 Environmental 
S7ɸ7Ha Myoviridae S7 Environmental 
S7ɸ10a Myoviridae S7 Environmental 
S7ɸ12a Myoviridae S7 Environmental 
S7ɸH3a Myoviridae S7 Environmental 
10ɸ5dHa Myoviridae 10 Environmental 
10ɸB2a Siphoviridae 10 Environmental 
T6ɸ7ha Myoviridae T6 Environmental 
T6ɸ12eHa Myoviridae T6 Environmental 
T6ɸ12a Myoviridae T6 Environmental 
T6ɸF2a Myoviridae T6 Environmental 
T6ɸH2a Myoviridae T6 Environmental 
T6ɸ1b Myoviridae T6 Environmental 
T6ɸ2b Myoviridae T6 Environmental 
T6ɸ3b Myoviridae T6 Environmental 
T6ɸ4b Myoviridae T6 Environmental 
T6ɸ5b Myoviridae T6 Environmental 
T6ɸ6b Myoviridae T6 Environmental 
T6ɸ7b Myoviridae T6 Environmental 
ATJɸF2a Myoviridae ATJ Clinical 
ATJɸH2a Myoviridae ATJ Clinical 
AIUɸX2a Siphoviridae AIU Clinical 
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3.3.6   Phage titres and phage stock preparation  
Phage infection and replication was determined by plaque assays and spot tests using 
the double agar layer method (Kropinski et al. 2009). 
3.3.6.1   Spot tests 
300 µl of FA C. difficile culture grown overnight (Section 3.3.1) was mixed with 1.5 ml 
semi-solid BHI 0.4% agar and 1.5 ml salts (0.4 M MgCl2 and 0.1 M CaCl2) (Chapter 9, 
Table 9.1). The mix was poured on a dried BHI 1% agar plate (Chapter 9, Table 9.1) and 
set for 5 minutes. 10 µl of phage was spotted onto the bacterial lawn in triplicate, 
dried for 10 minutes and incubated anaerobically overnight at 37°C. 
 Phage titre of stock solution was calculated as Plaque-Forming Units per ml 
(PFU/ml) with the Miles and Misra (1938) method. Briefly, serial dilutions of the phage 
stock were made from 10-1 to 10-8 with BHI broth. Each dilution was spotted in 
triplicate as described above on a lawn of C. difficile on BHI 1% agar plates and plates 
were incubated anaerobically overnight. PFU/ml was calculated by this equation: 
 (Number of plaques x 1/Dilution factor) x 100 = PFU/ml 
3.3.6.2   Plaque assays  
300 µl of overnight FA C. difficile culture was mixed with 1.5 ml semi-solid BHI agar, 
1.5 ml salts and 100 µl of phage stock. Mixture was mixed well, poured onto BHI 
1% agar plates, set for 5 minutes and incubated overnight at 37°C inside the anaerobic 
chamber. The plates were checked for complete lysis and plaques.   
3.3.6.3   Preparation of phage stock  
Over 20 plates of plaque assays were prepared. If confluent lysis was observed the soft 
agar layer of the plates was collected into a 50 ml centrifuge tube (Corning, USA) with 
an L-shaped spreader (Microspec, UK). The soft agar was mixed well by inversion and 
stored overnight at 4˚C. The next day, the sample was centrifuged at 5,000 x g for 
10 minutes to form an agar pellet. The supernatant was filtered through a 0.22 μm 
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pore filter (Millipore, USA) and the phage stocks were then stored at 4˚C. Filtered 
phage stocks were referred to as crude phage lysate.  
3.3.6.4   Phage propagation in liquid culture 
500 µl of overnight FA C. difficile culture was transferred to pre-reduced 50 ml BHI 
broth inside the anaerobic chamber. Optical Density (OD) at 550 nm wavelength was 
used to check growth of bacterial culture, for the optimum OD550 of 0.2. At this stage, 
100 µl of phage was added to the culture and left overnight. The samples were 
centrifuged at 5,000 x g for 10 minutes; the supernatant was filtered before its titre 
was calculated via spot tests as described in Section 3.3.6.1. 
3.3.7   Characterisation of C. difficile phages 
C. difficile phages were characterised by TEM, PFGE, one step growth curves and host 
range analysis. 
3.3.7.1   Transmission electron microscopy 
TEM was conducted by Stefan Hyman and Natalie Allcock (The Electron Microscope 
Laboratory, University of Leicester, UK). Before addition of phage samples, Athene 
3 mm copper grids (Agar Scientific, UK) were prepared by carbon coating for 
3 seconds, after which high-voltage glow was discharged for 30 to 60 seconds and 
then coated with 0.25% pioloform. A phage sample (8 µl) was transferred to the grids 
and stained with 5 µl of 1% uranyl acetate (wt/vol) for 5 to 10 seconds. Phages were 
visualised with a JEOL 1220 (Joel, UK) TEM run at 80 kiloVolts (kV) and the images 
were taken by the SIS Megaview III camera with analySIS software (Olympus) 
(Hargreaves et al. 2013b; Shan et al. 2012). 
3.3.7.2   Pulse-field gel electrophoresis  
To 100 µl of high titre phage lysate (approximately 109 PFU/ml) prepared as described 
in Section 3.3.6.3, 1 µl of 30 mg/ml DNase and 1 µl of 100 mg/ml RNase (Sigma, UK) 
were added and incubated overnight at 37°C. The next day agarose plugs were made 
with 0.5 x Tris-Borate-EDTA (TBE) Buffer (Chapter 9, Table 9.2), 24 mg agarose 
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(Seeplaque, UK) and heated to 100°C until the agarose dissolved. 40 µl of the enzyme 
treated phage was mixed with 40 µl melted agarose, transferred to a gel mould and 
left to set at 4°C for 3 hours. The plugs were then excised from the gel mould and 
transferred to 1 ml of lysis Buffer (Chapter 9, Table 9.2) with 0.5 mg/ml Proteinase K 
(Sigma, UK). The plugs were incubated overnight at 55°C and were washed with 40 ml 
of 1 x Tris-EDTA (TE) Buffer (Chapter 9, Table 9.2). 
A 1% agarose gel in 0.5 x TBE Buffer was prepared and set in a gel case at room 
temperature for 20 minutes. The washed plugs were inserted into the gel wells, 
alongside a low range DNA ladder at a final concentration of 25 µg/ml (New England 
Biolabs, UK) and the tops of the wells were sealed with agarose (Seeplaque, UK). The 
gel was carefully placed in the PFGE gel box with these settings: initial switch time of 
5 seconds, final switch time of 13 seconds, run time 17 hours at 6 Volts/cm and set at 
an angle of 120°. The gel was then carefully removed and stained with 200 ml of 
0.5 x TBE Buffer, 10 µl of 0.2 µg/ml ethidium bromide and gently rocked for 2 hours. 
The gel was viewed under UV light with a G:BOX, Genesnap (Syngene, UK). 
3.3.7.3   One step growth curve 
A previously described protocol with slight alterations was used for one step growth 
analysis (Ellis and Delbruck 1939; Hyman and Abedon 2009). 5 ml of overnight 
C. difficile BHI culture (Section 3.3.1) was transferred to 45 ml pre-reduced BHI broth 
and grown until an OD550 of 0.3 was reached. The culture was then infected with 
phage at a Multiplicity Of Infection (MOI) of 0.01, which is the ratio of phage to 
bacterial cells i.e. at MOI 0.01 for every 100 bacterial cells there is one phage. After 
which phages were left to adsorb to C. difficile cells for 15 minutes and during this 
time the phage infected culture was gently mixed at regular intervals. The host and 
phage suspension was pelleted via centrifugation at 5,000 x g for 10 minutes, washed 
once with 5 ml pre-reduced BHI broth and the centrifugation step was repeated. The 
pellet was re-suspended in 5 ml of BHI broth and then diluted to 50 ml. At specific 
time-points, every 20 minutes for 180 minutes, 5 ml of the host/phage suspension was 
taken and 3 ml was used for OD550 reads. 1 ml was used to calculate CFU/ml and 
PFU/ml count by the Miles and Misra (1938) method, which is described in Section 
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3.3.6.1. For the PFU/ml count the suspension was centrifuged at 21,000 x g for 
5 minutes prior to spotting on a lawn of C. difficile.  
3.3.7.4   Host range analysis 
Spots tests were conducted as described in Section 3.3.6.1 to determine the infectivity 
of all C. difficile phages at a titre of approximately 2 x 108. Representative isolates of 
dominant C. difficile ribotypes found within the UHL Trust, UK and the environment 
were screened. Clearing, plaques, turbid clearing and no clearing were noted (Figure 
3.1). Three biological replicates were performed, each with three technical replicates 
and the average phage infectivity was noted. 
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Figure 3.1 Images represent different types of phage infection observed in host range 
analysis. 
 
A C. difficile phage was spot tested on a lawn of C. difficile culture to identify if the 
phage could infect the strain, after which the plate was incubated anaerobically 
overnight. The subsequent day the plate was checked for infection and examined for 
a) clearing that represented complete lysis, b) phage plaques, c) turbid clearing and 
d) no clearing that represented no infection. 
 
 
 
Figure 3.2 Equipment used for chromatography-based phage purification. 
Image a) the strong anion exchange QA methacrylate-based CIM® disk (3 x 12 mm I.D., 
CV: 0.34 ml) monolithic column (BIA Separations, Slovenia). Image b) the CIM®QA disk 
monolithic column was attached to an AKTA® 10 purifier FPLC system (GE Healthcare 
Life Sciences, UK).   
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3.3.8   Chromatography-based purification and concentration of phages  
3.3.8.1   Phage purification with CIM®QA monolithic column 
A strong anion exchange QA (Quaternary Amine) methacrylate-based CIM® disk 
(3 x 12 mm I.D., CV: 0.34 ml) monolithic column (BIA Separations, Slovenia) was used 
to purify crude phage lysate (Figure 3.2a). The phage lysate solution was prepared by 
overnight dialysis of 4 ml of phage lysate against 3 L of SM Buffer without NaCl 
(8 mM MgSO4.7H2O and 50 mM Tris–HCl). Phage binding Buffer A consisted of SM 
Buffer without NaCl and elution binding Buffer B was made with 2 M NaCl SM Buffer 
(2 M NaCl, 8 mM MgSO4.7H2O and 50 ml of 50 mM Tris–HCl) (Chapter 9, Table 9.2). 
CIM®QA disk monolithic column was attached to an AKTA® 10 purifier FPLC system 
(GE Healthcare Life Sciences, UK) (Figure 3.2b). It was first equilibrated with Buffer B 
then Buffer A for ten column volumes before phage was loaded either through an 
injection valve with a 5 ml sample loop or through the FPLC pump. Absorbance at 280 
and 260 nm was measured, flow rate was fixed at 3 ml/minute and the length of the 
run was approximately 45 minutes.  
Elution of phage from column was initially optimised with a linear gradient of 
Buffer B that ranged from 0 to 2 M NaCl and the preferred method for elution was a 
stepwise gradient of three steps: 0.2 M, 0.4 M and 2 M Buffer B for 20 column 
volumes. Eluted fractions were collected and the phage titres were calculated via spot 
tests (Section 3.3.6.1). 
3.3.8.2   Purification of phage DNA with CIM®DEAE monolithic column 
Phage was purified with the weak anion exchange CIM®DEAE (Diethylamine) 
monolithic column (BIA separations, Slovenia) that consisted of a disk shaped highly 
porous matrix inside a non-porous self-seal fit ring (3 x 12 mm I.D., CV: 0.34 ml). Phage 
lysate was treated to release phage DNA from capsid before being loaded onto the 
column. This was done by addition 10 mM Ethylenediaminetetraacetic acid (EDTA) and 
DNase (30 mg/ml), RNase (100 mg/ml), Benzonase (100 mg/ml), which were all 
incubated at 37°C for 2 hours or Proteinase K (50 mg/ml) incubated at 55°C for 1 hour 
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(all reagents from Fisher Bioreagents, UK). The phage was then placed in liquid 
nitrogen for 10 seconds and heat shocked at 70°C for 10 minutes. 
The lysed phage solution was bound to the CIM®DEAE monolithic column with 
binding Buffer C (0.125 M NaCl, 1 mM EDTA, 10 mM Tris, 15% propan-2-ol). Phage 
DNA was eluted with the elution Buffer D (2 M NaCl, 1 mM EDTA, 10 mM Tris, 15% 
propan-2-ol). Buffers were filtered and degassed before use (buffers are listed in 
Chapter 9, Table 9.2).  
CIM® DEAE monolithic disk were placed and attached to an AKTA® 10 purifier FPLC 
system as per the manufactures instructions (Figure 3.2b). The system was first 
equilibrated with distilled water followed by a pump wash purifier step with Buffers A 
and B at flow rate 4 ml/minute. Absorbance at 280 and 260 nm was observed. 
Between runs, the monolithic column was washed with 0.5 M NaOH for 10 column 
volumes to remove any residual DNA contamination.  
For phage purification 4 ml of lysed phage was injected with the 5 ml sample loop. 
Elution was carried out with a linear gradient from 0 to 50% Buffer B for 30 column 
volumes followed by step gradient from 50 to 100%. Fractions were subsequently 
collected. Eluted fractions were precipitated and phage DNA extracted with 1 volume 
of propan-2-ol (Fisher Scientific, UK) that was incubated for 1 hour on ice followed by 
centrifugation at 14,000 x g for 20 minutes at 4°C. The pellet was washed with 
70% ethanol, centrifuged again at 14,000 x g for 20 minutes at 4°C, air-dried for 10 
minutes and re-suspended in 30 µl of ultra-purified water. This was then run on a 1% 
agarose gel to validate the isolation of phage DNA and to check for genomic 
contamination. 
3.3.9   Statistical analysis 
GraphPad Prism 6 was used for all statistical analysis, which includes calculated 
averages, Standard Error of the Mean (SEM) and p values calculated by T-tests.  
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3.4   Results 
3.4.1   Isolation of C. difficile strains and C. difficile phages  
Ten water and three soil samples were collected from the River Tame and used as 
material for isolation of C. difficile strains and associated phages.  
3.4.1.1   Isolation of C. difficile strains via enrichment 
After enrichment as described in Section 3.3.3, the 13 samples were streaked in 
triplicate on CCEY plates, therefore there were 39 plates in total. A range of colony 
morphologies were observed from round to irregularly shaped colonies but C. difficile 
forms distinct star shaped colonies on CCEY agar (Figure 3.3). On 36/39 plates bacterial 
colonies were visible. Colonies were picked from these CCEY plates from each sample 
(round or star shaped) and a series of further tests were conducted to determine 
whether these colonies were C. difficile (Table 3.2). For the first test plates were 
viewed under UV light and 25/39 plates had the positive yellowish-greenish glow but 
the remaining 14/39 plates had blue or red glow instead. The next test was to 
characterise the smell produced by the samples. Plates were checked for the ‘horse 
manure’ odour and 25/39 samples produced the scent whilst 14/39 had no distinct 
smell. 
Samples were characterised further via PCR. The PCR with 16S C. difficile-specific 
primers found 22/39 samples had the correct size PCR product. However, the results 
from the PCR found not all the samples produced the expected band; therefore a 
subsequent PCR with universal 16s primers was conducted (Figure 3.4). 36/39 samples 
produced the correct size band on the 1% agarose gel and 16/39 PCR products were 
sequenced (Table 3.3). Sequences were then compared to the database: Nucleotide 
National Center for Biotechnology Information NCBI Blast (USA) to identify the isolated 
bacteria (http://blast.ncbi.nlm.nih.gov-/Blast.cgi). NBCI Blast showed 9/16 were 
C. difficile isolates and these were the samples that were also positive for all 
characterisation tests. 2/16 were other Clostridia, 2/16 Lactobacillus, 1/16 Pediococcus 
acidilactici, 1/16 Serratia sp. and 1/16 Eubacterium contortum.  
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Figure 3.3 Image displays the morphology of C. difficile colonies (star shaped) when 
grown on CCEY agar selective media. 
 
 
Figure 3.4 Molecular characterisation of samples isolated from River Tame, 
Birmingham (UK) to determine if they are C. difficile.  
1 kb ladder followed by samples 1-39: isolates from the River Tame, 40: positive 
control with DNA isolated from C. difficile strain T6 (R076) and 41: negative control 
that had the PCR mix with no template.  
Image a) results from PCR with C. difficile-specific primers FCD16S and RCD16S that 
target the small C. difficile 16S rRNA. If positive, a band of approximately 157 bp is 
visible on a 1% agarose gel. 22/39 isolates showed the correct size band. Image b) 
results from PCR with universal 16S primers 8F and 1391R that target the conserved 
16S rRNA bacterial gene. If positive, a band of approximately 1200 bp band is visible 
on a 1% agarose gel. 36/39 isolates showed the correct size band. 
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Table 3.2 Summary of samples collected from the River Tame, Birmingham (UK). A tick represents a positive result.  
a Approximate band size of 157 bp visualised on a 1% agarose gel. 
b Approximate band size of 1200 bp visualised on a 1% agarose gel. 
 
Sample number Star shaped 
colonies on CCEY 
plates 
Round colonies 
on CCEY plates 
Growth on 
blood agar 
plates  
 
Glow under 
ultraviolet light 
‘Horse manure’ 
odour  
Positive band 
for C. difficile-
16s specific 
primersa 
Positive band 
for universal 16S 
primersb 
1        
2        
3        
4        
5        
6        
7        
8        
9        
10        
11        
12        
13        
14        
15        
16        
17        
18        
19        
20        
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Table 3.2 continued 
a Approximate band size of 157 bp visualised on a 1% agarose gel. 
b Approximate band size of 1200 bp visualised on a 1% agarose gel. 
Sample 
number 
Star shaped 
colonies on 
CCEY plates 
Round colonies 
on CCEY plates 
Growth on 
blood agar 
plates  
 
Glow under 
ultraviolet light 
‘Horse manure’ 
odour  
Positive band 
for C. difficile 
specific 
primersa 
Positive band 
for universal 
16S primersb 
21        
22        
23        
24        
25        
26        
27        
28        
29        
30        
31        
32        
33        
34        
35        
36        
37        
38        
39        
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Table 3.3 NCBI blast results of bacterial 16s rRNA gene from samples isolated from the 
River Tame.  
Sample Bacteria (Top hit)a e-valueb Percentage 
similarity (%)c 
Accession 
numberd 
2 Clostridium difficile BI1 0.00 99 FN668941.1 
3 Clostridium difficile BI1 0.00 99 FN668941.1 
5 Pediococcus acidilactici strain 
LAB4 
0.00 99 KF111711.1 
7 Clostridium frigidicarnis 0.00 99 AB610573.1 
9 Clostridium perfringens strain 
LGM-J1 
0.00 99 JF764801.1 
10 Lactobacillus casei strain T22 16S 0.00 99 KM350168.1 
12 Serratia sp. FW2 16S ribosomal 
RNA gene, partial sequence 
0.00 99 JN674080.1 
18 Clostridium difficile BI1 
chromosome, complete sequence 
0.00 99 FN668941.1 
20 Lactobacillus mucosae strain: JCM 
7717 
0.00 99 AB911466.1 
23 Clostridium difficile BI1 
chromosome, complete sequence 
0.00 99 FN668941.1 
24 Clostridium difficile BI1 
chromosome, complete sequence 
0.00 99 FN668941.1 
27 Clostridium difficile BI1 
chromosome, complete sequence 
0.00 99 FN668941.1 
30 Clostridium difficile BI1 
chromosome, complete sequence 
0.00 99 FN668941.1 
32 Clostridium difficile BI1 
chromosome, complete sequence 
0.00 99 FN668941.1 
35 Eubacterium contortum strain 
DSM 3982T, clone 2 
0.00 97 KC331160.1 
37 Clostridium difficile BI1 
chromosome, complete sequence 
0.00 99 FN668941.1 
a NCBI blast was used to determine which bacteria the isolates had closest homology 
to. Only the top hit has been shown. 
b e-values represent the probability the alignment occurred by chance. 
c The percentage similarity of the isolate sequence to the top hit.  
d Accession number is the unique identifier given to the DNA sequence.  
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3.4.1.2   Isolation of C. difficile phages via enrichment 
The 13 enriched soil and water samples were screened for phages and were spotted 
on lawns of C. difficile strains AIU (R027), T6 (R076) and ATJ (R014/020). Small, round 
plaques were visible that had diameters between 0.5 to 1 mm for 7/13 samples on 
strains T6 and ATJ.  
3.4.1.3   C. difficile phage morphology 
TEM revealed all seven phages belong to the Myoviridae family within the order 
Caudovirales with contractile tails reminiscent of members from this family (Figure 
3.5). The phages differed in their overall size and the capsid diameters varied from 
63.0 nm to 73.4 nm (Table 3.4). Tail lengths ranged from 131.3 nm to 264.4 nm.  
3.4.1.4   C. difficile phage genome size 
The genome size of the seven phages was estimated with PFGE (Section 3.3.7.2) and 
the results showed that all the genome sizes were very similar (Figure 3.5). All seven 
phages have dsDNA genomes and the size of the genomes ranged from approximately 
45-55 kilo base pair (kbp) on the basis of their migration on the gel in relation to the 
ladder. Phages T6ɸ1 and T6ɸ2 have the smallest genomes (Table 3.4). 
3.4.1.5   C. difficile phage growth analysis 
Investigation of phage growth parameters via the one-step growth curve experiment 
provided an insight into one synchronised infection cycle of the phage. Phage growth 
analysis was studied for the seven new phages (Figure 3.6) and a general pattern was 
observed for all phages. This was at time-point 0 minutes the PFU/ml count was 0 and 
represented adsorption of all phages and the start of both the latent and eclipse 
periods. From 20 to 40 minutes a steady increase in the PFU/ml count was observed 
showed by the steep linear line on all graphs in Figure 3.5. This represented the first 
phage burst.  
Although a general trend was observed for all seven phages, the latent periods and 
burst sizes varied between the phages. 3/7 phages had short latent periods of 
approximately 20 minutes and 4/7 phages had longer latent periods. After the latent 
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period, a rise in PFU/ml was noted and phage burst was calculated as the division of 
the PFU/ml count at the end of the first phage burst by the PFU/ml count at the end of 
the latency period. The phage burst per infected cell was calculated with the below 
equation: 
Phage burst / initial bacterial count = phages released per infected cell 
T6ɸ1 had the smallest burst size with a release of 70 phages per infected cell and 
T6ɸ6 had the biggest burst size at 360 infectious particles produced per cell. Phages 
T6ɸ3, T6ɸ4 and T6ɸ7 had very similar burst sizes, where 110 to 150 infectious 
particles were released per bacterial cell (Table 3.4). Three different lengths of the first 
complete phage replication cycle across the seven phages were found: 60 minutes for 
phages T6ɸ1 and T6ɸ5, 80 minutes for phages T6ɸ2, T6ɸ3 and T6ɸ7 and 100 minutes 
for phages T6ɸ4 and T6ɸ6.  
After the first full infection cycle a drop in the PFU/ml count was noted and 
displayed on the one-step growth curves as a dip. This represented the latent period 
where the new phage progeny had infected and began replication inside bacterial 
cells. At around 160 minutes, the start of the second phage burst was observed by the 
increase in the PFU/ml count for phages T6ɸ1, T6ɸ2 and T6ɸ7. Phage T6ɸ5 had the 
fastest replication cycle and the second phage burst was observed earlier at 
140 minutes. 
The initial CFU/ml count for all seven one step growth curve experiments was 
approximately identical. After, for phages T6ɸ2, T6ɸ4 and T6ɸ5 the CFU/ml count 
remained steady throughout the 180 minutes time course but for 4/7 phages CFU/ml 
fluctuated. With phage T6ɸ1 there was a reduction in the CFU/ml from 60 to 
140 minutes followed by an increase. For phages T6ɸ3, T6ɸ6 and T6ɸ7 the CFU/ml 
count oscillated too and for all the three phages a significant increase in the CFU/ml 
was noted after 160 minutes. 
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Table 3.4 Properties of seven isolated C. difficile phages from the River Tame, Birmingham (UK). 
                                                           C. difficile phages 
 T6ɸ1 T6ɸ2 T6ɸ3 T6ɸ4 T6ɸ5 T6ɸ6 T6ɸ7 
Phage isolated on C. difficile  
strainsa 
T6 and ATJ  T6 and ATJ T6 and ATJ T6 and ATJ T6 and ATJ T6 and ATJ T6 and ATJ 
Phage morphologyb 
 
       
Width of phage capsid (nm) 63.0 ± 4.7 73.4 ± 5.4 70.3 ± 1.3 69.2 ± 1.5 66.1 ± 1.9 65.1 ± 1.3 67.5 ± 4.5 
Length of tail (nm) 247.4 ± 8.6 264.4 ± 8.6 144.4 ± 1.7 245.5 ± 3.9 131.3 ± 5.2 141.3 ± 4.0 249.5 ± 7 
Classification  Myoviridae Myoviridae Myoviridae Myoviridae Myoviridae Myoviridae Myoviridae 
Approximate genome  
size (kb)c  
48 48 52 52 52 53 50 
One step growth curved 
 
       
Number of phages released 
per infected celle 
70 ± 1 80 ± 2 140 ± 2 150 ± 3 100 ± 1 360 ± 1 110 ± 1 
Length of first infection 
cycle (minutes) 
60 80 80 100 80 100 80 
a T6 is classified as R076 and ATJ as R014/020. 
b The width of phage capsid and the length of tails were measured on five different phage particles and the mean values are presented with ± 
standard deviation. 
c Phage genome sizes were estimated through PFGE analysis. 
d One step growth curve experiments were conducted at MOI 0.01. 
e Mean yield of viruses per infected bacterial cell presented with ± standard deviations were calculated from three biological replicates, each with 
three technical repeats.   
Chapter 3 
69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Morphology of isolated C. difficile phages from the River Tame, Birmingham (UK).  
Phage samples 1: T6ɸ1, 2: T6ɸ2, 3: T6ɸ3, 4: T6ɸ4, 5: T6ɸ5, 6: T6ɸ6 and 7: T6ɸ7.  
a) TEM images of the seven phages and their structures reveal they belong to the Myoviridae family. The white bars represent 200 nm. b) PFGE 
analysis was performed to estimate the sizes of the phage genomes. Phage DNA was run on PFGE, gel stained with ethidium bromide and 
visualised under UV light. A low range PFGE ladder was included and the genome sizes of the phages ranged from 45 to 55 kb. 
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Figure 3.6 One-step growth analysis at MOI of 0.01 of seven C. difficile phages isolated from the river Tame, Birmingham (UK).  
One step growth curves were carried out for 180 minutes and at regular 20 minutes intervals CFU/ml (black line) and PFU/ml (grey line) were 
determined. For each data point mean of CFU/ml and PFU/ml were calculated from three biological replicates, each with three technical 
repeats ± SEM. Graphs represent one-step growth curves for phages a) T6ɸ1, b) T6ɸ2, c) T6ɸ3, d) T6ɸ4, e) T6ɸ5, f) T6ɸ6 and g) T6ɸ7. 
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3.4.2   Host range analysis 
Host range analysis was conducted for the seven phages isolated in this study 
(Chapter 9, Table 9.4) and for 25 C. difficile phages (Table 3.1 and Chapter 9, Table 9.3) 
previously isolated in our laboratory. Phages were screened against 160 C. difficile 
isolates: 115 clinical and 45 environmental strains, which in total consisted of 29 
different ribotypes (different genotypes). Therefore for each ribotype one or more 
representative isolates were screened. 
3.4.2.1   Host range analysis of the seven newly isolated C. difficile phages   
All seven phages were able to infect 16/16 isolates from the clinically relevant ribotype 
R014/020. Also 5/7 phages were able to infect 7/7 isolates of R220 whilst 2/7 phages 
were able to infect all but one isolate of R220. However, the phages were unable to 
infect 11/29 ribotypes screened, which included: 012, 013, 023, 027, 081, 087, 100, 
103, 016, 107 and 137 (Table 3.5).  
Phage T6ɸ6 had the broadest host range and infected 35% of all isolates screened 
that covered 15/29 ribotypes. The next broadest phages were: T6ɸ3 that infected 34% 
of all isolates, which accounted for 15/29 ribotypes, T6ɸ7 infected 33% of isolates of 
16/29 ribotypes and T6ɸ5 infected 24% of 10/30 ribotypes. Phages T6ɸ1 infected 8/29 
of ribotypes, T6ɸ2 infected 8/29 ribotypes and T6ɸ4 infected 6/30 ribotypes. Phages 
T6ɸ2 and T6ɸ4 had the narrowest host ranges and infected 19% of isolates (Figure 
3.7). However, it should be noted that when mentioning the number of ribotypes the 
phages can infect, it means there are able to infect at least one isolate from the 
ribotype. In most cases the phages were not able to infect all isolates for one ribotype. 
Phages T6ɸ3, T6ɸ6 and T6ɸ7 have almost identical host ranges and all could infect 
R009 and 9/11 isolates of R010, R021, R026 and R035. All three phages were also able 
to infect the same 1/17 isolate of R078. There were two exceptions where there were 
differences in host range, the first only where phage T6ɸ6 was able to infect 1/13 
isolates of R002. The second was where only phages T6ɸ6 and T6ɸ7 were able to 
infect 1/20 isolates of R015. 
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Overall a pattern was noted with the host range analysis and strain specificity. It 
was found that a number of phages were able to only infect a single isolate from a 
specific ribotype and not infect other isolates from the same ribotype. An example of 
this was for 1/7 isolates of R005, where 5/7 phages were only able to infect one isolate 
and no others. This was also found for R087 where 5/7 phages could infect 1/3 isolates 
from this ribotype. 
Turbid clearing was also noted with the host range analysis and is usually a result of 
incomplete clearing or may be the result of an infection by temperate phages. This 
was observed as a hazy clearing. 6/7 phages produced turbid clearing on all or some of 
these ribotypes: 002, 013, 015 and 017. Phage T6ɸ1 produced the most turbid clearing 
on 4/160 isolates. In comparison, phage T6ɸ4 did not produce any turbid clearing. 
Although it should be noted turbid clearing could also resemble clearing from a phage 
that has a low plaquing efficiency on the strain being screened. This means (plaquing 
efficiency) on one host the phage may be able to propagate itself to a titre of 8 x 108 
but on another host the same phage may amplify itself at a significantly lower titre to 
only 8 x 104. This could be seen as hazy clearing.  
3.4.2.2   Host range analysis of C. difficile phage catalogue 
From the C. difficile phage catalogue 23/25 phages were able to infect at least one 
clinical relevant ribotype but ribotypes 017, 085, 103 and 137 were not infected by the 
current phage collection (Table 3.5). Although these four ribotypes have not been 
reported as prevalent infecting ribotypes.  
The phages with the broadest host range were: 
• AIUфX2 that infected 17/29 ribotypes and 32% of 160 isolates. 
• T6ф12eH that infected 13/30 ribotypes and 29% of 160 isolates. 
• T6фF2 that infected 8/30 ribotypes and 16% of 160 isolates.  
• ATJɸH2 that infected 8/30 ribotypes and 14% from 160 isolates.  
Phages S7ф7, S7ф10, S7фH3, T6ф12, T6ф7h and ATJфH3 also had broad host ranges 
and infected clinically relevant ribotypes (Figure 3.7). 
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Some phages showed trends, such that they were able to infect all isolates within a 
ribotype as observed for the R027. Phages AIUфX2 and T6ф12eH were the only phages 
able to infect all clinical and environmental R027 isolates, which included 22 MVLA 
typed strains (Fawley et al. 2008). However, phages S1ɸ5B, S1ɸ10bH and ATJɸH2 
were able to only infect one or both of the environmental strains of R027 but none of 
the clinical isolates. Another trend was observed for R014/020, as all representative 
isolates from this ribotype were infected by phages T6фF2 and T6ɸH2. Again though, 
phages T6ɸ7H, T6ɸ12eH, T6ɸ12, ATJɸF2, ATJɸH2 and AIUɸX2 only infected a few 
isolates from R014/020. 
 However, with most phages a pattern was not observed and phages were highly 
specific to one ribotype or to individual isolates within a ribotype. Therefore, if the 
phage displayed different specificity on different isolates from the same ribotype, this 
highlighted the very specific nature of the phage. For example phage S1ф5b was only 
able to infect 1/4 isolates from R031. This was also found with R078 where phages 
T6ɸF2 and S1ɸ10H infected only 1/17 isolates tested and phage T6ɸ12eH could infect 
3/17 strains. 
Aside from lytic clearing produced by phages, 22/25 phages produced turbid 
clearing and overall this was only found with 6% or less of isolates screened. The 
highest was noted with phage T6ɸ12eH for 6% of clinical and environmental isolates 
from R002, R010, R014/020, R015, R031 and R087. In addition, phage S1ɸ16 produced 
turbid clearing on 4% of isolates from R002, R010, R013, R021, R026 and R220. 
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Figure 3.7 The percentage infectivity for 32 C. difficile phages against 160 environmental and clinical C. difficile isolates, which represent 29 
different ribotypes.  
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Table 3.5 The number of ribotypes infected by 32 C. difficile phages isolated at the University of Leicester, UK (Table 9.3 and Table 9.4).
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005 7                                 
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010 11                                 
012 1                                 
013 3                                 
014/ 
020 
16                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
015 12                                 
017 1                                 
021 4                                 
023 1                                 
026 4                                 
027 25                                 
031 4                                 
035 1                                 
050 1                                 
076 1                                 
078 17                                 
081 1                                 
087 3                                 
100 2                                 
103 3                                 
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137 1                                 
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3.4.3 Optimisation of chromatography-based phage purification and 
concentration  
C. difficile phage T6ɸ12eH has a broad host range and is able to infect clinically 
relevant ribotypes. Due to this reason the phage was selected to optimise 
chromatography based phage purification. High titre stock of 8 x 109 PFU/ml phage 
T6ɸ12eH was used and purposes of the experiments were: 
1. To design a protocol to purify and concentrate phages with the CIM®QA disk 
monolithic column.  
2. To design a rapid method to extract phage DNA with the CIM®DEAE disk 
monolithic column. 
3.4.3.1   Phage purification and concentration  
A method was developed to purify T6ɸ12eH phage lysate by chromatography with the 
CIM®QA disk monolithic column. Initially a linear gradient from 0 to 100% of Buffer B 
was used to identify at what percentage and concentration phage was eluted at. As a 
test 3 ml of dialysed phage T6ɸ12eH was loaded onto the CIM®QA disk monolithic 
column. The run was repeated three times and in all occasions three peaks were 
observed at wavelengths 280 and 260 nm (Figure 3.8a). The first peak was due to the 
flow through, the step where the column is washed with Buffer A and so the peaks of 
interest were the second and third. The second peak was distinctly larger than the 
third. The larger peak was observed at approximately 20% of Buffer B (0.4 M NaCl of 
Buffer B) and the third peak between 40 to 60 % of Buffer B (0.8 to 1.2 M NaCl of 
Buffer B). All fractions were collected to determine which peak was the phage elution 
peak. It was found that during the flow through step 3.4% of phage was lost. For the 
larger peak 4% of phage T6ɸ12eH was recovered and for the smaller peak 0.3%. 
Therefore, it can be predicted phage was eluted at the second peak. 
Since phage T6ɸ12eH was eluted at 20% of Buffer B, the second run incorporated a 
step gradient of Buffer B at 20, 40 and 100% (Figure 3.8b). Again 3 ml of phage lysate 
was loaded, repeated three times and a similar chromatogram to the first attempt 
with the linear gradient was observed. Two peaks were present at 20 and 40% of 
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Buffer B respectively and the second peak was approximately the same height as the 
first peak. Recovery of phage T6ɸ12eH remained low with mean values for phage 
recovery at the flow through step of 1%, at 20% of Buffer B was on average 6% and at 
40% Buffer B was 2.2 % (Table 3.6).  
Runs with CIM®QA disk monolithic column were repeated but different initial 
volumes of phage T6ɸ12eH were added to establish the capacity of the column. This 
was to investigate if C. difficile phage purification could be conducted on a larger scale 
with the column and volumes used were: 10, 20, 22, 25 and 75 ml. For each volume 
runs were repeated twice and average values were calculated. Phage recovery varied 
between the volumes and results are summarised in Table 3.6 but the highest total 
phage recovery was noted with 75 ml of phage at 28.71%. However, 7.48% of phage 
was lost during the flow through step and this was also the highest phage loss found at 
the flow through step. When 20 ml of phage was loaded, 27.92% of phage was 
recovered and only 0.26% of phage was lost at the flow through. From the results it 
can be concluded 20 ml of phage loaded onto the column may be the optimum 
volume to maximise phage output. The lowest recovery was found with 22 ml of 
phage at 0.58%, with 0.22 % phage lost at the flow through step. 
It should be noted that the optimised phage purification method with the CIM®QA 
disk monolithic column used in this study did not consistently yield the same results. 
For some runs phage elution peaks on the chromatogram were low (Figure 3.8c) and 
this correlated with less than 4% phage recovery. 
3.4.3.2   Chromatography to extract phage DNA 
A protocol was devised to purify phage T6ɸ12eH with CIM®DEAE monolithic column in 
order to then extract DNA from the purified phage sample. Phage lysate loaded onto 
the column was prepared in three different ways: 
1. Untreated crude phage lysate. 
2. Phage lysate treated with DNase, RNase and Proteinase K that were added 
individually to remove bacterial DNA and protein. 
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3. Phage lysate treated with Benzonase, which is a combination of both DNase 
and RNase to remove bacterial DNA. 
A liner gradient for the elution of Buffer D (Section 3.3.8.2) was used up till 50% 
(1 M NaCl) for all three prepared phage samples and phage was eluted at 
approximately 10% of elution Buffer D (three biological replicates). Two peaks were 
visible on the chromatograms; the first peak was the flow through and the second 
represented phage elution (Figure 3.9). The only difference between the pre-treated 
phage samples and the crude phage sample was that with the crude sample the peak 
was sharper and taller. For all samples phage elution occurred between fractions six to 
nine. 
After the run, phage DNA was extracted from fractions where phages were eluted. 
To confirm DNA had been collected, samples were run on a 1% agarose gel (Figure 
3.10). Strong DNA bands were visualised on the gel from crude phage lysate run on the 
column and phage lysate pre-treated with DNase, RNase and Proteinase K. However, 
for phage T6ɸ12eH pre-treated with Benzonase a very faint DNA band was observed, 
which represented a low DNA yield. 
Although, a bright DNA band was observed on the 1% agarose gel and the DNA 
concentration was 25 ng/μl with the crude phage DNA sample, there was a large 
smear (brightness on the gel was the same as the DNA band itself) near the bottom of 
the agarose gel. The smear could represent bacterial protein or bacterial RNA 
contamination. In addition, a fraction after the peak of DNA elution was collected with 
the crude phage sample and DNA was also extracted from this fraction. However, a 
very faint DNA band was observed on the agarose gel and the DNA concentration was 
low. 
Similar to the crude phage lysate, the phage samples pre-treated with DNase, 
RNase and Proteinase K also had bacterial contamination. This was visible on the 
agarose gel as a very strong DNA band was present on the top of the well. This was 
unexpected as precautions were taken to remove bacterial genomic DNA 
contamination. However, the phage sample pre-treated with Benzonase had no 
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bacterial genomic contamination but a very faint phage DNA band was observed on 
the agarose gel.  
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Figure 3.8 Chromatograms represent gradient elution of phage T6ɸ12eH with CIM®QA disk monolithic column connected to a FPLC machine. 
 
Dotted black line shows UV at 280 nm, black line shows UV at 260 nm, grey line represents concentration of Buffer B and fractions are labelled 
at the bottom of the graphs.  
 
A flow rate of 3 ml/minute was used and 3 ml of phage T6ɸ12eH phage lysate was injected. Graph a) shows addition of Buffer B with a linear 
gradient to investigate at what concentration of Buffer B phage is eluted at. Graph b) represents phage elution at a step gradient of 20, 40 and 
100% addition of Buffer B.  
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Table 3.6 The recovery of phage T6ɸ12eH after purification with CIM®QA Monolithic 
column. 
 
 
 
 
Figure 3.9 Chromatograms represent elution of lysed phage T6ɸ12eH with the CIM®QA 
CIM®DEAE monolithic column connected to a FPLC machine. 
Dotted black line shows UV at 280 nm, black line shows UV at 260 nm, grey line 
represents concentration of Buffer B and fractions are highlighted at the bottom of the 
graphs.  
 
A flow rate of 3 ml/minute was used and 4 ml of lysed phage T6ɸ12eH lysate was 
injected. Graphs show results for a) no prior pre-treatment of lysed phage lysate. 
Graph b) pre-treatment of lysed phage lysate with DNase, RNase and Proteinase K or 
Benzonase.  
T6ɸ12eH initial 
phage titre 
Volume of phage 
T6ɸ12eH loaded (ml) 
Percentage (%) of 
phage T6ɸ12eH lost 
in flow through 
Total percentage (%) 
recovery of phage 
T6ɸ12eH 
1.67 x 108 3 3.4 12 
1.95 x08 10 0.06   2.17 
2 x 108 20 0.26 27.92 
2 x 108 22 0.22 0.58 
2 x 108 25 0.63 8.09 
2 x 108 75 7.48 28.71 
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Figure 3.10 1% agarose gel illustrates DNA extraction from phage T6ф12eH after 
purification of phage lysate with the CIM®DEAE monolithic column. 
The gel corresponds with the peaks observed on the chromatograms (Figure 3.9), from 
which fractions were collected and used to extract phage DNA. 
 
Lane 1: 1 kb ladder. Lane 2: DNA extracted from the fraction with the highest peak 
where lysed phage lysate was run on the column (DNA concentration was 25 ng/μl). 
Lane 3: DNA extracted from the fraction after the highest peak where lysed crude 
phage lysate was run on the column (DNA concentration was 5 ng/μl). Lane 4: DNA 
extracted from the highest peak fraction where lysed phage lysate was pre-treated 
with DNase, RNase and Proteinase K (DNA concentration was 36 ng/μl) to remove 
genomic bacterial DNA. Lane 5: DNA extracted from the highest peak fraction where 
lysed phage lysate was pre-treated with Benzonase to remove genomic bacterial DNA 
(DNA concentration was 2 ng/μl). 
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3.5   Discussion 
Current diagnostic tests used for detection of C. difficile from patients lack specificity 
and sensitivity. Consequently multiple tests are required to confirm presence of CDI, 
but still false-positives remain an issue. In addition, the tests are unable to distinguish 
between active infections and dead C. difficile cells (Burnham and Carroll 2013). In 
comparison, a phage-based diagnostic test would be able to differentiate between live 
and dead cells and such tests are both specific and sensitive. Ideal phages required for 
the development of a patient and environmental phage-based diagnostic assay would 
be phages that have a broad spectrum of infectivity. These are phages that can infect 
numerous ribotypes and so would ensure maximum coverage and detection of 
C. difficile. This chapter has focused on the isolation, characterisation and purification 
of such broad host range C. difficile phages.  
3.5.1   Isolation of C. difficile strains via enrichment   
It has been noted in the literature that phages are commonly isolated from sites where 
their bacterial hosts are abundant (Hargreaves et al. 2013a). C. difficile is copious in 
the natural environment and this was the reason why water and soil samples were 
taken from the River Tame, Birmingham (UK) polluted with sewage. The river is also an 
outlet for medical waste. The samples were collected in the hope of isolation of 
C. difficile phages that would be suitable for use in a diagnostic test.  
Both C. difficile and its target phages were successfully isolated from the samples 
via the enrichment method. A similar approach was used by Hargreaves et al. (2013a) 
who collected sediment and water samples for two consecutive years from an 
estuarine in Hampshire, UK polluted with sewage. 27 C. difficile strains were isolated 
from a total of 47 samples and from the 27 strains 20 phages were isolated. However, 
unlike the current study they were unable to isolate C. difficile from water samples and 
were only found in sediment samples. The reason could be that the bacterium was 
simply absent from the sample sites. Nonetheless, studies have found a high 
prevalence of C. difficile from samples taken from rivers, seas and lakes. In addition 
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the bacterium has also been isolated from tap water (Kotila et al. 2013; al Saif and 
Brazier 1996). 
From all the physical and molecular tests conducted to isolate and confirm 
presence of C. difficile for further work two tests would be sufficient: presence of star 
shaped colonies on Brazier’s CCEY plates and PCR along with sequencing. This is 
because both methods can discriminate for C. difficile even if other pathogens are 
present. This was the reason why Brazier’s CCEY media was used as current literature 
has suggested it to be the most selective media for C. difficile isolation (Burnham and 
Carroll 2013; Lister et al. 2014; Shapey et al. 2008). Furthermore, previous research 
conducted by Dr Krusha Patel in the Professor Martha Clokie’s laboratory, found that 
with CCEY media C. difficile yielded the highest recovery in comparison to FA or BHI 
media (personal communication with Dr Krusha Patel). In addition on CCEY media 
C. difficile produces distinctive star-shaped colonies, which were observed in the 
present study. However round colonies were also isolated and were identified as other 
bacterial species, for example Lactobacillus. Therefore Braziers CCEY media is not 
100% specific for C. difficile, but through colony morphology it was possible to 
differentiate C. difficile from other bacterial species.  
3.5.2   Isolation of lytic C. difficile phages  
In the hope of isolation of virulent lytic phages, which would be highly desirable for 
the development of the diagnostic test, as there would be no issue of lysogeny to 
consider, samples taken directly from the River Tame were filtered and spotted on 
lawns of C. difficile. However the attempt was unsuccessful and no phages were 
isolated via this method. Horgan et al. (2010) used the same method but was also 
unsuccessful despite screening a variety of samples, which included pig faecal, slurry 
samples, faecal samples from healthy humans, healthy pigs and inflammatory bowel 
disease patients. Another study conducted by Shan et al. (2012) screened 400 stool 
samples, that were C. difficile toxin A/B positive but still no lytic phages were isolated. 
Though, to date no true lytic C. difficile phages have been isolated. It has been 
hypothesised it could be due to the ability of C. difficile to exist as spores in the 
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environment due to extreme oxygen sensitivity. The spores may be insensitive to 
phage infection and therefore the propagation of lytic phages in these conditions is 
unlikely. Additionally, phages are unable to bind to C. difficile spores (personal 
communication with Dr Katherine Hargreaves) and consequently the phage infection 
cycle is unlikely to occur. Instead phages would favour the lysogenic cycle because 
prophages are not restricted by the availability of metabolically active anaerobic 
bacterial cells (Goh et al. 2005; Hargreaves and Clokie 2014; Sekulovic et al. 2011). 
3.5.3   Isolation of C. difficile phages from enriched samples 
Whilst lytic phages were not isolated by the previous method, seven phages were 
isolated from enriched samples that could potentially be used for the development of 
phage-based diagnostic test. The phages are highly likely to be spontaneous release of 
prophages as they were isolated from samples that were also positive for C. difficile. 
However, temperate phages could also be used in the development of the phage-
based diagnostic test, as long as the phages are able to infect C. difficile isolates 
lytically. To confirm that the seven phages are prophages their genomes would need 
to be sequenced and the integrase gene identified within their genome.  
A similar phage isolation approach was utilised by Mahony et al. (1985) who 
screened for spontaneous release of phages from 94 isolates of C. difficile and two 
phages were found. Likewise, Sekulovic et al. (2011) found 10% of faecal samples 
screened were positive for free phage but they were unable to isolate phages from 
sewage samples and water treatment plants, unlike the data produced in this study. 
Goh et al. (2005) was also unsuccessful in the isolation of phages from soil, animal 
faeces and untreated sewage samples from treatment plants collected in Australia. 
Various factors can affect phage isolation, which could possibly explain why 
Sekulovic et al. (2011) and Goh et al. (2005) were unsuccessful at isolating phages 
from water and soil samples. The major factor is the processing of collected samples 
and studies highlight that water and soil samples should be processed quickly and 
stored at 4°C for no longer than 48 hours. Therefore to maximise the chances of phage 
isolation samples were processed within four hours of collection. Another limiting 
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factor for phage isolation could be the selection of C. difficile isolates used as indicator 
strains. In the present study isolates from three different C. difficile ribotypes were 
chosen to screen the enriched samples from River Tame. Two clinically relevant 
ribotypes (R027 and R014/020) were used and T6 (R076), which is a ribotype 
commonly isolated from the environment. T6 was used because previous research 
conducted by Dr Katherine Hargreaves found this host to be particularly effective for 
phage isolation as five phages from the phage collection were identified on T6. This 
study further supports the theory that T6 is one of the ‘best’ hosts for phage isolation, 
as all seven phages were isolated on that host and were also able to infect the 
R014/020 isolate. The R076 and R014/020 strains are currently being sequenced and 
will provide insight into why they are so susceptible to phages. 
One argument could be that more phages may have been isolated if more 
C. difficile ribotypes were used to screen the filtered enriched samples. However, 
Sekulovic et al. (2011) used eight different ribotypes of C. difficile to screen for phages, 
that included three R027 strains but they were only able to isolate four phages. Goh et 
al. (2005) also found four phages but they used 16 different strains. These studies 
highlight that C. difficile phages have narrow host ranges and could explain why even 
after so many strains are used for phage isolation very few are isolated. In comparison, 
in this study a limited number of ribotypes were used but more phages were isolated. 
Again, this supports the idea that the best strains were used for phage isolation or it 
could be that phages were abundant in the sampling site used for phage isolation.   
3.5.4   Host range analysis of 32 C. difficile phages 
A thorough host range analysis was conducted on the seven newly isolated phages and 
25 C. difficile phages previously isolated in Professor Martha Clokie’s laboratory. This 
was to identify broad infecting phages that can be used for the development of the 
phage-based diagnostic test. This study is the first to screen a large collection of 32 
phages against 160 C. difficile isolates. Most ribotypes were infected by at least one 
phage from the catalogue of phages except 4/29 ribotypes. However the currently 
most dominant ribotypes in UK: 002, 005, 014/020, 015, 027 and 078 (England 2014) 
were all infected by at least three phages. Overall from the host range analysis three 
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distinct patterns were observed: some phages had broad host ranges, whilst others 
were highly specific to an isolate or ribotype and a number of phages could infect the 
same isolates.  
3.5.4.1   Broad host phages 
Phages T6ɸ12eH, T6ɸ12, T6ɸF2, T6ɸ7h and AIUɸX2 had the broadest host ranges and 
infected the most number of C. difficile isolates from clinically relevant ribotypes. Any 
of the five broad host phages would be ideal candidates to be used for the 
development of the phage-based diagnostic test. It should be noted, although the 
seven newly isolated phages were able to infect multiple ribotypes their range of 
infectivity was not as broad as the phages mentioned above and they infected 
significantly fewer ribotypes.  
Isolation of broad host range C. difficile phages has also been reported in the 
literature. For example, Sekulovic et al. (2011) isolated a broad host range temperate 
phage фCD38 that could infect 99/207 isolates, which represented 11 different 
ribotypes. However, the other ribotypes infected were not assigned by their official 
ribotype, instead they were labelled with internal nomenclature; therefore it is unclear 
exactly which ribotypes were infected by фCD38. 
3.5.4.2   C. difficile phages specific to one isolate or ribotype 
Phages 10ɸB2, S1ф5b, S1фS8, S1ф11 and S1ф17.1 had very narrow host ranges and 
were highly specific to one ribotype or to an individual isolate within a ribotype. Mayer 
et al. (2008) also found the C. difficile phage фCD27 had a very narrow host range and 
only infected 4/30 isolates. Similarly, Mahony et al. (1985) found that phages ɸ41 and 
ɸ56 could infect and 5/94 isolates respectively. Phages from this group would not be 
ideal candidates for the development of the bacterial diagnostic test due to increased 
specificity and thus limited number of isolates would be detected. Aside from specific 
phages a degree of overlap was observed with phage infectivity such that 15 phages 
were able to infect R014/020, 12 phages infected both R076 and R220. Another 
observation was that the seven new phages, T6ɸF2 and T6ɸH2 were all able to infect 
all strains of R014/020.  
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3.5.4.3   Possible explanations for variances observed in the host range of 
C. difficile phages  
A possible explanation for the differences in infectivity seen across the phage 
catalogue could be due to the ability of phages to recognise and adsorb to different 
C. difficile receptors. For example, broad host range phages may recognise and bind to 
more C. difficile receptors in comparison to narrow host range phages (Hyman and 
Abedon 2009). Furthermore, phages that infect the same ribotypes may bind to the 
same receptors found on the ribotypes (Sekulovic et al. 2014a). Although little 
research has been conducted on C. difficile phage receptors, it has been hypothesised 
that phages bind to the S-layer of C. difficile (Fagan and Fairweather 2014; Hargreaves 
and Clokie 2014).  
Another possible explanation for the variances observed in the host range analysis 
could be that some phages in the collection are less prone to restriction modification 
systems, used by bacteria to defend against phage infection (Hargreaves et al. 2014; 
Dupuis et al. 2013). A study was conducted by Jenson et al. (1998) to investigate this. 
They studied ten phages of Sphaerotilus natans, E. coli and Pseudomonas aeruginosa 
and found modified bases within the phage genomes that allowed them to be 
insensitive to restriction modification systems and endonucleases. This may have 
occurred in the broad host range phages found in this study but can only be confirmed 
when the phages are fully sequenced. In contrast the ribotypes not infected by the 
phage collection may have many multiple restriction modification systems.    
Unfortunately not all phages were able to infect lytically, as some phages produced 
hazy, turbid circular spots on a number of C. difficile isolates. This result is highly 
suggestive that the phages are temperate and consequently there is a possibility that 
phages could integrate into the bacterial genome instead of lysis of the host (Goh et al. 
2005). Phage T6ɸ12eH produced hazy spots on the highest number of isolates at 6% in 
comparison to the other phages within the catalogue but is one of the broadest-host 
ranges in the collection. Overall hazy spots were only noted for a small number of 
phages, at very low percentages and mostly the phages in the collection behaved in a 
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lytic manner. Therefore, these phages can still be used for the development of the 
phage-based diagnostic test.   
3.5.5   Purification and DNA extraction of C. difficile phage from lysate using 
chromatography  
After characterisation of the C. difficile phage catalogue and identification of suitable 
phages that could be used to construct a diagnostic test, it needs to be considered 
how phage lysate could be purified. The phage lysate contains bacterial debris and 
DNA that could potentially interfere with the diagnostic test and could result in false-
positive results. A rapid method would be needed for phage purification and 
concentration; anion exchange chromatography could potentially provide this. 
Monolithic columns have previously been used for anion exchange chromatography 
for phage purification but have not been investigated for C. difficile phages. This study 
attempted to establish a protocol for C. difficile phage purification.  
3.5.5.1   Phage purification with the CIM®QA disk monolithic column 
A protocol was established with the CIM®QA disk monolithic column and the optimum 
salt concentration for phage elution was 0.4 M NaCl. According to the literature 
phages have been eluted at various different NaCl salt concentrations, which ranged 
from 0.25 M NaCl for Pseudomonas phages ɸE2005A, ɸPaer14 and ɸE2005-C 
(Adriaenssens et al. 2012) to 0.8 M NaCl for Staphlococcus phage ISP (Vandersteegen 
et al. 2011). The elution of phage T6ɸ12eH falls right in the middle of this spectrum 
similar to the elution of E. coli phage T4 (Smrekar et al. 2008).  
Although the optimum salt concentration was identified, phage yield was 
consistently low and the same yield was not observed with run hence the method was 
not reproducible. Overall phage recovery did not exceed 28% even though phage 
volumes loaded onto the column were altered in order to attain the best recovery 
protocol. Low recovery was also noted for the Pseudomonas phage ɸM4 at 40% 
(Adriaenssens et al. 2012) but with another Pseudomonas phage ɸ15, 87% of phage 
was recovered (Shaburova et al. 2009). Highest recovery at 99.9% was noted for 
Dickeya phage LIMEstone1 but the overall range of phage recovery was between 40 to 
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99.9% (Adriaenssens et al. 2012). The recovery of phage T6ɸ12eH falls outside this 
interval and maybe the increase of the elution concentration of NaCl could improve 
recovery. However, at high salt concentrations unwanted particles are eluted, such as 
bacterial and phage debris. Further optimisation is required for phage purification with 
chromatography and could not be completed in this study due to time constrains.  
However it should be highlighted although phage recovery was low and not always 
consistent, phage lysate was successfully purified and bacterial debris was removed. 
The recovery volume of phage was also significantly higher than with CsCl2 method, 
where approximately only 200 μl of phage is recovered. In addition with CsCl2, phage 
infectivity can be affected but as observed in this study with the column-based 
method phage infectivity was not altered. Therefore, in conclusion further 
optimisation of column-based phage purification method would be beneficial, as it 
would increase yield of purified phage. 
Further optimisation should focus on minimising phage loss during the flow 
through step. Other studies have also found this to be a common problem as they 
have found 30 to 65% phage lose during the flow through step. In addition, another 
factor that contributes to low phage recovery is that after multiple uses of the column 
the efficiency of phage binding and capacity to hold all phage particles is reduced. In 
order to preserve optimal conditions for the column the disk should be maintained in 
accordance with the manufactures instructions (Adriaenssens et al. 2012). Also pH of 
buffers used in chromatography may play a role in phage loss and optimisation of the 
pH could help to maximise phage recovery. 
3.5.5.2   Phage purification with the CIM®DEAE disk monolithic column 
Phage T6ɸ12eH was also used to optimise purification with the CIM®DEAE disk 
monolithic column and after purification the fractions were used to extract phage 
DNA. As phages used for the development of the diagnostic test will need to be 
sequenced first, a quick protocol for DNA extraction needs to be devised. Similar to 
CIM®QA disk monolithic column the optimum NaCl concentration for elution was 
initially optimised and found to be approximately 0.2 M NaCl. Ceyssens et al. (2009) 
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found 0.6 M of NaCl was the optimum elution concentration for Pseudomonas phage 
ɸLUZ19 and the same NaCl concentration was used for Dickeya phage LIMEstone 2 
(Adriaenssens et al. 2012). 
Lysed phage preparation was then optimised to calculate which method could give 
the highest yield of phage T6ɸ12eH DNA. Phage lysate was either untreated or treated 
to remove bacterial genomic contaminations before being loaded onto the column. 
Pre-treatment of phage lysate did aid to reduce bacterial contamination as with 
untreated phage lysate bacterial RNA or protein contamination was found after DNA 
extraction. However there seemed to be a compromise between yield and removal of 
bacterial contamination, as the best results in terms of bacterial contamination 
reduction was with prior treatment with Benzonase but the DNA yield was low. The 
reduced DNA yield may be due to reduced capacity of the column due to multiple runs 
already conducted with the column, which was previously mentioned for CIM®QA disk 
monolithic columns (Adriaenssens et al. 2012). One way to overcome this could be to 
collect multiple fractions close to where phage is eluted and combine these fractions. 
A similar protocol was used as developed by Reddy et al. (1988). The only 
difference was they used chromatography to extract DNA from E. coli lambda phage 
and they obtained DNA yields between 0.5 to 1 mg. The yield was significantly higher 
to that obtained in this study and it was free from bacterial DNA, RNA and proteins. It 
could be DNA extraction with CIM®DEAE disk monolithic column is phage dependent 
that would explain the differences observed in Reddy et al. (1998) results and the 
present study. 
3.5.6   Conclusions 
Isolation, characterisation and purification of C. difficile phages have been the aim of 
Chapter 3. Seven new C. difficile phages were successfully isolated from the River Tame 
and were characterised to identify their morphology, infection cycle and host range. 
The seven phages were able to lytically infect numerous ribotypes of C. difficile. Host 
range analysis was also conducted for a catalogue of 25 C. difficile phages previously 
isolated in Professor Martha Clokie’s laboratory and at least one phage was able to 
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infect the dominant ribotypes found in the UK. Phages T6ɸ12eH, T6ɸF2, T6ɸ12, T6ɸ7h 
and AIUɸX2 had the broadest host ranges and the next chapters will focus on using 
these phages to develop the phage-based diagnostic test specific for C. difficile.  
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3.6   Chapter 3 summary  
• Water and soil samples collected from the River Tame were enriched to isolate 
new C. difficile strains and to screen for phages. 
• Seven phages were isolated on R014/020 and R076 isolates. 
• All seven phages belonged to Myoviridae family within the order Caudovirales. 
• PFGE revealed the size of the phage genomes ranged from 45 to 55 kb. 
• One step growth curve experiments were conducted to calculate the burst size 
of the seven phages and burst sizes ranged from 7 to 36 phages released per 
infected cell. 
• Host range analysis was conducted on the newly isolated seven phages and on 
a collection of 25 C. difficile phages against 160 isolates of C. difficile that 
consisted of 29 clinically relevant ribotypes. 
o At least one phage was able to infect the dominant UK ribotypes: 002, 
005, 014/020, 015, 027 and 078. 
o Phages T6ɸ12eH, T6ɸ12, T6ɸ7h, T6ɸF2 and AIUɸX2 had the broadest 
host range and will be used for the development of the phage-based 
diagnostic test. 
o Phages S1ф5b, S1фS8, S1ф11 and S1ф17.1 had the most selective host 
ranges and infected only one isolate from a ribotype. 
o An overlap in phage infection was observed, as 15 phages were able to 
infect isolates from R014/020, 12 phages infected both R076 and R022. 
• Anion exchange chromatography with CIM®QA and CIM®DEAE disk monolithic 
columns were used to establish a method for C. difficile phage purification. 
o With CIM®QA disk monolithic column phage T6ɸ12eH was eluted at 
0.4 M NaCl concentration and phage recovery ranged from 0.58 to 
28.71% dependent on the initial phage lysate. 
o With CIM®DEAE disk monolithic column phage T6ɸ12eH was eluted at 
0.2 M NaCl and after purification phage DNA was extracted. 
o High concentrations of phage DNA were isolated but phage lysates had 
to be pre-treated to remove bacterial DNA, RNA and protein. 
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4.1   Introduction 
In recent decades there has been renewed research into the development of phage-
based diagnostic tests for use in the food industry, agriculture and for diagnosis of 
bacterial diseases in both animals and humans (Storms et al. 2012). Phage-based 
diagnostic tools can be constructed to monitor any of the key events of the phage 
infection cycle, which are: adsorption, replication, release of new phages and lysis of 
bacterial cells (Schofield et al. 2012). This chapter will aim to understand the first step 
of phage adsorption to determine if an adsorption-based test could be developed to 
detect C. difficile. Ideal phages to be used in the test would be those, which can bind 
efficiently to numerous C. difficile ribotypes. This would ensure the maximum number 
of isolates would be detected with the phage-based test. In addition, the adsorption 
rates of the phages should be significantly higher to C. difficile in comparison to other 
common bacteria found in similar environments to C. difficile. Therefore, the phages 
would be able to detect C. difficile, even when a variety of different bacteria are 
present in the sample and hence minimal sample processing would be required. 
4.1.1   Phage adsorption process 
Before an adsorption-based phage diagnostic test can be developed, adsorption rates 
of the phages to be used in the test needs to determined. Adsorption rates are 
expressed as a percentage to represent the proportion of phages that have bound 
over a specified time. The adsorption step of the infection cycle is typically consistent 
across most phages and adsorption usually occurs when both long and short phage tail 
fibres bind to their respective receptor(s) present on the surface of the bacterial cell. 
First, long tail fibres reversibly attach to the bacterial cell surface followed by 
irreversible attachment with short tail fibres, after which the phage infects the cell 
(Le et al. 2013). The reversible and irreversible interaction can occur with the same 
receptor or more commonly involves phage binding to two different bacterial 
receptors (Baptista et al. 2008). 
Reversibly adsorbed phages can be released from bacterial cells by dilution of the 
phage and bacterial samples but irreversibly absorbed phages are unrecoverable as 
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they have already committed to host infection. This is because after the irreversible 
attachment occurs the bacterial receptor(s) causes a conformational change of the 
phage tail, which triggers the release of phage DNA within the bacterial cell. The whole 
process is rapid and occurs within a few seconds to minutes (Tomat et al. 2014).  
4.4.2   Phage adsorption-based bacterial detection tests 
Phage adsorption-based diagnostic tests have been developed for a number of 
bacteria and assays have exploited the initial specific interaction of phage to its target 
bacterium. The adsorption step can be used as a marker by the addition of fluorescent 
dyes to label phage DNA and once phages bind to their target bacterium they can be 
visualised. For example Takehiko et al. (2006) labelled E. coli phage T4 with 4′,6-
Diamidino-2-Phenylindole (DAPI) to detect E. coli from contaminated canal waters in 
Thailand. The DAPI labelled phages were able to identify E. coli within 30 minutes with 
an epifluorescence microscope and therefore the assay permitted delivery of quick 
results. Mosier-Boss et al. (2003) used a different fluorescent dye called SYBR Gold 
Nucleic Acid Gel Stain to label Salmonella typhimurium-specific phage P22. Following 
incubation of the labelled phage with a mixed bacterial sample, only 10 minutes was 
required to identify S. typhimurium with an epifluorescence microscope. 
Sensitivity and specificity of phage adsorption-based tests have been further 
improved by the addition of a purification and concentration step. Although, this 
increases the length of the assay, detection limits are significantly improved and as 
few as 10 bacterial cells can be detected. This was observed in a study conducted by 
Goodridge et al. (1999) in which they fluorescently labelled the phage LG1 specific for 
E. coli 0157:H7 with the dye YOYO-1 (green-fluorescent dye). The labelled phage was 
paired with anti E. coli Immuno-Magnetic Separation beads (IMS beads). IMS beads 
consisted of antibody coated polymer beads against the target bacteria and facilitated 
separation and concentration of the target bacteria from a mix of bacteria. Following 
separation with IMS beads, an epifluorescence microscopy was used to detect cells 
infected with phage and was represented as a fluorescent halo around the E. coli cells. 
The detection limit of fluorescent-phage assay was approximately 104 CFU/ml without 
the IMS step and was improved to 10 to 100 CFU/ml with the addition of a six-hour 
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enrichment and IMS step. The assay could successfully identify E. coli from ground 
beef and raw milk. However, the main concerns with the method are that the use of 
epifluorescence microscopy is expensive and using specialised equipment restricts the 
use of the assay outside a laboratory.   
To overcome these obstacles Willford et al. (2011) improved on the phage 
adsorption-based test by removal of the need to use as an epifluorescence microscope 
to visualise phage binding and by the development of an easy to use and self-
contained test. They developed a SnapValve-based device, for the detection of E. coli 
STEC serogroups (sub-groups) and for the test they selected three phages with broad 
host ranges with rapid adsorption kinetics. The three phages were chemically labelled 
with a luminescence marker, horse radish peroxidase and the labelled phages were 
incorporated into the device. The self-contained test works as such, a swab is taken 
from a contaminated sample, added straight to a tube with growth media, enriched 
for eight hours, STEC serogroup-specific IMS beads are added and the final step is the 
addition of the labelled phages. If STEC is present, labelled phages bind to cells and a 
luminescence signal is produced, which is measured with a hand-held luminometer. 
This simple and step-by-step assay has allowed identification of STEC from spinach, 
meat and water samples at levels as low as 1 CFU/g. Another benefit of the assay is 
that it can be completed in one working day. This study demonstrates it is possible to 
harness the adsorption step in order to develop an assay that is not restricted to 
laboratory use and could be applied for detection of C. difficile too. 
4.1.3   Mathematical equations to predict phage adsorption 
Several mathematical equations have been designed to explain and predict the phage 
adsorption phenomena. Models have taken into consideration the reversible and 
irreversible attachment of phage to its host, the concentration of bacterial cells and 
the time required for phage adsorption (Cairns et al. 2009; Moldovan et al. 2007; Shao 
and Wang 2008; Storms et al. 2012; Weld et al. 2004). The common model frequently 
used in the literature calculates the adsorption rate constant (k) to predict the 
likelihood of phage attachment to bacterial cells after collision and irreversible phage 
binding. k is specific for an individual phage and its bacterial host (Hyman and Abedon 
Chapter 4 
98 
 
2009; Kasman et al. 2002). Calculation of the adsorption rate will estimate the 
probability of phage binding to bacterial cells and predict how it could translate to a 
phage adsorption-based diagnostic test. It is important to bear in mind that most 
adsorption models are based on E. coli phage systems and other bacterial phage 
systems have not been investigated, such as for C. difficile phages.  
4.1.4   Adsorption of C. difficile phages  
Despite development of models to understand phage adsorption there has been 
limited research in the characterisation of C. difficile phage adsorption. Only one study 
to date has investigated phage adsorption at a large scale of a single phage: ɸCD140 to 
11 different strains of C. difficile. In the study phage ɸCD140 was only able to infect 
one out of 11 strains screened and adsorption was also tested on four other bacteria 
species. The highest adsorption rate recorded was for the strain that the phage could 
infect but distinct levels of binding were noted for C. difficile strains not infected by 
the phage. In comparison, very low binding was noted to other bacterial species 
(Ramesh et al. 1999). The study highlights that even if phages are incapable of 
infecting, they may still be able to bind to their target bacterial species.  
4.1.5   Factors that can influence phage adsorption   
After determination of phage attachment and constant rates, factors that affect phage 
adsorption also need to be investigated to determine the ideal conditions required to 
maximise phage adsorption. This is because the adsorption-based phage diagnostic 
test will be carried out in vitro where conditions can be easily altered. Studies have 
shown factors that can affect phage adsorption are: temperature, MOI (the ratio of 
bacteria to phage), shaking of bacterial and phage suspension and addition of divalent 
cations, such as calcium ions. This is because studies have predicted calcium ions are 
necessary for phage infection, the penetration of phage DNA (Binetti et al. 2002; 
Cairns et al. 2009; Krueger 1931; Mahony et al. 1985; Suarez et al. 2008; Tomat et al. 
2014). These factors can lead to either an increase or decrease in the phage 
adsorption rates.  
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4.2   Aim of this study  
Chapter 3 identified broad host range phages, which are able to infect numerous 
C. difficile ribotypes. This study will investigate the adsorption rates of five of these 
phages: T6ɸ7h, T6ɸ12eH, T6ɸ12, T6ɸF2 and AIUɸX2 to explore the possible 
development of an adsorption-based diagnostic test for C. difficile. Adsorption of the 
phages was tested on 12 representative isolates from 12 clinically relevant ribotypes 
within the UK over a 30 minute time period. The phages were not able to infect and 
propagate on all 12 ribotypes, and therefore binding to both infected and non-infected 
isolates was studied. Adsorption to other common bacteria found within healthcare 
environments: E. coli, Pseudomonas aeruginosa and Methicillin-resistant 
Staphylococcus aureus (MRSA), was also tested. Furthermore, the influence of 
movement of bacterial and phage suspension, MOI and extension of the adsorption 
assay to six hours was investigated to identify the optimal in vitro conditions to 
maximise phage adsorption to C. difficile. 
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4.3   Methods  
4.3.1   Bacterial strains and phages  
All bacterial strains and phages used in this study are listed in Table 4.1. 
4.3.2   Adsorption assay experiments 
4.3.2.1   Adsorption assays for C. difficile 
C. difficile was cultured from blood plate to 7 ml BHI broth (Chapter 3, Section 3.3.1). 
After overnight incubation 1.5 ml of BHI culture was transferred to pre-reduced 
13.5 ml BHI broth inside the 37°C anaerobic chamber. OD550 was checked every 
30 minutes and once the culture reached OD550 0.3, phage was added. Both the initial 
bacterial CFU/ml and phage PFU/ml used in the experiments were dependent on the 
MOI of the experiment.  
The bacterial and phage suspension was mixed by gentle inversion before being 
aliquoted into seven labelled 1.5 ml Eppendorf tubes inside the anaerobic chamber. At 
specific time-points: 0, 0.5, 1, 5, 10, 15 and 30 minutes aliquots were removed and 
centrifuged at 4°C for 5 minutes at 21,000 x g to pellet the phage-adsorbed cells. The 
supernatant was transferred to a new Eppendorf tube, which contained the un-
adsorbed phages and was serially diluted from neat to 10-8. Dilutions in triplicate were 
spotted on a lawn of C. difficile (Chapter 3, Section 3.3.6.1) and the strain used was the 
propagation host of the phage (Chapter 3, Table 3.1). The un-adsorbed phages were 
compared to the initial phage counts to calculate the number of phages bound, which 
was then expressed as a percentage. 
4.3.2.2   Adsorption assay for common hospital pathogens 
Adsorption assays were also conducted for representative isolates of E. coli, 
Pseudomonas aeruginosa and MRSA at 37°C under aerobic conditions, optimum for 
the bacteria. Strains from cryopreservation stocks were streaked onto Luria Broth (LB) 
1% agar plates (Chapter 9, Table 9.1) and incubated overnight at 37°C. A single colony 
was inoculated into LB broth and grown overnight whilst being shaken at 200 rpm. 
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1.5 ml of the culture was then transferred into 13.5 ml of fresh LB broth and grown 
until culture reached OD600 0.3. After which phage was added to the culture and the 
procedure described in Section 4.3.2.1 was followed. 
4.3.2.3   Adsorption assay whilst the bacteria and phage suspension was 
shaken 
The same protocol was used to prepare the phage adsorption samples as described in 
Section 4.3.2.1. The only difference was after the bacterial and phage suspension were 
aliquoted into Eppendorf tubes they were placed on a shaker (Scientific Industries, 
USA) set at 100 rpm, inside the anaerobic chamber at 37°C. At the specific time-points 
samples were removed from the shaker to determine phage adsorption. 
4.3.3   Statistical analysis 
All adsorption data was analysed with GraphPad Prism 6 (GraphPad software, USA) 
and experiments were repeated three times, each with three technical replicates and 
mean values were plotted. SEM was also calculated and is shown on all graphs as error 
bars. Mean values were used to statistically analyse the results using T-tests, with one 
star being assigned to p<0.05 and two stars if p<0.01.  
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Table 4.1 A list of all bacterial strains and phages used in this study. 
 Strain/phage identity Ribotype Reference 
Bacteria     
C. difficile  AKC 002 This study 
C. difficile AIN 005 This study 
C. difficile ASH 013 This study 
C. difficile ATJ 014/020 This study 
C. difficile ARD 015 This study 
C. difficile ARU 026 This study 
C. difficile AIU 027 This study 
C. difficile T6 076 This study 
C. difficile ASS 078 This study 
C. difficile ANQ 081 This study 
C. difficile APT 087 This study 
C. difficile ARZ 107 This study 
E. coli EC1 - This study 
P. aeruginosa PA14 - This study 
MRSA MRSA1 - This study 
C. difficile phages    
 T6ɸ7h - This study 
 T6ɸ12eH - This study 
 T6ɸ12 - This study 
 T6ɸF2 - This study 
 AIUɸX2 - This study 
 
 
Table 4.2 Infectivity of five C. difficile phages against representative isolates from 12 
different C. difficile ribotypes used in adsorption experiments.   
                     C. difficile phages 
C. difficile 
Ribotype 
Sample 
identity 
T6ɸ7h T6ɸ12eH T6ɸ12 T6ɸF2 AIUɸX2 
002 AHE      
005 AIN      
013 ASH      
014/020 ATJ      
015 ARD      
026 ARU      
027 AIU      
076 T6      
078 ASS      
081 ANO      
087 APT      
107 ARZ      
 - Phage produced turbid clearing on the C. difficile strain. 
 - Phage is able to infect C. difficile strain. 
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4.4   Results 
4.4.1   Analysis of C. difficile phage adsorption  
In Chapter 3 32 different phages were screened against 160 C. difficile isolates and 
from the collection phages that can infect multiple clinically relevant ribotypes were 
identified. Five of these broad host range C. difficile phages: T6ɸ7h, T6ɸ12eH, T6ɸ12, 
T6ɸF2 and AIUɸX2 (Table 4.2) were selected to determine their adsorption rates to 12 
clinically relevant UK ribotypes: 002, 005, 013, 014/020, 015, 026, 027, 076, 078, 081, 
087 and 107 (Table 4.2) at a MOI 1 over a 30 minute time-course (Figure 4.1). Although 
R076 is not a common ribotype found in UK healthcare, it was included in the study as 
phages T6ɸ7h, T6ɸ12eH, T6ɸ12 and T6ɸF2 were propagated on isolate T6 (R076). 
Regardless of whether the phage was able to infect the particular ribotype, adsorption 
kinetics were tested on all 12 ribotypes (Table 4.2). Adsorption experiments were also 
performed on common hospital pathogens: E. coli, MRSA and P. aeruginosa. 
The adsorption efficiency of phage T6ɸ7h varied for all ribotypes tested (Figure 
4.1a). The highest adsorption rate observed after 30 minutes was when phage T6ɸ7h 
bound by over 70% to its propagation host ribotype R076. However for R014/020, a 
ribotype the phage is able to infect lytically, the phage only bound by 30%, which is a 
similar rate observed for the R015 strain. This is an isolate the phage produces turbid 
clearing on. The 30% adsorption rate was also noted for R027 a ribotype not infected 
by the phage. For other ribotypes not infected by the phage, T6ɸ7h bound between 5 
to 15% and the phage bound by less than 15% to other common hospital bacteria.  
Phage T6ɸ12eH had a very similar adsorption profile (Figure 4.1b) to phage T6ɸ7h 
and again the highest adsorption efficiency at over 70% was observed with its 
propagation host R076. Adsorption rates were between 15 to 30% for other ribotypes 
013, 014/020 and 027, the phage is able to infect lytically. Similar binding rates were 
observed for the isolate from R002 and R087, on which the phage produces turbid 
clearing on these bacterial lawns. Phage T6ɸ12eH bound by less than 20% to other 
ribotypes it is unable to infect and bound by less than 3% to: E. coli, MRSA and 
P. aeruginosa similar to control of phage T6ɸ12eH in BHI broth. 
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Similar to phages T6ɸ7h and T6ɸ12eH, T6ɸ12 had high adsorption efficiency at 
75% to its propagation host R076 (Figure 4.1c). However, in contrast the overall 
highest adsorption efficiency below 80% was noted for the isolate from R014/020, a 
strain the phage infects lytically. This is the first example, other than phage binding to 
their propagation host where high phage adsorption efficiency leads to the lytic life 
cycle. Conversely for the isolate from R026 that is infected by phage T6ɸ12 an 
adsorption rate of 15% was found, which is almost identical to the phage binding rates 
to ribotypes: 002, 005, 013, 015, 026, 027, 078, 081, 087 and 107. The representative 
isolates from these ribotypes are not infected by the phage. Surprisingly the phage 
also bound by 15% to P. aeruginosa but only by 5% to MRSA and 0% to E. coli. 
In comparison to phages T6ɸ7h, T6ɸ12eH and T6ɸ12, phage T6ɸF2 bound by a 
low efficiency to its propagation host R076, by over 15% after 30 minutes (Figure 
4.1d). The adsorption rate was higher at 22% for the isolate from R014/020, which is 
infected by the phage. However, for the R026 isolate also infected by the phage 
T6ɸF2, a 12% adsorption rate was found similar to the rate observed for R087, on 
which the phage produces turbid clearing. The highest adsorption rates were noted for 
the R002 and R015 isolates at over 25%. Again, a high adsorption rate was recorded 
with P. aeruginosa at 10%, which was the same adsorption rate found with R078. For 
MRSA and E. coli, the adsorption rate was less than 7%. 
Phage AIUɸX2 had almost identical adsorption rates to phage T6ɸ7h for 3/12 
ribotypes (R013, R014/020 and R076) screened (Figure 4.1e). Additionally, similar to 
phage T6ɸ7h, phage AIUɸX2 bound to its propagation host AIU, R027 by 12% and the 
same adsorption rate was found with R076, a ribotype the phage does not infect. 
Interestingly phage AIUɸX2 displayed a higher adsorption rate of 17% towards 
ribotypes 015, 014/020 and 107, despite that this phage does not infect them. 
Furthermore, less than 5% adsorption was observed to other bacteria tested. Overall 
with all ribotypes, P. aeruginosa and MRSA the adsorption of AIUɸX2 ranged from 3-
17% and adsorption of the phage to E. coli was equal to the control of phage AIUɸX2 
in BHI broth.  
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In summary, phage T6ɸ12 appears to be the most specific phage and binds the 
most efficiently to strains it can infect. Phages T6ɸ7h and T6ɸ12eH showed a similar 
specificity but only for their propagation host. However, for ribotypes they could infect 
and for those they could not similar adsorption rates were observed. Phages T6ɸF2 
and AIUɸX2 consistently displayed low adsorption rates to all ribotypes tested.
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Figure 4.1 The adsorption rates of C. difficile phages to representative isolates from 12 different C. difficile ribotypes and to the pathogens: E. coli, MRSA 
and P. aeruginosa. 
 
Graphs represent adsorption kinetics of C. difficile phages a) T6ɸ7h, b) T6ɸ12eH, c) T6ɸ12, d) T6ɸF2 and e) AIUɸX2.All adsorption experiments were 
conducted at a MOI of one (3 x 107 PFU/ml and CFU/ml) and PFU/ml count was monitored over a 30 minute period via phage spot tests. Adsorption rates 
were calculated by the comparison of PFU/ml count at the start of the experiment to PFU/ml count after 30 minutes. A control of phage in BHI broth was 
included. For all experiments average adsorption rates were calculated ± SEM values (error bars) from three biological replicates, each with three technical 
repeats (Figure is zoomed in on pages 107, 108 and 109). 
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Figure 4.1 Continued on next page.  
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Figure 4.1 Continued on next page.  
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Figure 4.2 The adsorption rates of C. difficile phages to representative isolates from 12 
different C. difficile ribotypes and to the pathogens: E. coli, MRSA and P. aeruginosa. 
Graphs represent adsorption kinetics of C. difficile phages a) T6ɸ7h, b) T6ɸ12eH, 
c) T6ɸ12, d) T6ɸF2 and e) AIUɸX2. 
 
All adsorption experiments were conducted at a MOI of one (3 x 107 PFU/ml and 
CFU/ml) and PFU/ml count was monitored over a 30 minute period via phage spot 
tests. Adsorption rates were calculated by the comparison of PFU/ml count at the start 
of the experiment to PFU/ml count after 30 minutes. A control of phage in BHI broth 
was included. For all experiments average adsorption rates were calculated ± SEM 
values (error bars) from three biological replicates, each with three technical repeats.  
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4.4.2   Attempts to increase C. difficile phage adsorption rates 
Three strategies were employed in an attempt to increase the adsorption rates of 
phage T6ɸ12eH, which is one of the broadest host range phages within the collection: 
1. The bacterial and phage suspensions were constantly shaken throughout the 
adsorption experiment. 
2. Three different MOIs were used for binding experiments. 
3. The length of the phage adsorption experiment was increased to six hours. 
4.4.2.1   Movement of bacterial and phage suspension  
To investigate if constant movement throughout the adsorption experiment could 
help increase adsorption rates, representatives of 12 different ribotypes were tested 
under both shaking and static conditions at an MOI of one. Under the same conditions, 
adsorption experiments were also repeated for E. coli, P. aeruginosa and MRSA (Figure 
4.2).    
In comparison to the unshaken samples, a significant increase (p<0.01) in the 
adsorption rate was found for the isolates from three ribotypes: 014/020, 026 and 
087. The biggest difference was noted with R014/020, a ribotype the phage is able to 
infect and with shaking the adsorption rate was 63% in comparison to the 30% rate 
noted with the unshaken samples. Shaking also led to an increased adsorption rate 
from 10% to 25% for the R026 strain, which is not infected by the phage. Similarly with 
the R087 isolate for which phage T6ɸ12eH produces turbid clearing on, shaking led to 
a 6% increase in the adsorption rate. A smaller but significant difference (p<0.05) was 
noted with ribotype R027, where a 5% increase in the adsorption rate was observed. 
R027 is a ribotype the phage T6ɸ12eH is able to infect lytically.  
However, a significant reduction (p<0.01) in the adsorption rate with the shaken 
samples was found for ribotype 107 where a 7% drop occurred. Also a 6% reduction in 
the adsorption rate was found with the phage’s propagation host R076 (P<0.05). 
Previously (Section 4.4.1) it was found that ribotype 076 had the highest adsorption 
rate to phage T6ɸ12eH at over 65%. However, with shaking the bacterial and phage 
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suspension R014/020 and R076 now had identical adsorption rates at over 60%. In 
contrast, no significant changes in adsorption with shaken and unshaken samples were 
noted for representative isolates from R002, R005, R013, R015, R078, R081, E. coli, 
MRSA, P. aeruginosa and the control of phage T6ɸ12eH in BHI broth. 
4.4.2.2   Influence of MOI on phage adsorption 
To investigate if changes in MOI could influence adsorption of phage T6ɸ12eH three 
different MOI’s: 1, 0.1 and 0.01 were investigated for 4/12 ribotypes used throughout 
this study. The ribotypes were selected based on the infectivity of phage T6ɸ12eH. 
R002 was chosen as the phage turbidly clears this host, R027 as the phage infects this 
strain, R076 as this is the phage’s propagation host, and R081 as the phage is unable to 
infect the isolate (Table 4.2). This selection encompasses an example of all types of 
infectivity observed in the host range analysis in Chapter 3, Section 3.4.2. 
Overall reduction of MOI from one to 0.1 and 0.01 lowered adsorption rates for all 
four ribotypes and no change was noted with the phage control of phage T6ɸ12eH in 
BHI broth (Figure 4.8). At an MOI of 0.1, a significant (p<0.05) reduction in adsorption 
was found in comparison to the MOI of one for R002 and R027. With R002, a 20% 
reduction occurred and the adsorption rate was similar to that of the control. For R027 
the drop in the adsorption rate was approximately 15%. No significant change in 
adsorption at MOI of 0.1 was found for ribotypes 076 and 081. 
In comparison to MOI of one, at MOI of 0.01 a significant (p<0.05) drop of 25% was 
found for the adsorption rate of phage T6ɸ12eH to R076. The 25% reduction was the 
highest reduction noted across all four ribotypes tested. Furthermore a 15% reduction 
in adsorption was also found for R027. For ribotypes 002 and 081, no significant 
changes in adsorption were noted.  
4.4.2.3   The effect of increasing the duration of the adsorption assay to six 
hours on binding rates 
The duration of the phage adsorption experiments carried out in this chapter has been 
30 minutes and it was investigated whether extension of the experiment to six hours 
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would help to increase the adsorption rates of phage T6ɸ12eH. This would allow more 
time for irreversibly phage binding to occur. Consequently adsorption was tested on 
representative isolates from 12 different ribotypes, common hospital pathogens and a 
control of phage T6ɸ12eH in BHI broth was included (Table 4.3). 
Overall it was found the six hour time-course of the experiment did not help to 
increase the overall adsorption efficiency of phage T6ɸ12eH. For ribotypes 005, 015, 
026 and 081 and pathogens E. coli, MRSA and P. aeruginosa no change in the 
adsorption percentage was found throughout the six hour assay. However, for 
ribotypes 002, 013, 027, 078, 087 and 107 the adsorption rate at one hour was the 
highest, followed by a drop in the rate. For ribotypes 002 and 013 phage T6ɸ12eH 
bound by 24%, after which the rate reduced to 10% and remained consistent 
thereafter. Similarly, 15% of phage had adsorbed to R027 after one hour and after 
which the adsorption rate averaged to 4%. Furthermore between 10 to 17% phage had 
bound to ribotypes 078, 087 and 107 after one hour followed by a constant adsorption 
rate between 7 to 0%.  
With the extension of the phage adsorption assay, phage bursts were observed for 
ribotypes 014/020 and 076; which are ribotypes the phage infects lytically. It was 
evident from previous phage growth analysis (Chapter 3, Section 3.4.1.5) that 
C. difficile phage bursts occur approximately after 60 minute incubation of phage and 
bacteria. The phage burst occurred at the two hour time interval and the PFU/ml 
count was high until the end of the experiment (these values have been expressed as 
negative values in Table 4.3).  
However, phage T6ɸ12eH can also infect ribotypes 013 and 027 but no phage 
bursts were observed with these ribotypes. To determine whether the phage can 
replicate on isolates from R013 and R027, the phage stock of T6ɸ12eH at titre 
1 x 109 PFU/ml was serially diluted and spot tested. The phage was also spot tested on 
R014/020 and R076 as controls as phage bursts were observed for these ribotypes. 
The results found for ribotypes 013 and 027 clearing was only noted on the neat spot 
i.e. the spot with undiluted phage. No clearing or individual plaques were found for 
the dilutions, indicating the phage is unable to replicate on these hosts as presence of 
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plaques indicate replication. Therefore as clearing was only observed the phage is only 
able to kill these isolates. However, plaques were found with ribotypes 014/020 and 
076, an indication the phage can replicate on these strains, which correlates with the 
data obtained in Table 4.3. 
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Figure 4.3 A comparison of adsorption rates of phage T6ɸ12eH under two different conditions: the bacterial and phage suspensions unshaken 
(white bars) and shaken (black bars). 
Adsorption of phage T6ɸ12eH was tested on representative isolates from 12 different C. difficile ribotypes and strains from common 
pathogens found in healthcare care settings: E. coli, MRSA and P. aeruginosa. Phage adsorption was compared to the starting phage 
concentration to calculate the percentage of phage T6ɸ12eH bound after a 30 minute time-course. For each strain averages ± SEM (error bars) 
of PFU/ml were calculated from three biological replicates, each with three technical repeats. Columns, which represent adsorption data with 
shaken samples were compared to unshaken samples and asterisks represent significant differences (one star p<0.05 and two stars p<0.01).  
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Figure 4.4 Comparison of adsorption rates of phage T6ɸ12eH at three different MOI’s: 0.1 (white bars), 0.01 (grey bars) and 0.001 (black bars).  
Adsorption of phage T6ɸ12eH at different MOI’s was tested on representative isolates from four different C. difficile ribotypes: 002, 027, 076 
and 081. Phage adsorption was compared to the starting phage concentration to calculate the percentage of phage T6ɸ12eH bound after 
30 minutes. For each strain averages of PFU/ml ± SEM (error bars) were calculated from three biological replicates, each with three technical 
repeats. Columns that represent adsorption data at MOI 1 were compared to data from MOI 0.1 and 0.01. T-tests were used and one star 
signifies p<0.05.  
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Table 4.3 Adsorption rates of C. difficile phage T6ɸ12eH over a six hour time course.    
                                       % of phage adsorbed (hours)a 
 1 2 3 4 5 6 
C. difficile ribotype      
002 24.1 ± 0.3 0.0 ± 0.5 3.5 ± 0 3.9 ± 1 10.4 ± 0.2 1.2 ± 0.9 
005 13.0 ± 2.0 0.0 ± 0.5 -3.5 ± 1.5b -6.1 ± 0.8 -3.5 ± 0.3 -8.0 ± 0.3 
013 25.0 ± 3.0 6.5 ± 1.1 9.1 ± 0.2 6.9 ± 0.4 8.0 ± 0.6 1.9 ± 1.0 
014/020 25.5 ± 3.0 -25.6 ± 1.5 -30.8 ± 4.0 -40.7 ± 0.4 -58.7 ± 5.0 -89.0 ± 8.0 
015 9.2 ± 2.2 0.6 ± 1.2 4.6 ± 1.5 2.0 ± 0.9 5.6 ± 2.1 3.6 ± 0.1 
026 10.1 ± 2.2 -2.8 ± 0.79 -5.9 ± 0.6 1.8 ± 0.7 -2.8 ± 0.7 -2.8 ± 0.8 
027 15.0 ± 2.0 4.9 ± 1.1 8.0 ± 0.8 4.9 ± 0.9 0.8 ± 0.0 -3.2 ± 0.7 
076 65.0 ± 5.5 -25.3 ± 3.4 -32.6 ± 2.4 -41.9 ± 3.4 -54.7 ± 5.0 -54.5 ± 0.2 
078 10.6 ± 1.2 -4.4 ± 0.7 -1.9 ± 0.1 -7.8 ± 1.2 -6.3 ± 1.2 -7.8 ± 1.3 
081 11.8 ± 3.3 -3.0 ± 0.8 2.0 ± 0.2 3.5 ± 0.3 2.1 ± 0.4 0.47 ± 0.0 
087 14.5 ± 1.7 6.6 ± 0.5 6.6 ± 1.2 13.5 ± 3.1 13.5 ± 2.2 12.8 ± 1.2 
107 17.2 ± 1.1 1.2 ± 0.4 1.2 ± 1.3 -2.0 ± 1.1 0.0 ± 0.0 0.0 ± 0.0 
Controls       
E. coli 2.2 ± 0.1 2.2 ± 0.1 0.0 ± 0.0 -1.2 ± 0.3 0.0 ± 0.0 -1.3 ± 0.4 
P. aeruginosa 3.1 ± 1.1 0.0 ± 0.0 -1.1 ± 0.3 -2.0 ± 1.0 -1.9 ± 0.4 -3.1 ± 1.2 
MRSA 3.5 ± 0.9 -0.9 ± 0.0 -1.2 ± 0.0 -1.0 ± 0.0 -1.2 ± 0.5 -1.5 ± 0.1 
T6ɸ12eH 1.0 ± 0.0 -2.2 ± 0.3 -1.5 ± 0.4 0.0 ± 0.0 0.0 ± 0.0 -3.4 ± 1.1 
a For each time-point the mean phage adsorption percentage with ± SEM were calculated from three biological replicates of the experiment, 
each with three technical repeats and compared to the starting phage concentration at time-point 0.  
b Negative values in the table represent an increase in the phage titre and are underlined.  
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4.5   Discussion 
This study has investigated the adsorption kinetics of five broad host C. difficile phages 
from Chapter 3 to determine whether a phage adsorption-based diagnostic test could 
be developed for detection of C. difficile. Adsorption of broad host range phages 
T6ɸ7h, T6ɸ12eH, T6ɸ12, T6ɸF2 and AIUɸX2 was determined to 12 different phage 
susceptible and unsusceptible C. difficile ribotyped isolates. Adsorption rates were not 
consistently high for C. difficile and with some ribotype and phage combinations 
adsorption rates were identical to phage binding to E. coli, MRSA and P. aeruginosa. 
Therefore, it was investigated how adsorption rates could be increased to make the 
phage adsorption-based diagnostic test more specific to C. difficile. However, with all 
attempts adsorption rates were not constantly higher. It will be discussed in this 
section the possible reasons to why adsorption rates were not increased and if a 
phage adsorption-based diagnostic test would be specific for detection of C. difficile.  
4.5.1   Adsorption efficiencies of C. difficile phages  
Adsorption rates varied with different C. difficile phage and ribotype combinations but 
natural variation in adsorption rates is to be expected. Overall the data can be placed 
into two distinct groups: high adsorption and infection: and low adsorption and 
infection. The first group consists of phages T6ɸ7h, T6ɸ12eH and T6ɸ12, for which 
the results suggest there was a strong correlation between infectivity and adsorption. 
In other words high adsorption rates above 30% were found for ribotypes the phages 
were able to infect. The only exception was with phage T6ɸ12eH, which even though 
was able to infect lytically four out of the 12 ribotypes tested, it was only able to 
replicate on two of these isolates. Consequently, adsorption rates were marginally 
higher for these strains.  
In contrast, phages T6ɸF2 and AIUɸX2 were part of the second group and the data 
suggested there was no correlation between phage infectivity and adsorption. 
Adsorption was consistently low regardless of whether the phage was able to infect or 
not. The data suggests high adsorption rates were not required for phage infection 
and even if less than 15% of phages bound infection can still be established. From the 
Chapter 4 
118 
 
two adsorption groups, the data is highly suggestive adsorption and infectivity are 
phage specific and in terms of C. difficile it is not possible to predict adsorption based 
on infection. 
4.5.2   Adsorption efficiencies of C. difficile phages can be further grouped  
In addition to the two groups mentioned, the adsorption of C. difficile phages can also 
be further sub-divided into four categories:  
1. Phages bound by over 30% and can infect the isolate.  
2. Phages bound by over 30% but are unable to infect the isolate.  
3. Phages bound by less than 30% and can infect the isolate.  
4. Phages bound by less than 30% and are unable to infect the isolate.  
The first category is characterised as C. difficile phages bound by over 30% to 
isolates they can infect and a limited number of phage and ribotype combinations 
tested fell into this category. This was only observed with phages T6ɸ7h, T6ɸ12eH and 
T6ɸ12, which all bound by over 70% to their propagation strain R076 and to an isolate 
from R014/020 that the phages are able to infect. In addition the ability of the phage 
to replicate on the C. difficile strain may also play a role on its ability to bind. For 
example phage T6ɸ12eH has a high efficiency of plaquing on the RO76 and R014/020 
strains but the phage is unable to replicate on other ribotypes which it infects. This 
could suggest there may be a link between adsorption and replication of the phage. 
Overall the high adsorption rates noted in the first category is in accordance with 
other characterised C. difficile phages. For example Mahony et al. (1985) found two of 
their C. difficile phages: ф41 and ф56 bound to their propagation host by 65 to 70% 
over 10 minutes. High adsorption was also noted with the E. coli phage ф56, which 
bound by 69% after 20 minutes to its propagation host (Willford et al. 2011). However, 
higher adsorption rates above 90% have also been noted in the literature, such as 
Ramesh et al. (1999) found the C. difficile phage фCD140 bound by 90% to its 
propagation host after 30 minutes. High adsorption rate was also noted for E. coli 
phage фCBA120 that adsorbed by 93.1% after 20 minutes to a strain the phage could 
infect (Willford et al. 2011). C. difficile phages from this category would be ideal for 
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use in the development of adsorption-based diagnostic test as they would adsorb by 
distinctly higher percentage to their target C. difficile hosts. This would also lower the 
probability of false positives.  
The second category is defined as the phage binds by 30% or over but is unable to 
infect the isolate. Only two distinct incidences of this were found throughout this 
current study, the adsorption of phage T6ɸ7h to ribotypes 015 and 027. Only one 
other group in literature have investigated C. difficile phage adsorption to strains the 
phage is unable to infect, however the strains they investigated were not classified by 
PCR ribotype. They found the highest adsorption rates of phage ɸCD140 for 
uninfected C. difficile strains #7 was 33% and for #124 was 31% after 30 minutes 
(Ramesh et al. 1999). Similar rates were found in the current study. The phages in this 
category demonstrate that C. difficile phages can adsorb by high percentages to 
several different C. difficile ribotypes even though they are unable to infect and lyse 
the bacterial cell itself. Therefore, phages from this category would also be ideal for 
use in the development of an adsorption-based diagnostic test as the phage 
adsorption profiles would allow detection of multiple ribotypes. 
Phages that fell into the third category are those which have adsorption rates of 
less than 30% but the phage can still successfully infect the isolate. Bacterial and 
phage combinations that fell into this group were observed for the phage AIUɸX2 to 
ribotypes 002 and 027. Additionally, adsorption rates of phage T6ɸF2 to ribotypes 
014/020, 026 and 076 fell into this category. A low binding rate was also found for 
phage ɸHISC that bound to host Listonella pelagia HISC-2 by less than 5% after 
26 minutes but the phage was able to successfully replicate within the host 
(Williamson et al. 2001). It is unusual to find such low adsorption rates for strains 
which the phage infects and most characterised phages bind by a high efficiency to 
strains they infect (Hyman and Abedon 2009). Phages from this category would 
therefore not be ideal for construction of the adsorption-based diagnostic test as both 
phages AIUɸX2 and T6ɸF2 had similar adsorption rates for C. difficile ribotypes and to 
common hospital pathogens.  
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The fourth category consists of phages that bind by less than 30% and are unable 
to infect the isolate tested. This is the category where most phage and ribotype 
adsorption combinations fell into and was observed for all five C. difficile phages 
studied. This also included adsorption of the five phages to common hospital 
pathogens. Similar results were noted by Ramesh et al. (1999) who found adsorption 
rates of phage ɸCD140 ranged between 2 to 33% after 30 minutes to C. difficile strains 
the phage was unable to infect. Again phages from this category would not be ideal for 
the development of the phage diagnostic test due to their low adsorption efficiencies 
to C. difficile and hence would not be specific for its detection over common hospital 
pathogens.  
4.5.3   Suitable phages for the development of an adsorption-based diagnostic 
test 
From the four adsorption categories phages T6ɸ7h, T6ɸ12eH and T6ɸ12 from the first 
and second category could be potentially used for the development of an adsorption-
based diagnostic test due to their distinctively high adsorption rates to C. difficile 
ribotypes they infect. Additionally, phage T6ɸ7h has high adsorption rates for isolates 
it is unable to infect too. For all three phages there is also a significant difference 
between adsorption rates to C. difficile in comparison to rates observed with other 
common hospital pathogens. However, generally higher adsorption rates were found 
for ribotypes the phages could infect and so the test would be limited in the number 
of ribotypes the phages could detect. Ideal phages would be those that have 
adsorption rates above 30% for isolates infected and not infected by the phage as this 
would help increase the number of ribotypes detected and the sensitivity of the 
adsorption-based test. Unfortunately, none of the five phages fulfil this criteria and 
therefore would not be ideal for the development of the phage adsorption-based 
diagnostic test. 
4.5.4   Binding efficiencies of C. difficile phages to common hospital pathogens  
All five phages bound to isolates of E. coli, MRSA and P. aeruginosa by a low efficiency 
and were therefore part of the fourth category. In addition, there were numerous 
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examples whereby binding rates of phages to the other hospital pathogens were 
similar to binding rates observed with C. difficile ribotypes. Consequently, these results 
need to be taken into consideration as if a C. difficile phage-based diagnostic test is 
developed by exploitation of phage adsorption there is a likelihood common 
healthcare associated pathogens would also be detected by the test, yielding false 
positive results.  
Only one other study has investigated the adsorption of C. difficile phage ɸCD140 
to other bacteria: C. perfringens, C. sordellii, C. bifermentans and Lactobacillus sp. They 
found binding rates were less than 1% over 30 minutes (Ramesh et al. 1999) but the 
binding rates found in this current study were between 1 to 15%. This could be due to 
different methodology used as Ramesh et al. (1999) spun down an overnight bacterial 
culture, re-suspended in broth and then added phage. Although in this study phage 
was added directly to a bacterial culture during its exponential stage in growth. 
Generally phages, which have high adsorption efficiencies to other bacteria can not be 
used for the development of the adsorption-based diagnostic test. They would be 
unable to discriminate between C. difficile and other bacteria.  
4.5.5  Differences in the expression of phage receptors to explain variances in 
adsorption rates  
Differences in the adsorption rates found within the four groups may be correlated to 
the level of expression of phage receptors (Hyman and Abedon 2009). Although the 
C. difficile phage receptor(s) has not yet been identified, previous studies with other 
bacterial and phage combinations have found fluctuations in the level of expression of 
phage receptor(s) can significantly influence phage adsorption. In addition not all 
bacterial strains express phage receptors continuously at constant levels (Erickson et 
al. 1982; Hyman and Abedon 2009). For example Chai (1983) found metals, 
detergents, chemicals and differences in media composition affected expression of cell 
surface proteins of E. coli  and hence affected phage adsorption.  
Furthermore bacteria are able to resist phage adsorption by the control of the 
availability of phage receptor(s) or by masking the receptor with a surface component, 
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such as a capsule and consequently the phage is unable to access its receptors 
(Samson et al. 2013). This was observed by Nordstorn and Forsgren (1974) with 
Staphylococcus aureus where they found the bacterium produced a cell wall anchored 
virulence factor, immunoglobulin G-binding protein A that could reduce phage 
adsorption. They altered the expression of the virulence factor and reduction in 
expression of protein A lead to a significant improvement in phage absorption 
efficiency. Similarly there may be a component on the C. difficile bacterial cell surface 
that blocked or reduced expression of the phage receptor, which may explain why low 
adsorption rates were observed to ribotypes the phage were able to infect. 
In addition to fluctuations in the expression of phage receptors, studies have 
highlighted two different receptors are required for phage adsorption, one for 
reversible and one for irreversible phage attachment. For example a study conducted 
by Baptista et al. (2008) found two different receptors are involved in phage 
adsorption of Bacillus subtilis phage SPP1. The phage first binds reversibly to 
glycosylated poly(glycerolphosphate) cell wall teichoic acid and irreversibly to the host 
cell membrane protein YueB. Although phage SPP1 can still bind without first binding 
reversibly but the reversible interaction strongly accelerates irreversible binding. One 
analogy to explain this observation was that after reversible phage binding occurs it 
allows the phage to ‘scan’ the bacterial cellular surface until it identifies and captures 
the YueB receptor to bind irreversibly.  
A similar two step adsorption cycle may be required for C. difficile phage 
attachment and both of the receptors may have been present and expressed higher 
for ribotypes in adsorption categories one and two. This could explain why high 
adsorption rates were observed for phages T6ɸ7h, T6ɸ12eH and T6ɸ12 to their 
propagation R076 host. Furthermore it would also explain why in Chapter 3 seven 
phages were isolated on this strain. The strain allows sufficient phage adsorption and 
hence infection to occur. However, only one of the receptors may have been 
expressed or both expressed in low amount for ribotypes in adsorption categories 
three and four. This would explain the low adsorption rates observed and may have 
also been influenced by temperature or the conditions used for the experiment.  
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The nature of the phage receptor can also influence phage adsorption, as in 
whether the receptor is a protein or a carbohydrate. If the phage binds to a protein 
receptor the interaction is stronger in comparison to if the phage binds to a 
carbohydrate receptor due to the high affinity of protein interactions. The phage tail 
fibres themselves are proteins and when bound to another protein the interaction is 
strong (Mahony and Sinderen 2012). In terms of C. difficile, phages have been 
predicted to bind to the S-layer that consists of a top layer of proteins and a second 
layer of carbohydrates and proteins. It could be that on isolates where high adsorption 
rates were observed in this study phages may have bound to a protein receptor. 
Although all the points made in regard to C. difficile phage receptors are hypothesis. 
Once the C. difficile receptor(s) has been characterised by on-going research in 
Professor Martha Clokie’s laboratory, it will allow adsorption kinetics to be 
investigated further and to understand the factors that can influence expression of 
phage receptors. These results will help to improve C. difficile phage adsorption rates, 
which will aid in the development of a robust adsorption-based bacterial diagnostic 
test.  
4.5.6   Other possible explanations for differences in adsorption rates observed 
There are other probable reasons to explain the variances in adsorption efficiencies of 
C. difficile phages used in this study, especially to explain the behaviour of phages, 
which fall into the second adsorption category. Why is it that even if the phage has a 
high adsorption rate to an isolate it is unable to infect? This could be due to the 
presence of a resident prophage within the isolate, which prevents further replication 
of infecting phage referred to as superinfection immunity (Stern and Sorek 2011). This 
is a probable cause as around 90% of C. difficile strains harbour prophages (Shan et al. 
2012). Another possibility could be the C. difficile isolate degrades viral DNA with 
restriction endonucleases, which are enzymes that cut DNA near or at particular 
recognition nucleotide sequences. Different C. difficile strains (ribotypes and MLVA 
types) have diverse restriction endonuclease patterns (Kristjansson et al. 1994; Wren 
and Tabaqchali 1987) and this could explain the differences in the binding rates for the 
variety of phage and ribotype combinations. Additionally, the host bacterium could 
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have prevented the entry of the phage genome or it may have been unable to support 
phage replication (Ramesh et al. 1999).   
4.5.7   Factors that may influence C. difficile phage binding 
In an attempt to increase C. difficile phage adsorption rates factors that could 
influence adsorption were investigated for phage T6ɸ12eH. This is because high 
binding rates are required for the development of a phage adsorption-based 
diagnostic test. The factors tested in this study included movement of the bacterial 
and phage suspension, MOI and whether an increase in the duration of the adsorption 
experiment to six hours could improve adsorption. It is important to investigate such 
factors as it has been reported that optimised conditions for phage adsorption could 
increase the rate by six-fold (Delbrock 1940).  
The first parameter tested was if the bacterial and phage suspension was shaken 
throughout the adsorption experiment would it increase adsorption rates. Although it 
should be noted generally C. difficile grows under static conditions in the anaerobic 
chamber. However, increased movement did help to increase the adsorption rates for 
three out of 12 ribotypes but only for ribotype 014/020 the rate was above 30% and 
was also mirrored with the value of k. The increased motility of the bacterial culture 
increased Brownian motion, which may be the reason why adsorption rates were 
raised (Abedon and Thomas-Abedon 2010; Delbruck 1940). Also, it may have increased 
the likelihood of phage and bacterial interactions and consequently it may have helped 
to increase the rates of reversible and irreversible phage attachment (Baptista et al. 
2008). This could be the reason why the high adsorption rates were observed for 
R014/020 and R076. However too much movement can also reduce phage adsorption 
(Delbruck 1940), which may also have been observed in this study. Therefore, it is 
likely the speed used to shake the bacterial and phage sample needs to be optimised 
per phage and ribotype combination. This would not be ideal for the development of 
an adsorption-based phage diagnostic test as it would not be viable and would not 
make the test easy to use. For these reasons it was not investigated further.  
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Next, the influence of MOI was studied to investigate whether reduction of the 
MOI ratio could increase the adsorption rates as has been suggested in the literature 
(Hyman and Abedon 2009). A high MOI can lead to ‘lysis from without’ and also when 
the host density is reduced the stochastic nature of phage adsorption dominants (Shao 
and Wang 2008). For example at a MOI of 0.001, adsorption of E. coli phages DT1, DT5 
and DT6 was almost 100% (Tomat et al. 2014). Similarly, the adsorption kinetics of four 
Lactococcus lactis phages studied at MOI of 0.02 was approximately 97% (Suarez et al. 
2008). Conversely this study found a drop in MOI reduced adsorption rates 
significantly across four different ribotypes, with the highest rates observed with the 
original MOI of one used for all previous adsorption experiments. The drop in MOI also 
led to lower adsorption constant rate values and hence represents the reduction in the 
probability of irreversible adsorption. These results are hard to explain but one 
explanation could be at MOI of one the ratio of phage and bacteria are equal hence 
one phage per bacterial cell creates the optimal adsorption conditions. This would 
suggest that the most suitable MOI was used in this study to investigate adsorption 
rates of C. difficile phages. Perhaps this MOI would also be ideal for the potential 
adsorption-based diagnostic test.  
Although a point to consider with the MOI experiments is that the phage 
concentration was kept constant and only the C. difficile bacterial count was altered. 
Therefore, phage adsorption was tested at different stages of bacterial growth and it 
has been noted in the literature the state of the bacterial cell can influence phage 
adsorption (Erickson et al. 1982; Hyman and Abedon 2009). This could explain why a 
reduction in MOI led to a drop in the adsorption rates. Variations in the physiological 
state on the bacterial cells may have caused this (Delbruck 1940) and it could be phage 
T6ɸ12eH prefers adsorption to bacterial cells in their exponential stage of growth 
rather than at the later stage of the bacterial cycle. In addition, at high bacterial 
densities there are delays in the transition between reversible and irreversible phage 
attachment. This may also contribute to the reason why low adsorption rates were 
noted with higher bacterial concentrations (Hyman and Abedon 2009).     
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The last factor tested was whether an increase in the duration of the phage 
adsorption experiment could help to increase adsorption rates. Although phage 
adsorption occurs within a few seconds to minutes (Hyman and Abedon 2009) it has 
been noted from Chapter 3 the replication cycle of C. difficile phages ranges from 60 to 
90 minutes. Therefore, through extension of the adsorption experiment to six hours, it 
is possible for multiple rounds of replication to occur, which may help to increase 
adsorption rates. It would also increase the opportunity of reversible and irreversible 
attachment to occur, especially to ribotypes which phage T6ɸ12eH had low 
adsorption rates too. However, there was no change in adsorption rates even for 
ribotypes that are infected by phage T6ɸ12eH. Therefore, it can be concluded an 
increase in the length of phage adsorption experiment does not help to increase phage 
adsorption rates. This is beneficial as otherwise it would take the adsorption-based 
diagnostic test several hours to identify if C. difficile is present or not. 
4.5.8   Conclusion  
There are a number of points that need to be considered if a C. difficile diagnostic test 
is designed based on phage adsorption:  
1. Adsorption rates varied greatly for ribotypes infected and not infected by the 
five phages investigated in this chapter. Most adsorption rates were below 30% 
and comparable to phage adsorption rates to common hospital pathogens. 
While for C. difficile phages T6ɸ7h, T6ɸ12eH and T6ɸ12 higher adsorption 
rates were noted for ribotypes they could infect. Therefore, although the 
adsorption-based phage diagnostic test would be specific in detection of 
C. difficile only a limited number of ribotypes would be identified.  
2. Phage binding rates are dependent on a number of factors, which are MOI and 
movement of bacterial and phage suspension. The results in this chapter found 
the changes caused by the factors can also be ribotype-specific. If the 
diagnostic test is to be used in a clinical environment it would be hard to fulfil 
these criteria and the test would be time-consuming.  
3. The C. difficile phage receptor(s) has not yet been identified and would be an 
obstacle in the development of adsorption-based diagnostic test as ‘ideal 
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conditions’ for increased phage receptor to increase phage adsorption could 
not be created.  
Due to these reasons it was decided not to engineer a phage adsorption-based 
C. difficile diagnostic test and alternatively the detection test could be developed by 
exploitation of the infection step of the infection cycle by construction of reporter 
phages. The construction of C. difficile reporter phages will be discussed in Chapters 5 
and 6. 
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4.6   Chapter 4 summary  
• Adsorption rates of five broad host range C. difficile phages: T6ɸ7h, T6ɸ12eH, 
T6ɸ12, T6ɸF2 and AIUɸX2 were investigated to 12 clinically relevant ribotypes 
(not all ribotypes were infected by the phages) and common hospital 
pathogens. This was to investigate whether a C. difficile diagnostic could be 
developed based on phage adsorption. 
• Overall there was not a correlation between phage infectivity and adsorption 
but the adsorption rates could be placed into four categories dependent on 
their adsorption rates and value of k: 
1. Phages bound by over 30% and can infect the isolate. Phages from this 
group could be used for the development of adsorption-based 
diagnostic test. 
2. Phages bound by over 30% but are unable to infect the isolate.  
3. Phages bound by less than 30% and can infect the isolate. 
4. Phages bound by less than 30% and are unable to infect the isolate.  
• Overall most ribotype and phage combinations fell into the fourth group. 
Consistent high adsorption rates were not observed for C. difficile in 
comparison to common hospital pathogens. 
• In an attempt to increase phage adsorption rates, adsorption experiments 
were repeated for phage T6ɸ12eH with alterations of three different 
conditions: 
1. Bacterial and phage suspension was shaken.  
2. MOI was changed from 1 to 0.1 and 0.01. 
3. The duration of the adsorption experiment was extended to six hours. 
• However, significant changes in adsorption rates were observed but they were 
not observed for all ribotypes, instead they were ribotype specific. Therefore, 
alteration of the three parameters would not be beneficial for the test. 
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5.1   Introduction  
From chapter 4 it was concluded that the development of a phage-based detection 
assay dependent on phage adsorption would not be suitable for the detection of 
C. difficile due to lack of specificity and sensitivity for this organism. Consequently, a 
new approach needs to be considered to develop a phage-based detection test that is 
highly sensitive, specific and a general improvement on those currently used in 
hospitals. A phage-based assay that would have the potential to fit these criteria has 
been developed for other bacterial species and is called the reporter assay. The test 
has been constructed by the incorporation of luciferase reporter genes to the phage 
genome after which the reporter genes are expressed upon phage infection. 
Expression occurs within minutes with the addition of a long-chain fatty aldehyde 
substrate N-decanal, which leads to the production of a measureable bioluminescence 
signal. The signal can be read with a hand held or a 96 well microplate luminometer 
(Schmelcher and Loessner 2014; Smartt and Ripp 2011; Goodridge and Griffiths 2002).  
The reporter assay is dependent on phage infection and therefore reporter phages 
only produce a bioluminescence signal after infection occurs with their target 
bacterium, which makes the assay highly specific (Merwe et al. 2014). This motivated 
the decision to develop reporter phages for identification of C. difficile and is the first 
study to construct of C. difficile-specific reporter phages. It may not have previously 
been attempted due to a lack of appropriate phages to exploit, however, suitable 
broad host range phages have been identified in Chapter 3. These phages would allow 
detection of multiple ribotypes when used in the reporter assay.  
 Chapter 5 will concentrate on using these broad-host range phages as templates 
for the development of C. difficile reporter phages. They will be genetically 
manipulated to insert reporter genes within their genomes. Not only would the 
development of the C. difficile reporter phage assay speed up diagnosis of CDI, it could 
also be used to as a test to identify C. difficile in healthcare settings, rather than 
associated with patients, in order to determine if sufficient cleaning has been 
conducted in hospital wards. This could help to limit the spread of CDI in healthcare 
environments. 
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5.1.1   Advantages and disadvantages of the use of reporter phages for 
bacterial detection  
There are several advantages of using reporter phages over culture, PCR or ELISA-
based tests for bacterial detection, especially for identification of C. difficile. They are: 
1. Reporter phages can detect target bacterial cells rapidly due to expression of 
the reporter genes being dependent on phage infection, which occurs within 
20 minutes after phage adsorption. Therefore, the reporter assay can 
theoretically be completed within a short period of time comparable to the 
two hours it takes to complete the C. difficile specific PCR diagnostic test 
(Smartt and Ripp 2011). 
2. Reporter phages are able to distinguish between live and dead bacterial cells. 
This is because reporter genes are only expressed upon a productive infection 
with an active bacterial cell, which is required for the reporter genes to be 
transcribed, translated and expressed. Therefore, a bioluminescence signal is 
only produced for active cells. In contrast, PCR-based diagnostic methods used 
in hospitals to diagnose C. difficile are unable to differentiate between live and 
dead bacteria (Burnham and Carroll 2013).  
3. The reporter assay is very sensitive and is able to detect 100 bacterial cells 
without enrichment (Schofield et al. 2015). 
4. Due to the robustness and the high specificity of the reporter assay no prior 
lengthy sample preparation or purification is required. In other words the 
target bacterium can even be detected even if multiple bacteria species are 
present in the test sample (Smartt and Ripp 2011; Schmelcher and Loessner 
2014). This is particularly advantageous when the reporter assay will be used 
to detect the presence of C. difficile on hospital ward surfaces, as multiple 
bacteria are likely to be present.  
Although there are many benefits with reporter-based phage assays a number of 
drawbacks have also been identified but most can be overcome without difficulty and 
will be discussed further in this chapter. The disadvantages are:   
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1. Construction of reporter phages can be labour-intensive and detailed 
knowledge of the phage genome is required. This is because the best location 
for insertion of the luxAB genes within the phage genome needs to be 
identified (Schmelcher and Loessner 2014).  
2. The amount of genetic material that can be introduced into the phage genome 
is limited as its capsid sets a natural limit to allow packaging of phage DNA. If 
the limit is exceeded i.e. the original genome size is expanded, it can lead to a 
defective phage that can no longer infect its target bacterial host (Brigati et al. 
2007).  
3. Reporter phages are classed as Genetically Modified Organisms (GMOs) and 
hurdles may be encountered with regard to regulatory approval and consumer 
acceptance. However, as reporter phages would be used as diagnostics and not 
for therapy progress has been made to bring reporter phages to the 
commercial market. Especially by the US based company Sample6 
(www.sample6.com), who specialise in the development of phage derived 
products (Lu et al. 2013; Schmelcher and Loessner 2014).   
5.1.2   Examples of reporter phages and their sensitivity and specificity for 
detection of their target bacteria  
The most common luciferase reporter genes used to develop reporter phages are the 
luxAB genes from naturally bioluminescent marine microbes Vibrio harveyi and Vibrio 
fischeri. The luxAB reporter phages have been developed to detect a number of 
pathogens: E. coli (Waddell and Poppe 2000), Salmonella (Kuhn et al. 2002), Listeria 
monocytogenes (Loessner et al. 1996), Yersinia Pestis (Schofield et al. 2009), Bacillus 
anthracis (Schofield and Westwater 2009) and Pseudomonas cannabina pv. alisalensis 
(Schofield et al. 2012). With all reporter phages detection limits to their target 
bacterium ranged from 106 CFU/ml to 102 CFU/ml but if a short enrichment step is 
included as few as 10 bacterial cells can be detected by the assay (Schmelcher and 
Loessner 2014). Overall though, previous studies have implied reporter phages are 
highly sensitive, which was another incentive to construct C. difficile specific reporter 
phages. 
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To further expand and give examples on the sensitivity of previously developed 
reporter assays, the L. monocytogenes reporter phage was able to detect 103 CFU/ml 
without enrichment. Sensitivity was increased by a prior enrichment step, which was 
incubation of the sample that may contain the target bacteria in nutrient broth. After 
which the broth culture was incubated in ideal conditions for bacterial growth. 
Subsequently the reporter phage was added, which allowed identification of one 
L. monocytogenes cell per gram in artificially contaminated salad, ricotta cheese, 
cabbage and chocolate pudding. Although, the enrichment step increased the time of 
whole assay to 22 hours in comparison to just two hours without enrichment 
(Loessner et al. 1996). 
The high levels of sensitivity observed with the L. monocytogenes reporter phage 
was also noted for the reporter phage developed to detect the plant pathogen 
P. cannabina pv. Alisalensis. Similarly, without enrichment a minimum 103 CFU/ml was 
sufficient to elicit a bioluminescence signal after 90 minutes but with enrichment as 
few as ten bacterial cells were detected (Schofield et al. 2012). Both the 
L. monocytogenes and P. cannabina pv. Alisalensis reporter phage assays indicate a 
pre-enrichment step substantially improves sensitivity, which will be considered with 
the development of C. difficile reporter phages. This will be particularly vital when the 
assay is used to detect the bacterium directly from environmental surfaces, as 
C. difficile may be present at low concentrations.  
Aside from the high sensitivity of reporter phages, they are also highly specific for 
detection of their target bacteria and produce an enhanced bioluminescence signal in 
response even if a variety of bacteria are present in the sample. For example the 
Y. pestis reporter phage transduced a 15,896 RLU bioluminescence signal to a Y. pestis 
strain but no signal was produced with two E. coli strains tested. Sensitivity to other 
closely related Yersinia species was also tested and two out of ten 
Y. pseudotuberculosis strains produced an attenuated response. However, the signal 
was 100 fold lower in comparison to the response noted with Y. pestis (Schofield et al. 
2009). Furthermore, the S. flexneri reporter phage was screened to identify if a 
bioluminescence signal was produced for non-Shigella Enterobacteriaceae (E. coli, 
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S. enterica, Y. enterocolitica and K. pneumoniae). One out of 29 S. enterica strains 
resulted in a bioluminescence response but again the signal was 100 fold lower than 
that noted for S. flexneri (Schofield et al. 2015). These studies support the statement 
that it is possible to detect the bacteria of interest even if multiple bacteria are 
present within the sample. This will be particularly useful when using the C. difficile 
reporter phages both as a diagnostic and environment test as most likely many 
different bacteria will be present in the samples. 
5.1.3   Construction of reporter phages 
One of the constraints of the development of reporter phages is the physical size of 
the inserted reporter genes as incorporation of lengthy DNA genes within the phage 
genome could compromise phage infection (Smartt and Ripp 2011). Consequently, 
instead of using the whole 7 kb luxCDABE operon, it is preferred to construct reporter 
phages with 2.2 kb luxAB genes instead. Although it needs to be highlighted that as the 
whole reporter operon is not used, it is necessary to add the N-decanal substrate for 
the production of the bioluminescence signal.  
To further avoid disruption of the phage genome the most common method used 
to incorporate the reporter genes within the phage genome is by replacement and 
exchange with a similar-sized gene in the phage genome. Typically the gene exchanged 
is one that is not required for phage infection and structural assembly. For example 
Schofield et al. (2012) successfully replaced the P. cannabina pv. alisalensis phage 
gene phoH, which was predicted to be inessential with the luxAB genes and phage 
infection was unaffected (Schofield et al. 2012). However, in terms of C. difficile 
phages, when they have been sequenced and annotated many genes have been 
labelled as hypothetical genes as their functions are unknown. Only though RNA 
sequencing has it been possible to identify which of these hypothetical genes are 
dominantly expressed during phage infection (Hargreaves et al. 2015 submitted). 
The strategy of gene replacement and exchange for incorporation of the luxAB 
genes within the phage genome can be achieved by two methods. The first method is 
by direct cloning of phages. Although most methods to date have been directed 
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towards phages infecting Gram-negative bacteria. This is because the method was first 
described for E. coli and since then been employed for phages that infect Salmonella, 
Shigella and Mycobacterium tuberculosis. The second method of gene replacement is 
by the genetic manipulation of phages by transposition via homologous 
recombination, which is the transfer of genetic material between organisms. The 
transfer is achieved by using shuttle plasmids and is the most common approach used 
as it can be applied to phages that infect both Gram-negative and positive bacteria 
(Schmelcher and Loessner 2014). Homologous recombination is a form of genetic 
recombination whereby nucleotide sequences are exchanged between identical or 
similar nucleotide sequences (Sambrook and MacCallum 2000). Due to previous 
homologous recombination methods described for C. difficile by the use of 
Clostridium-E. coli shuttle plasmids (Chapter 2, Section 2.2.2), the homologous 
recombination strategy was chosen to construct C. difficile reporter phages (Heap et 
al. 2009). 
5.2   Aim of this study 
The aim of chapter 5 was to develop reporter constructs in Clostridium-E. coli shuttle 
plasmids in order to transfer the reporter genes to broad host range and fully 
sequenced C. difficile phages: T6ɸ12 (official name is CDHM1) and T6ɸF2 (official 
name is CDHM6). The reporter luxAB genes were used and the strategy was to replace 
and exchange the luxAB genes with predicted non-essential phage genes. These non-
essential genes were those that were not required for phage infection and were either 
annotated as hypothetical proteins, i.e. they have no assigned function or identified 
via RNA sequencing (Hargreaves et al. 2015 submitted). In summary, three putative 
genes were identified as potential genes to be replaced with the luxAB genes for 
phage T6ɸ12 and four genes for phage T6ɸF2. Multiple genes were targeted to 
identify the optimise location of the luxAB genes within the phage genome. 
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5.3   Material and Methods 
5.3.1   Bacterial strains, phages and plasmids 
All bacterial strains, phages and plasmids used in Chapter 5 are listed in Table 5.1.  
5.3.2   Recombinant DNA procedures 
The recombinant DNA cloning procedure used was as described by Sambrook et al. 
(2000) but briefly the key steps are highlighted in this section. Overall the process was 
separated into four key stages: fragmentation, ligation, transformation and the 
process of screening transformation colonies to check for the presence of insert 
(Sambrook and MacCallum 2000).  
5.3.3   Fragmentation  
5.3.3.1   Bacterial plasmid preparation, purification and quantification 
DNA plasmids were all isolated, stored and grown in DH5α E. coli cells in LB media 
supplemented with the appropriate antibiotic that was dependent on the antibiotic 
marker on the plasmid being used. Cultures were grown for 24 hours at 37°C with 
shaking at 200 rpm. Plasmid DNA was extracted with the GenElute™ Plasmid Miniprep 
Kit (Sigma Aldrich, UK) as guided by the manufacturer’s instructions. After which, 
plasmid concentrations were determined with the Nanodrop (Thermo Scientific, USA). 
5.3.3.2   Oligonucleotide design 
Oligonucleotides, which will now be referred to as primers, were used for the 
recombinant DNA procedure and were designed manually to include restriction 
endonuclease sites. PCR screen primers were designed with softwares: Primer 3 
(http://primer3.ut.ee/) or Primer 3 plus (http://www.bio-informatics.nl/cgi-
bin/primer3plus/primer3plus.cgi/). All primers were purchased from IDT Integrated 
DNA Technologies, UK and the working primer stocks used were 10 mM. All primers 
are listed in Table 9.5, Chapter 9.  
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Table 5.1 List of bacterial strains, phages and plasmids used in this study.  
 Description  Accession number 
and/or reference 
C. difficile strain  
T6 Propagation host for phages T6ɸ12 
and T6ɸF2.  
This laboratory 
C. difficile phages   
T6ɸ12 Myovirus. This laboratory, 
HG531805 (Hargreaves 
et al. 2014) 
T6ɸF2 Myovirus. This laboratory 
E. coli cloning strain   
DH5α Highly competent cloning cells. Lucigen, UK  
Plasmids  
pUC18-mini-Tn7T-Gm-
lux  
11,299 bp plasmid carries the 
reporter operon luxCDABE, 
ampicillin and gentamycin 
resistance marker cassettes 
(working concentration 100 µg/ml 
ampicillina and 15 µg/ml 
gentamicina).  
AY962893 (Choi and 
Schweizer 2006)  
pBlueScript II SK+ 2,964 bp high transformation 
efficiency cloning plasmid that has 
an ampicillin resistance marker 
(working concentration 100 
µg/mla). 
X52328 
pMTL84422 7,371 bp Clostridium-E. coli shuttle 
plasmid that has an tetracycline 
resistance marker (working 
concentration 10 µg/mla). 
FJ797650 (Heap et al. 
2009)  
pMTL82151 5,254 bp Clostridium-E. coli shuttle 
plasmid that has an 
chloramphenicol/thiamphenicol 
resistance marker (working 
concentration 25 µg/mla).  
FJ797645 (Heap et al. 
2009)  
pMTL83151 4,476 bp Clostridium-E. coli shuttle 
plasmid that has an 
chloramphenicol/thiamphenicol 
resistance marker (working 
concentration 25 µg/mla). 
FJ797647 (Heap et al. 
2009)  
a Working antibiotic concentration for the bacterium E. coli. 
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5.3.3.3   Polymerase chain reaction 
Genes cloned, which will be referred to as inserts were PCR amplified from boiled 
plasmid or C. difficile phage lysate. The specific templates used are listed alongside the 
list of primers (Table 9.5, Chapter 9). The high-fidelity Q5 polymerase (New England 
Biolabs, UK) was used to amplify inserts that were cloned into plasmids. In a total 
volume of 25 µl the following regents were added (all reagents purchased from NEB, 
UK): 0.5 µM of each primer, 200 µM dNTPs, 5x Q5 reaction buffer, 0.02 U/µl of BioTaq 
polymerase and 50 ng of template DNA. The PCR cycle used was as follows: initial 
denaturation at 98°C for 30 seconds, followed by 30 cycles of denaturation at 98°C for 
10 seconds, primer annealing step was between 50 to 65°C for 20 seconds, extension 
at 72°C for 30 seconds per kb and a final extension at 72°C for 2 minutes. 
Biotaq polymerase was used for colony PCR’s that were conducted to screen if 
inserts had successfully been ligated. In a total volume of 50 µl the following regents 
were added (all reagents purchased from Bioline, UK): 0.5 µM of each primer, 
0.25 mM dNTPs, 3 mM MgCl2, 0.5 U of BioTaq polymerase and 50 ng of template DNA. 
The Biotaq polymerase PCR cycle was as follows: denaturation at 95°C for 5 minutes, 
followed by 30 cycles of denaturation at 95°C for 50 seconds, primer anneal step 
between 45 to 55°C for 50 seconds, extension at 68°C for 4 minutes and a final 
extension at 68°C for 7 minutes.  
5.3.3.4   Restriction endonuclease digestion  
After successful amplification of the insert, the PCR product was purified with the 
Isolate II PCR and gel kit (Qiagen, UK) as per the manufactures instructions and eluted 
to a final volume of 20 µl. Then the purified PCR product was digested with 
complimentary restriction endonucleases. Simultaneously, the plasmid at a final 
concentration 500 ng/µl, in which the insert was cloned into, was also digested with 
the same restriction endonucleases. The restriction endonucleases were all purchased 
from New England Biolabs (UK) and the manufactures instructions were followed. All 
endonuclease digests were incubated at 37°C for 2 hours.  
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5.3.3.5   Dephosphorylation of plasmid 
Alkaline Phosphatase, Calf Intestinal (CIP) (New England Biolabs, UK) was added to 
catalyse the dephosphorylation of the 5’ and 3’ end of DNA. CIP prevents re-
circularisation of the plasmid and was used as per the manufactures instructions. 
5.3.3.6   Gel extraction 
After enzyme digestion and/or CIP treatment the PCR products and plasmids were run 
on a 1% agarose gel made with 100 ml 1 x TAE buffer and 0.5 µg/ml ethidium bromide 
(Fisher Scientific, UK). Products were separated by electrophoresis on agarose gels, 
run at 100 V for 1 hour and visualised with UV light. DNA was extracted from gels with 
the Isolate II: PCR and gel kit (Qiagen, UK) as per the manufactures instructions. 
5.3.4   DNA ligation 
Plasmid and inserts were ligated with the T4 DNA ligase kit (New England Biolabs, UK). 
Ligations were made to a final volume of 20 µl as per the manufactures instructions 
and a plasmid only control was included. Samples were incubated at 16°C overnight.  
5.3.5   Transformation  
5.3.5.1   Preparation of chemically competent cells  
DH5α cells were streaked from -80°C cryopreservation vials onto a LB 1% agar plate 
(Table 9.5. Chapter 9) and incubated overnight at 37°C. A single colony was inoculated 
into 5 ml LB broth, grown overnight at 37°C whilst being shaken at 200 rpm. 400 µl of 
the overnight culture was added to 200 ml of LB and grown until the culture reached 
OD600 of 0.3. Cells were chilled on ice for 15 minutes followed by centrifugation at 
11,000 x g for 15 minutes at 4°C. The cell pellet was resuspended in 33 ml of pre-
chilled, filter sterilised RF1 solution (Table 9.2, Chapter 9) and incubated on ice for 
1 hour. Cells were then centrifuged again and the pellet was resuspended in 12.5 ml of 
pre-chilled, filter sterilised RF2 solution (Table 9.2, Chapter 9) and incubated on ice for 
15 minutes. 100 µl of the competent cell suspension was aliquoted into 1.5 ml ice-cold 
Eppendorf tubes, snap frozen with liquid nitrogen and stored at -80°C. 
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5.3.5.2   Transformation via heat shock 
The ligation mix (Section 5.3.4) was transformed into competent E. coli DH5α cells. 
Competent cells were initially thawed on ice for 15 minutes, 10 µl of the ligation mix 
was added to the DH5α cells and was incubated on ice for 60 minutes. Cells were heat 
shocked at 42°C for 1 minute after which 300 µl of Super Optimal Broth (SOC) was 
added and the mixture was incubated at 37°C whilst being shaken at 200 rpm for 
1 hour. All the transformation mix was plated on LB 1% agar plates with antibiotics 
specific for the plasmid and incubated overnight or up to 48 hours at 37°C.  
5.3.5.3   Screen transformation colonies to check for insert  
Possible transformation colonies found on the LB 1% agar plates after ligation were 
screened via three steps: colony PCR, enzyme digestion and sequencing.  
Colony PCR involved selection of single colonies, after which they were re-
suspended in 20 µl of ultra-purified water, boiled at 99°C and centrifuged at 11,000 x g 
for 30 seconds. 1 µl of the crude supernatant was used as the template for PCR 
reaction with Taq Polymerase as described in section 5.3.3.3. PCR products were run 
on a 1% agarose gel. If positive bands were visualised on the gel, the colony was 
inoculated into 5 ml LB broth with plasmid specific antibiotics and grown overnight at 
37°C whilst being shaken at 200 rpm. After which, plasmid DNA was extracted, 
quantified (Section 5.3.3.1), digested with appropriate restriction endonucleases and 
visualised on a 1% agarose gel.  
If after restriction endonuclease digest expected bands were observed on the 
agarose gel, the plasmid DNA was sent for sequencing (Supreme-runTM sequencing) to 
GATC Biotech, UK alongside primers specific for the insert. Sequenced data were 
retrieved from the GATC website as chromatogram files (.abi format) and as fasta 
sequences. The multiple sequence alignment tool ClusterW2, EMBL-EBI 
(http://www.ebi.ac.uk-/Tools/msa/clustalw2) was used and the fasta sequences were 
aligned against the original insert sequence to check for homology.  
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5.4   Results 
5.4.1   Identification of C. difficile phages for construction of reporter phages 
A large-scale host range analysis (Chapter 3, Section 3.4.2) of 35 phages against 160 
C. difficile isolates identified five phages with a wide-range of infectivity that were able 
to infect multiple ribotypes. Any of these five phages: T6ɸ12eH, T6ɸ12, T6ɸ7, T6ɸF2 
and AIUɸX2 could be used for the development of the diagnostic test. However, in 
addition to host range data, for the construction of reporter phages phage genome 
information is required but not all five phages have been fully sequenced. Therefore, 
on the basis of host-range and sequence data two from the five phages were chosen: 
T6ɸ12 (Figure 5.1a and accession number HG531805) and T6ɸF2 (Figure 5.1b and 
unpublished genome). Phages T6ɸ12 and T6ɸF2 are able to infect the most clinically 
relevant ribotypes in the UK:  010, 013, 015, 014/020, 026, 076, 087 and 220. 
Furthermore, the two C. difficile phages have been extensively characterised in our 
laboratory and were therefore, chosen to test the proof of concept as to whether 
C. difficile reporter phages can be developed and used to detect the bacterium.   
5.4.2   Phage genes targeted for replacement with luxAB reporter genes 
The following criteria were closely followed to identify phage genes that could be 
targeted for replacement with the luxAB genes: 
1. Gene has been annotated as a ‘hypothetical protein’ or is not required for lytic 
phage infection based on RNA sequencing. 
2. Size of the targeted gene is of appropriate length, which is comparable to the 
luxAB genes to avoid major disruption of the phage genome. 
3. It was intended to avoid the disruption of any of the three open reading frames 
of the phage genome when the reporter phage was generated. 
After identification of such phage genes, multiple genes from the phage genomes of 
T6ɸ12 and T6ɸF2 were targeted for replacement with the reporter genes. As this is 
proof of concept study, it was unsure whether the location of the luxAB genes within 
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the phage genome would impact their stability, expression and hence the 
bioluminescence signal. Therefore, targeted genes were located in different regions of 
the phage genomes: structural, lysogeny control and DNA replication. 
Consequently, three genes, in three different regions of phage T6ɸ12 were 
targeted for replacement with the reporter genes (Table 5.2 and Figure 5.1). The first 
encoded for the Scaffold Protein (SF) located within the structural genes, the second 
gene was Hypothetical Protein (HP1) within the lysogeny control region and the third 
gene was the NTPase gene (NTPase) within the DNA replication site. The selection of 
these three genes was further supported through research conducted in our 
laboratory by Dr Katherine Hargreaves as part of her post-doctoral research. 
Dr Katherine Hargreaves conducted an RNA sequencing study of phage T6ɸ12 
infection (Hargreaves et al. 2015 submitted). The purpose of this work was to identify 
which phage genes are expressed and the level of expression throughout the lytic and 
lysogenic cycle in one C. difficile host. From the data it was concluded all three genes 
were either not expressed (SF and HP1) or expressed at minimal amounts in the 
duration of both infection cycles (NTPase). 
The transcriptome of phage T6ɸF2 has not been determined, and therefore in an 
effort to minimise risk, four predicted hypothetical proteins were targeted for 
replacement in different regions of the phage genome. Two hypothetical proteins 
within the structural region of the phage genome: Hypothetical Protein 2 (HP2) and 
Hypothetical Protein 3 (HP3). The third Hypothetical Protein 4 (HP4) is located within 
the lysogeny site and the fourth Hypothetical Protein 5 (HP5) located within the DNA 
replication site. NCBI Blast was also used to identify if the hypothetical proteins had 
been annotated and assigned a function in other phages. Only four to five hits were 
found with other Clostridium phages, and again the genes have no obvious homology 
to known phage genes and are labelled as hypothetical proteins. 
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Table 5.2 A list of phage genes targeted for replacement with the luxAB genes for 
development of C. difficile reporter phages. 
a All PCR primers and their sequences used in this study are listed in Table 9.5, 
Chapter 9. 
b DNA sequences in Table 9.6, Chapter 9. 
c DNA sequences in Table 9.7, Chapter 9. 
d DNA sequences in Table 9.8, Chapter 9. 
e DNA sequences in Table 9.9, Chapter 9. 
f DNA sequences in Table 9.10, Chapter 9. 
g DNA sequences in Table 9.11, Chapter 9. 
h DNA sequences in Table 9.12, Chapter 9. 
 
 
 
 
C. difficile 
phage 
Gene targeted for 
replacement with 
reporter luxAB genes  
Location of gene 
within the phage 
genome (bp) 
Size of 
gene (bp) 
PCR 
primersa  
T6ɸ12 Scaffold proteinb 5351 – 5915 564   
Flanking region 1 4040 – 5350 1311 P13, P14 
Flanking region 2 5915 – 6640  1290 P17, P18 
Hypothetical protein 1c 34788 – 34929 141   
Flanking region 1 33507 – 34787 1281 P21, P22 
Flanking region 2 34930 – 36234  1305 P25, P26 
NTPase gened 52177 – 54211 2034   
Flanking region 1 51160 – 52176 1017 P29, P30 
Flanking region 2 54212 – 55205  994 P33, P34 
T6ɸF2 Hypothetical protein 2e 6390 – 7427  1038   
Flanking region 1 5226 – 6389 1164 P45, P46 
Flanking region 2 7428 – 8591  1164  P49, P50 
Hypothetical protein 3f 23886 – 25121  1236  
Flanking region 1 22851 – 23885  1035 P53, P54 
Flanking region 2 25122 – 26156  1035  P57, P58 
Hypothetical protein 4g 28079 – 29665  1587  
Flanking region 1 26915 – 28078 1164  P61, P62 
Flanking region 2 29666 – 30754  1089 P65, P66 
Hypothetical protein 5h 42125 – 42125 795  
Flanking region 1 40628 – 42124 1497 P69, P70 
Flanking region 2 42126 – 43272  1146 P73, P74 
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Figure 5.1 Genome DNA maps of two C. difficile phages: T6ɸ12 and T6ɸF2 used for 
construction of reporter phages.  
The linear maps of phages a) T6ɸ12 that is approximately 54 kb (Hargreaves et al. 
2014) and T6ɸF2 that is approximately 51 kb (unpublished genome) represents the 
position of the coding regions of the phages. Phages were sequenced and annotated 
by Dr Katherine Hargreaves. Arrows indicate the labelled phage genes targeted for 
replacement with the reporter luxAB genes.  
a 
b 
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5.4.3   Construction of the reporter cassette  
Allele exchange also referred to as gene replacement in the literature, was the 
strategy used for the development of C. difficile reporter phages. Allele exchange is 
used for directed mutagenesis where a native allele in a genome is exchanged with an 
alternative allele, which contains a mutation or a gene planned to be inserted next to 
or exchanged with the native allele in the genome. In the case of this study a phage 
gene was being replaced with the luxAB genes via homologous recombination. In 
order to achieve this, the alternative allele was flanked upstream and downstream 
with DNA regions identical to those DNA regions, which flank the native allele 
sequence. The DNA regions are referred to as flanking regions. Homologous 
recombination events occur between both pairs of identical DNA regions and are 
necessary to mediate the gene exchange (Table 5.2). Consequently the targeted gene 
is knocked out and the luxAB genes are inserted. 
To design reporter constructs appropriate for homologous recombination three 
steps were followed (Figure 5.2): 
1. luxAB reporter genes were PCR amplified and cloned. 
2. Flanking regions of the native allele were PCR amplified and cloned either side 
of the reporter genes. 
3. Complete reporter construct was transferred to modular Clostridium-E. coli 
shuttle plasmids. 
However, before any cloning began to develop the reporter construct it was 
investigated which restriction endonuclease sites were not present in the sequences of 
the luxAB genes and flanking regions. Only restriction endonucleases that are unable 
to cleave the luxAB genes and flanking regions can be used for the cloning procedure 
otherwise the regions would be cut during the process. This was checked via the 
software APE: A plasmid editor (designed by Wayne Davies: http://biologylabs-
.utah.edu/jorgensen/wayned/ape/). After which 5’ and 3’ primers were designed and 
incorporated restriction endonuclease sites at the beginning of the primer sequences. 
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Data on PCR’s with internal primers and images of PCR products ran on agarose gels 
that were carried out to screen for inserts have not been included. 
5.4.3.1   Amplification and insertion of reporter genes to pMTL84422 
The Vibrio harveyi reporter genes luxAB were PCR amplified using plasmid pUC18-
mini-Tn7T-Gm-lux as the template and primers included restriction endonuclease sites 
NdeI in the forward primer and NheI in the reverse primer (primers P1 and P2 
respectively Table 9.5, Chapter 9). The PCR product was endonuclease digested with 
NdeI and NheI. Then the insert was cloned into complementary restriction 
endonuclease sites in the Multiple Cloning Site (MCS) of the linearized pMTL84422 
plasmid between restriction endonuclease sites Ndel and NheI. The reporter genes 
were inserted upstream of Clostridium Pthl promoter between restriction sites NotI and 
NdeI and downstream of the terminator sequence between restriction sites NheI and 
AscI. By the addition of the strong Clostridium promoter sequence it ensures the 
reporter genes are constitutively expressed (Figure 5.2). 
However, difficulties were encountered with the insertion of the reporter genes 
inside plasmid pMTL84422 and the cloning procedure was attempted several times. 
Even though two different restriction endonucleases, which produced two non-
compatible sticky ends were used and therefore should have theoretically allowed the 
gene to be cloned directionally. Instead, with each attempt after ligation and 
transformation 30 to 50 colonies were found and they were all PCR negative for the 
presence of the luxAB genes.  
The presence of negative colonies may have been due to self-ligation of the 
plasmid pMTL84422 but as mentioned previously the use of two different restriction 
enzymes should have lowered the probability of this occurring. To ensure this was not 
the case CIP was added, which catalysed the removal of the 5’ phosphate group from 
DNA hence the plasmid was unable to self-ligate. In addition to self-ligation, the 
ligation ratio may not have been optimum. Five different ligation ratios: 1:1, 1:3, 1:5, 
1:10 and 1:20 (plasmid: insert) were trialled. The ligation ratio 1:3, with the addition of 
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CIP was found to be optimum as with the other ligation ratios no PCR positive 
transformation colonies were isolated.  
At the 1:3 ligation ratio over 50 colonies had grown after ligation and 
transformation across 10 plates. All 50 colonies were picked, used as templates for 
colony PCR but only one out of 50 colonies produced the estimated band size. The 
positive colony was further analysed and enzyme digested with restriction 
endonucleases NdeI and NheI. After digestion a DNA band around 2000 bp was 
observed (Figure 5.3 step 1), which confirmed the presence of the luxAB genes in 
pMTL84422 and the plasmid was referred to as pMTL84422-luxAB (Table 5.3, Step 1). 
However, to confirm the sequence of the luxAB genes in the MCS region of the 
plasmid and to investigate whether any mutations or nucleotide base mismatch had 
occurred the plasmid was sequenced. M13 primers and the primer set used to 
originally amplify the reporter sequence: P1 and P2 (Table 9.5, Chapter 9) were used 
for sequencing. After which the sequenced data was compared to the original luxAB 
sequence and they were 100% identical. 
5.4.3.2   Insertion of flanking regions to plasmid pMTL84422-luxAB 
In order for homologous recombination to occur between 800 to 1200 bp 5’ upstream 
and 3’ downstream of the gene targeted for replacement with the luxAB genes needed 
to be cloned either side of promoter sequence, luxAB genes and terminator sequence 
respectively. It was first attempted to clone flanking regions either side of the NTPase 
gene from phage T6ɸ12 and to optimise the cloning procedure with this construct.  
From the previous step the reporter genes were cloned into pMTL84422 between 
restriction sites NdeI and Nhel in the MCS site and either side of the luxAB genes, 
promoter and terminator sequences were present. Due to this reason only one 
endonuclease site was available on either side: NotI before the promoter sequence 
and AscI after the terminator sequence. Flanking region 1 was cloned at the NotI site 
and flanking region 2 at the AscI site (Figure 5.2). The construct was developed in this 
manner to ensure when reporter genes were incorporated within the phage genome 
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via homologous recombination, the promoter and terminator sequences were also 
added.  
The method of cloning inserts into one restriction site is called non-directional 
single site restriction clone and was used to add the flanking regions to pMTL84422-
luxAB. NTPase flanking region 1 and flanking region 2 were first PCR amplified, which 
contained restriction endonuclease sites corresponding to insertion sites in plasmid 
pMTL84422-luxAB. After which PCR products and the pMTL84422-luxAB plasmid were 
enzyme digested, CIP added and products ligated. Again, different ligation ratios were 
tested: 1:1, 1:3, 1:10 and 1:20 (plasmid: insert) and after transformation 
approximately 30 colonies had grown for both flanking regions 1 and 2. All colonies 
were PCR screened to test for the presence of the flanking genes but all colonies 
tested were PCR negative. The procedure was repeated seven times and each time all 
colonies screened were negative (data not included). Three different sets of primers 
were also used; to unsure there were no problems with the PCR. Furthermore, five 
colonies were picked which grew after transformation to extract their plasmid DNA 
and the DNA was endonuclease digested. Again, no positive digestion band was 
identified; only a band that represented the plasmid itself was visible. As the flanking 
regions had not been successfully inserted, the other phage genes from T6ɸ12 and 
T6ɸF2 targeted for replacement with luxAB were not cloned.   
The complications encountered with insertion of the flanking regions to 
pMTL84422-luxAB may have been due to the low cloning efficiency of the method of 
single site restriction in comparison to when genes are cloned between two different 
restriction endonuclease sites. Additionally, pMTL84422 is a large plasmid, above 7 kb 
and usually the transformation frequency observed with large plasmids is low. These 
reasons could explain why positive transformatants were not isolated. 
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Figure 5.2 Schematic of the three-step plan designed for the development of the 
reporter construct in plasmid pMTL84422.  
 
Step 1. The luxAB genes were PCR amplified (primers P1 and P2, Table 9.5, Chapter 9) 
from pUC18-mini-Tn7T. Step 2. The luxAB genes were ligated to pMTL84422 at 
restriction sites NdeI and NheI. Step 3. Flanking regions, corresponding to the site of 
insertion in the phage genome were added before the promoter and after the 
terminator sequences in pMTL84422. Flanking region 1 was ligated at restriction site 
NotI and Flanking region 2 was ligated at restriction site AscI. 
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5.4.4   Reporter construct development in plasmid pBlueScript II Sk+ 
Due to difficulties faced with non-directional single site restriction cloning and the low 
copy number of plasmid pMTL84422-luxAB a new approach was developed. The whole 
reporter construct that consisted of: flanking region 1, promoter sequence, luxAB 
genes, terminator sequence and flanking region 2 were instead cloned into plasmid 
pBlueScript II Sk+. This is a high copy number plasmid, its MCS has over 23 restriction 
endonuclease sites and includes sequences of general sequencing primers: T7, T4 and 
M13. In addition, the MCS contains the lacZ gene that codes for β-galactosidase and 
provides an additionally screening method. The lacZ screening method works such 
that when the lacZ gene is uninterrupted blue bacterial colonies are produced in the 
presence of X-gal after transformation. However, when the lacZ gene is disrupted, 
when cut with restriction endonucleases to add gene inserts, white colonies are 
observed instead. This provides a quick method to screen for plasmids, which contain 
the insert. Due to these reasons, pBlueScript II sk+ with E. coli strain DH5a was used as 
the parental vector for all further cloning. 
Restriction endonuclease sites selected for cloning in pBlueScript II sk+ were: NotI, 
XbaI, SpeI and BamHI. Although, it should be noted restriction endonuclease sites at 
the start of flanking region 1 and at the end of flanking region 2 needed to be identical 
to restriction endonuclease sites in the MCS region of the modular Clostridium-E. coli 
shuttle plasmids. This is because after the reporter constructs were developed in 
pBlueScript II Sk+ they were transferred to the shuttle plasmids. This was to allow 
plasmid transfer from E. coli to C. difficile phage via conjugation and for homologous 
recombination to occur.   
To clone the reporter constructs in pBlueScript II Sk+ the same method was used 
for the development of all reporter constructs, so for all phage genes targeted for 
replacement with the reporter genes (Figure 5.3). Flanking region 1 was cloned 
between restriction endonuclease sites NotI and Xbal. Flanking region 2 cloned 
between sites SpeI and BamHI. The Clostridium Pthl promoter, luxAB genes and 
terminator sequence were cloned between restriction endonuclease sites XbaI and 
SpeI.  
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Again, the method was optimised with the reporter construct that targets the 
NTPase gene of phage T6ɸ12. After which it was applied to other phage genes 
targeted for replacement with the luxAB genes and in total seven individual reporter 
constructs were developed (Figures 5.3 and 5.4).  
5.4.4.1   Addition of flanking region 1 to pBlueScript II Sk+ 
Flanking region 1 was PCR amplified from boiled phage lysate with primers that 
incorporated restriction endonuclease sites that were compatible for being cloned 
inside pBlueScript II Sk+. The ligation ratio of 1:3 was used and five to 20 bacterial 
colonies had grown after transformation. Approximately half the colonies were blue 
and the rest were white. White colonies were selected and screened via PCR with 
internal primers specific for the targeted gene. All white colonies were positive for the 
insert of flanking region 1 and were further analysed by endonuclease digestion with 
NotI and XbaI. After which at least one colony with the correct digestion bands was 
isolated, sequenced and revealed to be 100% identical to the original flanking region 
(Table 5.3, Step 2). However, some white colonies showed the wrong size band or no 
insert were found when digested with restriction endonucleases. These colonies were 
sequenced and data revealed partial gene deletion, impairment of restriction 
endonuclease sites or that the insert was not present.    
5.4.4.2  Addition of flanking region 2 to pBlueScript II Sk+ with flanking 
region 1 
Flanking region 2 was PCR amplified from phage lysate and primers included 
restriction endonuclease sites SpeI at the 5’ end and BamHI at the 3’ end. The insert 
was cloned into plasmid pBlueScript II Sk+ with flanking region 1 and initially a 1:3 
ligation ratio was used. However, after ligation and transformation over 50 bacterial 
colonies were screened via PCR and all were found to be negative for the insert. Other 
ligation ratios tested were: 1:5, 1:10 and 1:20 but no positive colonies that contained 
the insert were isolated.    
Therefore, instead of addition of flanking region 2 directly to the incomplete 
reporter construct, the gene was cloned separately into pBlueScript II Sk+. This was to 
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allow the use of the lacZ screening method to check for presence of insert. A ligation 
ratio of 1:3 was used and 10 to 20 colonies were isolated after transformation. From 
these colonies at least five colonies were white. The white colonies were all PCR 
screened, enzyme digested and if positive for insert, they were sent for sequencing. 
One to three positive colonies were found to have 100% homology to the original 
flanking region 2 sequence. 
After which one positive colony with flanking region 2 was cut from pBlueScript II 
Sk+ with restriction endonucleases SpeI and BamHI and ligated to pBlueScript II Sk+ 
with flanking region 1 at corresponding restriction sites. Ligation ratio of 1:3 was used; 
over 30 colonies were isolated after transformation and after being screened at least 
one positive colony with the insert was isolated (Table 5.3, Step 3).  
5.4.4.3   Addition of luxAB genes to pBlueScript II Sk+ with flanking regions 1 
and 2 
The Clostridium Pthl promoter upstream of luxAB, the reporter genes luxAB and 
terminator sequence downstream of luxAB were PCR amplified from plasmid 
pMTL84422-luxAB. Restriction endonuclease sites XbaI before the promoter and SpeI 
after the terminator sequence were incorporated in the primers (Primers P3 and P4, 
Table 9.5, Chapter 9). Respective restriction endonuclease sites were present in 
pBlueScript II Sk+ between flanking region 1 and 2.   
Ligation ratios of 1:3 and 1:5 were tested first and over 50 bacterial colonies were 
PCR screened after transformation but all colonies were negative for the insert. This 
could be due to the production of similar overhang sequences (CTAG) generated after 
digestion of plasmid and insert with restriction endonucleases SpeI and XbaI. This 
would promote self-ligation of the plasmid.  
In an attempt to overcome this, the promoter, luxAB and terminator sequence 
were cloned into the original pBlueScript II Sk+ plasmid without any sections of the 
reporter construct, similar to flanking region 2. The plasmid was dephosphorylated 
with CIP after which the vector and insert were ligated at a ratio of 1:20. Over 25 
bacterial colonies were isolated after transformation and two were positive for the 
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insert. One positive colony was enzyme digested and cloned into pBlueScript II Sk+ 
with flanking regions 1 and 2 with the ligation ratio 1:20. Again, 25 bacterial colonies 
were found after transformation and one colony was positive for the insert. This last 
step completed the reporter construct (Table 5.3, Step 4). 
5.4.4.4   Final method used for the development of reporter constructs  
Since the promoter, luxAB and terminator sequences were cloned separately into 
pBlueScript II Sk+, this was used as the parental vector. After which, flanking region 1 
was added as described in Section 5.4.4.1 followed by insertion of flanking region 2 as 
described in Section 5.4.4.2 (Table 5.3, Steps 1 to 4). This was the final procedure used 
for the development of reporter constructs for all phage genes targeted for 
replacement with the luxAB genes. 
5.4.5   Transfer of reporter construct with pBlueScript II Sk+ to Clostridium-
E. coli shuttle plasmids 
The reporter construct flanked by restriction endonucleases NotI at 5’ end and BamHI 
at 3’ end was cut from pBlueScript II Sk+ and cloned into complementary sites in 
linearized Clostridium-E. coli shuttle plasmids: pMTL4422, pMTL82151 and pMTL83151 
(Figure 5.4). A ligation ratio of 1:3 was used and 10 to 20 colonies were present after 
transformation. Colonies were screened and between two to five colonies were 
positive for the full reporter construct (Table 5.3, Step 5). After which, the plasmids 
were referred to as pMTL4422-luxAB, pMTL82151-luxAB and pMTL83151-luxAB. 
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Figure 5.3 Schematic of the steps followed for the development of the reporter 
construct.  
Step 1. The luxAB genes were PCR amplified (primers P1 and P2) from pUC18-mini-
Tn7T. Step 2. The luxAB genes were ligated inside pMTL84422 at restriction sites NdeI 
and NheI. Step 3. luxAB genes (primers P3 and P4) were PCR amplified using step 2 as 
template to include promoter and terminator sequences from pMTL84422. Restriction 
endonuclease sites XbaI and SpeI were added to primer sequences and the product 
was ligated to pBlueScript II Sk+. Step 4. Flanking regions, corresponding to the site of 
insertion in the phage genome were added either side of the luxAB genes in 
pBlueScript II Sk+. Flanking region 1 ligated at restriction sites NotI and XbaI. Flanking 
region 2 ligated at restriction sites SpeI and BamHI. 
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Figure 5.4 Labelled schematic of plasmids assembled for the development of the 
reporter construct. 
Images represent full reporter constructs and their final sizes in plasmids a) pBlueScript 
II SK+-luxAB, b) pMTL84422-luxAB, c) pMTL83151-luxAB and d) pMTL82151-luxAB. 
Restriction endonuclease sites have been included to highlight where flanking region 1, 
the luxAB reporter genes and flanking region 2 were inserted.  
 
Plasmid maps were made with the APE: Plasmid editor program. 
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Table 5.3 The key steps that were involved in the development of the full reporter 
construct. Each step highlights the different plasmids, ligation ratios and restriction 
endonucleases used.  
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Table 5.3 continued  
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5.5   Discussion  
In Chapter 5 research was presented on the development of luxAB reporter phages for 
detection of C. difficile using phages T6ɸ12 and T6ɸF2 as templates. The reporter 
assay can be used as both an environmental test to check if sufficient cleaning has 
been conducted to eliminate presence of C. difficile and as a patient diagnostic test.     
5.5.1   C. difficile phages selected for reporter phage construction 
For the development of reporter phages ideal phages to be used are those, which have 
been fully sequenced, annotated and have broad-host ranges. For it to be possible to 
develop reporter phages for detection of C. difficile 35 phages were characterised in 
Chapter 3 and five phages were found to have broad-host ranges. The identification of 
such phages made it possible to test whether reporter phages could be designed and 
used for C. difficile detection as to date no C. difficile reporter phages have been 
developed.   
Out of the five broad host range C. difficile phages, two phages that fully fulfilled 
the necessary criteria were phages: T6ɸ12 and T6ɸF2. Similarly, all reporter phages 
developed to date have utilised broad-host range phages to ensure maximum 
detection of bacterial isolates. For example Kuhn et al. (2002) used the sequenced 
Salmonella phage Felix 01 for construction of the reporter phage, which was able to 
infect over 98% of 2000 strains of Salmonella screened. Likewise, Schofield and 
Westwater (2009) used the sequenced Bacillus anthracis phage Wβ, which is able to 
infect all 171 B. anthracis strains screened. Loessner et al. (1996) used the lytic Listeria 
monocytogenes phage A511, which is strictly genus specific and can infect 95% of 
Listeria monocytogenes serovar 1/2 (subgroups). Furthermore, Schofield et al. (2012) 
chose phage PBSPCA1, which is able to infect all P. cannabina pv. alisalensis isolates 
from numerous different geographical locations. 
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5.5.2   Justification of the gene replacement strategy for insertion of the luxAB 
genes within the phage genome  
After broad host range and sequenced phages were identified to develop reporter 
phages, the next step was to identify how the reporter genes would be inserted within 
the phage genome. The strategy used was to replace a predicted hypothetical gene or 
a gene not involved in phage infection with the reporter genes. The luxAB genes are 
2.2 Kb in size and if the genes are added directly within the phage genome without 
replacement with another gene, it is highly probable that the addition of several 
kilobases could compromise phage infection and lead to a defective phage. This is due 
to the strict DNA phage packaging within the phage capsid and has also been 
previously observed with other well characterised phages, such as E. coli and Y. pestis 
phages (Kuhn et al. 2002; Schofield et al. 2009). Although, to date DNA packaging has 
not thoroughly been investigated for C. difficile phages, but there may be some 
similarities with E. coli and Y. pestis phages.  
Overall though, a similar DNA packaging mechanism is utilised by most tailed 
dsDNA phages, which is the group phages T6ɸ12 and T6ɸF2 are part of. Phages use a 
molecular motor, called the terminase to package their DNA into empty capsids, 
during assembly of phage progeny, as part of the phage infection cycle. Typically the 
DNA packaging process consists of three components: the portal protein that threads 
the viral DNA through the capsid, the large terminase motor protein that’s provides 
the energy for packaging and the small terminase that initiates packaging (Sun et al. 
2012). By the action of the three components, typically, phage DNA is packaged via the 
headful packaging scheme, where the capsid is filled to full capacity. Some phages 
have specific sequence cut sites, which are recognised by the terminase motor and 
precisely one full copy of the genome length is inserted. In contrast, some phages have 
non-specific cut sites so when their phage DNA is packaged, the terminase motor can 
delete random segments of the phage genome in the process (Rao and Feiss 2008). 
Although, it is unknown via which mechanism C. difficile phages T6ɸ12 and T6ɸF2 
package their DNA. However, with regards to packaging of the reporter genes, those 
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phages that that specific cut sites would be highly suited for this study as it would 
ensure the luxAB genes are included in the genome of all phage progeny.   
However, regardless of the packaging mechanism, it is the terminase motor that 
sets the upper limit on the length of the genome that can be packaged to ensure 
infectious virions are produced. The phage DNA packaging process works such that 
initially the force exerted by the packaged DNA is smaller in comparison to the 
terminase motor. However, as more and more of the phage genome becomes 
packaged the forces swap and if the phage genome is too long it will affect DNA 
packaging and thus phage infectivity. Therefore, there is a strong correlation between 
the efficiency of viral packaging and infectivity with genome length (Nurmemmedov et 
al. 2012). Consequently the introduction of a large gene, such as the reporter genes 
has the potential to affect phage infectivity and this may be a possibility with phages 
T6ɸ12 and T6ɸF2. Due to this the gene replacement strategy was chosen.  
Furthermore, the size of the phage genome itself may influence DNA packaging 
and the impact addition of several kilobases could have on phage infectivity (Kuhn et 
al. 2002). For example the S. flexneri phage shf125875 has a genome size of 169 Kb 
and it was hypothesised addition of the reporter genes would not impact phage 
packaging or have an effect on phage infection. This is because the size of the phage 
genome is already so large and so as predicted the phage remained infectious 
(Schofield et al. 2015).  
In contrast to the S. flexneri reporter phage, the genome size of C. difficile phages 
T6ɸ12 and T6ɸF2 are significantly smaller at 52 kb. Therefore, it may be likely 
insertion of several kilobases will have an impact on phage infectivity. This was 
another contributing reason to why the gene replacement strategy was selected and 
why the same approach may have been used to design the P. cannabina pv. alisalensis 
reporter phage. Although, in the research article there was no mention of the phage 
genome size but it was stated they chose this method to limit disruption of the phage 
genome. The phage genome size was increased by 1.3 Kb instead of 2.2 Kb if the 
reporter genes were added directly within the phage genome. The reporter phage 
remained viable and the infection cycle was not affected (Schofield et al. 2012).  
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Similar to Schofield et al. (2012), in the present study the genes selected for 
replacement with the reporter genes would increase the phage genome size between 
2 to 0.17 Kb. It is unknown how this would potentially affect any part of the phage 
infection cycle and so multiple genes of different sizes were selected for replacement. 
Furthermore, the genes selected for replacement with the reporter genes were 
located in different locations within the phage genomes of T6ɸ12 and T6ɸF2. This 
strategy was chosen because it has been noted in previous studies that the location of 
the reporter genes within the phage genome can affect expression of the reporter 
genes. Also, the location could potentially impact on the stability of the reporter genes 
within the genome too (Schmelcher and Loessner 2014).  
5.5.3   Development of the reporter construct in plasmids pMTL84422 and 
pBlueScript II Sk+ 
In order to design reporter phages, reporter constructs were developed in plasmids via 
molecular techniques. It was originally attempted to develop the reporter constructs 
directly in the Clostridium-E. coli shuttle plasmid pMTL84422 (Heap et al. 2009) but 
numerous difficulties were faced. The main issues were: there were limited number of 
restriction sites available to clone all sections of the reporter construct and the 
plasmid was self-ligating. In addition, the Gram-negative replicon had a low copy 
number and the overall size of the plasmid was large, therefore only approximately 
seven colonies were isolated after transformation. Instead, with a high copy number 
Gram-negative replicon it is possible to isolate over 20 colonies after transformation. 
This allows more colonies be screened and increases the probability of isolation of a 
colony with insert. Therefore, the experimental method was altered and the reporter 
construct was cloned in pBlueScript II Sk+. The plasmid has a high copy number Gram-
negative replicon and so tackled the previous issues encountered with pMTL84422. 
Similar approaches of cloning the reporter construct initially in pBlueScript II Sk+ 
before being transferred to specific bacterial shuttle plasmids have been used 
previously for the development of reporter phages (Loessner et al. 1996; Schofield et 
al. 2009; Schofield and Westwater 2009; Schofield et al. 2012).  
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Consequently, after all reporter constructs were developed in pBlueScript II Sk+ 
they were transferred to three different Clostridium-E. coli shuttle plasmids: 
pMTL4422, pMTL82151 and pMTL83151 (Heap et al. 2009). These three plasmids were 
chosen specifically as they all contain different Gram-positive replicons. This was 
because it was unsure at this stage which replicon would favour homologous 
recombination and hence would be the most efficient for mutant isolation. Therefore, 
by testing different replicons the optimum replicon for homologues recombination 
was identified. In addition the activity of the Gram-positive replicon can differ in 
different C. difficile strains used for conjugation (Cartman and Minton 2010; Faulds-
Pain and Wren 2013).  
5.5.4   Addition of promoter sequence upstream of the reporter genes  
In the reporter construct a strong promoter sequence Pthl from Clostridium 
acetobutylicum (Girbal et al. 2003) was included and added upstream of the luxAB 
genes. The addition of the promoter would ensure expression of the reporter genes 
and therefore production of the bioluminescence signal. The promoter sequence Pthl 
was already included in the Clostridium shuttle plasmids and the authors had 
discussed the promoter would be applicable to the whole of Clostridium genus (Heap 
et al. 2009). This was the reason why it was selected to be included in the reporter 
construct and because one previous study by Aubry et al. (2012) validated the 
promoter sequence Pthl ensured gene expression in C. difficile. Aubry et al. (2012) 
investigated if C. difficile toxin production is altered if flagella genes are knocked out. 
After which they complemented (genes were added again into the bacterial genome) 
the genes and added the promoter Pthl to ensure gene expression occurred.  
Similarly, other studies in the literature have developed reporter phages by 
addition of strong bacterial promoters upstream of the reporter genes during the 
cloning process. Examples include addition of a Bacillus promoter to the B. anthracis 
reporter phage (Schofield and Westwater 2009), a cps promoter to the Listeria 
reporter phage (Loessner et al. 1996) and a strong constitutive promoter for the 
P. cannabina pv. alisalensis reporter phage (Schofield et al. 2012). Due to the presence 
of the promoter between four to seven-fold increase in bioluminescence signal was 
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noted with the reporter phages when their respective bacteria were detected. Due to 
these promising results with other promoter and luxAB genes combination, it can be 
predicated the addition of the Pthl promoter to the C. difficile reporter phages will aid 
in production of similar fold increases in bioluminescence signal.  
5.5.5   Addition of flanking regions for homologous recombination 
For insertion of the luxAB genes to the phage genome the allele exchange method was 
used (Chapter 6) to allow homologous recombination events to occur and has also 
previously been used to construct all reporter phages to date (Schmelcher and 
Loessner 2014). The rates at which recombination events occur can vary between 
plasmids and bacterial species and are dependent on a number of factors (Sambrook 
and MacCallum 2000).  
The main factor that has been reported in the literature to influence homologous 
recombination events is the overall length of the flanking regions. For example a study 
conducted by Kung et al. (2013) compared recombination rates with flanking regions 
lengths of 26, 35, 50, 96, 200, 508 and 1000 bp in the bacterium Xylella fastidiosa. No 
homologous recombination occurred below 200 bp and the recombination efficiency 
increased exponentially with the size of the flanking regions. Maximum recombination 
rates were observed with 1000 bp homology regions. Furthermore similar 
observations were noted by Faulds-Pains and Wren (2013) with regards to C. difficile. 
They conducted a study to delete the erythromycin gene in C. difficile strain M68 and 
used three different flanking region lengths: 300, 600 and 1200 bp. Overall, 
recombination rates were significantly higher with 1200 bp of homology but 
homologous recombination did occur with 300 and 600 bp flanking regions. Although, 
recombination rates were significantly lower by over 15% and mutants were not 
isolated consistently in comparison to with 1200 bp homology.  
Consequently, taking Kung et al. (2013) and Faulds-Pains and Wren (2013) studies 
into consideration in the present study flanking region lengths ranged from 994 to 
1497 bp for all genes targeted for replacement with the luxAB genes for phages T6ɸ12 
and T6ɸF2. The long flanking regions lengths will promote homologous recombination 
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rates and isolation of reporter phage mutants. In addition, when the flanking regions 
were cloned into pBlueScript II Sk+ in order to develop the reporter construct they 
were sequenced when successful cloned. This was to check the flanking regions had 
100% homology to the original phage sequence as even a single base pair difference 
can prevent homologous recombination. This is particularly important for C. difficile as 
previous studies have noted recombination rates are very low (Faulds-Pain and Wren 
2013; Heap et al. 2009). 
5.5.6   Conclusion  
Chapter 5 has focused on the development of a C. difficile diagnostic test based on 
phage infection by designing reporter phages. This is the first study to consider 
reporter phages for C. difficile detection and so as proof-of-concept two broad-host 
range and sequenced C. difficile phages: T6ɸ12 and T6ɸF2 were used as templates. To 
avoid major disruption of the phage genomes multiple phage genes were targeted for 
replacement with the reporter genes to allow identification of the best position and 
location of the luxAB genes in the phage genome. These were three phage genes from 
phage T6ɸ12 that are not expressed when phage infection occurs confirmed via RNA 
sequencing and four hypothetical phage genes of phage T6ɸF2.  
Seven individual reporter constructs for the genes being targeted for replacement 
with the luxAB genes were developed after extensive optimisation. The constructs 
included a 5’ flanking region, promoter sequence, luxAB genes, terminator sequence 
and a 3’ flanking region in pBlueScript II Sk+. The constructs were then transferred to 
Clostridium-E. coli shuttle plasmids to allow transfer from E. coli via conjugation of the 
reporter constructs to their respective C. difficile phage, which will be discussed in 
Chapter 6. 
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5.5   Chapter 5 summary 
• Two C. difficile phages T6ɸ12 and T6ɸF2 were selected for construction of the 
luxAB reporter phages.  
• For both phages, phage genes not required for infection were identified via 
RNA sequencing or annotated as hypothetical proteins were targeted for 
replacement with the luxAB genes: 
o For phage T6ɸ12 three genes were identified: SF, HP1 and NTPase.  
o For phage T6ɸF2 four genes were identified: HP2, HP3, HP4 and HP5. 
• Genetic tools were used to develop reporter constructs and for each gene 
targeted for replacement an individual construct was developed, seven in total 
by these steps: 
o luxAB genes were PCR amplified, cloned into plasmid pMTL84422 
between restriction endonuclease sites NdeI and NheI, upstream of a 
promoter sequence and downstream of a terminator sequence with a 
ligation ratio of 1:3. 
o Flanking regions were attempted to be cloned either side of luxAB 
genes in pMTL4422-luxAB but all attempts were unsuccessful despite 
the use of different ligation ratios. 
o A new strategy was implemented and the promoter, luxAB genes and 
terminator sequence were PCR amplified and cloned into pBlueScript II 
Sk+ between endonuclease sites XbaI and SpeI with a ligation ratio of 
1:20. 
o Flanking region 1 was cloned between restriction endonuclease sites 
NotI and XbaI and flanking region 2 between restriction sites SpeI and 
BamHI were added either side of pBlueScript II Sk+-luxAB at a ligation 
ratio of 1:3. 
o The reporter construct was then transferred to Clostridium shuttle 
plasmids: pMTL4422, pMTL82151 and pMTL83151 with a ligation ratio 
of 1:3. 
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6.1   Introduction  
In Chapter 5 reporter constructs were developed in Clostridium-E. coli shuttle plasmids 
that targeted insertion of the luxAB genes by replacement with non-essential genes 
into the genomes of C. difficile phages T6ɸ12 and T6ɸF2. However, these constructs 
were stored in plasmids within E. coli cells and need to be transferred to their 
respective C. difficile phages to complete the construction of reporter phages. This was 
done via the horizontal gene transfer method of conjugation from E. coli into 
C. difficile, and this chapter has focused on the optimisation of conjugation.  
Conjugation is the vital step that makes it possible for homologous recombination 
events to occur, in other words it is necessary for the insertion of the reporter genes 
within the phage genomes. After which, construction of reporter phages is complete.     
6.1.1   Genetic manipulation in C. difficile 
Genetic manipulation of C. difficile can be a challenge as plasmid transfer and 
homologous recombination rates are consistently low (Heap et al. 2009; Hargreaves 
and Clokie 2014). Mutants are only isolated after extensive optimisation, which is both 
time-consuming and laborious. Overall though, the widely implemented method of 
directed mutagenesis is allele exchange, whereby a native allele is exchanged with an 
alternative allele that contains the desired mutation. The alternative allele is flanked 
either side with identical DNA regions that flank the original sequence and 
homologous recombination events occur between the identical DNA regions to 
mediate the gene exchange.  
Typically replication-defective plasmids, such as suicide or conditional plasmids are 
used for this approach but as with C. difficile the frequency of DNA transfer via 
conjugation is low it is not feasible to use such plasmids. Instead ‘pseudosuicide’, a 
term coined by Professor Nigel Minton’s research group, University of Nottingham 
plasmids are used. These are plasmids that are able to replicate in C. difficile but are 
segregationally unstable as they replicate at a slower rate in comparison to the host 
chromosome (Cartman et al. 2012). The Clostridium-E. coli shuttle plasmids can be 
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used for the ‘pseudosuicide’ approach and have previously been used in C. difficile to 
mediate gene exchange (Faulds-Pain and Wren 2013).    
When ‘pseudosuicide’ plasmids with the allele exchange cassette are used to 
replace a native allele with a mutant allele, the exchange occurs via four steps (Figure 
6.1): 
1. The plasmid that contains a construct with the alternative allele is transferred 
from E. coli to C. difficile by conjugation. To achieve this, E. coli cells with the 
plasmid and recipient C. difficile cells are mated for a minimum of 24 hours. 
Then the mated mixture is spread over selective plates, which contain 
antibiotics that supress growth of E. coli and antibiotics selective for the 
plasmid. Following 72 hours of incubation colonies are isolated, they are a 
mixture of wild-type colonies, and colonies in which the first homologous 
recombination has occurred. The latter colonies are referred to as 
transconjugants. 
2. All colonies are screened for the first homologous recombination event, also 
called single crossover mutants via PCR. This is when the plasmid with the 
construct integrates within the bacterial chromosome. 
3. Once single crossover mutants are identified, the same colonies are used to 
screen for the second homologous recombination event. Colonies that have 
undergone the second homologous recombination event have successfully 
inserted the alternative allele within the bacterial chromosome and are 
referred to as double crossover mutants.  
4. Mutants are re-streaked to excise the plasmid and this can either cause 
reversion of colonies back to wild-type or isolation of mutants.    
All four steps do not occur at the same time instead each step can take days with 
multiple sub-culturing and cell growth. Due to this the steps do not happen in the 
same cells but the later events occur in cells descended from cells in which earlier 
steps have been completed (Sambrook and MacCallum 2000). These steps for allele 
exchange have also been previously used for the development of many reporter 
phages (Schofield et al. 2009; Schofield et al. 2012). 
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Figure 6.1 Schematic describes the allele exchange method used for C. difficile 
mutagenesis. 
 
The different coloured lines represent: light blue for plasmid, red for the alternative 
allele, black for the native allele and dark blue for the C. difficile genome. Numbers 1 
and 2 in red represent flanking regions in the plasmid. Numbers 1 and 2 in black 
represent the identical corresponding flanking regions within the C. difficile genome. 
 
Image a) represents the first step of homologous recombination that occurs between 
the identical flanking regions in the plasmid and the C. difficile genome. The plasmid 
with the alternative allele can either be inserted b) before or c) after the flanking 
regions in the C. difficile genome. The orientation of insertion and to screen for single 
cross-over mutants can be confirmed via PCR: for b) with primers 1 (anneals to 
chromosomal sequence) and 2 (anneals to plasmid) and for c) primers 3 (anneals to 
plasmid) and 4 (anneals to chromosomal sequence).  
 
Diagrams b) and c) represent the second homologous recombination step that occurs 
when the plasmid is excised. If the sections underlined in purple are removed a 
mutant is created and the alternative allele incorporated within the C. difficile 
genome. However, if the sections underlined in green are excised then cells revert 
back to wild type.  
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6.1.2   Bacterial conjugation  
The first step of allele exchange is conjugation and is a process whereby the donor 
E. coli cells provide a mobilisable genetic element, such as a plasmid that needs to be 
transferred to recipient C. difficile cells. The exchange occurs via direct contact 
between cells and is referred to as mating of E. coli and C. difficile cells. Plasmid 
exchange is only possible by the use of conjugative plasmids, which can integrate 
within the bacterial chromosome by homologous recombination. These plasmids 
contain specialised sets of coding regions: origin of transfer (oriT) and transfer genes 
(TraJ), which both enable successful recombination (Llosa et al. 2002; Sambrook and 
MacCallum 2000).  
The oriT is essential to transfer DNA from donor to recipient cells during the 
conjugation process and consists of three domains: nicking, transfer and termination. 
At the start of the conjugation process, the relaxosomes that are protein complexes 
assemble and bind around the oriT, which leads to a cut in one strand of the nicking 
domain. The cut strand is inserted into recipient cells and replication of the plasmid 
occurs within these cells. The other specialised set of coding regions are the TraJ genes 
and when expressed set of a cascade of plasmid gene activation, which all act to allow 
mating of donor and recipient cells. The characteristics include growth of a pilus, a 
long tread like apparatus utilised to hook and join the donor and recipient cells and 
also causes outer bacterial membranes to become fused that allows for the transfer of 
genetic material (Sambrook and MacCallum 2000).   
Conjugative plasmids that contain the oriT and TraJ are available for C. difficile on 
the pMTL modular Clostridium-E. coli shuttle plasmids, which have been used in the 
present study. All pMTL modular plasmids contain an origin of replication and the 
Gram-negative replicon module is coupled with the oriT. In addition, the oriT is flanked 
either side by the restriction endonuclease site ApaI and therefore can be deleted 
without great difficulty. This is particularly useful when trying to determine the rate of 
spontaneous mutants, i.e. those which are resistant to the antibiotics used to screen 
for mutants. This is because when the oriT is deleted the plasmid would no longer be 
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able to integrate within the bacterial chromosome and hence homologous 
recombination would not occur (Heap et al. 2009).     
6.1.3   Homologous recombination events 
The second step of allele exchange is the first homologous recombination event, 
whereby the plasmid is integrated into the bacterial genome and occurs after 
conjugation colonies are purified by re-streaking three times on selective plates. 
Recombination can take place in two different locations within the chromosome 
(Figure 6.1). The first location is insertion before and the second location is after the 
gene being replaced with the alternative allele. Consequently, when colonies are 
screened to check for the first homologous recombination step two different sets of 
primers need to be designed so both possibilities can be screened for. At this stage a 
high proportion of colonies will not be PCR positive and only those that are, typically 
less than 10% are further re-streaked in order to isolate double crossover mutants. 
Overall, double-crossover mutants are consistently isolated at even lower rates with 
C. difficile, and only isolated if the plasmid is excised without the alternative allele. 
However, if plasmid excision occurs with the alternative allele then cells revert back to 
wild-type (Figure 6.1) (Sambrook and MacCallum 2000).  
The isolation of double crossover mutants can by improved and quickened by the 
incorporation of a counter-selection marker onto the plasmid used for allele exchange. 
Counter-selection markers are typically toxic for cells and cause cell death under 
correct conditions. Therefore, when the counter selection markers are expressed, 
bacterial cells excise the plasmid to avoid cell death but identification of suitable 
counter-selection markers is difficult and is often organism specific (Lin et al. 2012). 
However, for C. difficile allele exchange can be mediated without the addition of a 
counter-selection marker, as presented by Faulds-Pain and Wren (2013). They found 
by including long regions of homology to the native allele (flanking regions) 
recombination rates were increased. After colonies positive for the first step of 
homologous recombination were isolated they were serially subcultured nine times to 
excise the plasmid. Although the efficiency of the method was low and the whole 
procedure from start to finish took at least 20 days to complete, mutants were 
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isolated. Consequently as the method does successfully generate double-crossover 
mutants it will be used to complete construction of C. difficile reporter phages (Figure 
6.1).  
6.2   Aim of this study 
The aim of chapter 6 was to complete construction of C. difficile reporter phages by 
the transfer of reporter constructs developed in Chapter 5 to phages T6ɸ12 and 
T6ɸF2 by allele exchange. This is to incorporate the luxAB genes within the phage 
genome to complete construction of C. difficile reporter phages. 
In order for this to be achieved, induced lysogens of phages T6ɸ12 and T6ɸF2 
were created in C. difficile strains K12, T6, ATJ and CD630. After which the induced 
lysogens (recipient cells) were mated with E. coli cells (donor cells) that contained the 
reporter constructs to allow conjugation to occur. Conjugation was initially optimised 
with plasmid pMTL84422-luxABNTPase (targeted the NTPase gene of T6ɸ12 for 
replacement with the luxAB genes) in E. coli donor cells with strain K12 that harboured 
phage T6ɸ12. To optimise the method a number of factors were altered: antibiotic 
concentrations, donor cells, recipient cells, media and Gram-positive replicons. In 
addition control experiments were conducted. First, conjugation and homologous 
recombination was tested in E. coli cells to determine whether the reporter construct 
had been designed appropriately. Second, the oriT was deleted and conjugation was 
repeated to determine background growth after conjugation.  
After successful optimisation double crossover mutants were isolated and the 
reporter phages were induced from their C. difficile hosts using the antibiotics: 
mitomycin C and norfloxacin. It was then attempted to establish a clonal reporter 
phage stock by plaque purification and by PCR screening individual plaques for the 
presence of the luxAB genes. To optimise the stability of the reporter phages further 
the host and media used to propagate the reporter phages were altered.     
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6.3   Methods  
6.3.1   Bacterial strains and plasmids 
All E. coli and C. difficile strains used in this study are listed in Table 6.1. 
6.3.2   Isolation of phage resistant C. difficile strains, induced lysogens   
A similar procedure as described previously was used (Sørensen et al. 2011) but with 
minor modifications to create induced C. difficile phage lysogens. The method used 
was as follows: C. difficile phage at a titre of 106 was mixed with 3 ml top agar (Chapter 
3, Section 3.3.6.1) and poured onto a BHI 1% agar plate. Phage lawns were set for 
15 minutes before 100 µl of overnight C. difficile culture was poured and spread over 
the plate to create an even lawn. Serial dilutions of the C. difficile culture were made 
from 10-1 to 10-6 and the procedure was repeated for each individual dilution. After 
24 hours incubation at 37°C inside the anaerobic chamber, single colonies were 
observed at higher dilutions. The colonies were picked and inoculated into pre-
reduced FA broth. After which, the whole procedure was repeated five times and on 
the last step a single colony was streaked onto blood agar plates (Chapter 3, Section 
3.3.1). The colony was re-streaked five times and screened via PCR with BioTaq 
polymerase to check if lysogens had been made (primers listed in Table 9.5, Chapter 
9). If after PCR a positive band was visualised on a 1% agarose gel then glycerol stocks 
of the lysogens were made and stored at -80°C.  
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Table 6.1 List of bacterial strains, phages and plasmids used in the present study.  
 Description  Reference 
C. difficile strains  
K12 Naturally harbours phage T6ɸ12 within 
its genome. 
This laboratory 
T6 Used to produce induced lysogen of 
phage T6ɸF2. Also propagation host for 
phages T6ɸ12 and T6ɸF2. 
This laboratory 
CD630 Used to produce induced lysogens for 
phages T6ɸ12 and T6ɸF2. 
(Eijk et al. 2015) 
ATJ Used to produce induced lysogens for 
phages T6ɸ12 and T6ɸF2. 
This laboratory 
E. coli conjugation donor strains  
S17.1 λpir  The genotype of the strain is: TpR SmR 
recA, thi, pro, hsdR-M+RP4: 2-Tc:Mu: 
Km Tn7 λpir. 
This laboratory 
CA434 The genotype of the strain is: HB101 (F- 
mcrB mrr hsdS20(rB-mB-), recA13, leuB6 
ara-14 proA2 lacY1 galK2 xyl-5 mtl-1 
rpsL20(SmR ) glnV44 λ-) with plasmid 
R702. 
Dr Gillian Douce, 
Scotland 
Plasmids  
pMTL84422-luxABNTPase Contains NTPase reporter construct to 
develop reporter phage for T6ɸ12. 
Chapter 5 
pMTL82151-luxABNTPase 
pMTL832151-luxABNTPase 
pMTL84422-luxABHP1 Contains HP1 reporter construct to 
develop reporter phage for phage 
T6ɸ12. 
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 pMTL82151-luxABHP1 
pMTL83251-luxABHP1 
pMTL84422-luxABHP5 Contains HP5 to develop reporter 
phage for phage T6ɸF2. 
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 pMTL82151-luxABHP5 
pMTL83251-luxABHP5 
C. difficile reporter phages   
T6ɸ12::luxAB-NTPase-  T6ɸ12 reporter phage developed by 
replacement of phage gene NTPase 
(NTPase-) with the luxAB genes.  
This study, 
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T6ɸ12::luxAB-HP1- T6ɸ12 reporter phage developed by 
replacement of phage gene HP1 (HP1-) 
with the luxAB genes. 
This study, 
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T6ɸF2::luxAB-HP5- T6ɸF2 reporter phage developed by 
replacement of phage gene HP5 (HP5-) 
with the luxAB genes. 
This study, 
Chapter 6 
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6.3.3   Antibiotic sensitivity of induced lysogens  
The susceptibility of antibiotics to C. difficile strains used for conjugation was tested 
with antibiotic E-tests strips (Biomérieux, France). 300 µl of overnight C. difficile 
culture was spread evenly on a BHI 1% agar plate, dried for 5 minutes and the E-strip 
was placed with sterile tongs on top of the bacterial lawn. Plates were incubated 
overnight anaerobically at 37°C. Plates were then checked and average antibiotic 
susceptibility was recorded. Along each E-test strip antibiotic concentrations 
increased. Consequently, a zone of clearing around the strip represented bacterial 
death and the Minimum Inhibitory Concentration (MIC) was noted whereas bacterial 
growth represented resistance. 
6.3.4   Plasmids transferred to conjugation donor cells 
All reporter constructs designed in plasmids pMTL84422, pMTL2151 and pMTL3151 
stored in DH5α cells (Chapter 5) were transferred to E. coli conjugation donor cells 
S17.1 and CA434 via transformation (Chapter 5, Section 5.3.5.2). 
6.3.5   Conjugation procedure in C. difficile 
Plasmids with reporter constructs in E. coli acted as the donor cells and were 
transferred to C. difficile recipient induced lysogens via conjugation as previously 
described (Purdy et al. 2002). The donor plasmids: pMTL84422-luxAB, pMTL2151-
luxAB and pMTL3151-luxAB stored in E. coli S17.1 or CA434 strains were streaked on 
LB 1% agar plates with either 10 µg/ml chloramphenicol or tetracycline and incubated 
aerobically overnight at 37°C. A single colony was inoculated in LB broth with either 
10 µg/ml chloramphenicol or tetracycline and incubated overnight at 37°C whilst being 
shaken at 200 rpm. In parallel the recipient C. difficile lysogenic strain was streaked on 
a blood agar plate. The strain was incubated anaerobically at 37°C overnight and a 
single colony was inoculated into anaerobically pre-reduced 7 ml BHI broth. 
1.5 ml of the overnight E. coli donor broth culture was centrifuged at 3,000 x g for 
two minutes and the supernatant was discarded. The pellet was re-suspended gently 
with 1 ml PBS and the centrifugation step was repeated. The supernatant was 
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discarded and the donor pellet was taken immediately inside the 37°C anaerobic 
chamber. The pellet was re-suspended gently with 200 µl of the C. difficile recipient 
culture and the conjugation mixture was spotted with eight to 12 spots onto BHI 1% 
agar plates or non-selective BHIS agar plates (BHI supplemented with 1% agar, 25% L-
cyestine and 0.5% Yeast. Chapter 9, Table 9.5). Donor-only and recipient-only controls 
were also spotted with the same procedure as above.  
The spotted E. coli and C. difficile mixtures were incubated anaerobically for a 
maximum of 24 hours and the conjugation mixture was scraped with an L-shaped loop 
with 700 µl of sterile PBS. 100 µl of the neat sample and diluted cultures by a factor of 
10, 100 and 1000 were spread onto either: 
• Selective CCEY agar plates (CCEY agar autoclaved and cooled to 50°C, followed 
by addition of: 2.5% egg yolk emulsion, 15 µg/ml thiamphenicol or 10 µg/ml 
tetracycline, and the antibiotic mixture of cycloserine (250 mg/l) and cefoxitin 
(16 mg/l))  
• Selective BHIS agar plates (BHI supplemented with 1% agar, 0.5% yeast, 
autoclaved and the media cooled to 50°C. 25% L-cyestine, 15 µg/ml 
thiamphenicol or 10 µg/ml tetracycline, and the antibiotic mixture of 
cycloserine (250 mg/l) and cefoxitin (16 mg/l) were added). 
The selective plates were incubated anaerobically for 72 hours or until colonies 
formed. Isolated colonies were picked and re-streaked onto the same selective media 
three times. This was to remove any possible traces of E. coli, which could have been 
carried when colonies were picked. After purification colonies were screened via PCR 
to detect presence of (primer sequences are listed in Table 9.5, Chapter 9): 
1. luxAB genes: primers P9 and P10. 
2. Plasmid primers: M13F and M13R. 
3. First homologous recombination step as shown in Figure 6.1. Two sets of 
primers were designed (5’ and 3’ integration primers) to identify the 
orientation of insertion of the plasmid: 
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a. HP1 homologous recombination primers: P29, P30, P31, P32, P33, P34, 
P35 and P36. 
b. NTPase homologous recombination primers: P47, P48, P49, P50, P51, 
P52, P53 and P54. 
c. HP5 homologous recombination primers: P89, P90, P91, P92, P93, P94, 
P95 and P96. 
4. To check if the genes replaced by the luxAB genes have been knocked-out: 
a. To detect presence of HP1 primers P37 and P38 were used. 
b. To detect presence of NTPase primers P55 and P56 were used. 
c. To detect presence of HP5 primers P97 and P98 were used. 
The PCR DNA template was prepared as described in Chapter 3, Section 3.3.3.1 
with the Chelex-100 method or with the method described in Chapter 5, Section 
5.3.5.3 where bacterial colonies are boiled at 99°C followed by centrifugation. The 
latter method is used for crude DNA isolation. PCR was conducted with BioTaq 
polymerase (Chapter 5, Section 5.3.3.3), Q5® High-Fidelity DNA Polymerase (Chapter 5, 
Section 5.3.3.3), Phusion® High-Fidelity DNA Polymerase (New England Biolabs, UK) 
and Herculase II Fusion DNA Polymerase (Agilent Technology, UK). PCR products were 
run on a 1% agarose gel at 100 V for one hour. 
The PCR regents used for Phusion® High-Fidelity DNA Polymerase were as follows 
in a total volume of 20 µl (all reagents purchased from NEB, UK): 0.5 µM of each 
primer, 200 µM dNTPs, 5x Phusion® High-Fidelity reaction buffer, 1 U/µl of Phusion® 
High-Fidelity DNA Polymerase and 50 ng of template DNA. The PCR cycle used was: 
initial denaturation at 98°C for 30 seconds, followed by 30 cycles of denaturation at 
98°C for 10 seconds, primer annealing between temperatures 45 to 72°C for 20 
seconds, extension at 72°C for 30 seconds/per Kb and a final extension at 72°C for 
7 minutes. PCR products were stored at 4°C. 
The PCR regents used for Herculase II Fusion DNA Polymerase were as follows in a 
total volume of 50 µl (all reagents purchased from Agilent Technologies, UK): 0.25 µM 
of each primer, 250 µM dNTPs, 5x Herculase II buffer, 1 U/µl of Herculase II Fusion 
DNA Polymerase and 50 ng of template DNA. The PCR cycle used was: initial 
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denaturation at 95°C for 2 minutes, followed by 30 cycles of denaturation at 95°C for 
10 seconds, primer annealing between 45 to 60°C for 20 seconds, extension at 72°C 
for 30 seconds/per kb and a final extension at 72°C for 3 minutes. PCR products were 
stored at 4°C. 
6.3.6   Selection of double crossover clones 
After conjugation colonies, which could be possible transconjugants were purified via 
replica streaking onto non-selective BHIS plates nine times. Each time the colony was 
streaked it was also simultaneously streaked onto selective BHIS plates to screen for 
loss of plasmid. Plates were incubated for 24 hours inside the anaerobic chamber. 
Colonies were screened via PCR with Q5® High-Fidelity DNA Polymerase for presence 
of the luxAB genes, loss of plasmid and for homologous recombination. 
6.3.7   Plasmid extraction from C. difficile cells 
Possible transconjugants colonies were inoculated overnight anaerobically in 5 ml pre-
reduced BHI broth supplemented with either 15 µg/ml thiamphenicol or 10 µg/ml 
tetracycline. Cultures were then treated with lysozyme for 30 minutes at 37°C, plasmid 
DNA was extracted (Chapter 5, Section 5.3.3.1), DNA was transformed into E. coli 
DH5α cells (Chapter 5, Section 5.3.5.2) and digested with restriction endonucleases 
(Chapter 5, Section 5.3.3.4). 
6.3.8   Induction of reporter phages 
Reporter phages were induced from double-crossover mutants (Section 3.3.6) by 
transfer of 500 µl overnight C. difficile culture in BHI broth to 14 ml pre-reduced BHI 
broth. Cultures were grown till an OD550 0.6 was reached after which 3 µg/ml 
mitomycin C or 3 µg/ml of norfloxacin (both purchased from Sigma-Aldrich, UK) were 
added and culture was incubated overnight anaerobically. The next day cultures were 
centrifuged at 4,200 x g for 15 minutes, supernatant filtered and stored at 4°C. The 
supernatant contained potential reporter phages.  
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6.3.9   Establishing a clonal reporter phage stock  
With the induced phages from Section 6.3.8 plaque assays were conducted with 
overnight C. difficile culture grown in FA, BHI, BHIS or Tryptic Soy Broth (TSB) media. 
After which 100 individual plaques were picked and stored in 500 µl BHI broth. The 
plaques were screened via PCR for presence of the luxAB genes and loss of the gene 
targeted for replacement with the luxAB genes. If plaques were positive for the luxAB 
genes then a further plaque assay was conducted and the whole procedure was 
repeated. Plaque purification was carried out between three to seven times. Also, in 
each round plaques were also screened for bioluminescence by the addition of N-
decanal (Fisher Scientific, UK) to the petri-dish lid, left to stand for 5 minutes after 
which plates were viewed under UV light. Due to the presence of the luxAB genes 
phage plaques would glow.  
In addition to plaque purification reporter phages were also bulked up via liquid 
culture. 500 µl of an overnight BHI C. difficile culture was transferred to 50 ml pre-
reduced BHI broth and grown until OD550 0.2 was reached. At this point 100 µl of 
phage (plaque that was PCR positive for the luxAB genes) was added and incubated 
anaerobically overnight. Phage infected culture was then centrifuged at 4,200 x g for 
15 minutes; supernatant filtered and screened via PCR for presence of luxAB genes 
and deletion of the knock out gene (Section 6.3.5).   
 
Chapter 6 
180 
6.4   Results  
6.4.1   Induced lysogens of C. difficile phages T6ɸ12 and T6ɸF2  
Genetic manipulation of C. difficile and its associated phages has been difficult 
(Hargreaves and Clokie 2014). However Clostridium-E. coli shuttle plasmids have 
helped to increase recombination rates (Cartman et al. 2012; Heap et al. 2009). 
Therefore, in order to use the shuttle plasmids for the transfer of reporter constructs 
from E. coli to C. difficile induced lysogens were generated for phages T6ɸ12 and 
T6ɸF2. The method created temperate phages i.e. phages incorporated within the 
bacterial genome. 
6.4.1.1 Antibiotic sensitivity of C. difficile strains used to create induced 
lysogens 
Before induced lysogens were created the antibiotic sensitivity of the C. difficile 
strains, which were used for the generation of induced lysogens were tested for the 
antibiotic markers present in the Clostridium-E. coli plasmids. The values were then 
compared to estimated working concentrations suggested by Heap et al. (2009). This is 
because after the induced lysogens were generated they were used for conjugation 
and appropriate antibiotic concentrations were used to allow necessary homologous 
recombination events to occur. 
Four different antibiotic markers are present on the Clostridium–E. coli shuttle 
plasmids: chloramphenicol for cloning in E. coli/thiamphenicol for cloning in 
Clostridium, spectinomycin, tetracycline and erythromycin. The plasmids pMTL84422, 
pMTL82151 and pMTL83151 that contain the reporter constructs have either 
tetracycline or chloramphenicol/thiamphenicol as antibiotic markers. Therefore, the 
MIC was determined for these two antibiotics to C. difficile strains: T6 (R076), CD630 
(R012), ATJ (R014/020) and K12 (R220). In addition, MIC was determined for 
spectinomycin and erythromycin in case resistance was observed to tetracycline or 
thiamphenicol and therefore another antibiotic marker could be used in its place. 
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The four strains were very sensitive to antibiotics thiamphenicol, tetracycline and 
erythromycin (Figure 6.2 and Table 6.2) so the suggested working concentrations can 
be used. Exceptions were observed such as, CD630 which was resistant to 
erythromycin but this was consistent with published data (Goh et al. 2007; Eijk et al. 
2015). Additionally, a high MIC at 29.3 µg/ml of tetracycline was required to prevent 
growth of strain CD630, which was three times the recommended working 
concentration (Heap et al. 2009). Therefore, a higher concentration of tetracycline at 
approximately 40 µg/ml was used for the conjugation experiments. With the antibiotic 
spectinomycin high MICs were noted for all four C. difficile strains above 96 µg/ml but 
the recommended working concentration was also high at 750 µg/ml.  
6.4.1.2   Generation of induced lysogens 
Phage T6ɸ12 is naturally present as a lysogen within strain K12 and the phage was 
originally isolated via antibiotic induction. This strain is therefore maintained in this 
form. However, in order to increase the number of isolates that harbour phage T6ɸ12 
additional lysogens were created in C. difficile strains CD630 and ATJ. In contrast, the 
‘natural’ lysogenic host strain of phage T6ɸF2 is unknown as the phage was isolated 
from an enriched sediment sample. In order to have a ‘working lysogen’ of phage 
T6ɸF2 to manipulate, lysogens were generated in C. difficile strains CD630, ATJ and T6. 
The generation of induced lysogens was not straightforward and in the three initial 
attempts induced lysogens were not isolated. When colonies were screened via PCR 
(Figure 6.3a), all colonies were negative for the phage. In a further attempt induced 
lysogens were successfully generated and confirmed by PCR. Though, after the 
bacterial colonies were stored for longer than a week at -80°C in glycerol they tested 
PCR negative for the phage. However, on the fifth attempt lysogens were successfully 
isolated. 50 bacterial colonies were picked for both phages T6ɸ12 and T6ɸF2, 
screened and stored at -80°C. The bacterial colonies were streaked from 
cryopreservation weekly and screened for four weeks. For phage T6ɸ12 11 out of 50 
colonies remained positive after 4 weeks and therefore multiple induced lysogens 
were generated for strains CD630 and ATJ. Although, from the agarose gel it was 
found 15 bacterial colonies produced the wrong size band around 500 bp (Figure 
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6.3b). For phage T6ɸF2 28 out of 50 colonies stayed positive for the phage after 
4 weeks and induced lysogens were successfully produced for strains CD630, ATJ and 
T6 (Figure 6.3c). The induced lysogens became the working stocks and were termed 
with the phage nomenclature after the strain identify, for example lysogen of T6ɸ12 
on strain ATJ was labelled as ATJ12. 
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Figure 6.2 Examples of E-test strips used to determine antibiotic susceptibility of 
induced C. difficile isolates that harbour phages T6ɸ12 and T6ɸF2.  
The E-test strip, which increases in antibiotic concentration was added to a lawn of 
C. difficile on a BHI 1% agar plate. If the isolate was susceptible a zone of clearing was 
observed around the strip at the exact concentration on the E-test strip as observed in 
both images. However, if no clearing was detected, it indicated the isolate was 
resistant to the antibiotic.   
 
Table 6.2 Antibiotic sensitivity of C. difficile isolates used to generate induced lysogens 
of phages T6ɸ12 and T6ɸF2 to antibiotic markers present on the Clostridium-E. coli 
shuttle plasmids.  
  MIC (µg/ml) on C. difficile isolatesa 
Antibiotics Recommended 
working 
concentration 
(µg/ml)b 
T6 
(R076) 
CD630 
(R012) 
ATJ 
(R014/20) 
K12 (R220) 
Thiamphenicol 15 2 ± 0.8 1.7 ± 0.9 2.2 ± 0.6 5.3 ± 0.9 
Spectinomycin 750 96 ± 0.0 192 ± 0.0 192 ± 0.0 128 ± 0.0 
Tetracycline 10 0.64 ± 0.0 29.3 ± 3.8 0.42 ± 0.1 0.7 ± 0.3 
Erythromycin 20 0.21 ± 0.1 Resistant 0.7 ± 0.4 0.3 ± 0.0 
a Average MIC values from three technical and biological repeats. 
b Recommended working antibiotic concentration as stated by Heap et al. (2009) 
(Heap et al. 2009).  
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Figure 6.3 Isolation of C. difficile induced lysogens for phages T6ɸ12 and T6ɸF2. 
Image a) overnight C. difficile cultures were diluted from 10-1 to 10-4 and individual colonies were visible at higher dilutions. Bacterial colonies 
circled on the 10-3 dilution plate were picked and used for the next round of induced lysogen purification. Image b) 50 bacterial colonies, 
labelled 1 to 50 on the gel image were screened to test for the presence of phage T6ɸ12 (primers P23 and P24), positive bands were observed 
at approximately 250 bp. Positive control (P) was crude phage T6ɸ12 lysate, negative control (N) consisted of PCR mix without template and a 
1 kb ladder was included. Image c) 50 bacterial colonies, labelled 1 to 50 on gel image were tested for the presence of phage T6ɸF2 (primers 
P87 and P88), and positive bands were visualised at 200 bp. Positive control (P) was crude phage T6ɸF2 lysate, negative control (N) consisted 
of PCR mix without template 1 kb ladder was included. 
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6.4.2   Conjugation  
The conjugation process was initially optimised with E. coli conjugation donor cells 
S17.1 with plasmid pMTL84422-luxABNTPase and recipient C. difficile strain K12. Once 
the procedure is optimised it can be applied to the other two reporter constructs 
developed for phage T6ɸ12 (for HP1 and SF) and the four constructs for phage T6ɸF2 
(for HP2, HP3, HP4 and HP5) described in Chapter 5.  
6.4.2.1   First conjugation attempt  
The conjugation E. coli donor cells S17.1 with pMTL84422-luxABNTPase and recipient 
cells K12 were mated for eight hours. After which the mated cultures were spread on 
selective CCEY agar plates and no growth was observed on the E. coli S17.1 control 
plates after 72 hours of incubation. On plates where neat and 10-1 dilution of the 
mated samples were spread a lawn of bacterial growth was observed. On 10-2 and 10-3 
dilution CCEY plate’s individual colonies had grown across the plate (Figure 6.4). Over 
50 isolated colonies were picked from these plates and re-streaked on selective CCEY 
plates. On the first round of streaking 10 out of 50 colonies grew, second round three 
grew and on the final round the same three maintained growth.  
However, it should be noted between 11 and 20 colonies were present on the 
control K12 plates. No growth should have been observed on the control plates as the 
presence of the antibiotic tetracycline should have de-selected for C. difficile wild-type 
growth. In addition, the E-tests used to determine antibiotic sensitivity of K12 to 
tetracycline found it was highly susceptible and only 0.7 µg/ml was required to kill 
K12. Therefore, it was unclear why colonies were recovered. 15 colonies from multiple 
K12 control plates were also re-streaked three times on selective plates and 10 
maintained growth till the third round of re-streaking. As the control K12 colonies 
grew it is highly probable the three colonies isolated from the mating experiment after 
re-streaking could also be due to growth of K12 wild-type strain. To confirm this 
theory the three colonies alongside three colonies isolated from the K12 control plates 
were PCR screened. No positive PCR products were found with PCR primers that 
screened for the presence luxAB genes, pMTL84422 plasmid and the first homologous 
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recombination event. The conjugation experiment was repeated a further three times 
with selective CCEY plates with 10 µg/ml tetracycline but the same results were 
observed as the first attempt.  
6.4.2.2   Tetracycline and doxycycline concentrations  
To resolve the issue of growth of wild-type K12, and to isolate transconjugants, 
selective CCEY agar plates were made with different concentrations of tetracycline at: 
10, 20, 25, 50, 75, 100, 125, 150, 175 and 200 µg/ml. Also, CCEY agar plates were 
made with doxycycline, a potent member of the tetracycline antibiotic class at 
concentrations: 10, 15, 20, 25, 30, 35, 40, 45 and 50 µg/ml. K12 was streaked from 
cryo-preservation in triplicate and also 100 µl of overnight K12 BHI broth culture was 
evenly spread for each antibiotic concentration in triplicate. The spreading of 
overnight culture resembled how the S17.1 and K12 mated mixture was spread after 
mating. Growth was checked on plates after 24, 48 and 72 hours.  
For tetracycline selective CCEY plates in which K12 was streaked and for plates in 
which 100 µl of K12 culture was evenly spread no growth was observed after 24 and 
48 hours at all tetracycline concentrations. However, after 72 hours some a lawn of 
hazy growth was evident at 10 µg/ml of tetracycline but not at higher concentrations. 
The results show concentrations of tetracycline above 10 µg/ml are sufficient to 
prevent growth of K12. In addition, K12 did not grow in the presence of all 
concentrations of doxycycline tested and therefore the lowest concentration of 
10 µg/ml would be adequate for conjugation. 
6.4.2.3   Conjugation with different concentrations of doxycycline 
Conjugation of S17.1 cells with pMTL84422-luxABNTPase and recipient K12 was 
repeated. After the cells had mated they were spread on selective CCEY plates 
supplemented with different concentrations of doxycycline: 10, 15, 20, 25 and 
30 µg/ml. Plates were checked after 24 and 48 hours but no growth was visible. 
Furthermore, after 72 and 96 hours of incubation no growth was observed on all 
plates. This could be due to the potency of doxycycline, as it is three times more 
potent than tetracycline (Pena-Miller et al. 2013) and therefore may have prevented 
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growth of transconjugants. Consequently, conjugation was repeated and mated cells 
were spread on selective CCEY media with 5 µg/ml doxycycline but there was no 
growth on both the control and mating plates after 96 hours.          
6.4.2.4   Conjugation with different concentrations of tetracycline 
Due to failure of isolation of transconjugants with selective CCEY media supplemented 
with doxycycline, a new strategy was implemented. S17.1 and K12 cells were mated 
for eight hours and growth compared to cells, which had been mated for 16 hours. 
Furthermore, all mated cells were spread on selective CCEY media supplemented with 
10, 20, 30, 40 and 50 µg/ml of tetracycline (Table 6.3).  
  Growth was observed after 72 hours on plates with S17.1 and K12 cells mated for 
eight hours. When the mated mixture was plated without dilution a lawn of bacterial 
growth and colonies were observed on selective plates with 10, 20 and 30 µg/ml of 
tetracycline. Growth was also found on mated cultures diluted by factors 10, 100 and 
1000 on selective plates with 10 and 20 µg/ml of tetracycline. However, no growth 
was observed on selective plates supplemented with 40 and 50 µg/ml of tetracycline. 
In addition, with the S17.1 E. coli control no growth was found at all tetracycline 
concentrations but with the K12 control, growth was found on plates with 10 and 
20 µg/ml of tetracycline. 
Similar results to those observed with eight hour mated cultures were found with 
16 hour mated culture plated on the different concentrations of tetracycline. The only 
exception was that individual colonies were noted on selective CCEY plates 
supplemented with 20 µg/ml on neat and 10-1 diluted mated cultures. Growth of K12 
control was found on both 10 and 20 µg/ml selective CCEY plates. 
Due to limited wild-type K12 background growth on selective CCEY 20 µg/ml 
tetracycline plates, individual colonies from mated plates were selected. Also, all 
colonies that had grown on plates with 30 µg/ml tetracycline were picked. Overall a 
total of 64 colonies were picked. In addition, three colonies from the control K12 on 
selective CCEY 20 µg/ml tetracycline plate were selected as negative controls for the 
screening process. After the first round of streaking 48/64 colonies grew, on the 
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second round 40/64 colonies grew and on the final round 32/64 colonies grew (50% 
colonies grew). For the three colonies re-streaked from the control K12 plate, in the 
first round all three grew, second round only one colony grew and the same colony 
maintained growth in the third round. 
Crude DNA was isolated by boiling at 99°C from the 32 colonies and from the one 
colony that maintained growth on the K12 control plate. The crude DNA was used as 
PCR template and a PCR was conducted to screen for the presence of the luxAB genes 
but all colonies were PCR negative. Therefore, no further PCRs were conducted to 
check for the presence of the plasmid or to identify if the first homologous 
recombination step had occurred.  
In addition to PCR screen, it was attempted to extract plasmid DNA from 5/32 
colonies. Plasmid DNA concentrations were all below 30 µg/ml and the DNA was 
digested with the restriction endonucleases NotI and BamHI, the endonuclease sites 
that flank the reporter construct. No bands were recovered on the 1% agarose gel 
even after three attempts and each time plasmid DNA was extracted the DNA 
concentrations were consistently low.  
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Table 6.3 Summary of results when S17.1 E. coli donor cells with pMTL84422-
luxABNTPase were mated with recipient K12 cells for eight and 16 hours and spread 
on selective CCEY media supplemented with different concentrations of tetracycline. 
 Tetracycline concentration (µg/ml) added to selective CCEY media 
 10 20 30 40 50 
 S17.1 and K12 cells mated for eight hours 
Neat mated 
sample 
Lawn of 
bacterial 
growth 
Lawn of 
bacterial 
growth 
30 colonies No growth No growth 
-1 dilution of 
mated 
sample 
Lawn of 
bacterial 
growth 
Lawn of 
bacterial 
growth 
No growth No growth No growth 
-2 dilution of 
mated 
sample 
Lawn of 
bacterial 
growth and 
individual 
colonies had 
grown on top 
of lawn 
Individual 
colonies 
No growth No growth No growth 
-3 dilution of 
mated 
sample 
60 colonies 10 colonies No growth No growth No growth 
K12 control  45 colonies  4-10 colonies  No growth  No growth No growth 
S17.1 control No growth No growth No growth No growth No growth 
 S17.1 and K12 cells mated for 16 hours 
Neat mated 
sample 
Lawn of 
bacterial 
growth 
50 colonies 15 colonies No growth No growth 
-1 dilution of 
mated 
sample 
Individual 
colonies 
1 colony  1 colony  No growth No growth 
-2 dilution of 
mated 
sample 
Individual 
colonies 
No growth No growth No growth No growth 
-3 dilution of 
mated 
sample 
5 colonies No growth No growth No growth No growth 
K12 control  Lawn of K12 
growth 
20 colonies No growth No growth No growth 
S17.1 control No growth No growth No growth No growth No growth 
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6.4.2.5   Optimisation of PCR screen method 
To establish an optimised PCR protocol for screening transconjugants two PCR 
parameters: the DNA extraction method and the fidelity of the polymerase were 
altered to identify if they caused procedural errors. For these experiments 32 colonies 
that displayed a negative PCR result in Section 6.4.2.4, where used as PCR templates.  
DNA was previously extracted by boiling colonies at 99°C and to compare DNA 
extraction methods, DNA was extracted with the same samples by using the Chelex-
100 method. The extracted DNA was PCR screened but no positive bands were 
visualised on the 1% agarose gel except for the positive control. Next, the fidelity of 
the polymerase was tested and PCR was conducted with Q5® High-Fidelity DNA 
Polymerase with DNA extracted by boiling and by using the Chelex-100 method. With 
both DNA extraction methods 26/32 colonies gave the expected PCR band size for 
presence of the luxAB genes at approximately 300 bp (Figure 6.5) and for presence of 
the plasmid at 2100 bp. Therefore, Q5® High-Fidelity DNA Polymerase was used for 
screening of conjugation colonies. 
However, no positive bands were observed for the PCR to check whether the 
homologous recombination steps had taken place. Consequently, the same PCR was 
repeated with two other high fidelity polymerases: Phusion® High-Fidelity DNA 
Polymerase and Herculase II Fusion DNA Polymerase but all colonies remained PCR 
negative. From the PCR results it can be concluded the first homologous 
recombination event had not taken place in any of the colonies screened. 
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Figure 6.4 Growth of bacterial colonies on CCEY selective media after S17.1 E. coli cells 
with pMTL84422-luxABNTPase and C. difficile K12 after they were mated for eight 
hours. 
Images represent dilutions of the mated mixture in PBS a) by a factor of 100 (10-2) and 
b) by a factor of 1000 (10-3). In both dilutions individual bacterial colonies were 
observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 PCR screen for the presence of the luxAB genes of 32 colonies obtained 
after conjugation and colony purification. 
Lanes 1 to 32 represent different 32 colonies screened and 26/32 (colonies: 1, 2, 3, 4, 
5, 6, 7, 9, 11, 12, 14, 15, 16, 17, 19, 20, 21, 22, 24, 25, 27, 28, 29, 30, 31, 32) gave the 
correct expected band of over 300 bp when compared to the 1 kb ladder. K12: the 
colony, which grew on the conjugation K12 control selective CCEY plate supplemented 
with 20 µg/ml tetracycline. P: is the positive control with pMTL84422-luxABNTPase 
DNA. N: is the PCR negative control, which contains all PCR reagents except template.  
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6.4.2.6   Conjugation with E. coli CA434 donor cells 
In order to improve conjugation efficiency and to isolate single cross-over mutants the 
E. coli donor cells were changed from S17.1 to CA434 cells (Heap et al. 2009). The 
plasmid pMTL84422-luxABNTPase was transformed to CA434 cells and the conjugation 
process was repeated. The E. coli and C. difficile cells were mated for 8, 16 and 
24 hours after which the mated mixtures were spread on selective CCEY media 
supplemented with 20 and 30 µg/ml tetracycline. These antibiotic concentrations 
were selected as in Section 6.4.2.4 it was observed there was limited growth of wild-
type K12. Colonies grew after 72 hours and were observed on neat to 10-1 dilution 
plates with both tetracycline concentrations. 75 colonies were picked for re-streaking 
and 30 colonies maintained growth. The 30 colonies were PCR positive for presence of 
the luxAB genes and the plasmid but negative for the first step of homologous 
recombination. However, as previous studies have suggested conjugation efficiencies 
were higher with CA434 cells, they were used as the E. coli donor cells for all further 
experiments (Cartman et al. 2012; Heap et al. 2009). 
6.4.2.7   Conjugation with BHIS media 
The media used for conjugation could potentially influence recombination efficiencies 
and aside from CCEY media, in the literature BHIS media has been shown to be 
effective. This is because in theory on BHIS media positive transconjugants produce 
larger colonies as they grow quicker due to the presence of the plasmid in comparison 
to background wild-type growth of C. difficile that produce smaller colonies 
(Cartman et al. 2012; Faulds-Pain and Wren 2013; Heap et al. 2009). Therefore, 
conjugation experiments were conducted with selective BHIS agar plates 
supplemented with 10 µg/ml tetracycline.  
Conjugation with CA434 cells and K12 was repeated and no colonies grew on both 
CA434 and K12 control plates. Individual colonies had grown on the mated plates and 
the colonies were either distinctly small and round or large and round in shape (Figure 
6.6). No growth was observed on 10-1, 10-2 and 10-3 dilution plates. 50 large colonies 
were picked from neat plates, re-streaked three time but only 20 maintained growth 
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after purification. All 20 colonies were PCR positive for presence of the luxAB genes 
and the plasmid (Figure 6.7a and b) but PCR negative for the first step of homologous 
recombination. However, as growth was not observed on control plates and colonies 
were distinctly shaped, BHIS media was used for subsequent conjugation experiments. 
6.4.2.8   Conjugation with different C. difficile recipient strains 
It was investigated if the C. difficile recipient strain could influence recombination 
efficiencies as to this point only the strain K12 has been used for conjugation. 
Conjugation experiments were repeated with C. difficile strains CD63012 and ATJ12 
(Section 6.4.1). On all E. coli donor and C. difficile recipient BHIS control plates no 
growth was observed. Again, a combination of small and large colonies grew with both 
CD63012 and ATJ12 recipient strains but with ATJ12 colonies were larger in 
comparison. The large colonies were selected for purification: 70 for ATJ12 and 50 for 
CD63012. 25 colonies from ATJ and 19 colonies from CD630 retained growth after 
rounds of re-streaking. These colonies were PCR positive for the presence of the luxAB 
genes and the plasmid (Figure 6.7a and b) but as found with all other previous 
attempts PCR negative for the first step of homologous recombination.  
6.4.2.9   Test conjugation in E. coli cells 
To determine if the design of the construct had restricted the first homologous 
recombination event the conjugation procedure was conducted in E. coli cells. The 
NTPase gene and its flanking regions from phage T6ɸ12 were cloned into pBlueScript II 
Sk+ in DH5α cells). The plasmid in E. coli DH5α cells acted as the recipient cells for the 
conjugation experiment and the pMTL84422-luxABNTPase plasmid in CA434 cells were 
the donor cells (Figure 6.7 and 6.8). 
Both DH5α and CA434 cells with constructs were mated at a one to one ratio and 
mated for 4 hours on LB 1% agar plates at 37°C. The mated mixture was scraped and 
spread over LB 1% agar plates supplemented with 100 µg/ml carbenicillin and 
10 µg/ml chloramphenicol and incubated overnight at 37°C. Growth was observed 
after 24 hours and a lawn of bacterial growth was found but distinct colonies had 
grown on top of the lawn. 13 of these colonies were picked, re-streaked three times 
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and screened via PCR. All 13 colonies grew after re-streaking and were PCR positive for 
the presence of the luxAB genes and first homologous recombination step (Figure 6.7). 
Therefore the results from this experiment conclude the design of the reporter 
construct itself was not limiting homologous recombination, instead there may be a 
issue with the conjugation procedure used for C. difficile. 
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Figure 6.6 Colonies observed on BHIS plates after mating of E. coli CA434 cells with 
pMTL84422-luxABNTPase to C. difficile induced lysogens. 
Colonies were visible on selective BHIS agar plates after 72 hours of incubation in the 
anaerobic chamber. In image a) small colonies are circled in red which are most likely 
to be negative. In image b) larger colonies are circled in blue and are likely to be either 
positive transconjugants or spontaneous resistant colonies.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7 PCR screen of conjugation colonies for presence of the luxAB genes, plasmid 
and the first step of homologous recombination. 
Lanes labelled 1 to 13 were conjugation colonies screened after three rounds of re-
streaking on selective BHIS agar plates. N is the negative control that contains all PCR 
reagents except template and a 1 kb ladder was included. 
 
Gel images a) screen for the presence of the luxAB genes, positive product found at 
300 bp. b) screen for the presence of the plasmid, positive product found at 2100 bp. 
c) screen for the first step of homologous recombination, positive product found at 
1700 bp.  
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Figure 6.8 The conjugation process was conducted in E. coli cells to determine if the design of the reporter construct had prevented 
homologous recombination events.  
Images a) and b) present constructs developed to allow replacement of the NTPase gene of phage T6ɸ12 with the luxAB genes. The reporter 
construct and flanking regions either side of NTPase gene of T6ɸ12 was constructed in plasmid pMTL84422 in CA434 cells. The NTPase gene 
and identical flanking regions either side of NTPase gene were cloned in plasmid pBlueScript II Sk+ in DH5α cells. Reporter construct in CA434 
cells (donor) and in DH5α cells (recipient) were mated and the first step of homologous recombination occurred between the identical flanking 
regions. This was confirmed via PCR c) for presence of luxAB genes (lane 1) and a positive band at 300 bp was found. In Lane 2: PCR to screen if 
integration of the luxAB genes had occurred within plasmid pBlueScript II Sk+ and a positive band found at 1600 bp.  
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6.4.2.10   Deletion of the origin of transfer 
After elimination of the possibility there being a problem with the design of the 
reporter construct the next factor to consider was there may be a large amount of 
background growth i.e. growth of wild-type C. difficile. These could also be bacterial 
colonies with spontaneous resistance to tetracycline and therefore not true 
transconjugants. To investigate this possibility the oriT in Clostridium-E. coli shuttle 
plasmids was deleted, which created a non-mobilisable plasmid. Consequently, the 
oriT deletion prevented the transfer of the reporter construct to C. difficile and hence 
no colonies should grow after conjugation. 
The oriT region is flanked either side by the restriction endonuclease site ApaI in 
plasmid pMTL82244-luxABNTPase. The plasmid was endonuclease digested with ApaI, 
the oriT region was cut to be deleted and the plasmid was re-ligated. Additionally, the 
oriT was also deleted in plasmid pMTL82244-luxABHP5 (plasmid with hypothetical 
protein five construct for integration of the luxAB genes in phage T6ɸF2). 
After which, the conjugation procedure was conducted with both plasmids without 
the oriT in E. coli CA434 cells with C. difficile strains K12, CD63012 and ATJ for phage 
T6ɸ12 and strains T6F2, ATJF2 and CD630F2 for phage T6ɸF2. No growth was 
observed on control E. coli and C. difficile BHIS agar plates. In comparison, large and 
small colonies had grown on all plates with the mated mixture with all combinations of 
plasmid and induced phage lysogens. It should be noted, the number of colonies that 
grew were fewer than those observed with conjugation of plasmids with the oriT 
region (Section 6.4.2.8). 15 large colonies for both constructs with different induced 
lysogen combinations were picked and re-streaked three times. 10/15 colonies were 
able to grow in all rounds and were all PCR negative for the luxAB genes. The results of 
this experiment confirm there is background growth and colonies selected for 
purification may not all be true transconjugants. The results further explain why in 
previous experiments all colonies picked for purification were not all PCR positive for 
the presence of luxAB genes.  
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6.4.2.11   Influence of the Gram-positive replicon on conjugation efficiencies 
The next factor tested to aid in isolation of colonies positive for the first step of 
homologous recombination, was the influence of different Gram-positive replicons 
present on the Clostridium-E. coli plasmids. Plasmid pMTL84422-luxABNTPase contains 
the Gram-positive replicon pCD6 (from C. difficile) but the NTPase reporter construct 
was also transferred to plasmids pMTL82151 with pBPI replicon (from C. botulinum) 
and pMTL83151 with the pCD102 replicon (from C. butyricum) in Chapter 5.  
Conjugation was repeated with plasmids pMTL82151-luxAB and pMTL83151-luxAB 
in CA434 cells with the NTPase and HP1 construct targeted at phage T6ɸ12 in CA434 
cells with C. difficile recipient strains K12, CD63012 and ATJ12. Also, conjugation of 
HP5 for phage T6ɸF2 in plasmids pMTL82151-luxAB and pMTL83151-luxAB with 
C. difficile strains T6F2, ATJF2 and CD630F2 was conducted.  
After 72 hours of incubation a mixture of both small and large colonies were 
observed for most plasmid constructs and induced lysogen combinations (Table 6.4). 
Except for the combinations pMTL82151-luxABNTPase and pMTL82151-luxABHP1 
mated with K12, where either limited growth or no growth was observed respectively. 
The combination that yielded the highest number of large colonies was of pMTL82151-
luxAB and pMTL83151-luxAB with both the NTPase or HP1 construct with C. difficile 
strains CD63012 and ATJ12. These two C. difficile strains may be highly efficient 
recipients for conjugation. In comparison, fewer large colonies were noted for the HP5 
construct in both pMTL82151-luxAB and pMTL83151-luxAB plasmids with C. difficile 
strains T6F2, ATJF2 and CD630F2. 
All large colonies for all combinations were picked to be purified and number of 
colonies selected are listed in Table 6.4. Overall, all colonies that grew after 
conjugation were picked, as it is highly probable a mixture of spontaneous mutants 
and transconjugants were present. Therefore, only after screening all colonies would 
transconjugants be identified. For phage T6ɸ12 highest rates of recovery were noted 
as above 90% of colonies maintained growth after three rounds of re-streaking for 
plasmids pMTL82151-luxABHP1 and pMTL83151-luxABHP1 mated with strain 
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CD63012. The lowest rate of recovery at 21% was observed with combination 
pMTL82151-luxABHP1 with strain ATJ12. In comparison, for phage T6ɸF2 highest 
recovery at 82% was found with plasmid pMTL83151-luxABHP5 with strain ATJF2. In 
contrast with the same plasmid and construct but with a different recipient strain 
CD630F2 only 20% of colonies grew after purification.  
Colonies that retained growth after purification were all subjected to further 
analysis via PCR. Colonies were screened for the presence of luxAB genes, plasmid and 
first homologous recombination step. Overall over 85% of colonies were positive for 
the first two PCRs (Figure 6.7a and b) and not for the latter.  
6.4.2.12   Isolation of double cross-over mutants 
A possible reason to explain why when colonies were screened for the first 
homologous recombination step they are negative, could be because the colonies 
contained a mixture of wild-type C. difficile cells and luxAB mutants. The mutants may 
be present at a lower proportion in comparison to wild-type cells and so when crude 
DNA is used as PCR template mutants are not identified. Therefore, instead PCR was 
only used to screen for the presence of the luxAB genes and the plasmid. Homologous 
recombination events were instead checked after the double crossover protocol had 
been completed.  
Presence of the luxAB genes and the plasmid was already confirmed in the 
previous experiment in Section 6.4.2.11 for a number of different combinations of 
plasmids with reporter construct and recipient C. difficile strains (Table 6.4). These 
positive colonies that were isolated with different recipient strains for one plasmid 
construct were pooled together. For example purified colonies that were isolated with 
construct NTPase in plasmid pMTL83151-luxAB with strains K12, CD63012 and ATJ12 
were combined into one category. Colonies from each category were re-streaked on 
non-selective BHIS agar plates where thiamphenicol selection was removed for nine 
days constitutively. Growth from non-selective BHIS agar plates was also re-streaked 
on selective BHIS agar plates. The replica-plating step on selective BHIS agar plates 
screened for the loss of thiamphenicol antibiotic marker present on plasmids 
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pMTL82151-luxAB and pMTL83151-luxAB, hence loss of plasmid. Consequently, if the 
colony is unable to grow on selective plates than the double-crossover events may 
have taken place, i.e. plasmid excised and luxAB genes inserted within the phage 
genome. However, there is a possibility that with the excision of the plasmid cells can 
also revert back to wild-type.  
After each round of replica-streaking more colonies in comparison to the previous 
streaking step were unable to grow on selective thiamphenicol BHIS agar plates 
(Figure 6.9). By the seventh passage a plateau was reached for all plasmid construct 
combinations and no further colonies that could not grow on selective plates were 
identified. Over 90% of these colonies were isolated for both HP1 and HP5 constructs 
in pMTL82151-luxAB. In contrast over 50% of these colonies were found with 
pMTL83151-luxABHP1.  
Colonies from first, third, fifth, seventh and ninth passages were PCR screened for 
presence of luxAB genes, plasmid and double crossover mutants. Less than 9% of 
colonies for all combinations from the seventh and ninth round of re-streaking were 
PCR positive for the luxAB genes, negative for plasmid and positive for homologous 
recombination (Figure 6.10). This represents the luxAB genes had successfully been 
integrated into the phage genome. The most number of mutants that were isolated 
were for pMTL83151-luxABNTpase, where eight mutants were found. In contrast only 
two mutants were identified with pMTL83151-luxABHP1. Overall though, mutants 
were isolated at low rates as more than 91% of colonies had reverted back to wild-
type after excision of plasmid (Table 6.4).  
Furthermore, a PCR was conducted with the mutants to screen whether the gene 
being replaced with the luxAB genes had been knocked out but a band was observed 
on the 1% agarose gel for all three mutants (Figure 6.10). The PCR to check for 
homologous recombination was repeated again to confirm whether all colonies were 
mutants. Positives band were found for all mutants and so it is highly probably a mixed 
population of wild-type C. difficile cells and luxAB mutants were present in all colonies. 
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Table 6.4 Growth of conjugation colonies after purification.  
Construct C. difficile 
lysogen/induced 
lysogen 
Induced lysogen mated with pMTL82151-luxAB Induced lysogen mated pMTL83151-luxAB 
Number of 
colonies 
pickeda 
% recoveryb % of cells 
reverted 
back to 
wild-typec 
Number of 
luxAB 
mutantsc  
Number of 
colonies 
pickeda 
% recoveryb % of cells 
reverted 
back to 
wild-typec 
Number of 
luxAB 
mutantsc 
Phage T6ɸ12        
NTPase K12 5 0   25 60   
 CD63012 50 46 87 7 45 82 91 8 
 ATJ12 50 60   60 53   
Phage T6ɸ12          
HP1 K12 0 0   19 32   
CD63012 50 100 92 6 29 93 93 2 
 ATJ12 48 21   63 33   
Phage T6ɸF2        
HP5 T6F2 43 74   18 78   
ATJF2 17 65 94 4 11 82 91 3 
CD630F2 23 22   20 20   
a Only large colonies present on selective BHIS agar plates were selected to be re-streaked and purified. 
b Percentage recovery calculated as the number of colonies, which continued to grow after they were re-streaked three times. In addition, the colonies 
were also PCR positive for the presence of the luxAB genes and plasmid. 
c Colonies that were PCR positive for the presence of the luxAB genes and plasmid (b) were re-streaked every 24 hours for nine days on non-selective and 
selective BHIS agar plates. After replica-plating colonies were PCR screened for presence of luxAB genes, plasmid loss and homologous recombination. 
Colonies either reverted back to wild-type or luxAB mutants were generated. 
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Figure 6.9 Percentage of possible transconjugants that were unable to grow on 
selective BHIS agar plates supplemented with 10 µg/ml thiamphenicol after being re-
streaked every 24 hours for nine days. 
Lines represent colonies from targeted deletion of NTPase gene of phage T6ɸ12 and 
replacement with the reporter genes in pMTL82151-luxAB (light grey line) and in 
pMTL83151-luxAB (dotted light grey line). Targeted deletion of HP1 of phage T6ɸ12, 
with reporter construct in pMTL82151-luxAB (dark grey line) and in pMTL83151-luxAB 
(dotted dark grey line). Targeted deletion of HP5 of phage T6ɸF2 with reporter 
construct in pMTL82151-luxAB (black line) and in pMTL82151-luxAB (dotted black 
line).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10 PCR screen to confirm isolation of double crossover mutants.   
A 1 Kb ladder was used and compared to all lanes. Lane 1: gene targeted for 
replacement with the luxAB genes remains at 1200 bp. Lane 2: negative for primers 
that anneal to the plasmid backbone. Lane 3: positive for 5’ integration primers at 
1100bp. Lane 4: positive for 3’ integration primers at 1400 bp. Lane 5: positive band 
for presence of luxAB genes at 300 bp. 
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6.4.3   Induction of reporter phages  
Multiple double-crossover mutants were isolated in Section 6.4.2.12 (Table 6.4) but 
only one was selected for each plasmid combination. Therefore six bacterial colonies 
in total: four which harboured phage T6ɸ12::luxAB and two that harboured 
T6ɸF2::luxAB were selected. C. difficile reporter phages were induced from the six 
bacterial colonies by the addition of the antibiotics mitomycin C and norfloxacin. Both 
antibiotics successfully excised phages: T6ɸ12::luxAB-NTPase-, T6ɸ12::luxAB-HP1- and 
T6ɸF2::luxAB-HP5- at an average titre of 2.4 x 104. All induced phage stocks were then 
screened via PCR for the presence of the luxAB genes and all stocks were PCR positive. 
Brighter bands on the agarose gel were noted for phages induced with norfloxacin 
(data not shown) and were subsequently those reporter phage stocks were used for 
further experiments. Five rounds of plaque assays were conducted to enrich for the 
reporter phages with the C. difficile strain T6 as this is the propagation host for both 
wild-type phages T6ɸ12 and T6ɸF2. With each round the soft agar was scrapped and 
used for the next plaque assay to enrich for the reporter phages and to increase the 
titre of the phage stocks. In addition, with each round phage stocks were examined via 
PCR to confirm presence of the luxAB genes. 
After the fifth round of plaque assays, 100 individual plaques were picked, 
screened via PCR to detect the luxAB genes and all positive plaques were used for the 
next round of plaque purification. A plaque assay was conducted again with the 
positive plaque, 100 plaques were picked and screened. This whole procedure was 
repeated seven times to establish clonal phage stocks (Figure 6.11a-g). However, with 
the first to the fourth step less than 5% of plaques screened were PCR positive and this 
was noted with all phages T6ɸ12::luxAB-NTPase-, T6ɸ12::luxAB-HP1- and 
T6ɸF2::luxAB-HP5-. Furthermore, in the fifth and sixth plaque purification steps less 
than 2% of plaques were PCR positive and in the seventh round no positive plaques 
were identified for all phages. The results can be interrupted as the reporter genes are 
not stable within the phage genomes and with each round of purification fewer phage 
plaques had retained the reporter genes. 
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In addition to screening plaques for the presence of the luxAB genes, a PCR was 
also conducted to screen for presence of the phage gene being replaced by the luxAB 
genes. For phage T6ɸ12 two different reporter phages were made therefore both 
phage genes NTPase and HP1 were screened for. For phage T6ɸF2 the presence of 
HP5 was screened for. The PCR results showed that for each round of plaque 
purification all plaques that were positive for the luxAB genes remained PCR positive 
for the genes targeted for replacement for the reporter genes (Figure 6.11h). This 
indicated phage plaques remained mixed even after multiple rounds of plaque 
purification. Furthermore, another screening method was used to identify luxAB 
positive plaques by screening plaque assays for bioluminescence after addition of 
substrate N-decanal but no glowing plaques were identified.   
6.4.3.1   Establishing a clonal reporter phage stock via liquid media 
Plaques PCR positive for presence of the luxAB genes, which were isolated in Section 
6.4.3 were used to propagate the phages via liquid bulk up. After which, plaque assays 
were conducted and 100 individual plaques were selected to be PCR screened. For all 
reporter phages T6ɸ12::luxAB-NTPase-, T6ɸ12::luxAB-HP1- and T6ɸF2::luxAB-HP5- all 
plaques were PCR negative for the luxAB genes. 
6.4.3.2   Change of C. difficile growth media to stabilise reporter genes 
It was investigated whether the media used to grow the propagation host T6 could 
influence the stability of the reporter genes (personal communication with Dr David 
Schofield, Guild Biosciences). For the previous plaque purification steps T6 was grown 
overnight in FA broth and then used for plaque assays. Instead T6 was grown 
overnight in: BHI, BHIS and TSC media and used for plaque assays. With the same 
media plaque purification was repeated three times and each time 100 plaques were 
selected for screening via PCR. Overall, as noted with T6 grown in FA broth less than 
5% of plaques were PCR positive in the first round of purification and less than 2% for 
the second and third round. All plaques, which includes those positive for the luxAB 
genes were positive for the knock out genes. 
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6.4.3.3   Change in C. difficile propagation strain to stabilise reporter genes  
It was explored whether the propagation host and its corresponding ribotype used for 
plaque assays for all three reporter phages: T6ɸ12::luxAB-NTPase-, T6ɸ12::luxAB-HP1- 
and T6ɸF2::luxAB-HP5- could impact stability of the reporter genes within the phages. 
Consequently, the following strains were used to purify T6ɸ12::luxAB-NTPase- and 
T6ɸ12::luxAB-HP1-: ATJ (R014/020), ARU (R026), AIH (R087) and Y (R220). The strains 
used to purify T6ɸF2::luxAB-HP5- were: H15 (R002), ATJ, AIH and Y. Three rounds of 
plaque purification was conducted with each strain and with each round 100 plaques 
were picked to be screened. However, in all rounds of purification less than 4% of 
plaques were positive for the luxAB genes and all plaques screened, remained positive 
for the knock-out gene. When plaque assays were viewed under UV light, again no 
‘glowing’ plaques were observed. 
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Figure 6.11 Plaque purification of C. difficile reporter phages: T6ɸ12::luxAB-NTPase-, T6ɸ12::luxAB-HP1- and T6ɸF2::luxAB-HP5- to establish a 
clonal reporter phage stock. 
Plaque assays were conducted with the three reporter phages, after which 100 individual plaques were selected for plaque purification, stored 
in 500 µl of BHI broth and screened via PCR for detection of the luxAB genes. Positive bands were observed at 300 bp and were compared to 
the 1 kb ladder. Further plaque assays were conducted with the positive plaques (highlighted in a white box) and were used for the b) second 
round of purification. Plaque purification was repeated seven times. The plaque purification rounds were: c) third, d) fourth, e) fifth, f) sixth 
and g) seventh. In addition h) plaques were PCR screened for presence of the phage genes of T6ɸ12 and T6ɸF2 that were replaced with the 
luxAB genes. Positive bands were noted at 200 bp.  
Chapter 6 
207 
6.5   Discussion 
The aim of Chapter 6 has been to complete construction of reporter phages for the 
development of a phage-based detection test for C. difficile. The process began in 
Chapter 5 where reporter constructs were individually designed to replace three 
phage genes of T6ɸ12: SF, HP1 and NTPase and four genes of T6ɸF2: HP2, HP3, HP4 
and HP5 with the luxAB genes.  
The next step, which has been the prime focus in the current study, was the 
transfer of the reporter constructs to their respective phages for incorporation of the 
luxAB genes within the phage genome. The method used for horizontal gene transfer 
was conjugation, which enabled the Clostridium-E. coli shuttle plasmids with the 
reporter construct to transfer the luxAB genes from E. coli cells to C. difficile phages. 
However, it was found in this study both conjugation and homologous recombination 
occurred at very low frequencies and substantial optimisation was required. Following 
optimisation C. difficile reporter phages were successfully constructed but the luxAB 
genes were unstable within the phage genome. 
6.5.1   Induced C. difficile phage lysogens 
For conjugation to be possible induced lysogens of C. difficile phages T6ɸ12 and T6ɸF2 
were generated. Aside from phage T6ɸ12 naturally being a lysogen of strain K12, 
induced lysogens were created for phages T6ɸ12 and T6ɸF2 with a number of 
C. difficile strains: T6, ATJ and CD630. These strains were selected as: T6 is the 
propagation host of both phages, ATJ as again both phages can infect the strain 
lytically and CD630 as it is a reference strain therefore extensive molecular 
characterisation has been conducted (Eijk et al. 2015). In addition, all four C. difficile 
strains used where all different ribotypes and this was to identify which ribotyped 
strain would be ideal for conjugation. Furthermore, antibiotic sensitivity of the 
C. difficile isolates used to generate the induced lysogens was tested to all antibiotic 
present on the Clostridium-E. coli plasmids. This was because it has been reported 
C. difficile ribotypes have different antibiotic susceptibility and resistance profiles 
(Zidaric et al. 2012). However, it was found all strains were susceptible to tetracycline 
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and thiamphenicol except CD630, which was less susceptible to tetracycline. This is 
likely due to the presence of the CTn3 (Tn5397) transposon that harbours a 
tetracycline gene, annotated in the CD630 genome (Eijk et al. 2015). 
After determination of antibiotic susceptibility induced lysogens were successfully 
developed for both phages on all selected C. difficile strains after four failed attempts. 
Over 50 different bacterial colonies were screened in each attempt and as they were 
all isolated from different phage infected cells it could explain why differences in 
stability were noted. This could be why not all colonies screened were not positive for 
the presence of the phage. In addition to why induced lysogens were not identified 
readily could be due to high rates of spontaneous phage release observed with 
C. difficile isolates (Hargreaves and Clokie 2014; Pinard et al. 2012).  
However, on the fifth attempt stable induced lysogens were generated. Possible 
explanations to explain why could be that the phage provides defence barriers against 
infection by other phages. Therefore, it would be worthwhile for the bacterial cell to 
retain the phage within its genome (Stern and Sorek 2011). Furthermore, the addition 
of the lysogen within the genome may have led to mutations within the bacterial 
chromosome that allowed the phage to be stably integrated or locked in within its 
genome (Sørensen et al. 2011). Although, the occurrence of both events described is 
rare and which is why only after multiple bacterial colonies were screened induced 
lysogens were isolated. 
6.5.2   Optimisation of C. difficile conjugation  
After induced phage lysogens were generated, the majority of this study has focused 
on optimisation of the conjugation procedure to promote homologous recombination 
events as genetic manipulation of C. difficile is difficult (Heap et al. 2009; Lin et al. 
2012; Heap et al. 2010; Faulds-Pain and Wren 2013; Al-Hinai et al. 2012). Initial 
optimisation of conjugation was conducted with plasmid pMTL84422-luxABNTPase 
and C. difficile lysogen K12. A number of factors were altered: the time for which 
E. coli and C. difficile cells were mated, antibiotic concentrations, antibiotic marker, 
bacterial DNA extraction method, fidelity of polymerase used to PCR screen colonies 
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after conjugation, E. coli donor cells, C. difficile recipient cells, oriT and the Gram 
positive replicon. Furthermore, conjugation was also tested in E. coli to confirm there 
was not an issue with the design of the reporter construct. Only after extensive trial 
and error, which will be discussed in this section, was an effective protocol developed 
that enabled the luxAB genes to be successfully incorporated within the phage 
genome.     
6.5.3   Mating incubation time and antibiotic concentration optimisation 
Different mating incubation times: eight, 16 and 24 hours were tested as although 
E. coli replicates every 20 minutes in aerobic conditions, cells were mated 
anaerobically. The change in growth environments could have affected E. coli growth 
and slowed the replication process. In addition, the replication time of C. difficile is 
twice as slow and takes 40 minutes and as the cells were combined with E. coli for 
mating the replication time could have also been affected. Also, in the literature a 
variety of mating incubation times that range from six to 24 hours have been utilised 
(Purdy et al. 2002; Heap et al. 2009; Cartman et al. 2012; Carter et al. 2007; Donald et 
al. 2013).  
However, regardless of the mating incubation time growth was observed on 
control K12 selective CCEY plates. This indicated conjugation had not worked and 
colonies that were screened were all PCR negative. This was because the colonies 
were likely to be spontaneous clones of C. difficile or maybe even E. coli. It is hard to 
explain why growth was observed on the control plates especially when antibiotic 
sensitivity of K12 was checked and found to be highly susceptible to tetracycline. 
Additionally, no previous C. difficile studies that have used conjugation have reported 
this problem either. A possible explanation to why growth was found could be due to 
CCEY media being a very rich and thick media due to the addition of egg yolk emulsion 
(Hill et al. 2013). Therefore, tetracycline may not have been able to diffuse through the 
media but concentrations above 20 µg/ml were efficient to prevent background 
growth. However, even after optimisation of antibiotic concentrations no colonies 
were isolated that were PCR positive for the presence of the luxAB genes, plasmid and 
the first step of homologous recombination.         
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Consequently, it was predicted there could be a problem with the PCR screen 
method, due to either the DNA extraction protocol or the polymerase used. Crude 
DNA lysate was used as template for PCR as it is the quickest DNA extraction method 
but there have been reports that the DNA degrades rapidly and often contains 
inhibitors to PCR (Nishiguchi et al. 2002). Therefore, DNA was extracted with the 
Chelex-100 method commonly used to extract DNA from C. difficile (Hargreaves et al. 
2013; Nale et al. 2012; Zidaric et al. 2010) and PCR was repeated but still no positive 
transconjugants were isolated. Instead it was noted PCR with a high fidelity 
polymerase enabled detection of transconjugants (Cartman et al. 2012).  
Although, all the colonies that were PCR screened were not positive for the first 
step of homologous recombination and a range of primers were tested that targeted 
both potential sites of plasmid integration. However, the main issue with these 
primers was that there was no positive control as the primers were designed to 
amplify overlapping sequences between the phage genome and the plasmid with the 
reporter construct. Consequently, optimisation of PCR with these primers was difficult 
and potential transconjugants had to be used for optimisation. This could explain why 
no positives were isolated.  
6.5.4   Media used for conjugation 
In the attempt to eliminate potential possibilities that could affect conjugation and 
homologous recombination events, media used to spread the mated culture was 
altered from CCEY to BHIS. This is because as previously mentioned CCEY is a rich 
media but BHIS media is not in comparison and therefore may be more efficient for 
the isolation of transconjugants. In addition, Cartman et al. (2012) reported 
transconjugants grow quicker and bigger in size and are distinctly visible on BHIS agar 
plates. Transconjugants when re-streaked three times for purification also grow 
quicker whereas growth of negative colonies halts after the first or second round of re-
streak.  
Possible reasons to explain variances in growth rates of colonies isolated after 
conjugation are that typically a colony picked is likely to contain 106 CFU and it is 
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highly probable the first homologous recombination has occurred in at least one of the 
cells in the colony. Cells in which the event has occurred will grow quicker, hence why 
larger colonies are produced in comparison to the population of cells that contain free 
plasmid. This is because free plasmid is unstable so cells lose the plasmid during 
growth and when antibiotic pressure is removed. This means you are able to isolate 
cells in which the first homologous recombination event has occurred by frequently 
sub-culturing larger colonies (personal communication with Dr Heap, Imperial 
university). The same observations on colony growth were found in this study and 
larger colonies were selected to be re-streaked. Some larger colonies did grow quicker 
and maintained growth throughout the three rounds of re-streaking but still all 
colonies were PCR negative for the first step of homologous recombination. 
6.5.5   Donor and recipient cells used for conjugation 
It has been frequently reported in the literature that conjugation efficiencies in 
C. difficile are notoriously low, which was also observed in the present study. 
Additionally, the E. coli donor and C. difficile recipient strains used for conjugation 
could potentially affect the efficiency further. Therefore, different donor and recipient 
cells were tested. 
For the first set of experiments S17.1 E. coli cells were used as the conjugation 
donor cells and have been previously shown to be effective for transfer of constructs 
between E. coli and C. difficile (Mani et al. 2002; Heap et al. 2009). Other studies have 
used CA434 donor cells (Cartman et al. 2012; Purdy et al. 2002; Carter et al. 2007) and 
CA434 cells have a different conjugative plasmid and genotype profile in comparison 
to S17.1 cells. Consequently, genetic transfer frequencies of both E. coli cells may vary 
in C. difficile. In addition, through personal communication with Dr John Heap, he 
advised the conjugation efficiency could be improved by use of CA434 cells as the 
donor cells. Therefore, conjugation was repeated with CA434 cells and bigger colonies 
were observed on selective BHIS plates than with S17.1 cells. However, when the 
colonies were screened they were all PCR negative for the first recombination step, 
but positive for the presence of the luxAB genes and the plasmid. 
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In an effort to isolate single crossover mutants conjugation was repeated with the 
reporter construct in CA434 cells and different C. difficile recipient strains ATJ12 and 
CD63012 to compare against isolation of transconjugants with K12. However, all 
colonies were PCR negative for the first homologous recombination step but twice as 
many large colonies were observed for conjugation with ATJ12 and CD63012 in 
comparison to K12.  
A possible theory to explain why a difference between the conjugation C. difficile 
recipient strains was found could be due to defence mechanisms present within the 
bacterial genome. Although isolates K12 and ATJ12 have not been sequenced yet, in 
other previously annotated C. difficile genomes Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPRs) have been identified (Hargreaves et al. 2014; 
Hargreaves et al. 2015). CRISPRs are a defence mechanism employed by bacteria and 
the system uses acquired short nucleotide sequences called spacers to target 
homologous sequences found in foreign nucleic acids, such as phages and plasmids. 
Consequently, when the sequences match, foreign DNA is cleaved and it could be 
homology regions in CRIPRS are present to the plasmids used in this study. Although, 
no studies to date have investigated this theory in C. difficile but it has been 
investigated experimentally in other bacterial systems. For example Marraffini and 
Sontheimer (2008) found that a clinical isolate of Staphylococcus epidermidis 
harboured a CRISPR spacer that matched a gene present in all Staphylococcus 
conjugative plasmids. Therefore, due to the CRISPR interference conjugation was 
inhibited with the isolate. 
The observations noted with S. epidermidis may apply to C. difficile and could 
explain why even after over 100 colonies are screened after conjugation not all are 
positive for presence of the luxAB genes or plasmid. It implies most colonies are likely 
to be spontaneous mutants of C. difficile or E. coli. This theory was confirmed when 
the origin of transfer was deleted from plasmids with the reporter constructs and after 
conjugation bacterial colonies had grown. The experiment concluded there is 
background growth of spontaneous clones that are likely to be mixed with 
transconjugants.   
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6.5.6   Influence of Gram positive replicons for isolation of mutants 
All reporter constructs developed in Chapter 5 were transferred to Clostridium-E. coli 
plasmids pMTL84422, pMTL82151 and pMTL83151, which all contained different 
Gram-positive replicons. The pCD6 replicon of pMTL84422 is naturally derived from 
C. difficile (Purdy et al. 2002) and is subsequently stable within the organism. 
Therefore, cells are more likely to retain free plasmids and the homologous 
recombination events are unlikely to occur (personal communication with Dr Heap, 
Imperial College London). This could possibly explain why no PCR positive colonies for 
the first homologous recombination were isolated and why they were PCR positive for 
the presence of the luxAB genes and plasmid.  
However, for the ‘pseudo-suicide’ method used for allele exchange a plasmid that 
replicates within the host cell and that is segregationally unstable is required (Cartman 
et al. 2012). This could explain why despite altering numerous factors in the 
conjugation protocol no single crossover mutants were isolated. In addition, Heap et 
al. (2009) found the transfer frequencies with replicon pCD6 was low at 7.00 x 10-6 in 
the reference strain CD630, which is the rate at which transconjugants colonies are 
generated per E. coli donor. 
In comparison plasmids: pMTL82151 with pBP1 replicon and pMTL83151 with 
pCB102 replicon had transfer frequencies of 3.36 x 10-6 and 2.23 x 10-6 respectively in 
CD630 (Heap et al. 2009). Although there is not a log difference between the transfer 
frequencies, both plasmids have been effectively used with the ‘pseudo-suicide’ 
approach previously. For example Faulds-Pain and Wren (2013) used plasmid 
pMTL82151 as their backbone for construction of a cassette targeted at deletion of 
the erythromycin gene in C. difficile reference strain M68. Also, Cartman et al. (2013) 
used both plasmids pMTL82151 and pMTL83151 for allele exchange in reference 
C. difficile strains R20291 and CD630 respectively. Different plasmids for both strains 
as it has been noted in the literature the Gram-positive replicon can be strain specific.  
Consequently, as three induced phage lysogens were made for phages T6ɸ12 and 
T6ɸF2 conjugation was repeated with all and with both plasmids. In comparison to 
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transconjugants isolated with pMTL84422-luxABNTPase distinctly larger colonies were 
found with donor plasmids pMTL82151-luxABNTPase, pMTL82151-luxABHP1, 
pMTL82151-luxABHP5, pMTL83151-luxABNTPase, pMTL83151-luxABHP1 and 
pMTL83151-luxABHP5 with all C. difficile recipient cells. In addition, a higher 
proportion of the colonies were PCR positive for presence of luxAB genes and the 
plasmid. This indicated the combination of both the Gram-positive replicon and the 
recipient C. difficile strains used for conjugation influenced recombination efficiency. 
However, no colonies were PCR positive for the first homologous recombination 
step. Despite this the protocol to identify double-crossover mutants was conducted, 
with all colonies that had retained growth after three rounds of purification. 
Furthermore, the test conjugation experiment in E. coli cells found there was no issue 
with the design of the construct itself and homologous recombination occurred 
efficiently. Therefore, it was likely there was a problem with the screening method 
itself.  
Consequently, after nine rounds of replica streaking colonies that were PCR 
positive for the double crossover event were identified, hence luxAB mutants had 
successfully been isolated. Although, recombination rates were consistently low at 
least one luxAB mutant was isolated that replaced the NTPase gene and HP1 of phage 
T6ɸ12 and HP5 of phage T6ɸF2. Faulds-Pain and Wren (2013) also found similar low 
recombination rates. They screened 75 colonies and after nine rounds of replica 
plating only eight were PCR positive for the second homologous recombination event.  
The recombination rates and identification of double-crossover mutants could be 
improved in C. difficile by using a different strategy. Typically genetic manipulation 
occurs by a two-step allele exchange, via a positive antibiotic selection marker to 
select for transconjugants and with a counter-selection marker to excise the plasmid. 
Until recently no such method had been developed for C. difficile but Cartman et al. 
(2012) incorporated the Cytosine Deaminase Gene (codA) counter-selection marker to 
their plasmids. codA converts the pyrimidine analogy 5-fluorocytosine to 5-
fluorouracil, which is toxic to C. difficile and so forth the plasmid was used for allele 
exchange. Double crossover mutants were identified by plating on media with 5-
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fluorocytosine and approximately 27% were PCR positive for this event, a significantly 
higher rate than that found in the present study. However, this plasmid could not be 
accessed but for future mutagenesis work the addition of the counter-selection 
marker could help to make the process easier. 
6.5.7   Establishment of a clonal reporter phage stock 
After successful isolation of double crossover luxAB mutants the next step was to 
excise the reporter phages from their lysogenic hosts. After induction phages were 
enriched by plaque assays, as it has been shown to help with the production of a 
clonal reporter phage stock. For example Loessner et al. (1996) carried out plaque 
assays several times for L. monocytogenes reporter phages after which at least one 
positive reporter phage plaque was isolated from 100 plaques screened. The positive 
plaque was then taken forward to produce a high titre and stable reporter phage 
stock. However, this was not observed in the present study but instead after 
enrichment and plaque purification clonal reporter phage stocks were not produced. 
Less than 5% of plaques were PCR positive for the presence of the luxAB genes and by 
the seventh round of plaque purification no positive plaques were isolated. A clonal 
reporter phage stock was not successfully produced. 
It can be interpreted from this study that the reporter genes are unstable within 
the phage genome, even though they were inserted into three different locations 
within the phage genomes and two different phages were used as templates. With the 
reporter phage T6ɸ12::luxAB-NTPase- the NTPase gene and with T6ɸF2::luxAB-HP5- 
the HP5 were targeted for replacement and both genes were located within the DNA 
replication regions of the phages. Whereas, with reporter phage T6ɸ12::luxAB-HP1- 
the HP1 was targeted for exchange with the reporter genes and HP5 is located within 
the lysogeny control region of the phage. This could potentially indicate the location of 
the insertion of the luxAB genes may not affect stability but it could be instead the 
reporter genes are lost during the infection cycle. This could be because the phage 
does not require the reporter gene within its genome because they add no benefit 
with regards to infection (personal communication with Dr David Schofield, Guild 
Biosciences). In addition, during the assembly of new phage progeny the terminase 
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motor may have packaged phage DNA by cutting the genome at none specific cut sites 
and consequently the luxAB genes may have been deleted (Rao and Feiss 2008).  
In an attempt to stabilise the reporter genes different parameters used for plaque 
assay was altered, such as media and propagation host. However, no differences in 
stability were noted and clonal stocks were not established. In addition, all plaques 
screened in all seven rounds of plaque purification remained PCR positive for the 
genes that were targeted for replacement with the luxAB genes, including those 
plaques positive for the reporter genes. Therefore, the plaques remained mixed with 
both wild-type and mutant phages, which was also the case with the double-crossover 
mutants isolated after conjugation. Even though it was hypothesised the rounds of 
plaque purification would help to separate both wild-type and mutants phages. The 
presence of both wild-type and mutant phages may have contributed in the inability to 
produce a clonal reporter phage stock as during phage amplification, multiplication of 
wild-type phages may have been favoured over mutant phages. Consequently, after 
multiple rounds of screening fewer positive phage plaques were isolated. 
However, in the literature there is no mention of presence of both wild-type and 
mutant phages after rounds of plaque purification and all studies to date have been 
successful in producing clonal reporter phage stocks (Loessner et al. 1996; Schofield et 
al. 2009; Schofield and Westwater 2009; Schofield et al. 2012; Schofield et al. 2015). 
Although, the low frequencies encountered with isolation of phage plaques PCR 
positive for presence of the luxAB genes has been mentioned in all reporter phage 
studies. For example Schofield et al. (2015) screened approximately 100,000 plaques 
via bioluminescence but only one positive plaque was identified. However, in the 
present study bioluminescence was not able to detect positive plaques. This may have 
been due to mutant plaques being present at low levels and as the mutant plaques 
remained positive for the knock-out genes. 
Schofield et al. (2009) also described detection of low number of mutant reporter 
phages for Y. pestis as after eight rounds of purification a ratio of four out of 20 
plaques were PCR positive for luxAB genes. The single positive plaque was amplified 
via liquid culture to produce a high titre reporter phage stock of 1010 to 1011 PFU/ml. 
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However, when it was attempted to do the same in the present study no positive 
luxAB phages were isolated. As mentioned previously liquid media may have 
promoted amplification of wild-type phages and hence why the luxAB genes were lost 
during infection. The stability of the luxAB genes within the phage genome may be 
improved by conducting phage infection, both plaques assays and liquid bulk-up at 
different temperatures as has been described previously (Schofield et al. 2009). The 
only problem with C. difficile is that is grows at 37°C under anaerobic conditions and 
even slight alterations in these conditions can prevent bacteria growth and therefore 
affect phage infection too.  
6.5.8   Conclusions  
This study has concentrated on the completion of the construction of C. difficile 
reporter phages for T6ɸ12 and T6ɸF2 by the transfer of the reporter constructs 
developed in Chapter 5 to their respective phages via conjugation. The conjugation 
process proved to be difficult and copious amounts of optimisation was required. 
Though through the process of elimination it was found the media, PCR, recipient and 
donor cells and the Gram-positive replicon had a huge impact on recombination. 
Double-crossover mutants were isolated at very low rates but luxAB genes have now 
successfully been transferred to phages T6ɸ12 and T6ɸF2. For phage T6ɸ12 these are 
phages, which have replaced the NTPase gene and HP1 with the reporter genes. For 
phage T6ɸF2, HP5 has been replaced with the reporter genes.  
The phages T6ɸ12::luxAB-NTPase-, T6ɸ12::luxAB-HP1- and T6ɸF2::luxAB-HP5-were 
harboured within their lysogenic hosts and were induced. Although, after multiple 
rounds of purification the proportion of PCR positive reporter phages was consistently 
low and therefore a clonal reporter phage could not be produced. Future work will 
focus on stabilising the reporter genes within the phage genomes for the development 
of the C. difficile specific reporter phage-based diagnostic test.  
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6.5   Chapter 6 summary 
• The aim of this study has been to transfer the reporter construct developed in 
E. coli to C. difficile phages T6ɸ12 and T6ɸF2 via conjugation to allow 
homologous recombination events to occur for incorporation of the luxAB 
genes within the phage genome. 
• First Induced lysogens of phages T6ɸ12 and T6ɸF2 were generated in 
C. difficile strains K12, ATJ, T6 and CD630, which acted as conjugation recipient 
cells. 
• Reporter construct in plasmid pMTL84422-luxABNTPase was transferred from 
E. coli DH5α to conjugation donor cells S17.1.  
• Conjugation was then optimised by alteration of these parameters: E. coli 
donor cells, media used for conjugation, fidelity of PCR polymerase and Gram-
positive replicon on the Clostridium-E. coli shuttle plasmids. All were found to 
influence conjugation and homologous recombination rates. 
• However, despite extensive optimisation no colonies that were positive for the 
first homologous recombination step were isolated but they were PCR positive 
for the presence of the luxAB genes and plasmid.   
• Colonies that were PCR positive for the luxAB genes and plasmid were re-
streaked nine time on non-selective and selective BHIS media for isolation of 
double crossover mutants. 
o Multiple double-crossover mutants were isolated for both phages 
T6ɸ12 and T6ɸF2 at a low percentage of 9%. 
o However, double-crossover mutants were mixed and each colony 
contained a combination of both wild-type and mutant phages.   
• Double cross-mutants were used to induce the reporter phages: T6ɸ12::luxAB-
NTPase-, T6ɸ12::luxAB-HP1- and T6ɸF2::luxAB-HP5- from their lysogenic hosts. 
• Multiple rounds of plaque purification were conducted to establish a clonal 
reporter phage stock but the gene was highly unstable and therefore no clonal 
phage stock was produced.   
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7.1   Key findings of this study  
C. difficile produces resilient spores, which allows the bacteria to spread within 
healthcare environments. The spores are able to survive on hospital equipment and 
surfaces such as bed rails, door handles and floors for over six months (Barbut 2015; 
Biswas et al. 2015; Cheng et al. 2015). Consequently when patients or visitors come 
into contact with contaminated surfaces and digest the spores, they can become 
vegetative cells, and cause CDI. Although, strategies have been implemented to 
control the spread of C. difficile within the environment, it is still a matter of concern 
as spores are resistant to many disinfectants (Speight et al. 2011; Vohra and Poxton 
2011). Surprisingly, even though C. difficile contamination is a major issue there are no 
tests available to validate whether sufficient cleaning has been conducted to eliminate 
all presence of the bacteria (Barbut et al. 2014). 
In addition, current PCR and ELISA-based diagnostic tests used to identify CDI from 
patient faecal samples lack sensitivity and specificity, hence why there is a high 
frequency of misdiagnosis (Longo et al. 2015). Also, the reagents used for the 
diagnostic tests are expensive and specialised equipment is required. This high rate of 
misdiagnosis may have contributed to the spread of C. difficile within communities, 
the environment and between patients (Lessa et al. 2015).  
Therefore, the aim of this PhD research has been to overcome the issue of lack of 
specificity of current diagnostic tests and to introduce a test to verify if sufficient 
cleaning has been conducted in healthcare environments to eliminate all traces of 
C. difficile. The test was developed by using C. difficile phages, which could detect the 
presence of the bacteria and to date; no other research group has investigated this 
before. 
In the literature, such phage-based diagnostic tests have been developed by the 
manipulation of a stage of the phage infection cycle, be that: adsorption, phage DNA 
injection, replication, cell lysis or release of phage progeny (Schmelcher and Loessner 
2014; Smartt and Ripp 2011). Each stage can be used as a marker for bacterial 
detection as all stages are highly specific for phages and their target bacteria. In the 
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present study it was investigated whether a test based on phage adsorption or one 
based on injection of phage DNA within bacterial cells would be more suitable and 
specific for C. difficile detection.   
7.1.1   Broad host range phages were required for the development of the 
phage-based diagnostic test 
Before the phage-based test could be developed the first aim was to identify suitable 
phages that could be used for the construction of the test. These were phages that are 
able to infect several ribotypes and therefore would also allow detection of multiple 
ribotypes when used in the diagnostic and environmental test. To isolate and identify 
such broad host range phages, water samples were collected from the River Tame and 
from seven out of 13 samples C. difficile phages were successfully isolated.  
Host range analysis of the seven new phages was conducted by screening 
representative isolates from 29 different ribotypes that included dominant UK 
ribotypes (Public Health England 2014). In addition, host range analysis was carried out 
for a catalogue of 28 C. difficile phages previously isolated in Professor Martha Clokie’s 
laboratory. From the analysis it was found all 35 phages (seven newly isolated phages 
and 28 phages from the phage collection) had a range of infectivity that could be 
grouped into three categories. The first group consisted of phages that could infect 
multiple ribotypes, second group were phages that were specific to a one to three 
ribotypes and the third group were phages that could only infect one isolate from one 
ribotype. Phages that fell into the second and third group were not used for the 
development of the diagnostic test due to their narrow host ranges. Unfortunately, 
the seven newly isolated phages fell into the second category, as they were specific to 
two out of the 29 ribotypes tested. Instead, phages within the first group: T6ɸ12eH, 
T6ɸ12, T6ɸ7h, T6ɸF2 and AIUɸX2 were considered as candidates for the diagnostic 
test and they were able to infect up to 15 out of 29 ribotypes screened.  
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7.1.2   The diagnostic test could not be developed based on phage adsorption 
due to limited number of ribotypes being detected via this method 
After host range analysis, research began on the development of the phage-based 
diagnostic test. It was initially investigated whether the test could be developed by 
using phage adsorption as a marker for detection of C. difficile. Consequently, the 
adsorption efficiencies of the broad-host range phages T6ɸ12eH, T6ɸ12, T6ɸ7h, 
T6ɸF2 and AIUɸX2 were investigated against 12 representative isolates of dominant 
UK ribotypes and to the common hospital pathogens: E. coli, P. aeruginosa and MRSA 
found in similar environments to C. difficile. The phages were unable to infect all 
isolates and it was investigated whether phages could still bind by high efficiency even 
if they were unable to infect. If so, then a wide range of ribotypes could be detected 
following the development of a phage adsorption-based diagnostic test.  
Overall, though high adsorption efficiencies were not consistently observed for 
ribotypes the phages could infect and those they were unable to. Most phage and 
ribotype combinations fell into groups where the phages were able to bind by less 
than 30%, to isolates that the phages were both able to and unable to infect. Binding 
of all phages to common hospital pathogens also fell into this groups.  
However, for the development of the phage-based diagnostic test, phages that 
bound by over 30% to C. difficile were required as the binding was distinctly higher in 
comparison to common hospital bacteria. Three of the five phages: T6ɸ7h, T6ɸ12eH 
and T6ɸ12 were part of this group but high adsorption efficiencies were not 
consistently observed across all 12 ribotypes. High adsorption rates were only 
observed for the phages propagation host and another isolate from R014/020 the 
phages could infect. Consequently, if these phages were used for the development of 
the phage-based diagnostic test only a limited number of C. difficile ribotypes would 
be identified and others would be left undetected. 
Therefore, it was investigated whether adsorption rates could be increased. This is 
because the diagnostic test would be conducted in vitro and therefore, conditions can 
be controlled to favour phage adsorption to C. difficile ribotypes. Furthermore, in the 
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literature it has been reported favourable conditions can increase adsorption of 
phages to their target bacterial cells by up to six fold. Consequently the factors: 
movement via shaking of bacterial and phage suspension, MOI and length of 
adsorption period were investigated in the present study by using phage T6ɸ12eH as 
the model. Only shaking of bacterial and phage suspension lead to a significant 
increase in adsorption rates for three out of the 12 ribotypes tested. However, for 
three different ribotypes a significant drop in adsorption rates was also noted. 
Therefore, it can be concluded the effects observed with shaking were ribotype 
specific and hence it would not be worthwhile to include the shaking step for the 
development of phage adsorption-based test.  
Although extensive research had been conducted on C. difficile phage adsorption, 
it was concluded a diagnostic test based on adsorption would not be ideal for the 
detection of C. difficile. This is because there was a lack of consistency in adsorption 
rates of the five phages to the 12 ribotypes. Instead, to increase specificity of phage-
based diagnostic test to C. difficile it was decided to develop the test based on the 
injection of phage DNA step of the infection cycle.  
7.1.3   Reporter phages were developed to increase sensitivity of the phage-
based diagnostic test 
Reporter phages were developed by the incorporation of bioluminescence luxAB 
genes within the phage genome. The assay works such that the luxAB genes are only 
expressed by the phage when it infects its target bacterial cell and expression equates 
to a measurable bioluminescence signal. This crucial step of the expression of the 
luxAB genes means the assay would be highly specific and would only detect active 
C. difficile cells. This is unlike the current PCR tests being used to diagnose CDI, as PCR 
is unable to differentiate between active and dead cells. In addition, expression of the 
luxAB genes would be consistent for all ribotypes the phages could infect unlike if the 
test was developed based on phage adsorption.  
To date, no reporter phages have previously been developed for C. difficile 
detection and as a proof of concept two broad host range and sequenced phages were 
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selected to use as templates for the development of reporter phages. Phages T6ɸ12 
and T6ɸ7h both included hypothetical genes or genes not expressed during the lytic 
phage cycle within their genomes, which were targeted for replacement with the 
luxAB genes via homologous recombination. This was to avoid major disruption of the 
phage genome for both phages that could potentially affect phage infection and hence 
expression of the luxAB genes. Consequently, for phage T6ɸ12 the SF, HP1 and NTPase 
genes and for phage T6ɸF2 HP2, HP3, HP4 and HP5 genes were chosen to be knocked-
out and replaced with the reporter genes. The reason behind the selection of multiple 
genes was because it has been reported in the literature that the position of the 
reporter genes within the phage genome can affect expression of the genes and the 
corresponding bioluminescence signal. All genes selected for replacement were 
located in different regions of the phage genome to identify the optimum position for 
the luxAB genes within the phage genome.    
7.1.4   Conjugation of reporter constructs from E. coli to C. difficile phages 
required extensive optimisation and the Gram positive replicon profoundly 
affected homologous recombination  
Induced lysogens of phages T6ɸ12 and T6ɸF2 were generated and they acted as 
recipient cells during the conjugation experiment and the E. coli cells with plasmids 
that contained the reporter constructs were the donor cells. First, it was attempted to 
conduct conjugation experiments by using suggested protocols in the literature but 
due to numerous failed attempts extensive optimisation was conducted. From the 
experiments it was observed the plasmid was being transferred to the induced 
lysogens, which was confirmed via PCR but when screened for the first homologous 
recombination no positives were identified. This suggested the plasmid was free 
within the induced lysogens and optimisation of the protocol was required to force the 
first homologous recombination step to occur.  
Therefore, a number of factors that could potentially influence conjugation were 
investigated in detail: antibiotic concentrations, the antibiotic marker on the plasmid, 
mating incubation times, fidelity of polymerase, donor E. coli cells, recipient C. difficile 
cells, media and Gram-positive replicons incorporated in the shuttle plasmids. All 
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these factors played a vital role but it was observed the Gram-positive replicon 
influenced homologous recombination the most. Originally, conjugation was optimised 
with plasmid pMTL84422 that carries the pCD6 Gram-positive replicon; a replicon 
derived from C. difficile and hence is stable in C. difficile cells. However, for mutants to 
be generated successfully ‘pseudo-suicide’ plasmids with segregational unstable 
replicons are required and such replicons were incorporated in plasmids pMTL82151 
and pMTL83151. Consequently, after conjugation was repeated with these plasmids 
with the reporter constructs and the protocol followed to isolate double cross-over 
mutants, luxAB mutants were successfully isolated and confirmed via PCR. Although, 
when a PCR was conducted to screen if the gene targeted for replacement with the 
luxAB genes had been knocked-out, all samples were positive for the gene. This 
indicated a combination of both wild-type and mutant phages were present in all 
samples.   
7.1.5   The luxAB genes were unstable within the phage genomes  
The luxAB mutant phages were excised from the C. difficile induced lysogens, in which 
they were harboured in via antibiotic pressure. Plaques were then PCR screened for 
the presence of the luxAB genes and those that were positive were used for 
subsequent rounds of plaque purification. Over seven rounds of plaque purification 
was conducted but with each round instead of a clonal stock of reporter phages being 
established, fewer and fewer plaques were PCR positive for the presence of the luxAB 
genes. Surprisingly though, even after multiple rounds of plaque purification, those 
luxAB PCR positive plaques remained PCR positive for the gene that was targeted for 
replacement with the reporter genes. Therefore, a mixed population of both wild-type 
and mutants still remained.  
To resolve this issue of mixed mutant and wild type phages two factors were 
altered: growth media and the propagation host used for plaque purification. Despite 
this, both factors did not help to stabilise the luxAB genes within the phage genomes 
and as previously observed with multiple rounds of plaque purification fewer plaques 
were PCR positive for presence of the luxAB genes. This could be due to both phages 
excising the reporter genes during their infection cycle and as the phages are of mixed 
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population, the wild-type phages may have out competed the mutants. Also, retaining 
the reporter genes within the phage genomes adds no benefit to the phage or to its 
ability to infect and due to this reason the phage may excise the genes. After this issue 
has been resolved the reporter assay would be complete and can be used for the 
detection of C. difficile.   
7.1.6   Summary  
Despite not being able to successfully complete the reporter assay, the techniques 
used in the study and results obtained are all novel as to date, no other research group 
has investigated the development of a phage-based assay for the identification of 
C. difficile. Once the assay has been completed, it can be used as both a diagnostic and 
as an environmental test to validate sufficient cleaning has been conducted to 
eliminate all C. difficile from healthcare environments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 
227 
7.2   Future work 
This section contains recommendations for future work based on results obtained in 
the PhD research. 
7.2.1   Complete construction of C. difficile reporter phages  
To complete the construction of the phage-based diagnostic test based on detection 
of C. difficile by reporter phages it can be investigated further how the reporter genes 
can be stabilised within the phage genome. In addition, how a clonal phage stock can 
be produced. One of the limiting factors in the present study could have been the 
location of the insertion of the reporter genes. Only two genes of phages T6ɸ12 and 
one gene of T6ɸF2 that were targeted for replacement with the luxAB genes were 
tested. Although, identical results were observed with all three targeted genes a 
further construct targeting another gene had been created for phage T6ɸ12 and three 
more for phage T6ɸF2. The other four constructs target different genes across two 
different phages and are located in different regions of the phage genome. The 
conjugation and isolation of double crossover experiment can be conducted for these 
remaining constructs to determine if the luxAB genes would be more stable in these 
locations.   
However, if the location of the luxAB genes within the phage genome is not an 
issue then alternatively essential phage genes required for phage infection instead of 
predicted non-essential genes can be targeted for replacement with the reporter 
genes. Similar to how Kuhn et al. (2002) designed their reporter phage for detection of 
Salmonella. By using the approach of targeting essential genes the reporter genes 
were genetically locked within the phage genome and so the reporter genes may not 
be excised from the phage genome. This reporter phage itself was able to successfully 
detect Salmonella and elicit a strong bioluminescence response. However, the 
reporter phage was unable to propagate due to loss of the essential gene but this step 
is not required for the expression of the luxAB genes and hence production of the 
bioluminescence signal (Kuhn et al. 2002). This method could help to stabile and lock 
the reporter genes in place within the genomes of the C. difficile phages so the genes 
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would no longer be lost during the infection cycle. Although, it would require 
additional cloning but the present PhD study has described an optimised protocol for 
construction of C. difficile phage mutants and can be followed. 
7.2.2   Designing reporter phages with other bioluminescence markers 
It can be investigated if smaller bioluminescence markers could be incorporated within 
the phage genomes to resolve the issue of stability. Due to the smaller size of the 
marker it would avoid major disruption of the phage genome and the genes may be 
more stable than the 2.2 kb luxAB genes. An example of such a tag is the NanoLuc® 
Luciferase, which is commercially sold by the company Promega, UK. The NanoLuc® 
Luciferase is 513 bp therefore four times smaller than the luxAB genes in size and the 
gene is stable at a variety of temperatures. Also, a 100 fold brighter signal is produced 
in comparison to firefly Photinus pyralis luciferase gene when the novel substrate 
furimazine is added. NanoLuc® Luciferase can be added to the genomes of C. difficile 
phages in a similar manner to how luxAB genes were added in the present study.   
7.2.3   Further research into the development of a phage adsorption-based 
diagnostic test 
Aside from the development of reporter phages, once the C. difficile phage receptor 
has been identified development of adsorption-based diagnostic could be re-visited. 
The phage receptor itself could be overexpressed and tagged to allow production of a 
measurable signal when a C. difficile cell is encountered. Not only would this help to 
increase the specificity of adsorption-based diagnostic test, it could potentially allow 
detection of ribotypes not currently infected by the phages and hence would have a 
broader application as a diagnostic and environmental test.   
7.2.4   Exploiting phage endolysin for development of the phage-based 
diagnostic test  
A different approach for the development of phage-based diagnostic test could be 
investigated by using a component of phage infection instead of the whole phage. One 
phage component that is currently being investigated extensively is the Cell Wall 
Chapter 7 
229 
Binding Domains (CBDs) of the phage endolysin. Endolysin is the enzyme responsible 
for recognition and degradation of peptidoglycan, which is present on the bacterial cell 
wall and the enzyme is activated in the final stages of phage infection. In terms of the 
diagnostic test, the CBDs can be labelled with a fluorescence tag, for example a GFP 
tag and once the targeted bacterial wall is degraded a fluorescence signal would be 
produced. The signal can be measured using a hand held gamma camera or 
florescence microscopy.  
The main advantage of using CBDs for bacterial detection is that the host range is 
wider in comparison to the whole phage. Therefore, if an already broad host phage, 
such as the C. difficile phage T6ɸ12eH is used to design the diagnostic test, then the 
CBD from this phage is likely to have extensive applications as a C. difficile diagnostic. 
Due to this major benefit the CBDs-based diagnostic test will be investigated further in 
Professor Martha Clokie’s laboratory.  
7.2.5   Isolation of broad-host range phages to improve sensitivity of the 
phage-based diagnostic test 
To increase the sensitivity of the phage based diagnostic test, i.e. to allow detection of 
multiple ribotypes new phages can be isolated from sampling in natural environments 
similar to the present study, such as in estuaries, sewage outlets and soil. Hopefully, 
this will allow isolation of broader host range phages that would be ideal for the 
development of phage-based diagnostic tests. Alternatively, it has been noted in the 
literature that passaging phages on different bacterial host, i.e. on strains the phages 
are able to infect can help improve the infectivity of phages. This can be achieved by 
first producing a phage stock on one of the infected strains, after which the same stock 
can be used to determine its host range.  
7.2.6   Conclusion  
Overall all future work suggestions relate to the development of a C. difficile phage-
based test that can be used as a diagnostic or as an environmental test. Not only 
would the test be highly specific and sensitive in comparison to the ELISA and PCR 
tests used currently, it would also help to avoid misdiagnosis of patients. 
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Table 9.1 A list of all growth media used throughout the study. All media were made up to 500 ml using distilled water and autoclaved to 
121°C for 15 minutes, unless stated otherwise. 
Media  Composition of media Purchased from  Purpose  
Fastidious anaerobic (FA) broth  14.85 g FA BioConnections, UK Growing C. difficile 
Supplemented FA broth 14.85 g FA 
0.1% Sodium Taurocholate 
Add the following after media has cooled: 
5 ml cycloserine (250 mg/l) and cefoxitin (8 
mg/l) 
BioConnections, UK 
Fisher Scientific, UK 
 
BioConnections, UK 
Isolating new C. difficile strains  
Brain heart infusion (BHI) broth 18.5 g BHI broth Oxoid, UK Growing C. difficile 
BHI 0.4% agar (semi-solid medium) 37 g BHI broth 
4 g Bacteriological agar  
Oxoid, UK 
Oxoid, UK 
For C. difficile plaque assays and 
spot tests 
Salts (0.4 M MgCl2, 0.1 M CaCl2) 81.2 g MgCl2 
1.5 g CaCl2 
Argos Organics, UK 
Fisher Scientific, UK 
For C. difficile plaque assays and 
spot tests 
BHI 1% agar plates 18.5 g BHI broth 
5 g Bacteriological agar  
Oxoid, UK 
Oxoid, UK 
For C. difficile plaque assays and 
spot tests 
BHIS (Brain heart infusion 
supplemented) 1% agar 
18.5 g BHI broth 
7.5 g Bacteriological agar 
2.5 g Yeast extract  
Add the following after media has cooled: 
0.002% L-cysteine  
Oxoid, UK 
Oxoid, UK 
Oxoid, UK 
 
Fisher Scientific, UK 
For conjugation  
BHI 1% agar 7% defibrinated horse 
blood (DHB) plates (blood agar 
plates) 
18.5 g BHI broth 
5 g Bacteriological agar 
35 ml DHB (added once media is cooled) 
Oxoid, UK 
Oxoid, UK 
Sigma-Aldrich, UK 
Growing C. difficile 
Cycloserine-cefoxitin egg yolk 
(CCEY) agar 
28.25 g CCEY 
Addition of following after media has cooled: 
25 ml Egg yolk emulsion 
 
5 ml cycloserine (250 mg/l) and cefoxitin (8 
mg/l) 
BioConnections, UK 
 
Southern Group 
Laboratories Ltd, UK 
BioConnections, UK 
Growing C. difficile 
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Luria Broth (LB) 12.5 g LB 
Final pH at 7.2 
Fisher Scientific, UK Growing E. coli, MRSA and P. 
aeruginosa  
Luria Broth (LB) agar 12.5 g LB 
5 g Bacteriological agar 
Final pH at 7.2 
Fisher Scientific, UK 
Oxoid, UK 
Growing E. coli, MRSA and P. 
aeruginosa 
SOC media  10 g Tryptone 
2.5 g Yeast extract 
0.25 g NaCl 
0.093 g KCl 
1.476 g MgCl2 
Final pH at 7.2 
Oxoid, UK 
Oxoid, UK 
Fisher scientific, UK 
Fisher scientific, UK 
Argos Organics, UK 
For heat shock transformation  
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Table 9.2 List of solutions used throughout the present study. 
Media  Composition of media Purchased from  Purpose  
Phage buffer (SM buffer)  0.1 M NaCl 
8 mM MgSO4.7H2O 
50 ml of 1 M Tris–HCl 
Made up to 1 L with distilled H2O 
Autoclaved to 121°C for 15 minutes 
Fisher scientific, UK 
Fisher scientific, UK 
Fisher scientific, UK 
 
 
General phage suspension 
buffer  
  
0.5 M Ethylenediaminetetra acetic 
acid (EDTA) 
93.5 g EDTA 
450 ml distilled H2O (pH 8) 
Fisher scientific, UK 
 
Needed for making other 
solutions  
1 x TAE buffer  40mM Tris HCl 
1.14 mM Acetate 
1 M EDTA 
Fisher scientific, UK 
Fisher scientific, UK 
 
Used for gel electrophoresis  
5 x TBE buffer 54 g Tris Base 
27.5 g Boric acid 
20 ml 0.5 M EDTA pH8 
Up to 1 L with H2O 
Fisher scientific, UK 
Fisher scientific, UK 
Fisher scientific, UK 
 
For PFGE 
1 x TE buffer 100 mM EDTA 
100 mM Tris Cl (pH9) 
1% SDS 
Fisher scientific, UK 
Fisher scientific, UK 
Fisher scientific, UK 
For PFGE 
Lysis buffer 20 ml 1 M Tris Cl 
20 ml 10% SDS 
50 ml 500 mM EDTA 
120ml distilled H2O 
Fisher scientific, UK 
Fisher scientific, UK 
Fisher scientific, UK 
 
For PFGE 
RF1 0.48 g RbCl  
0.4 g MnCl2  
1.2 ml 1M KOAc  
0.06 g CaCl2.2H20 and  
6 ml glycerol  
Made up to 40ml with ultra-purified H20 (pH 
5.8) 
 
Sigma-Aldrich, UK 
Sigma-Aldrich, UK 
Sigma-Aldrich, UK 
Sigma-Aldrich, UK 
Fisher scientific, UK 
 
For making competent cells  
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RF2 0.02g RbCl 
0.4ml 0.5M MOPS  
0.22g CaCl2.2H20  
3ml glycerol 
Made up to 20ml with ultra-purified H20 (pH 
6.8)  
Sigma-Aldrich, UK 
Sigma-Aldrich, UK 
Sigma-Aldrich, UK 
Fisher scientific, UK 
 
For making competent cells 
Buffer A 8 mM MgSO4.7H2O 
50 ml of 1 M Tris–HCl 
Made up to 1 L with distilled H2O 
Sterilised filtered  
Fisher scientific, UK 
Fisher scientific, UK 
 
Millipore, UK 
Buffer for chromatography-
based phage purification 
Buffer B 2 M NaCl 
8 mM MgSO4.7H2O 
50 ml of 1 M Tris–HCl  
Made up to 1 L with distilled H2O 
Sterilised filtered  
Fisher scientific, UK 
Fisher scientific, UK 
Fisher scientific, UK 
 
Millipore, UK 
Buffer for chromatography-
based phage purification 
Buffer C 0.125 M NaCl,  
1 mM EDTA,  
10 mM Tris 
15% propan-2-ol 
Made up to 1 L with distilled H2O 
0.5 M hydrochloric acid was added to reduce 
the pH to 7.2 
Sterilised filtered 
Fisher scientific, UK 
Fisher scientific, UK 
Fisher scientific, UK 
Fisher scientific, UK 
 
 
 
Millipore, UK 
Buffer for chromatography-
based phage purification 
Buffer D 2 M NaCl,  
1 mM EDTA,  
10 mM Tris 
15% propan-2-ol 
Made up to 1 L with distilled H2O 
Sterilised filtered 
Fisher scientific, UK 
Fisher scientific, UK 
Fisher scientific, UK 
Fisher scientific, UK 
 
Millipore, UK 
Buffer for chromatography-
based phage purification 
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Table 9.3 Host range analysis of 25 C. difficile phages against environmental (in red) and clinical (in 
black) ribotyped isolates of C. difficile. Clinical isolates include MLVA typed R027 (in blue). White 
indicates no clearing, light grey shows turbid clearing and black displays complete clearing. 
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Table 9.3 continued.
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Table 9.3 continued.  
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Table 9.3 continued.  
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Table 9. 4 Host range analysis of 7 newly isolated C. difficile phages against environmental (in red) and clinical 
(in black) ribotyped isolates of C. difficile. Clinical isolates include MLVA typed R027 (in blue). White indicates 
no clearing, light grey shows turbid clearing and black displays complete clearing. 
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Table 9.4 continued. 
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Table 9.5 List of primers used in this study. 
Primer 
name 
Forward and reverse PCR primer sequences from 
5’ to 3’ (restriction site shown in red) 
Restriction 
site  
Template  Description PCR product 
size (base pairs) 
luxab genes cloning primers 
P1 TTCTGCATATGAAATTTGGAAACTTTTTGCTTAC NdeI Vector pUC18-mini-
Tn7T-Gm-lux (Choi 
& Schweizer 2006) 
Amplifying luxAB gene from vector pUC18-
mini-Tn7T-Gm-lux  to clone inside pMTL84422 
2093 
P2 CCAATTGCTAGCTTAGGTATATTCCATGTGG NheI 
P3 ACAGTCTAGATTTTTAACAAAATATAT XbaI pMTL84422lux Amplification of promoter, the luxAB gene and 
terminator sequence from pMTL84422-luxAB 
2298 
P4 AGCAGTGATCATATAAAAATAAGAAGCC SpeI 
P5 GGAGCATCATTTCACGGAGT - Transformation 
colonies/plaques    
To screen for presence of the luxAB gene 707 
P6 GCCACTGCCCTTTATTGAAA - 
P7 CGCCAACTTGAAGATGTGAA - Transformation 
colonies/plaques    
To screen for presence of the luxAB gene 175 
P8 ATCCCTCTGTCATGCCATTC - 
P9 CAACCTCCCCAATTTTCTCA - Transformation 
colonies/plaques    
To screen for presence of the luxAB gene 214 
P10 GGGCTGTGGGAAGAACAATA - 
P11 TGCTTGGTAACCCTTATGTCG - Transformation 
colonies/plaques    
To screen for presence of the luxAB gene 352 
P12 GTGCGCCACCTCTGCTATAC - 
Primers for construction of T6ɸ12 reporter phage 
Cloning primers designed for replacement of the scaffold protein with the luxAB genes 
P13 TGGGGCGGCCGCATTTGATAATGACTG NotI Phage T6ɸ12 5’ flanking phage sequence for homologous 
recombination 
1311 
P14 TGATAGATCTCTTTTAAATATCTCC XbaI 
P15 GGACAACAACAGCTCCTTGG - Transformation 
colonies 
Screening primers for 5’ flanking phage 
sequence 
198 
P16 AGTTCTGCTTCTTCTTCTCTTCT - 
P17 GATGACTAGTGAGGAAATAAAATGG SpeI Phage T6ɸ12 3’ flanking phage sequence for homologous 
recombination 
1290 
P18 GGCTCCTAGGTTTATATTACAATCT BamHI 
P19 GGATGGAAAGTAGGAGCAGGA - Transformation 
colonies 
Screening primers for 3’ flanking phage 
sequence 
214 
P20 CTCCAGCTCCTTCAACAACA - 
Cloning primers designed for replacement of hypothetical protein 1 with the luxAB genes 
P21 TGGGGCGGCCGCTAGTCATAGTTCTAC NotI Phage T6ɸ12 5’ flanking phage sequence for homologous 
recombination 
1281 
P22 TGAGAGATCTACGCCTTCCCCCTAC XbaI 
P23 CCATCAACAGTCCAAGAATCAGA - Transformation 
colonies 
Screening primers for 5’ flanking phage 
sequence 
239 
P24 GACGAGAGGGAAGAACTTAGAGA - 
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P25 GTTGACTAGTTTTTCTTCTCTTTCT SpeI Phage T6ɸ12 3’ flanking phage sequence for homologous 
recombination 
1305 
P26 GGCTCCTAGGTATATGTTCAAAACC BamHI 
P27 GAGAATGGCGAAAGAGTACCG - Transformation 
colonies 
Screening primers for 3’ flanking phage 
sequence 
383 
P28 TTGCTCCTCTTTCAGTCCAAA - 
Hypothetical protein 1 homologous recombination screening primers 
P29 TTTTTGAAGGATATTGACCTTTGA - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 5’ end 
1320 
P30 TCCATATATCCCTCTGTCATGC - 
P31 TTTTTGAAGGATATTGACCTTTGA - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 5’ end 
1843 
P32 CCTGTAGCATCAATGTCTTTTTG - 
P33 AAGCTCAATAAATGAATCTAAAGGAA - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 3’ end 
829 
P34 TCCATATATCCCTCTGTCATGC - 
P35 AAGCTCAATAAATGAATCTAAAGGAA - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 3’ end 
1352 
P36 CCTGTAGCATCAATGTCTTTTTG - 
P37 GTGGAAAAATCAAAA - Transformant 
colonies/phage 
Primers to screen for the presence of the 
hypothetical protein 1 
115 
P38 CTATTCTCTTTCTTT - 
Cloning primers designed for replacement of the NTPase gene with the luxAB genes 
P39 TGATGCGGCCGCGAGGGGATTAATATGGAAGC NotI Phage T6ɸ12 5’ flanking phage sequence for homologous 
recombination 
1028 
P40 CTCAGAGATCTATGTGTTTCAAATAGTGCATCA XbaI 
P41 GCAGAAATGTATGTGCAGGC - Transformation 
colonies    
Screening primers for 5’ flanking phage 
sequence 
282 
P42 ACGCTTTGAAACTGTTAATGGT - 
P43 TTCTGACTAGTAGTGGTTTAAATCTAGAAGAATTCCAT SpeI Phage T6ɸ12 3’ flanking phage sequence for homologous 
recombination 
995 
P44 CTGATTCCTAGGTTTTTCTTCTTCCATTTCTTTTTC BamHI 
P45 GAGTCTAATCTGGTCTGTCATGT - Transformation 
colonies    
Screening primers for 3’ flanking phage 
sequence 
184 
P46 TGGATTCTGTAGCTGAAAGTTCT - 
NTPase gene homologous recombination screening primers 
P47 AAGCTCAATAAATGAATCTAAAGGAA - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 5’ end 
829 
P48 TCCATATATCCCTCTGTCATGC - 
P49 TTTTTGAAGGATATTGACCTTTGA - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 5’ end 
1843 
P50 CCTGTAGCATCAATGTCTTTTTG - 
P51 CCTCTCATCTTTAAGTGGGATGAT - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 3’ end 
545 
P52 TCCAGCTTTCCCAAGTAATCTT - 
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P53 CGGCTAAGTTGGCAATTGAA - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 3’ end 
822 
P54 TGAAAACCTTGTGGGTCCAG - 
P55 ACCATTAACAGTTTCAAAGCGT - Transformant 
colonies/phage 
Primers to screen for the presence of the 
NTPAse gene 
150 
P56 ATAGTCGATTTTCCCATACCCG - 
Primers for construction of T6ɸF2 reporter phage 
Cloning primers designed for replacement of the hypothetical protein 2 with the luxAB genes 
P57 GACT GCGGCCGC TTAGATGGAACTTTT NotI Phage T6ɸF2 5’ flanking phage sequence for homologous 
recombination 
1164 
P58 GAAT AGATCT CTATTGTTGAGGTAAT XbaI 
P59 ACGCCAAGCACAATAACACA - Transformation 
colonies 
Screening primers for 5’ flanking phage 
sequence 
231 
P60 CCCTGCCTCAAAAGCTTCTG - 
P61 GATTACTAGTATGACACCAGCTAGAGA SpeI Phage T6ɸF2 3’ flanking phage sequence for homologous 
recombination 
1164 
P62 GCCGCCTAGGTTAATCACTCCAATAC BamHI 
P63 GCACGTTGGACAGATAGAACA - Transformation 
colonies 
Screening primers for 3’ flanking phage 
sequence 
231 
P64 AGGCGTTGCTTTTGTACCAG - 
Cloning primers designed for replacement of the hypothetical protein 3 with the luxAB genes 
P65 AGGGGCGGCCGCATGACAGAAAAATTA NotI Phage T6ɸF2 5’ flanking phage sequence for homologous 
recombination 
1035 
P66 TGATAGATCTCCTACGCTGTTGGTTC XbaI 
P67 GCGTCTAAAATGCGTGCTGA - Transformation 
colonies 
Screening primers for 5’ flanking phage 
sequence 
218 
P68 CGAGCTGCATATGAACCATCT - 
P69 GATGACTAGTATGATTTATTTAGGA SpeI Phage T6ɸF2 3’ flanking phage sequence for homologous 
recombination 
1035 
P70 GGCTCCTAGGTTCGGGGCATATTAT BamHI 
P71 CGGGGCATGTACTTCTGCTA - Transformation 
colonies 
Screening primers for 3’ flanking phage 
sequence 
152 
P72 AGGCTCCTACACCACTTGAA - 
Cloning primers designed for replacement of the hypothetical protein 4 with the luxAB genes 
P73 TCAGGCGGCCGCAATGAGGGAGTTAAA NotI Phage T6ɸF2 5’ flanking phage sequence for homologous 
recombination 
1164 
P74 GGCAAGATCTATCTAAATAGCATTAAA XbaI 
P75 GGTGGTGGAGCATGTGAAAA - Transformation 
colonies 
Screening primers for 5’ flanking phage 
sequence 
229 
P76 CCAATCCACCTAAATCTTCGCT - 
P77 GATTACTAGTATGGATTTCAAAATC SpeI Phage T6ɸF2 3’ flanking phage sequence for homologous 
recombination 
1089 
P78 GCCGCCTAGGTAACTTATTCTTCTAAATT BamHI 
P79 ATTGCTCATGAACTTGGACATTT - Transformation Screening primers for 3’ flanking phage 155 
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P80 TTAGGCATCAACAAGGCTGC - colonies sequence 
Cloning primers designed for replacement of the hypothetical protein 5 with the luxAB genes 
P81 GACTGCGGCCGCATGAAAAGTTTAACT NotI Phage T6ɸF2 5’ flanking phage sequence for homologous 
recombination 
1497 
P82 CTTGAGATCTTTAATCAACATTTAT XbaI 
P83 GGAAATGGAAATGTAACAGACCA - Transformation 
colonies 
Screening primers for 5’ flanking phage 
sequence 
248 
P84 AGCTTTAAACTGCCCTCCCT - 
P85 GATGACTAGTATGGGGAGAATATAC SpeI Phage T6ɸF2 3’ flanking phage sequence for homologous 
recombination 
1146 
P86 GGCT CCTAGG TTATTCAACTGGCAT BamHI 
P87 AGGCAGAAGGAACAGCTACA - Transformation 
colonies 
Screening primers for 3’ flanking phage 
sequence 
200 
P88 TGATTCACCTTCAAACACTGC - 
Homologous recombination screening primers for hypothetical protein 5 
P89 AGAACTAAAATTTGAGGAAGTAGATGA - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 5’ end 
839 
P90 GTGCGCCACCTCTGCTATAC - 
P91 CCTCTCATCTTTAAGTGGGATGAT - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 5’ end 
545 
P92 CCTCTCATCTTTAAGTGGGATGAT - 
P93 TTTGTAAAAAGAGCAAATAAAAATCC - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 3’ end 
1864 
P94 CAGACTGGAAGAGCTTCATGG - 
P95 CCTCTCATCTTTAAGTGGGATGAT - Transformant 
colonies/phage 
Primers to screen if homologous 
recombination has occurred at 3’ end 
822 
P96 TGAAAACCTTGTGGGTCCAG - 
P97 GGTAGTGGTAGGATGGCAAGA - Transformant 
colonies/phage 
Primers to screen for the presence of the 
hypothetical protein 5 
189 
P98 ACTCCATGTACCACCTTGCT - 
General primers 
M13F TGTAAAACGACGGCCAGT - Transformation 
colonies 
Primer sites on vectors pMTL84422 and 
pBlueScript SK+ 
Dependent on 
template  M13R CAGGAAACAGCTATGACC - 
FCD16s TTGAGCGATTTACTTCGGTAAAGA - Bacterial colonies C. difficile 16s primers (Rinttilä et al 2004) 157 
RCD16s CCATCCTGTACTGGCTCACCT - 
8F AGAGTTTGATCCTGGCTCAG - Bacterial colonies Universal 16s primers (Turner et al. 1999) 1200 
1391R  GACGGGCGGTGTGTRCA - 
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Table 9.6 DNA sequences of flanking regions for the Scaffold protein of phage T6ɸ12 that was targeted for replacement with luxAB genes.  
 Sequence  
Flanking 
region 1 
atttgataatgactgaatcagctttctttgcatcagcaagtagaaaagattgttttagtgatttagatgtagagaaatatgagattattgctacattagatttaagaacttcaaatatatgcagagagttagatggaaaaatatttga
tatgaaagattatcaagttggaataacagctccaccatttcattgtcgttgtaggacaacaacagctccttggttcgaggatgaagaaggctatagagcagcaagaggagaagatggaaaaacatattatgtaccatctagtatg
aagtataatgagtggtatgagaagtatgttaaaaataatagtaaacaaactggtgcaaaatatactaaaggtgatatcgagtggaatataagaagagaagaagaagcagaactatattacgataatattagaaatagaaaag
atgatatttccaaaatatcaaagaatacaaattggtcagaaaaaagtataggtcaaattaaaaatcatattttctacaatactcatataatgagagatggaactagacgtatgttggattctgactatagtatgtcagttgcttggc
aaagacttataaatggtacatacgaagatattgatattctcttattaaaacatgaataccttgaaagtatatttgagaaaaagtataatataagtaacttagaagcccatagaatgactgagaaaaagcatgattggtataaaga
attaattaaacagaaaggagagtttgaagaagatgattgtcttaatgaacttattagaaaagaataatgaatatgttatatatagttatggatatgaagaaaataagcttgatggaagaataaaaatatatttagatgatttttat
aattatgaaataataaaagagtcaaaagatgaacatataagtaaatcagcaacgttaaaagctatttctaaacttataaaagctgctaaaaataacgatttgaaaaaagaaatgagttatcaatgttagaagcacttactgaac
aataaattagtaggtgcttttattatgtaaaagtttaaaaaagtaggtgattttaatgtatatattaactcaagttatagctgtagtttgtgtagtacaaatctttattaattgtattgctaatgtcaatgtaggtattctttgcaataaat
taaaagaaaaaaatgaagctaatatagataaagtttctgatgaaattctaaagagagtaggagaagaattaaataaatcactagacaaaagtctttaaagactttttttattgtgtaaaaaatgaaaggagatatttaaaag 
Flanking 
region 2 
gaggaaataaaatggcagcactaaattatgcaaaagaatattcaaatgttttagcacaagcatatccttatactttaaacttcggggatttgtatgcaacaccaaataatggaagatatagatggactggttctaaaacaataga
aataccaactatatctacaactggaagagtagattcaaacagagatacaatagcagtagctcaaagaaactatgataatgcttgggaacctaaggtattaactaatcaaaggaaatggtctacattggttcatccagcagatata
aaccaaactaattatgtggcttcaataggcaatataacaaaagtatataatgaggaacaaaagtttccagagatggatgcttactgtatatctaaaatatatgctgattggaccgcattaggtaacacagcagatacaactgttct
tacaacagcaaacgtattagaagtatttgataagttaatggaaaaaatgacagaagctagagtacctgaaaatggaagaatattgtatgttactccagtagtaaatacacttatcaaaaatgcaaaagagatacaaagaacag
taaatataaaggatgcaggaacttctcttaatcgtcaaacaactgatattgacacagttaaaataattaaagtaccatctaatctaatgaaaactgcatatgattttacaactggatggaaagtaggagcaggagctaaacaaat
ctttatgtccttagttcacccaagtgcaataattacacctgtttcttatcagttctctaagttagacgaaccaacagcagttacagagggaaaatacttctactttgaagaaagttttgaggatgtatttatattaaataaaaaagctg
atgcaatacaatttgttgttgaaggagctggagcataatggcacaagtaaggaaattaaatagaatattaactatagaagaatgtaaaatagatgatttcttagagatgggatatgatttgatagatgaaactggtaaggcagta
aagtatggcaagtcattaaatgtaaaagatttaatagctgaaaataatattttaaggtcaaaagttgagtctttagaagaagaaaataagcagcttaaagagaaaaataagcttactaaaaagtaggtgaaaattatggaaaat
aatctgattggtgaaatagaaaaaagacttgaaagtcttggatatatattaaaagatggagataagtggttaataggttttgtaagagaaaaaatagaaaatattattaaactagattgtaatataaa 
Gene 
targeted for 
replacement 
atggattggttaaaagaattgctagaaggaataaaaatagaaaataacaaaattgatgtagtttctcttcaaaaatctatagaaaagaaaataaaagagactacaattactcaagaagattatacaaatcttgaaacacagctt
aatacagctaatgaaactattaaaaagtttgaaggaggtatgacaaaagaagatgtagagaatctaaaaacaacttatgaaactgataagaaaactttggaagaaacttacaaaaaagaaattgaagaaaaagattttaatt
actggttaggtgatgcttttaaatctgttaaatgtagagatgaaatagcattaaaagctcatttagatatagaagcactaagaaatagtaaagacagacaaaaagcttttgaagagcaaataaatcctttgaaacaggataaag
attatttgtttaatgcaacactagaaggtgaagaacctaaaatagatactataacaccagggcaagagcctaagataaatgattttggttttaattttactggggtaagacctcatgaaaataataataaatag 
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Table 9.7 DNA sequences of flanking regions for the hypothetical protein 1 of phage T6ɸ12 that was targeted for replacement with luxAB genes.  
 Sequence  
Flanking 
region 1 
tagtcatagttctacctttttgaatacttccatcaacagtccaagaatcagaatattttacacctgttttatttcttattaatagtttttgtctttctcttatttcttttaatttttccatatactcatcggaattttcaaaatcatattttggatt
atataatccaaatgattgaagtagaacctcatcttcagtctgtattaattcctcagatagcctttttaactcttcttttttattttttaaagttgtatttatatctctaagttcttccctctcgtcttttaattcttctaaatgagcgtttaaagt
attaatattatccttaagtatatttttatcctttataagattatcaagtctttctttttctatttttagttcttcgataagtttaaatttatcttggttttctgaatcaaatttatcaatttcaactttctttttgtctaatagattggataattctt
ttaacttattttcatttgattcacataaatcttcaaagtgtttttctttcattttaatttcatcatttaatgaaatatatttattattgattttttcgatatcagataatagtatactaatgctatctttatgttttttcattatcttatttcttttaa
ataagaatattattgcaactataatgatatagagtatgttgaaaatgtagaaagaattagtatggatatagtccataaagaataataccagggtatcttgaaattaagatttttgatttttcatcgttgatgagtaaatcactttttaa
ctgttcattttcattgttcatatcaaaactccttttttattttttgttctacttcatgataataacaatttaagtatataaaattttctacaaaaatgctatgtatttaggaaaaatatgtaattaaatagcattaaaaagtaaatactata
tttatatggtataaaaagtaaaacgaagattttaaaattaaataataaaaaaaattataaaaacaagaaaatacaaaaaattataattaaaaagacgattaataatacacaggaatggaaaaaataaccaagactctacaaa
attcgatttttttgttacaattcccctttttttattgcatatatttaacaaaagtattattatgtaagtaagataattatccaagaaaattttgaataatctaaaaatatttttagaaatgaaaatacatagttatattttattaaaattcat
tagggaattttgactaaaaataagaacgtaagttctgatagtagggggaaggcgt 
Flanking 
region 2 
ttttcttctctttcttattttttctcattaagttcttcttcaagaaatacttttgctattttgaacattttttcttgactagaaggacttaattcgctaattagttttaaagcttcttttatatcatcagagaaatttagattttcaattagctcta
actcactaagattgtctatattttttacattgacctttccaagcaaataatctgtagatacattaaaaaaatctgataattttaaaattatgtcatgtggaggaaatctttcttccttctcataaaaagaaatcattttaggagtaagac
ctaaaaaagttgcaagttctttttgagtaatatctttttcttttcttaattcctttattctatatccaatcatgttatttagccacctttttaatttatattgaactattagttcttaattatcaattatagctcattttttttaaaaaagctattg
acaatgtactaatagtactgtactattagtacataagataaagtaaaagaaggtgaaaaaatgaataaactaaaagattttagaatacaaaaaggactaagtagaaatcagttaggagctgaattaggtcttacaagtaggtat
atagctttcttagagaatggcgaaagagtaccgtctctaaatacagctgtaaaaatagcagcttatttcaatacttcaatagagtatatttttttgaaaaacaactgtactaaaagtacatttaaagaaaaaggagctgaaaaata
tgaataacttacaagtaatagaaagaaataacgaaagagttttaactacacagcaactagcagatgtatatgaaacagatgcaagaaatataagcaacaattttaacaataacaaagatagatttattgaaggtaaacattatt
ttttattgcaaggtgatgatttaaaaaattttaaaggtattcatacagaatatgaaaacctaaaatttacttcaaaaatgtatctttggactgaaagaggagcaaatagacactgcaaaatattggatactgacaaagcttgggag
cagtttgataacttagaagaaacatatttcaaagttaagcaacataagccaacttgtatagaagatgtattaatagaaagtttaaaagaaatgaaagatttaagacttcaagttaatcaagcaaatagcattgctttagaagcaa
agacagaggttgaaacaataaaagatgtagtttcattagactcaaatagttggagaacaaatacacatcaactaattgcaagaatagcaaaaaaacaaggtggttttgaacatata 
Gene 
targeted for 
replacement 
gtggaaaaatcaaaaaaactactaattgacacaggggatacattgaacaaattaagagaaaataatagtgagaagttagaaaagtacatagaattattaaaagaatattataaacaagaaaataaaaaagaaagagaatag 
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Table 9.8 DNA sequences of flanking regions for the NTPase gene of phage T6ɸ12 that was targeted for replacement with luxAB genes.  
 Sequence  
Flanking 
region 1 
gcggccgcgaggggattaatatggaagcagaaatgtatgtgcaggcagctatgatggcaagaaaagttgtaaaagtaactggtgcagataaaatgatagaagatttagttaaaaaatttttaagtaataaagtagaagaagca
cttggaaaacaaaggagtaaaaaagaattaaaattaatagaaaataaatttaatgaatatatggaaagaagttataaaaattatatatacatgaatactatagtatttagaaatcaacaaaaaacaattgatgatttatatatac
cattaacagtttcaaagcgtaatgtttttgatgcttcttgcgaagaagatgtaaatgatattttaattaatagttataaagatgactttttaccaaattacaaaaaggttttgctgatagaccaagcgggtatgggaaaatcgactat
agctaaatatttatatttaagctcaataaatgaatctaaaggaatacctatattaatagaattaagaagattatcacaagaaaaagatataatagattttataatgaatgaaattaatggaataagtgaacacttcgataaagaa
ggagttttaaaattaattgaaagaggtgattttatatttttctttgatggttatgatgaaataaaaaaagaatataaaacgcaagttactgaaaaactccaaaattttgttgacaaagctggaaataataattttttaatgacatcaa
gagaagaggatgaacttctatcttttggtaattttcaaagtttttatatatatccactaaaaaaagaagaggcatataatttaattaaaaagtatagtgatgataaggaggaaatttcaaagttattaattaagaaaattgaagaa
gataaaaattttgaaataattaaagagtttttagaaaatcctttaatggtttctttgttatgtgaatctttcaaatacaaacaatcaattcctcataaaaaagatgctttttatagacaagtttatgatgcactatttgaaacacat 
Flanking 
region 2 
agtggtttaaatctagaagaattccataaaatattaagaacaattggatttataacattaactaaaggtgttagttattctaaagaagagcttattaatatagtgcataactcaaaaataaaaaatagaggaattgaatttaatga
aaatgatttagtttatgatttaattcataatgttcctatttttattaaagatggcattgaatatagatggtctcacaagtcttttcaagagtattttgcagcaagctatgtttgttatgattcagatgaaaaaactacattattaaggaaa
atgtttgaaggtaacaaaatgaataggtattataatgtgctagatttttgttatgatatagattataaaagttttatgcgaagtataatacttccaacaatagaagatttagaaaaattcttttgcaaggaatatgatgatgatgtata
taagaactttgatgaagatgaattattattaagaaaaactatgttatttaaccataaaaaagtgtatatgtatatattaagtgaaagcgaaaaaaattattttagcaataatggagtatcaagattagaaagaaacaaatatatta
aagataaatttcctatagaaaaagagggtatttccaatggattaattgttgatggactatttgcagtacatggttttaaaaaagagaatataatgaatttattgaagttattgaaaagaaaggagtctaatctggtctgtcatgtaat
acatagtttttttccgaatagcagactaatagatacttttaattgtggactacatacttttgaagataatgttgataatgaactaaataaaaaagaaaattttaaacttgcaaatgacattttaggtaaatatttagaactttcagcta
cagaatccagaaatgtggtttttaattataatgaatgtattagtataaaaagagagatagaaaaagaaatggaagaagaaaaaggcgcgcctgaggatcc 
Gene 
targeted for 
replacement 
aggatattgacctttgaagttgaattttatactttggaggggattaatatggaagcagaaatgtatgtgcaggcagctatgatggcaagaaaagttgtaaaagtaactggtgcagataaaatgatagaagatttagttaaaaaat
ttttaagtaataaagtagaagaagcacttggaaaacaaaggagtaaaaaagaattaaaattaatagaaaataaatttaatgaatatatggaaagaagttataaaaattatatatacatgaatactatagtatttagaaatcaac
aaaaaacaattgatgatttatatataccattaacagtttcaaagcgtaatgtttttgatgcttcttgcgaagaagatgtaaatgatattttaattaatagttataaagatgactttttaccaaattacaaaaaggttttgctgatagac
caagcgggtatgggaaaatcgactatagctaaatatttatatttaagctcaataaatgaatctaaaggaatacctatattaatagaattaagaagattatcacaagaaaaagatataatagattttataatgaatgaaattaatg
gaataagtgaacacttcgataaagaaggagttttaaaattaattgaaagaggtgattttatatttttctttgatggttatgatgaaataaaaaaagaatataaaacgcaagttactgaaaaactccaaaattttgttgacaaagct
ggaaataataattttttaatgacatcaagagaagaggatgaacttctatcttttggtaattttcaaagtttttatatatatccactaaaaaaagaagaggcatataatttaattaaaaagtatagtgatgataaggaggaaatttca
aagttattaattaagaaaattgaagaagataaaaattttgaaataattaaagagtttttagaaaatcctttaatggtttctttgttatgtgaatctttcaaatacaaacaatcaattcctcataaaaaagatgctttttatagacaagt
ttatgatgcactatttgaaacacatgattactcaaaaagagctggatactatagagaaaagaaaagtggtttaaatctagaagaattccataaaatattaagaacaattggatttataacattaactaaaggtgttagttattcta
aagaagagcttattaatatagtgcataactcaaaaataaaaaatagaggaattgaatttaatgaaaatgatttagtttatgatttaattcataatgttcctatttttattaaagatggcattgaatatagatggtctcacaagtctttt
caagagtattttgcagcaagctatgtttgttatgattcagatgaaaaaactacattattaaggaaaatgtttgaaggtaacaaaatgaataggtattataatgtgctagatttttgttatgatatagattataaaagttttatgcgaa
gtataatacttccaacaatagaagatttagaaaaattcttttgcaaggaatatgatgatgatgtatataagaactttgatgaagatgaattattattaagaaaaactatgttatttaaccataaaaaagtgtatatgtatatattaag
tgaaagcgaaaaaaattattttagcaataatggagtatcaagattagaaagaaacaaatatattaaagataaatttcctatagaaaaagagggtatttccaatggattaattgttgatggactatttgcagtacatggttttaaaa
aagagaatataatgaatttattgaagttattgaaaagaaaggagtctaatctggtctgtcatgtaatacatagtttttttccgaatagcagactaatagatacttttaattgtggactacatacttttgaagataatgttgataatgaa
ctaaataaaaaagaaaattttaaacttgcaaatgacattttaggtaaatatttagaactttcagctacagaatccagaaatgtggtttttaattataatgaatgtattagtataaaaagagagatagaaaaagaaatggaagaag
aaaaaagtgatatagattttctataa 
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Table 9.9 DNA sequences of flanking regions for the hypothetical protein 2 of phage T6ɸF2 that was targeted for replacement with luxAB genes.  
 Sequence  
Flanking 
region 1 
ttagatggaacttttgaagctttaagaatagatttaagagaagctttaaaagctaagttttctattaatgataataattcatatctctatatacaaaacataagatatgataacaatactgtcatatatgagttggagcaaaatggat
tatgcaagctttatagtataccatttactatagttgaaaataaaataaatctaggtgaagaaattgaagtaataaagaaaataagctatgaagctaaaggagaaatgaaaggagaggaaaacaaattggaaggaaaagagtt
aataaaaaatgtcaaaggattactgcaaactggtgaaatatcatattcagaggtcatacaaggaataggcttaactaaggaaattgtgacaggagagatggaagatgtaaaaagttcattaaaagcagaaaaagaattaaga
gaagtgaaaaaagtacttggaatagtaggagagatggacacagttgaagtggcaaaaaaggcttcaaaagctttagaaaatgagaaaaaggaagcttggaactgtatagttaataaagtaattaaagataaagtgtcaggtg
aaatagctcaaacattagttaagaaaatgttaaatgttgaggaaggctcaagtgaagaagtaataacaggagaaatagaaaatatattaaatgatgagtttgtaaaaaatacaatgtctaatatgtataaagataatccaacaa
caacaggattattaaactctagcaataatggaagtttaacaactaagaaaaatagaatataaatggcatttaaaggtcaaccaacgccaagcacaataacacagataacaagagcaaaaataagtgatgggaaatctgtaag
agttattctttcagaaggtgaaagcactaaaacacaacaattttatcttataaatggattctttggagtcgctatgcaagacggagaaaaaggcgatgaagttactttgcaaatagagcaagctgaatacgaaacggataatatt
gttacatcagaagcttttgaggcagggaaattgatttattgggataatacagctaagaaatttactactacatctgcaagtaataggctagttggtagagtaacagatgggaaagacagtaataatgtaatttggtttatattatta
cctcaacaatag 
Flanking 
region 2 
atgacaccagctagagatttaatagaaaaattaagactattattaaatgataaagataaaaaatcatttacagatgaagaattaaacttgtttttagaggaagcagactgtatttactgtgcagcttctcaaggatggatattaaa
atctttacaatatgaaaatacagtaggggaaatgtatgagtataaagtgggtcaagaaacatataaaagctctagtataaaagacctagtatctgtagcttatcaaaatgcagataaatttaaggatatgtgtactaacaaaaaa
gaaaagggaagttttatgttaggaattagcacagaatttgaaatatgaatgataaatattgatagaagaagaaaagatataataagaactattaatataaaccccactaatattactataactagtattaaaaaaaccgaaata
gatggagcttttgaagaaactgaaacagaaataaaatgtgttgttagaatatttaacgaaaagacagcagagaagcaaatatcaagtgaaaagcaaggtacatttagttctattagaacatatggaatgttagtaagtaatgat
gttatcttagaggttaacagtagagattctttagagtttgagtgcatatatgggagaatgaaaatagttaatatatatcctcaaattgtaaaaggagaactttgtggatatcaatgttcacttgaaaggattgattaagtggatatca
atgttcacttgaaaggattgattaaaatgagtgctttcacaaatgcaataaatgatataaatagaaaaaaagcaggtatgcttgtactttgtatgagtgcaagtgcaatgctagaaggtgaagctaaagcaaatgcacgttggac
agatagaacatcacatgcaagacaaagtttaaatgctaaaacacttagtggaggaaataattttatcattagattatctcatggtgcagaatatggagggatacttgaagaaggctcaaaaccacatgttattactccaaaatca
gctcaagccctatactggagaggtgcttcacatcctgtaaaatcagttcaacatcctggtacaaaagcaacgcctattataaaaccaactattgataaaaatataggtaaaataggtaatatgatttttaggtattggagtgattaa 
Gene 
targeted for 
replacement 
ggcatttaaagtaattagtcaggaaaatttgctggaacaaaaaagaaaagaaactttacaagaagatataccatttatagtaaatggtgaaatggaatatgtaacaaagaaaatatcaaatggagaaatggaaaccttggagt
taaataagccacttggtgaaatgatgacttttagctcgacttcaaatttaaaagagttattaagaaaagttgtattagatgttgaactaggcagagagcaagtacaactattatataaaccaatctatgacagtatagcagattcta
atttaccacaagttatggatgctaagtgggctttacaaggtaactgtgtattcctagagcatatagaaggtgaagaaattaaattcggtacaataaatgcagaaaatggtccagttgcaaggatacaaacttatgcaactggtttt
gagtatacaaaagaaatgaaggattttaaccaaacatttagtgttgaaatattaaataaatcaattggtgagagttacaatgccttgttaaaccacatacatctaagcccaataataaattttaattataaagcttctaataagaca
gcttttaaaggtgaaactaatgacccaatatggctaggaatttggagaacattaacacaagcacaaaaagatacagttatagcaaaaagacaaggtaatatattaatggcttctagtgctgaccaaattgaaatagaaatggcg
ttaaatggaggacatttattaaacggaagcatgtatccatctataaaaaatatatcaacagtaatttattatgatgggtgggaggttactgttggtaaaaaaacatattcttacaaaggtgttacaccaggcaaaggatatttgata
agacctaagcgaggatttaaagagttaataaagagagatttaacaacagaggttggaaatgctgatttaagtaagttagtagaaaatcaaattgtaggtcattgttatagaggtgcttttgcagcagtagaagaaaatgtacaag
aaataagttttagataaaacactcataagagtgttat 
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Table 9.10 DNA sequences of flanking regions for the hypothetical protein 3 of phage T6ɸF2 that was targeted for replacement with luxAB genes.  
 Sequence  
Flanking 
region 1 
atgacagaaaaattaactgaaaatgctagtttaggggaacttatggcagcattagaaaatgtacaaactgattttcaaactggtaaaaataatatatctagtgcattgggtagtccttttattggaacagataaatttggtacaact
aaaacaaaaatagaaacattaaaaaatgtattagtggagacgattaattctaaaaatgtttcagcaacatcatctgaaacatttactaatttgattgaaaaagttaactggatttttcaatcaatagaaattttttctttaaaaaata
gaattcaagctacaactttaaacactcctagcatcgtttacaatgaagtatctagtataaaaggcacattaagattcacaggcgaacttaaagcgtctaaaatgcgtgctgattatgcaacagcaaaaatagagatactatgtgg
aaaccgaaaagaatacttttatgttactgacgatactcctagtgcatcttcttcttttgtaagatttacaaaagatattattgttgagaatggcatggatataaaagtacaaatattattaacatctgtaggagcaggaaatttagat
ggttcatatgcagctcgtgcagaaatagaaaaattaacaatattaaggtagatgaaaaaacaagtatattataattctttagatgaaaaagaaaaaataattagtgaaaactctaatttatatgttatagaaatatatgaaacttt
aaatgaaaattatttagtgttatcaagtagtccaatacaagatgaaaaacttagttatgaagaattagaaaatgaattattaattatgactaatgaattacaaggaggattgttataaatgaatataaataatgttgtggtaagaa
tattagcagaaagaatattaaatggagggttaaaccctttgaaaaatagagagtttcaacttgatgatgtaactaacacagaatacagaaaagcagtagaggattatattataaaaaatagtggagtagtagaaggaatagaa
ccaacagcgtag 
Flanking 
region 2 
atgatttatttaggaaattttatggagacagatgaacaaaatataaaatatattgggatgatacactataaaccaactttactatcagaagaagagttaaaaaatggaattttaattgagaaattgccagtacaacaatatgtaga
aaataaagaagcaaagttatttataaatatagatactaaagaggttttctatagatatacagatattaaaagtagcatagaagataaagtaaattctacagaacaaacaatagcagatttaacatttcaattaatgagtaatggg
gtgatatagatgaattggtataagataataacagatttctataataatggtaattggactaaagagcaagttaaaacagcggttacaaagaataagataacagcaagtgaatataaagaaattgtaagagaggactatatagc
gtagatgaacgtaacaatagtttttttagcaacaaatatatttataaaattagtaatattagcaatagcatttgatacactgttaggttgcttaagagcaataaaaacacatcagtttaatagctcttttggaataaatggaggaata
agaaaagtagcaatgatagcatgtatattttttctagcagtagttgacattcttacaaagtttaactttttatttatgttaccacaagattgggttgattttttgcgattaaatcatcttggaatatctgaatttttctctattttatttattc
tatatgaaagtgtaagtatattaaaaaacatgtatttgtgtgggttaccagtacctagaaaattaaaagatagaataggtagtttattagatactatgacagatgaattaaatgttaaaggaggtagtaaataaatgaaaatatgt
ataacagtaggacacagcattttaaaaagcggggcatgtacttctgctaatggagtagttaacgagtatcaatacaataaatctcttgcaccagtattagcagatacttttagaaaagaaggtcataaggcagatgtaataatat
gccccgaa 
Gene 
targeted for 
replacement 
agagttagttaataaagttagaaatcttgtattagaagcaaagaatgtaactatagaagatacagagaataactttacaagtgataatgtagaaggagcattaaaagaggtttttcaaaatggagttaatgctaaaaataatgta
gtaacagcattaaactccaagggagcagaggttactacaagcgatacatgggaagaaataaagaataaaattgatataaaagaggggagattagatttaagagaaacaatacttgcaaatagttattcttcatatttggttaca
aatggtgctataaaatatattgaaaaatatagtgggagtttaaaagcattagaatatgaagaaccctatttttatgcaattaaaggtacacatttaattaaaattaatgcaattgatgaatctgtaatttttgatattactttagccaa
tgctaacttctcatgtatctgtgttactcaagagtatttatttatatctgacaatactaaattatataaaataaataagttaacaggaaatgaagcacagtcaatagaaggttcttattataagctatgtacttatggggaatttattta
tggaatatatggagatgagacttcttcaatacttcacaaaataagaatatcggatatgtatataatgctaactaaagatatgtcctctgatagaatttatgactttgaaagaggcaaatttgtatgtaataataatggtatttatgct
acaacagaacactcaaattcaagtggtcttacagaatgttacctaactaaaataaattttgattttagtgttgcgaaaagttttagaattggaggatatttatatgaaaaaaacattaagtttttaaatgattttgtttttgtatctgat
agtggcagaagcatagaagttgagagtggtaaaaaaagtggattagcaaaatatgatgcaaatctaaatttgattacttatggtgggtcagatagatatgaaaattttgaaatatataatggatatatatatacatttaattcactt
tctagtagcccatttataaaaataaatttaaatactcttaaagaagttaatagctaccgaacgctcattaacacaaatcctcaaaaaggtatgtttataataaacaatataattttttttattggtggtggcattcacagaaatatatt
atcaaaaaaggtttattcagatgaaaa 
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Table 9.11 DNA sequences of flanking regions for the hypothetical protein 4 of phage T6ɸF2 that was targeted for replacement with luxAB genes.  
 Sequence  
Flanking 
region 1 
aatgagggagttaaacagatgtacaaacatacaatcatttatgatggagaagttgacaaaatccctgcaactgttgttggatggggttataatgatgggaaaatattaatatgtgatataaaagattatgtacctggccagacac
aaaatctttatgttgttggtggtggagcatgtgaaaagataagttctattactaaagaaaaatttattatgataaaaggtaatgatagatttgatacactttataaagcattggattttattaatagatagataaaagttatcaacta
gaagtggttgtttgttgtgataactctattattgtaatataatgtaaatatattattgtgataatggaggatttatgtatggatgcattggtttatgagagatttgtaagagcagcttttagtattaaacttaataacttgattaatagaa
gcgaagatttaggtggattggctgaagctgatatctttagagcagcaaataatttacatgaattaaatgagataaaaataggtactgggtatgctattgcaatatttaataatgagatattagagtcttgtaatgtttctgataatga
tagcaatagaatgattgaactatttgatagaagtttaattgcaacttctagggaggaaatattggatattataagagaatatgaaacttatagaggacgatatcttacttttaattggaagagatagaatgtttaagttaggaagta
gtaattatagttagttattactttctttcacatatttttattatttcaataagattatttccaaataataatttattcaatgataataagtagaaaataaaattttgaatcaatataaaatttaatgaaatgaggtagtaaaatcatggat
aaaaaaatagacatagcgaagtttatagtaaatagaattgattactatattgaaaaatcagataataaagctagttttttactattattaaatagcgcaattataggttttttattttcagggaaggaaaaaataatgaatcactta
agtataagtaatatcagatgtttagagatgctattttacattgttatattatgtatatttgttatttcaatttatttttcgattatggttttaaagccaaggaattctaaaatagaaaatgaatataaatctattttttattataaagagat
agcatctttaaataatgaacagtacaaagaagcatttgaaaatgcatttaaagacgaagaaaacttgattaatgatgcacttgttcaaataaaagaattatctttaatctgtgataagaaaatgtataatgtaaaaaagtcagta
gaagcttttattttaggtggtattatattgtttatatatatacttgtagtagtttttaatgctatttagaaaatgttttatttg 
Flanking 
region 2 
atggatttcaaaatcagagagctaattaatgatataacccaagatattatccaaacatacaaaatccaaattccaatagtaaatataaatcaagttgttgatgctttaggaggcaaggtaatagaagatagttctttaagtggata
ctctgatggatttattagaaaagttgatgattcatttgaaatagtggtatctccttatcaaccagataccagaaagaattttaccattgctcatgaacttggacatttatttttacacatgggttatggcattgatgatgaactatggaa
tagtcaagatggaaatcagtattttagaagtggcaataccaataaggagtatcaatccaatgaatttgcagcagccttgttgatgcctaaacatgaatataaaagaattatggatgaaaacacagtaggtaataaggtcgacact
tcaaaaattgcagaatactttaatgtttcctcttatgcagcatctaatagagggaaatggttaggatatttacaatggtagatgactaagactatattatgtgattactgtaataaaggaataaataaagatgataataagtatatt
acttttcataagaaaagtcatatgaaaactaacatttgtattaattgtgcattaaatttgatagataaagataaattaaatgaaaatattataaataatcaacatgattattcaaagaaatgattgaaagaagaaatattagtaga
aaaattattaagagcagaattaatagtaatggagtatttatggaaaaaagattctctagtgactaaaaaagaaattgtaaaagaaatgagacaggtttatggatggcataaaagtacaataaaaatactactaaaaaggctagt
tgacaaaggttatttggccagagatattataaagtttcaatctcattataaaataataatagataacaaagaatattatgcttttaagaaaaaagtgttaaaatctagcaaaagcagaaaaataatgcgttctcttactactacac
ataagtctataagtaaagaaaaactagacgcattagaagaatattatagaaatttagaagaataa 
Gene 
targeted for 
replacement 
atggatttcaaaatcagagagctaattaatgatataacccaagatattatccaaacatacaaaatccaaattccaatagtaaatataaatcaagttgttgatgctttaggaggcaaggtaatagaagatagttctttaagtggata
ctctgatggatttattagaaaagttgatgattcatttgaaatagtggtatctccttatcaaccagataccagaaagaattttaccattgctcatgaacttggacatttatttttacacatgggttatggcattgatgatgaactatggaa
tagtcaagatggaaatcagtattttagaagtggcaataccaataaggagtatcaatccaatgaatttgcagcagccttgttgatgcctaaacatgaatataaaagaattatggatgaaaacacagtaggtaataaggtcgacact
tcaaaaattgcagaatactttaatgtttcctcttatgcagcatctaatagagggaaatggttaggatatttacaatggtagatgactaagactatattatgtgattactgtaataaaggaataaataaagatgataataagtatatt
acttttcataagaaaagtcatatgaaaactaacatttgtattaattgtgcattaaatttgatagataaagataaattaaatgaaaatattataaataatcaacatgattattcaaagaaatgattgaaagaagaaatattagtaga
aaaattattaagagcagaattaatagtaatggagtatttatggaaaaaagattctctagtgactaaaaaagaaattgtaaaagaaatgagacaggtttatggatggcataaaagtacaataaaaatactactaaaaaggctagt
tgacaaaggttatttggccagagatattataaagtttcaatctcattataaaataataatagataacaaagaatattatgcttttaagaaaaaagtgttaaaatctagcaaaagcagaaaaataatgcgttctcttactactacac
ataagtctataagtaaagaaaaactagacgcattagaagaatattatagaaatttagaagaataa  
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Table 9.12 DNA sequences of flanking regions for the hypothetical protein 5 of phage T6ɸF2 that was targeted for replacement with luxAB genes.  
 Sequence  
Flanking 
region 1 
atgaaaagtttaactatagtaagaaatgcagtagagcaacaactaaatagagctaatttagaaataaataaaaatgaggaactttatacaaaacttagaaaaaaagaaaaaagagatgtattagatgaaatagagttaagta
atgctttaagagaaaaaagtgtaaatgaaagattaaaaatatttgctgagtcattactagaaattatagatacacaaatcgaaataaaagaatatgaagaaagtgaggattacaagatatttcaattaatttcagaagaacttg
aaagagatagacctatagatgttcagatataaatgaaaacaaaaaatgaaataattaaggatttagaagatagattatttttattaagatttacaacagtagatgaagtagattgggatgtaaaatttggacaaatatcagcatt
agaatcttgcatagataaacatagaaaaggatggactttggaacaattcaaagagcatttagaaaagcacaaatcagaaaatatgtatggagattatatagatggctttatgtcagttttaagaagaaatataaaggatatgga
ggggttggaaaatgaataaatgaataataaagctttagaattagcaacatgtactttagaatcgggtcaaatacttgattacatgacagtaaagaattacttagtaagtggaaatggaaatgtaacagaccaagaagtgttaatg
tttatagaattatgtaaggctcaaaaactaaatccattcataaaagaagcatatttgataaaatttggtaattcaccagcaaatatagtagttggtaaagatgtatttgtaaaaagagcaaataaaaatcctaactttgagggtat
gaaagcaggaatagtaactgtaaataaaaatggagaagtatttgaaagggagggcagtttaaagctaccacaagaagaattaatcggtggatggtgtgaagtatcagttagaggaatgaagtttcctataaagtctgtagtgtc
tttagaagagtattcaaagagccaagctacttggaagcaaatgccttgtgtgatgataagaaaatgtgctattgttacagctttaagagaagcattcccagaagatttacaaggattatatgatagtgcagaaataaagactgtac
ccgataaattatctcaaaagcctattgaaataggtaaggcaagtccatcacaaaaacaaggaatacttaagttagcatcaatgaaaggtttatatgattatgagaataaaaaagatacatcaaagctagaggaattttgtgaga
gtaatggatttgatttaaaagaactaaaatttgaggaagtagatgaattaattgaattactaagtgaatatgaaccaaaagatgattttatagatgctgagtttgaagaggtgaaagaggatgaagttgaagtaagagaagaag
ctgaaaatatagattgccaaataagtatggaagaagctataaatgttgattaa 
Flanking 
region 2 
atggggagaatatacgcacagaaaagtggttctttaaatgaacaagatagattggaattgttaagattacttgggaaagctggatatacagtaaagattggtagagagaaacaaaatagtaagacaacttatacttactttgttg
agtatacagaagagcaggaagaaaaatagatgaatacaataactttagttggaagattagttgcagatgcagaattgaagtaccttccaaattcgggtactccaaaaataaccttttcaatggcagtagatagaaggtttaaag
ataaaaatggaaataaaataactgattttattcaatgtgagcaattaggaaaacatgtagagaatttagtgcaatatcttgttaaaggtaaacctatatatgctgttggagagttaaatatatataattacaaagatgaaaatggtt
gctgggaatctattactaaggttaatgtaaatgctttagaactactttctagtaaaaatgataataatgctaaacaagaatatgtaccaccaggactggacccacaaggttttcaagcaatagatgatgacgatatacctttttaaa
tgcaatattacttcctaggagttaaaatattggagggatggaaaatggaagaagagtatagaaaattttttttagagcgtaatggtgagaaaattgagatggtacaaaattgcgaaggagcaataaaaataagcttaaataata
taaaaacagataattcgcatagaccttggaatttaaaggcagaaggaacagctacagtgacgctatatctaggtaaactgctttttgaagaaatgctgtggcttaaaatattgtatttattagaagttatagcagaaaaaatgatg
atgggggtattaggaatgataataattagaagtcaaaataaattagatttaatgagagttaatagagttgaaatagatagtagatatgtatatgcagtgtttgaaggtgaatcaaatgttagagaaataggtaggtataaatcag
aagaaagagctattgaagtattaaacagaatacaggaggctattattgcaggaactaagtttgacattataaataaagacggggttagatgcaacaaagaaaaagtgtttgaaatgccagttgaataa 
Gene 
targeted for 
replacement 
ttgaaatatacaatattaggatttagtcagaaaaaagcagtagagttagggttaaacacaaaggatttacttatattgagatggtttgtagattttctaggtagtggtaggatggcaagaaaacttattaatgggattgaatactat
tgggttgattattcgggagttattaaggaactaccaattctttatacagagaaacacgatactatttatagagtactcaagaagctagataaaataggaatattagaacatgctactttaaagcaaggtggtacatggagttattac
aaattaggatatagatacatagagttgattagtgatagttatcaacaggtcggaaataaatccgactgctcggaaataaatccgtaccctccggatataaatccgacccaaacggatataaatccggaacgaaaaacccatcta
ctatatccttctactataccttgtaactatactacgcagtcgagtgctgtagtgaataaaaataaaaaaattattgaagaaaaaacacatttaaagctgagtaataatatgcaaaaaaaagtatctgcttgggatgaaaatagact
attaaaagcagtagatatattcatagaaaaaaagggagaagcatttagtttactagaaaaaatttatagagacaatagaaatttcatggataaggatgtagagcaggttaataagaataaatttagaaactttgatgaaaccttt
actcaatacacaactgatgaactagacgaaattattaaaaaaagtcaaaaagttaaattcaaataa 
 
 
